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Abstract 
Engineering Approaches to Control Activity and Selectivity of Enzymes for Multi-Step Catalysis 
Walaa K. Abdallah 
Enzymes are desirable catalysts as they may exhibit high activity, high selectivity, and may 
be easily engineered. Additionally, enzymes can be mass-produced recombinantly making them a 
potentially less expensive option than their organic or inorganic counterparts. As a result, they 
are being used more in industrial applications making their relevance ubiquitous. In this work, 
various engineering approaches were developed to control the activity and selectivity of 
enzymes for multi-step catalysis. Unlike nature, many industrial processes require multiple steps 
to produce the desired product, which is both timely and expensive. Through the use of 
enzymes, biosynthesis can be used to develop efficient multi-step catalytic cascades.  
The majority of this work focused on engineering a hyperthermophilic enzyme from the 
aldo-keto reductase (AKR) superfamily, alcohol dehydrogenase D (AdhD) from Pyrococcus 
furiosus, to develop approaches to control activity and selectivity. As the AKR superfamily 
contains many unifying characteristics, such as a conserved catalytic tetrad, (α/β)8-barrel 
quaternary fold, conserved cofactor binding pocket, and varying substrate loops, the approaches 
developed here can be applied to many enzymes. AKR members participate in a broad range of 
redox reactions, such as those involving aldehydes, hydrocarbons, xenobiotics, and many more, 
and are necessary in physiological processes in all living systems, making these enzymes 
industrially relevant. AdhD in particular can oxidize alcohols or reduce aldehydes/ketones in the 
presence of NAD(P)(H). Furthermore, the tools utilized here are modular and can  be used to 
develop pathways with enzymes from different superfamilies’ to expand their current 
capabilities.  
In our initial engineering efforts, AdhD cofactor selectivity was broadened or reversed 
through site directed mutations or insertions in substrate loop B, on the back side of the cofactor 
binding pocket. To further examine how substrate loops affect cofactor selectivity, allosteric 
control was added to AdhD through the insertion of a calcium-dependent repeat-in-toxin domain 
from Bordetella pertussis. Through the chimeric protein, β-AdhD, we demonstrated that the 
addition of calcium shifts cofactor selectivity in real-time, reminiscent of a protein dimmer. Our 
next focus shifted towards unnatural amino acid incorporation to add an extra level of selectivity 
to AdhD. This was done by merging the properties of AdhD and an organic catalyst, TEMPO, for 
selective alcohol oxidation. We also demonstrated the ability to impart enzymatic selectivity onto 
an organic catalyst. This was done both in solution and in AdhD hydrogels for added functionality. 
The next study focused on increasing catalytic efficiency while retaining AdhD structure by 
engineering the microenvironment of AdhD with supercharged superfolder GFP (sfGFP). The 
complex interplay between salt, pH, and protein charge was studied and it was determined that 
catalysis is a function of protein charge, which can affect apparent local ionic strength. The final 
study focused on utilizing the previous tools examined to engineer substrate channeling in a 
multi-step cascade with hexokinase II (HK2), sfGFP, and glucose-6-phosphate dehydrogenase 
(G6PD). 
In conclusion, we have utilized a myriad of tools to develop engineering approaches 
to regulate AdhD activity and selectivity. These tools were then extended to engineer 
substrate channeling in a three-enzyme system. These approaches are modular and provide a 
foundation for the development of multi-step catalytic cascades.
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Paraphrased versions of the AdhD section in this chapter are from “Extreme makeover: 
engineering the activity of a thermostable alcohol dehydrogenase (AdhD) from Pyrococcus 
furiosus” published in Biotechnology Journal in 2016 in volume 11, issue 12, pages 1483-1497. 
2 
1.1 Protein Engineering for Biomimetic Catalytic Cascades 
DNA is the basis of life and is a preliminary component in protein production where DNA 
is converted to RNA, which is then converted to protein. Proteins are involved in cell production 
and, second to water, are the most abundant component in cells. Proteins with function, enzymes, 
are found in almost every biochemical reaction needed to sustain life [1]. These include redox 
reactions for energy conversion, biosynthesis of metabolites, transcription and translation in genes, 
and transport of molecules, among others [1]. Protein engineering broadly defines the engineering 
of proteins to yield novel properties that were previously not present, primarily through changing 
their structure [1, 2]. This is commonly approached by altering enzyme kinetics through active site 
engineering making these proteins relevant in both industrial and biomedical processes.  
However, a new trend has emerged allowing for the merger between conventional 
engineering approaches, such as internal mutagenesis, and new engineering techniques involving 
microenvironment engineering. This new engineering approach involves changes in an enzymes 
local chemical or physical environment or active site resulting in a difference from the bulk 
environment [1]. Combining these two approaches can result in increasing catalytic rates, substrate 
selectivity, ability of enzymes to work in extreme conditions, and dynamic control allowing 
enzymes to respond to external stimuli [1]. 
The advancement of protein engineering techniques and their unique properties has 
resulted in the emergence of enzymes in all aspects of life such as in household products, 
pharmaceutical production, and energy production [3]. The ability to mass produce recombinant 
proteins and the optimization of related processes has made proteins extremely valuable molecules 
that are worth billions of dollars [4, 5]. In 2014, enzymes were worth $4.2 billion, and their worth 
is expected to increase seven percent from 2015 to 2020 [3]. Since structure and function go hand 
3 
in hand, we must study enzyme structure to understand what is happening on the molecular scale 
to enhance the development of industrially relevant proteins.  
Enzymes, which are biological catalysts, have several advantages over inorganic catalysts 
(metals and metal alloy nanoparticles) and organic catalysts. Although metals can be shaped, can 
be controlled using temperature and pressure, and can be used both homogenously and 
heterogeneously, they may lack selectivity [6]. Organic catalysts may work in extreme conditions 
and, like metals, can be used homogeneously or heterogeneously, however some may lack 
substrate specificity [7]. Biological catalysts have the ability to be chemoselective, 
enantioselective, and have substrate and site selectivity [1, 8]. Also their turnover rates (per site) 
can exceed homogenous and heterogenous catalysts [1]. Additionally, systems that solely use 
metals may require extra steps in industrial processes [9]. Overall enzymes have many advantages 
compared to their inorganic and organic counterparts, and their activity, selectivity, and ability to 
be easily engineered has made them desirable industrial catalysts [1]. 
By engineering proteins and utilizing different classes of catalysts we can develop novel 
biocatalysts and through biomimetics, we can use these catalysts to develop multi-step cascades. 
Nature or biosynthesis involves the conversion of reactant A to product D without halting the 
process to remove intermediates [10]. Reactions can proceed with low concentrations of all 
reagents, which decreases the chance of side reactions and unwanted products, resulting in 
maximum selectivity. The products are also recovered in situ, which allows for the recycling of 
energy and redox carriers such as ATP and NAD+, which again increases the throughput of the 
system. The success of these systems results from the inherent selectivity found in nature [10]. To 
mimic nature, we need man-made or organic synthesis that covers two key components: 
compatibility and compartmentalization. This requires the combination of various classes of 
4 
catalysts, selectivity, ability to work in a standard set of conditions, in situ product removal, 
techniques to screen products, and flexibility [10].  
To develop these systems, we generated a toolbox of engineering approaches to alter 
enzymatic structure and function. This was done through site-directed mutagenesis to retain 
protein structure, domain insertion which allowed for dynamic external control, the addition of 
unnatural amino acids to introduce new functionality and develop biological and organic catalytic 
hybrids, and the modification of enzyme microenvironments to alter activity and enable substrate 
channeling. 
The model enzyme we chose to generate a toolbox for developing multi-step cascades was 
thermostable alcohol dehydrogenase D (AdhD) from deep thermal sea vent archaea Pyrococcus 
furiosus. AdhD is monomeric, extremely thermostable, can withstand most chemical denaturation, 
and catalyzes many redox reactions [11]. It is also able to catalyze reactions in a wide pH range 
and is enantioselective. The Banta Lab has extensively engineered AdhD for over a decade making 
it a well-characterized enzyme while its ease of expression and purification makes it a great 
potential candidate for industrial applications.  
In this thesis work, we altered the cofactor selectivity of AdhD through site-directed 
mutagenesis (chapter 2) and allowed for external regulation of this selectivity via domain insertion 
with an intrinsically disordered protein (chapter 3). We also developed biological-organic catalytic 
hybrids with AdhD and TEMPO to selectively oxidize alcohols and impart enzyme selectivity onto 
an organic catalyst both in solution and in hydrogels (chapter 4). Furthermore, we altered the 
microenvironment of AdhD using a superfolder green fluorescent protein scaffold (sfGFP) 
(chapter 5). We used the tools we learned from chapters 2-5 to engineer substrate channeling in a 
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three-enzyme system with hexokinase II, glucose-6-phosphate-dehydrogenase, and a sfGFP 
scaffold (chapter 6). 
1.2 Alcohol Dehydrogenase D (AdhD) 
Alcohol dehydrogenase D (AdhD) is a thermostable protein from Pyrococcus furiosus 
(archaea from deep thermal sea vents). Its physiological role is unknown, but its gene is located 
next to the wor4 gene in P. furiosus. Wor4 is an aldehyde reductase, so it is presumed that AdhD 
is involved in the consumption or production of aldehydes/ketones from wor4 [12]. AdhD is a 
member of the aldo-keto reductase (AKR) superfamily, which catalyzes redox reactions. This 
superfamily has broad substrate specificity, which is used to participate in the detoxification of 
drugs and xenobiotics. This family of enzymes can synthesize and degrade intermediate 
metabolites including aldehydes, ketones, hydroxysteroids, prostaglandins, biotoxins, and 
glycosylated products [13]. Shared properties in this superfamily include the (α/β)8-barrel, which 
consists of eight beta sheets surrounded by eight alpha helices, a conserved cofactor binding 
pocket, conserved catalytic tetrad, and three substrate binding loops with different lengths and 
composition. This superfamily is subdivided into 14 families based on their amino acid sequences, 
with alcohol dehydrogenases in the ninth class [13]. Alcohol dehydrogenases can be further 
subdivided based on their cofactor specificity. These groups include enzymes that are dependent 
on: NAD(P); pyrrolo-quinoline quinone, heme, or cofactor F420; and flavin adenine dinucleotide 
[12]. AdhD falls into the first category, but is a unique alcohol dehydrogenase because it is 
monomeric, with a molecular weight of around 32 kDa, and does not require a metal ion for 
catalysis [11]. 
AdhD is an ideal catalyst because of its extreme thermostability which allows it to withstand 
detrimental effects upon protein engineering approaches. Studies have shown that mutations can 
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destabilize enzymes, meaning the more stable the initial scaffold, the more changes it can accept. 
Also, thermostable enzymes are more resistant to denaturation, they can work at higher 
temperatures which makes their purification easier and their chance of getting contaminated lower, 
increases their reaction rates, and decreases the diffusional and mass transfer constraints. 
Thermophilic enzymes (compared to mesophilic enzymes) can also work well in various organic 
solvents, have higher substrate solubilities, and overall, can be used for longer periods of time in 
various operations [11]. 
AdhD follows an ordered bi-bi mechanism with the cofactor binding first, followed by the 
binding of the substrate, this is proceeded by the release of the substrate followed by the cofactor. 
The cofactor binds in a cleft at the C-terminal region of the protein. The binding of the cofactor 
results in the structural rearrangement of the active site allowing for catalysis [14]. The amino 
acids that interact with the cofactor and make up the cofactor binding pocket include Tyr205, 
Lys249, and His255 (Figure 1.1). The four amino acids, catalytic tetrad, that aid in catalysis by 
transferring hydride ions between the cofactor and substrate include Asp59, Tyr64, Lys90, and 
His122 (Figure 1.1) [12]. Lys90 makes a charged hydrogen bond with the hydroxyl group of 
Tyr64, which makes a salt bridge with Asp59. When a hydrogen bond is formed between Lys90 
and Tyr64, the lone pair of electrons on the oxygen in the hydroxyl group of Tyr64 is delocalized 
which allows for the lowering of its pKa. This results in a pKa similar to that of the carbonyl group 
on the substrate, which starts catalysis. His122 is responsible for the binding and orientation of the 
substrate which gives the enzyme its substrate specificity and stereochemical selectivity [15]. 
Many members of the AKR superfamily are thought be active because of a “push-pull” mechanism 
[16]. His122 wants the reaction to proceed towards reduction by facilitating proton donation of 
Tyr64 while Lys90 wants the reaction to proceed towards oxidation by Tyr64 acting as a base and 
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accepting electrons from the substrate. However, in some members of the AKR family, the tyrosine 
and histidine are too far apart for this “push-pull” mechanism to occur. Therefore, although AdhD 
has the catalytic tetrad, it is unclear if it follows this push-pull mechanism. 
Figure 1.1 Homology model of AdhD.  Catalytic tetrad in yellow, residues comprising the 
cofactor binding pocket in purple, 2,3-butanediol in red, and NADP+ in blue [11]. 
AdhD works well with medium carbon chain lengths and prefers secondary alcohols over 
primary with its preferred substrate being 2,3-butanediol (acetoin in the reductive direction). Its 
preferred cofactor is NAD(H) and its optimum pH is 8.8 for alcohol oxidation and 6.1 for 
aldehyde/ketone reduction [12]. The Banta Lab has worked extensively with this enzyme to alter 
its cofactor specificity [17], introduce additional functionality [18], control cofactor and substrate 
selectivity [19], and to develop biofuel cells [20]. 
Here, extensive work has been done to develop tools and approaches to engineer AdhD to 
develop biomimetic multi-step cascades. Work involving AdhD will be addressed in chapters 2-5. 
1.3 Methods to Control Cofactor Selectivity 
Two predominant redox cofactors found in many biological systems include the nicotinamide 
nucleotides, nicotinamide adenine dinucleotide (NAD+) and nicotinamide adenine dinucleotide 
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phosphate (NADP+), as well as their reduced forms NADH and NADPH. The structural difference 
between NAD+ and NADP+ is the phosphate group attached to the adenosine ribose moiety in 
NADP+. In terms of function, both NAD+ and NADP+ have similar redox potentials but play 
different roles in the cell. NAD(H) is involved in catabolic reactions, while NADP(H) is involved 
in anabolic reactions [21]. Additionally, the oxidation of NADH results in ATP in aerobic 
organisms, while NADPH is used in reductive biosynthesis [22].  
AdhD uses both NAD(H) and NADP(H), with a preference for NAD(H). When these 
cofactors bind AdhD, the nicotinamide and adenosine ring bind in an anti-conformation compared 
to the pyrophosphate. The adenosine sticks outside of the barrel between β-strands 7 and 8 and α-
helices 7 and 8. The nicotinamide sits in a cavity leading towards the center of the barrel with the 
pyrophosphate group in a tunnel between the nicotinamide and the adenosine. For hydride transfer 
to occur, the nicotinamide needs to be orientated with its 4-pro-hydrogen facing upwards and 
directed to the open side of the active site allowing the cofactor to be closer to the substrate. In 
terms of interactions with surrounding residues, Tyr205 is close to the nicotinamide ring allowing 
for a stacking interaction with its benzene ring. In terms of interactions with the pyrophosphate, 
some AKR’S undergo these interactions through the “seatbelt” mechanism where the 
pyrophosphate group is held down through a salt bridge between a lysine and aspartate on one side 
and a lysine on the other [11, 23]. AdhD does not have many positively charged residues in that 
position so the salt bridge is unlikely [11, 19]. However, there may be a cationic-pi interaction 
between tryptophan 27 and lysine 210 that covers the pyrophosphate, which can also function as 
a seat belt [11, 24]. 
Extensive work has been in done in the Banta lab to regulate the cofactor specificity of AdhD, 
which is important as NAD+ is more stable and cheaper than NADP+. Additionally, being able to 
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selectivity regulate activity can prove useful in multi-step cascades. One of the first engineering 
efforts to control cofactor specificity was done by Scrutton et al. in the 1990’s where work was 
done with glutathione reductase to convert its specificity from NADP+ to NAD+ [22]. Previous 
work in the Banta Lab has altered cofactor specificity by point mutations and grafting substrate 
loops from another member of the AKR superfamily onto AdhD [17, 19]. The results indicated 
that making changes in the cofactor binding pocket or substrate binding loops can affect cofactor 
specificity.  
In this work, two ways to regulate cofactor specificity have been achieved. One way involved 
the insertion of single amino acids or single point mutations distal to the phosphate group of 
NADP+ to broaden/reverse cofactor specificity (chapter 2) [25]. However, this approach did not 
allow for dynamic control. 
A second approach is through domain insertion, which allowed for external dynamic 
regulation of cofactor specificity (chapter 3) [26]. Dynamic regulation is commonly found in 
nature where feedback loops are used to respond to environmental changes without having to wait 
for a change in gene expression [1]. Many engineering approaches have focused on developing 
protein switches which respond to external stimuli allowing for regulation and cellular control. 
This specific thesis work involves allosteric regulation, where the conformational change in one 
protein can affect the other, and can cause a change in the local environment [1]. 
Both methods will be described in-depth in chapters 2 and 3. 
1.4 Expanding the Genetic Code - Unnatural Amino Acid Incorporation 
One way to expand the capabilities of an enzyme is to introduce novel functional groups that 
were previously not present. This can be achieved through unnatural amino acid incorporation. 
There is a myriad of unnatural amino acids with different capabilities that can be used to increase 
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the potential applications of enzymes. Commonly used unnatural amino acids contain functional 
groups such as azides and alkynes, which allows for a selective method of conjugating enzymes. 
There are two ways to incorporate unnatural amino acids: global/residue-specific 
incorporation and site-specific incorporation. Residue-specific incorporation involves the use of 
cells that are auxotroph’s for one canonical amino acid [27]. Supplementing the cells with the 
unnatural amino acid (UAA) analog results in the replacement of the canonical amino acid. In this 
approach, all sites in the protein containing the canonical amino acid are replaced with the UAA. 
If only specific sites are desired, then the remaining positions containing the canonical amino acid 
need to be mutated to an alternate amino acid. The second approach is site-specific incorporation, 
which involves the introduction of an amber stop codon (TAG) at the desired position of unnatural 
amino acid incorporation [27]. This approach limits the incorporation to one single site. There are 
three stop or nonsense codons: UAG (amber), UGA (opal), and UAA (ochre), with the rarest being 
the amber stop codon leading to its use in incorporation [28]. 
When performing site-specific unnatural amino acid incorporation, the cells are provided with 
the unnatural amino acid, which is used to replace the amber stop codon in the gene of interest. 
The orthogonal aminoacyl-tRNA synthetase, an enzyme responsible for attaching an amino acid 
onto its tRNA and is unique to each tRNA, attaches the unnatural amino acid to the orthogonal 
amber suppressor tRNA [29]. This is referred to as nonsense codon suppression and results in 
orthogonal tRNA with the unnatural amino acid [29]. tRNA’s generally do not recognize the amber 
stop codon, therefore an engineered tRNA is used in this process. The ribosome decodes this 
tRNA-unnatural amino acid complex when it recognizes the amber stop codon (UAG) in the gene, 
resulting in the protein being synthesized with the unnatural amino acid [29]. 
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The incorporation of unnatural amino acids into proteins requires the use of two plasmids. The 
first plasmid contains the gene of the target protein with the amber stop codon. The second is the 
helper plasmid containing the tRNA synthetase and amber suppressing tRNA. In this work, two 
aminoacyl-tRNA synthetase/tRNA pairs are used: pDule2 pCNF and pULTRA pCNF, which has 
greater suppression [30, 31]. They both come from archaea Methanocaldococcus jannaschii [32]. 
This system is orthogonal only in bacteria not in eukaryotic cells [29]. Additionally, these plasmids 
can work with azide and alkyne containing unnatural amino acids, such as para-azidophenylalanine 
and o-propargyl-tyrosine (Figure 1.2). These are the two unnatural amino acids used in this thesis 
work. 
Figure 1.2 Structures of unnatural amino acids. (A) para-azidophenylalanine (from Chem-
Impex) (B) o-propargyl-tyrosine (from Psyclo Peptide) 
There has been advancement in numerous areas through the use of unnatural amino acids. The 
Dougherty Lab replaced key residues with unnatural amino acids to study magnesium binding in 
mammalian central nervous systems [33]. The Lewis Lab used it to merge metal and biological 
catalysts by clicking a functional group on the metal to an incorporated functional group on the 
enzyme [34]. This gave the metal selectivity that was previously not present. Unnatural amino 
acids were also used as an NMR probe to study structure and activity [35]. These are just a few of 
many examples of unnatural amino acid applications. In this work, unnatural amino acids were 
(A) (B)
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used to merge organic catalysts and enzymes to enable selective alcohol oxidation and to impart 
enzymatic selectivity onto organic catalysts. Essentially, the unnatural amino acids were used as a 
conjugation tool and as a way to expand protein functionality.  
Unnatural amino acid incorporation will be addressed in chapters 4 and 6. 
1.5 Hydrogels for Dual Functionality 
The ability to add extra functions to enzymes was also addressed through the use of hydrogels. 
Hydrogels are polymeric networks that can absorb water, are flexible, and biocompatible [36]. The 
hydrogels used here are made from HSH, a triblock forming polypeptide which is composed of 
two alpha helical leucine zipper domains (H) separated by a random domain (S) [37, 38]. 
Hydrogels form when the leucine zipper domains cross-link through protein-protein interactions 
resulting in a supramolecular hydrogel [37, 39]. The cross-linking is based on various interactions 
and is reversible based on pH making these hydrogels physical gels [36, 40]. It was observed that 
as the pH increases, the leucine zippers lose their alpha helical structure [40].   
 The leucine zippers found in HSH are formed through the helical wheel (Figure 1.3) [41]. 
The hydrophobic plane along the helix (residues a and d) is composed of leucine, isoleucine, or 
valine with leucine being predominant (hence the name). Due to the hydrophobic effect, a and d 
are buried in the core during the formation of the coiled coil. The remainder of the residues are 
charged (e and g) or neutral (b, c, and f). The backbone is made of alpha helices with a & g and d 
& e making the rungs [41]. The porosity can be controlled by varying the length and position of 
the S domain and there must be at least two H domains per monomer to cross-link [18, 39]. 
13 
Figure 1.3 Alpha helical leucine heptad.  Hydrophobic resides in red, charged residues in 
yellow, and neutral residues in blue.  
Previous work in the Banta Lab focused on developing chimeric enzymes with hydrogels [18]. 
AdhD in particular was fused to a hydrogel, resulting in HS-AdhD-H, an enzyme that had the 
ability to oxidize alcohols while forming hydrogels [18]. In this work, HSH, HS-AdhD-H, and 
HSH with an unnatural amino acid were combined to form hydrogels. The hydrogel containing 
unnatural amino acid has the ability to be clicked to an alkyne-containing organic catalyst 
(TEMPO) to introduce selectivity of alcohol oxidation (with AdhD and TEMPO) along with 
hydrogel formation. 
Hydrogels as a network are important as they are biocompatible and can be used in the 
development of numerous products. They are found in contact lenses, dressings for wounds, drug 
delivery, and much more [36]. 
Hydrogels will be discussed in chapter 4. 
1.6 TEMPO 
TEMPO, (2,2,6,6-tetramethylpiperidin-1-yl)oxyl, is an organic catalyst that has the ability to 
oxidize oxygen, nitrogen, and sulfur-containing functional groups [7]. Although its broad 
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reactivity can be seen as an advantage, TEMPO is known to work in basic pH’s and cannot break 
carbon-carbon bonds. However, one of the advantages of TEMPO is its ability to be modified. 
Previous work has shown that 4-amino-TEMPO (TEMPO-NH2) can oxidize alcohols and 
aldehydes and can work in acidic pH’s [7]. Advancements have also been made to oxidize alcohols 
using TEMPO in the presence of copper at room temperature with air as the oxidant [42]. This set-
up was selective toward primary alcohols and worked with allylic, benzylic, and aliphatic forms. 
This advancement removed the need for pure oxygen and removed the need for protecting groups 
to oxidize primary alcohols over secondary [42]. Additionally, as TEMPO has a high turnover rate 
with various alcohols, it has been used for electro-organic synthesis and for energy conversion 
processes [43]. For example, TEMPO has been used on electrodes to oxidize alcohols to carbonyl 
compounds for industrial applications [44].  
Technically, TEMPO by itself is not a catalyst as it needs to be oxidized for activity, making 
its active form the oxoammonium ion [45, 46]. It has the ability to oxidize primary alcohols and 
in turn it is reduced. Laccase can be used to revert the reduced form back to TEMPO and to convert 
TEMPO to the active form, the oxoammonium ion [46]. TEMPO can also be regenerated to its 
active form with an electrode [45]. 
Since TEMPO can oxidize primary alcohols and AdhD can oxidize secondary alcohols, a 
hybrid of these two catalysts opens up the possibility of selectively oxidizing alcohols. TEMPO 
must be regenerated to maintain activity and AdhD cannot proceed without a cofactor. Therefore, 
the direction the reaction proceeds can also be controlled. To develop these hybrids and to do so 
in a site-selective manner, functional groups are needed. AdhD was incorporated with an azide-
containing unnatural amino acid using the site-specific method previously described and TEMPO 
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was synthesized with an alkyne group. The chemistry required to conjugate the two will be 
described in the next section. 
Although previous work has shown the ability to develop AdhD-TEMPO hybrids, the methods 
used do not allow TEMPO to attach in a site-specific manner [45]. The site-specific hybrids in 
solution and hydrogels developed in this thesis work will be discussed in chapter 4. 
1.7 Conjugation Methods - Click Chemistry, SpyTag/SpyCatcher, 
SnoopTag/SnoopCatcher 
The incorporation of unnatural amino acids containing an azide or alkyne functional group 
adds an extra method for conjugating two entities. Reactions between azides and alkynes were 
studied in the 1800’s by Huisgen, who showed that 1,3-dipolar cycloaddition reactions resulting 
in triazoles were possible [47]. The drawbacks of this reaction involved excessive temperature and 
pressure, which are not feasible in many systems. As a result, advances have been made resulting 
in two main types of “click reactions”: copper-catalyzed and strain-promoted. 
The bioconjugation of azides and terminal alkynes can be completed in the presence of copper 
(I). The copper ligand reacts with the alkyne to form a copper acetylide [48]. The azide and 
acetylide then react forming a 5-triazolyl copper intermediate. The carbon-nitrogen bond occurs 
between the nucleophilic carbon of the acetylide and the electrophilic nitrogen of the azide [49]. 
The addition of copper increases the rate of reaction by seven orders of magnitude compared to 
the Huisgen technique [47]. Additionally, copper allows for the regioselectivity of the reaction 
with only the 1,4-disubstituted 1,2,3-triazole forming [49]. This reaction is referred to as copper-
catalyzed azide-alkyne cycloaddition (CuAAC).  
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The problem with the use of copper is that it can be toxic to living cells. One way to circumvent 
this is to use water soluble ligands. They increase the rate of reaction and are sacrificial reductants, 
protecting the cells and biomolecules from copper [50]. This has been successfully performed with 
sodium ascorbate and tris(3-hydroxypropyltriazoyl-methyl)amine (THPTA) [51]. The click 
reaction requires copper in the +1-oxidation state, but a common way to introduce copper as a 
catalyst for click reactions is through copper sulfate. Sodium ascorbate is a reducing agent that has 
been effective in reducing copper to the cuprous (+1) state. A copper-binding ligand that works 
well with sodium ascorbate is THPTA, which acts as a “sacrificial reductant” to prevent the 
oxidation of the biomolecules. It has been shown that reactive oxygen species can result from the 
reaction and can oxidize amino acids such as histidine, which is why THPTA is needed [51]. 
A second approach to circumvent the effects of copper is a second type of click reaction, 
strain-promoted cycloaddition, which proceeds in the absence of copper. The reaction occurs 
between a cyclooctyne and an azide and proceeds because it releases ring strain [52]. Different 
variations of the cyclooctyne (various functional groups) have all been used successfully, 
especially those with electron withdrawing groups, which increases reaction rates [47]. The 
various groups on the cyclooctyne have been observed to decrease the activation energy for the 
transition states [52]. However, it should be noted that the fastest reaction between a cyclooctyne 
and an azide is around ten times slower than a reaction between a terminal alkyne and an azide 
[50]. Additionally, the products include the 1,4-disubstitued triazole and its regioisomer [47]. Both 
copper-catalyzed and strain-promoted cycloaddition will be described in chapter 4. 
Another tool to combine two enzymes is through a covalent attachment between SpyTag 
peptide and SpyCatcher protein. These peptide tags originate from the fibronectin binding protein 
found in the gram positive bacteria Streptococcus pyogenes, specifically in its adhesion domain 
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(CnaB2), which has an isopeptide bond between Lys31 and Asp117 [53, 54]. When this bond is 
broken with lysine in the N-terminus fragment and aspartic acid in the C-terminus, the fragments 
combine spontaneously to reform that bond [53]. The two halves of this domain were modified 
and renamed SpyTag and SpyCatcher [53]. The formation of the bond can occur in as little as 
minutes and works in various conditions (temperature, pH, buffers) and results in a bond that can 
resist boiling [54]. This reaction will be discussed in chapters 5 and 6. 
A second method of covalent attachment through tags is SnoopTag and SnoopCatcher. These 
are from the RrgA adhesion from the gram-positive bacterium Streptococcus pneumoniae, 
responsible for septicemia, pneumonia, and meningitis [55]. It has been shown that if the D4 Ig-
like domain is split, it can spontaneously re-form a peptide bond between Lys742 and Asn854. 
This domain was split and re-named SnoopTag, which is composed of residues 734-745, and 
SnoopCatcher, which is composed of residues 749-860 [55]. This system is orthogonal to the 
SpyTag/SpyCatcher system and will be discussed in chapter 6. 
1.8 Engineering Protein Microenvironments with sfGFP Scaffolds 
The final goal of this thesis was to alter enzyme kinetics through microenvironment 
engineering. Supercharged superfolder green fluorescent protein (sfGFP) was used as a scaffold 
to alter the microenvironment of AdhD and as a platform for electrostatic guidance. 
The scaffold used here is a modified version of green fluorescent protein (GFP). The source 
is GFP from jellyfish Aequorea Victoria made of 11 β-strands wrapped around a central helix 
(PDB 1EMA) [56]. Folding reporter GFP, which contains the cycle 3 mutations F99S, M153T, 
and V163A, allowed GFP to be grown recombinantly in E. coli at 37 °C and allowed it to fold 
properly thereby resulting in fluorescence [57]. The chromophore consists of Ser65-Tyr66-Gly67 
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[58]. An absorbance scan of cycle 3 GFP shows the presence of a major peak at 397 nm and a 
minor peak at 475 nm, which are the excitation wavelengths [59]. The major peak corresponds to 
the GFP population with a neutral or protonated chromophore. The minor peak corresponds to the 
GFP population that has an anionic or deprotonated chromophore.  
The enhanced GFP mutations, F64L and S65T, increased the fluorescence of GFP. A 
superfolder GFP (sfGFP) variant was made that combined these previous mutations with six new 
ones (PDB 2B3P) [60]. This resulted in a more stable GFP that can be fused to various polypeptides 
while retaining the ability to properly fold and fluoresce through the maturation of its 
chromophore, T65-Y66-G67 [58, 60]. Additionally it was able to allow for circular permutation 
and chemical denaturants making it an ideal starting scaffold [60]. 
As this sfGFP is more stable than its predecessors, the Liu Lab was able to create supercharged 
versions of this variant while increasing its stability [61].  sfGFP has a net charge of -7 so mutations 
within the amino sequence along the surface of the protein were made to develop variants with 
very positive or negative charges. Residues that contributed to more positively charged variants 
included arginine and lysine, while aspartic acid and glutamic acid contributed to the negative 
charge. This resulted in the development of many sfGFP variants, which were done by mutating 
the solvent exposed residues to charged residues [61]. An advantage of charging proteins is less 
protein aggregation. There has been research indicating that there is a relationship between 
solubility and net charge - as proteins develop a net charge, their percent aggregation decreases. 
Protein aggregation is a problem in human disease and is one of the reasons why proteins are not 
commonly used as therapeutic or diagnostic agents [61].  
A spectral scan of sfGFP shows a major peak at 490 nm, corresponding to the anionic 
chromophore, and a minor peak at 390 nm, corresponding to the neutral or protonated 
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chromophore [62]. As the pH decreases, the hydrogen ions in solution allow sfGFP to become 
protonated, increasing the peak at 390 nm and decreasing the peak at 490 nm. This protonation 
quenches the fluorescence because it inhibits proton transfer [62]. The fluorescent properties of 
these supercharged variants were similar to sfGFP. However, when a charged variant and sfGFP 
were boiled and then cooled, sfGFP precipitated out indicating the loss of its fluorescence is 
irreversible, while the charged variants were able to retain some of their fluorescence [61]. These 
charged variants were also able to demonstrate a reversible affinity and subsequent complex with 
molecules of the opposite charge [61]. 
In this work, sfGFP was used to alter the microenvironment of AdhD. There has been 
extensive work done on altering proteins on the nanoscale level to alter their kinetics. More 
recently, the idea of controlling the local chemical and physical environment of proteins has been 
focused on, allowing proteins to retain their structure while enhancing their catalysis [1]. These 
efforts include changing the pH profile, engineering specificity, external regulation, and more, 
which can result in substrate channeling.  
In the first part of this engineering approach, sfGFP was used to alter the local environment 
of AdhD by introducing supercharged sfGFP proteins, while allowing AdhD to retain its structure. 
This technique allows for in vivo and in vitro applications and provides a way to enhance the 
catalytic efficiency of AdhD. This project will be discussed in chapter 5. 
In the final section of this work, previous tools and approaches were used to develop a multi-
step catalytic cascade through substrate channeling with enzymes other than AdhD. Substrate 
channeling allows chemical reaction intermediates to go from one enzyme to another without being 
released into the bulk solution [63]. The problem with channeling arises from the fact that the 
diffusion of the intermediate is usually faster than the catalytic rates of the enzymes [63]. If this 
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issue can be circumvented, substrate channeling can be achieved, which increases both yields and 
efficiencies. Therefore, another definition of channeling involves the ability to increase the kinetics 
of the system [64]. However, it should be noted that the rate of the cascade is limited by the rate-
limiting enzyme [63, 65]. In nature, many enzymes that participate in these channeling reactions 
have active sites positioned so that the mass transport of the reactants is controlled. These 
intermediates are usually sequestered next to the active site, which decreases their exposure to side 
reactions and can protect the cells from intermediates that may be unstable or toxic [63]. If these 
metabolites are sequestered at a high enough concentration, they can also overcome 
thermodynamic limitations in the bulk environment. In nature, channeling occurs via: 
intramolecular tunnels, electrostatic guidance, covalent swing arms, and spatial organization [63]. 
In nature, these “intracellular multienzyme structures” are referred to as metabolons.  
Intramolecular tunnels refer to a hydrophobic tunnel that connects two active sites such as 
those found in tryptophan synthase and bifunctional aldolase-dehydrogenase, among others. In 
tryptophan synthase the two active sites are connected by a 2.5 nm tunnel that essentially results 
in a bifunctional enzyme that can catalyze a two-step reaction [63]. The intermediate rapidly 
diffuses along the tunnel and the protein undergoes a conformational change at the active site. 
Electrostatic guidance refers to the ability of ionic strength to move intermediates along a surface 
of the opposite charge [63]. This results in bounded diffusion allowing the movement of an 
intermediate between two active sites. An example of this includes enzymes involved in the 
tricarboxylic acid (TCA) cycle, malate dehydrogenase and citrate synthase [63]. This mechanism 
of channeling with these enzymes was thoroughly studied in the Banta Lab. It was determined that 
a mutation in the highly conserved positive patch connecting these two enzymes results in a loss 
of substrate channeling [64]. The third method involves the intermediates binding to a swing arm 
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transferring it from one enzyme to another. An example of this includes the multienzyme pyruvate 
dehydrogenase complex, which participates in glycolysis and leads into the TCA cycle. The key 
concept in all methods includes the spatial organization of the enzymes to allow the active sites to 
be oriented appropriately [63]. The challenges that arise when developing these systems 
biomimetically stems from the fact that diffusion is usually faster than the catalytic rate so 
orientating two active sites close to one another is usually not strong enough to result in channeling. 
There are many ways to measure substrate channeling. One way is to measure the transient 
time (Ʈ), which is the time it takes the intermediate to reach steady state [63]. This value is a 
function of the maximum velocity and Michaelis constant of the second enzyme and the reaction 
velocity of the first enzyme in a two-step process [63]. Ideally, the transient time will approach 
zero in a perfect system. The reason for this is that if an intermediate is diffusing from one site to 
the next without any assembly between the two sites, it will require more time to reach its 
destination [64]. This can also be measured by plotting the product concentration as a function of 
time. Once the system reaches steady state, a linear fit can be determined and the point at which 
the concentration equals zero is the transient time [66]. A second method is the isotope dilution 
and enrichment method [63]. Here, if we monitor the reaction of A to B by enzyme 1 (E1) and B 
to C by enzyme 2 (E2), we can measure channeling by adding isotopically labeled A* in the 
presence of B. If the two enzymes sequester the intermediate, then A* should be converted to B* 
by E1 and B* should be converted to C* by E2. However, if the intermediates are not sequestered, 
then B can also be used by E2 to make C. The ratio of the labeled to unlabeled product (C* versus 
C) can be used to determine the degree of substrate channeling. Another method is to add a
competing enzyme to the cascade [63]. If the enzyme can utilize the intermediate, this suggests the 
intermediate is being released into the bulk, signifying leaky or no channeling depending on the 
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extent of the side reaction. A fourth method is to add an inhibitor to the bulk environment that 
inhibits the second enzyme from reacting [63]. Again, if a change in catalytic rate is observed, this 
signifies a decrease in substrate channeling. 
Here,  sfGFP with varying charge was used as a scaffold for substrate channeling between 
recombinant human hexokinase II (HK2) and human glucose-6-phosphate-dehydrogenase (G6PD) 
through electrostatic guidance.  
Hexokinases are responsible for catalyzing sugar phosphorylation (first step of glycolysis) and 
sending signals of glucose levels to the nucleus in a variety of organisms ranging from bacteria to 
mammals [67]. Glycolysis occurs in the cytosol in eukaryotic cells, making this a cytosolic protein. 
Additionally, studies have shown that hexokinase found in the mitochondria is involved in 
controlling apoptosis in mammals. This is significant as glucose metabolism is one of the main 
pathways used by all organisms to make energy in the form of ATP. Hexokinases in humans can 
be divided into four different types based on their kinetics and where they are in tissues. 
Interestingly, the amino acid sequence within each type of hexokinase is very similar between 
different organisms [67]. The three types of isozymes are referred to as type I, II, III and IV, with 
IV commonly referred to as glucokinase. The first three are approximately 100 kDa. They all 
contain a similar amino acid distribution in their N and C terminal halves, which suggests a 
duplication and fusion of a 50 kDa protein, presumably hexokinase IV, which corresponds to the 
correct molecular weight. This work focuses on hexokinase type II from humans, which is 
approximately 100 kDa and contains both an N and C domain with catalytic activity [67].  
Glucose-6-phosphate-dehydrogenase (G6PD) is an enzyme that participates in the first step of 
the pentose phosphate pathway, which aids in biosynthesis, prevents against oxidative stress, 
provides pentoses, and produces NADPH, which is the reducing power of the cell [68]. Here, work 
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is being done with human G6PD, which studies have shown has a catalytic and structural NADP+ 
site [69]. The structural site is required for the stability and refolding of the enzyme [69]. One of 
the main goals of G6PD is the production of NADPH. G6PD takes D-glucose-6-phosphate along 
with magnesium chloride and NADP+ to produce 6-phospho-D-gluconate and NADPH. 
Here we are monitoring the conversion of ATP and glucose to glucose-6-phosphate and ADP 
by HK2, followed by the conversion of glucose-6-phosphate and NADP+ by G6PD to 6-phospho-
gluconolactone and NADPH [70]. The intermediate, glucose-6-phosphate is negatively charged 
and therefore, should be guided along a positive patch. Previous work has shown that connecting 
HK2 and G6PD with a cationic peptide bridge (lysine residues) helped facilitate substrate 
channeling through electrostatic guidance as the intermediate, glucose-6-phosphate, is negatively 
charged [70]. In this thesis work, channeling was tested by fusing HK2 and G6PD to -30, 0, and 
+36 sfGFP to determine the extent of substrate channeling. This work will be addressed in chapter
6. 
The following are the specific aims of this thesis: 
In chapter 2, we address the cofactor specificity of AdhD. We identified a position distal 
to the cofactor binding pocket of AdhD that alters cofactor specificity with a single point mutation 
or insertion. This demonstrates that amino acids involved in substrate interactions can also affect 
cofactor specificity. This approach should be applicable to other members of the AKR superfamily. 
In chapter 3, we further examine the effect of insertions in AdhD and how this affects 
cofactor selectivity. This was done by domain insertion where an RTX domain from the adenylate 
cyclase of Bordetella Pertussis was inserted into substrate loop A of AdhD. Once again, we show 
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that cofactor specificity is affected. Additionally, the insertion allowed for dynamic regulation of 
cofactor specificity with calcium. 
In chapter 4, we continue working with AdhD to expand its catalytic properties by 
introducing a functionalized unnatural amino acid for click chemistry. The reaction between azide-
AdhD and alkyne-TEMPO results in an organic/enzyme catalytic hybrid. This hybrid allows for 
the selective oxidation of alcohols. This work was extended to hydrogels, by incorporating HSH, 
and to AdhD mutants with substrate loops from human aldose reductase to modify substrate and 
cofactor selectivity. 
In chapter 5, we alter the microenvironment of AdhD by using sfGFP to enhance catalysis. 
Fusions of AdhD with supercharged sfGFP demonstrate the ability to alter the local environment 
of AdhD while allowing AdhD to retain its structure. 
The tools and engineering approaches from chapters 2-5, which focused on AdhD, were 
used in chapter 6 to develop a multi-step cascade with sfGFP acting as the scaffold for electrostatic 
guidance between HK2 and G6PD. 
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Chapter 2 
Engineering the cofactor specificity of an alcohol 
dehydrogenase via single mutations or insertions 
distal to the 2’-phosphate group of NADP(H) 
Project Collaborators: Walaa Abdallah, Kusum Solanki, and Scott Banta 
A version of this chapter entitled “Engineering the cofactor specificity of an alcohol 
dehydrogenase via single mutations or insertions distal to the 2’-phosphate group of NADP(H)” 
was published in Protein Engineering, Design & Selection in 2017 in volume 30, issue 5, pages 
373-380. WA was responsible for helping with protein characterization, including enzyme
kinetics and circular dichroism studies.
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2.1 Abstract 
There have been many reports exploring the engineering of the cofactor specificity of aldo-
keto reductases (AKRs), as this class of proteins is ubiquitous and exhibits many useful activities. 
A common approach is the mutagenesis of amino acids involved in interactions with the 2’-
phosphate group of NADP(H) in the cofactor binding pocket. We recently performed a “loop-
grafting” approach to engineer the substrate specificity of the thermostable alcohol dehydrogenase 
D (AdhD) from Pyrococcus furiosus and we found that a loop insertion after residue 211, which 
is on the back side of the cofactor binding pocket, could also alter cofactor specificity.  Here we 
further explore this approach by introducing single point mutations and single amino acid 
insertions at the loop insertion site. Six different mutants of AdhD were created by either 
converting glycine 211 to cysteine or serine or by inserting alanine, serine, glycine or cysteine 
between the 211 and 212 residues. Several mutants gained activity with NADP+ above the wild-
type enzyme. And remarkably, it was found that all of the mutants investigated resulted in some 
degree of reversal of cofactor specificity in the oxidative direction. These changes were generally 
a result of changes in conformations of the ternary enzyme/cofactor/substrate complexes as 
opposed to changes in affinities or binding energies of the cofactors. This study highlights the role 
that amino acids which are distal to the cofactor binding pocket but are involved in substrate 
interactions can influence cofactor specificity in AdhD, and this strategy should translate to other 
AKR family members.   
2.2 Introduction 
The aldo-keto reductase (AKR) superfamily is comprised of over 100 oxidoreductases with 
importance in both health and industrial applications [23]. They are found in all organisms and 
play an important role in many physiological processes. All AKRs share a common (α/β) 8-barrel 
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(also known as triphosphate isomerase motif (TIM barrel)) three-dimensional structural motif and 
they utilize NAD(P)(H) as a cofactor. The active sites of the AKRs bind the cofactor in an extended 
conformation within a cleft that runs through the carboxy-terminal face of barrel, which is unlike 
other nicotinamide-dependent dehydrogenases that contain the Rossman-fold motif.  
The AKRs are generally categorized into three classes. Class I is the most studied and 
includes mammalian AKRs, which catalyze steroid and prostaglandin metabolism [71, 72]. 
Members belonging to this class have long substrate binding loops, which confer specific substrate 
specificity to AKRs. Class II comprises aldo reductases (ARs), which catalyze interconversion of 
glucose to sorbitol and have been studied as drug targets for the treatment of diabetes [73]. Class 
III AKRs are not yet assigned specific functions, but they have truncated substrate binding loops 
[74]. One of the enzymes belonging to Class III is the alcohol dehydrogenase D (AdhD) from the 
hyperthermophilic archaea Pyrococcus furiosus (Figure 2.1). This reversible enzyme has been 
well-characterized by our group and others [12] and we have been engineering various aspects of 
AdhD for several years [11].   
Engineering of the cofactor specificity of dehydrogenases has been of interest not only to 
understand the properties of the cofactor binding site, but also to redesign enzymes for various 
applications. The only difference between NAD(H) and NADP(H) is the 2’-monophosphate group 
attached to the ribose ring of the adenine moiety. The cofactor specificity of an AKR is thought to 
be determined by the presence of favorable interactions between the 2’-monophosphate group of 
NADP(H) and amino acids in the cofactor binding pocket. Generally, alteration in cofactor 
specificity can be achieved by systematic site directed mutagenesis of the side chains interacting 
with the 2’-phosphate group of NADP(H) and investigating the effect of mutations on cofactor 
specificity [75-80]. For example, Banta et al. made site-directed mutations at every amino acid 
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that interacted with the 2’-phosphate group in the 2,5-diketo-D-gluconic acid reductase (2,5-
DKGR) from Corynebacterium, and mutants were identified with cofactor specificity broadening 
such that mutants with NAD(H) were more active than wild-type with NADP(H) [76, 81]. 
Computational strategies for altering enzymes for cofactor preference have also been explored [82-
84]. Xia et al. (2013) utilized a molecular simulations approach to construct a 3D-structure model 
of xylose reductase to obtain favorable binding modes for both cofactors NAD+ and NADP+ based 
on hydrophobic and hydrophilic interactions. Others have used in silico approaches to calculate 
cofactor binding energy approximations and strength of hydrogen bond interactions to predict the 
relative affinity of an enzyme for the cofactor [82, 84]. All these reports, whether computational 
or experimental, utilize direct interactions (i.e. electrostatic, hydrophilic, hydrophobic, hydrogen 
bonding or steric) to stabilize or destabilize the 2’-phosphate group of NADP(H) in the cofactor 
binding pocket. We have also used this approach to engineer the cofactor specificity of AdhD, 
which has a natural preference for NAD(H) especially in the reductive direction. Lys249 and 
His255, which bind to the 2’-phosphate of NADP(H), were mutated to Gly and Arg respectively 
leading to cofactor specificity broadening with increased activity with both cofactors in the 
reductive direction [17] (Figure 2.1B). 
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Figure 2.1 Homology model of AdhD.  (A) Wild-type AdhD with loops A, B and C indicated. 
Homology models of cofactor binding pocket of (B) double mutant K249G/H255R (C) mutant 
G211S and (D) mutant G211InsS with bound NADP+. The NADP+ backbone is shown as blue 
sticks or spheres and the 2’monophosphate group is highlighted in magenta. Cofactor interacting 
residues, His 255 and Lys249, are shown as red sticks and labeled. Also, Glycine 211 is shown 
as red sticks and mutations are depicted in yellow.   
There have also been a few reports of engineering cofactor specificity of various oxo-
reductases by making mutations distal to the 2’-phosphate group of NADP(H) [85, 86]. Cahn et 
al. (2016) demonstrated that cofactor specificity of various NAD(P)H dependent enzymes can be 
altered by mutating amino acids distal to 2’ position of ribose, located within 5 Å of the N6 atom 
of NAD(P)(H) adenine. They have shown that single mutations at distal positions were beneficial 
for changing cofactor specificity in several enzymes with Rossmann and DHQS folds, but this 
approach did not work with the TIM barrel fold found in the AKRs.   
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Substrate specificity in the AKRs is imparted by three mobile loops A, B and C located at 
the top of the (α/β)8-barrel structure. Sequence alignments between Class I mesophilic AKRs and 
Class III thermophilic AdhD indicated that they differ at the substrate loops A, B and C (Figure 
2.1A). Loops A and B are significantly truncated in AdhD while loop C is absent. We recently 
reported the grafting of loops from mesophilic human aldose reductase (hAR, Class I) onto the 
AdhD core protein and this led to the grafting of hAR activity into the AdhD scaffold. And 
surprisingly, this loop-grafting approach led to a loss of NAD+-dependent activity while retaining 
NADP+-dependent activity in two mutants. Thus the grafted loops led to a significant change in 
cofactor specificity  in the oxidative direction as compared to the wild-type enzyme [19]. The most 
active mutants were then combined with the previously identified K249G/H255R cofactor 
specificity mutations (which interact with the 2’-phosphate group of NADP(H)) and surprisingly 
the impacts were not additive as these combined mutations inactivated the enzyme (Figure 2.1B).  
This led to the conclusion that there were two orthogonal pathways to altering cofactor specificity 
in AdhD – alter interactions with the 2’-phosphate of NADP(H) or insert new amino acids in a 
loop on the substrate binding site distal to the cofactor binding pocket to reduce NAD+-dependent 
activity [19].   
Based on this prior work, here we have investigated the minimal mutations or insertions 
required for altering the cofactor specificity in the oxidative direction at the loop B insertion site. 
A homology model of AdhD (Figure 2.1A) shows the location of loop B on the distal side of the 
cofactor binding pocket from the 2’-phosphate group of NADP(H). We have investigated single 
point mutations by converting Gly211 to Ser or Cys and inserting single amino acids (Ala, Gly, 
Ser or Cys) between the 211 and 212 positions. The effect of these mutations on cofactor 
specificity were determined, and we found that all of the site-directed mutations (Figure 2.1C) or 
31 
single amino acid insertions (Figure 2.1D) at the 211-position resulted in reversal of cofactor 
specificity in the oxidative direction.  
2.3  Materials and Methods 
2.3.1 Materials 
2,3-Butanediol, NAD+, NADP+, media, and buffer components were purchased from Sigma-
Aldrich (St Louis, MO, USA). Oligonucleotides were from Integrated DNA Technologies 
(Coralville, IA, USA). Isopropyl-ß-D-1-thiogalactopyranoside (IPTG) and ampicillin were 
purchased from Promega (Madison, WI, USA). Escherichia coli BL21(DE3) competent cells and 
Phusion high-fidelity DNA polymerase were from New England Biolabs (Ipswich, MA, USA). 
Pierce Commassie (Bradford) protein assay kit was from Thermo Fisher Life Technologies (New 
York, NY, USA). Precast sodium dodecyl sulfate-polyacrylamide gels, NuPAGE MOPS running 
buffer, and Novex sharp pre-stained protein standard molecular weight marker were from 
Invitrogen (Carlsbad, CA, USA). Gel filtration column Superdex 16/200 was from GE Healthcare 
(Piscataway, NJ, USA). Of note, 30 KDa MWCO centrifugal filters were from EMD Millipore 
(Billerica, MA, USA). 
2.3.2 Site-Directed Mutagenesis 
Mutants G211S, G211C, and the insertion of Ala, Gly, Ser or Cys between 211 and 212 residues 
(termed G211InsA, G211InsG, G211InsS, and G211InsC, respectively) were created by site-
directed mutagenesis of the wild-type AdhD gene in pET-20b vector [12] using the  Phusion high-
fidelity DNA polymerase. Sequences of the primers used are given in supporting information. All 
mutations and insertions were verified by DNA sequencing.  
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2.3.3 AdhD Expression and Purification 
Expression and purification of AdhD and mutants were performed using a previously established 
protocol [17]. A single colony harboring the wild-type AdhD or mutant plasmid was expanded in 
10 ml of Luria-Bertani (LB) media supplemented with 0.1 mg/ml of ampicillin and grown 
overnight at 37°C with shaking at 200 rpm.  The overnight cultures were then transferred into 1 L 
of LB medium containing 0.1 mg/ml ampicillin and grown at 37°C with shaking at 200 rpm until 
the O.D. reached 0.6. Cultures were then induced with 0.5 mM of IPTG followed by overnight 
incubation at 25°C shaken at 200 rpm. Cells were harvested by centrifugation at 5000g for 20 min, 
resuspended in 30 ml of Tris-HCl (pH 7.5), and were lysed by incubating at 80 °C for 1 h. 
Endogenous proteins and cell debris were removed by centrifugation at 10,000g for 30 min. 
Supernatant was concentrated using a 30 KDa MWCO centrifugal filter before being loaded onto 
a gel filtration column with 20 mM Tris-HCl (pH 7.5) containing 100 mM NaCl as an equilibrating 
and eluting buffer at a flow rate of 1.5 ml/min.  Fractions containing active enzyme solutions were 
pooled and concentrated to working concentration in 20 mM Tris-HCl buffer (pH 7.5) before use. 
2.3.4 Protein Concentrations and Purity 
The protein concentrations were determined using a Pierce Coomassie (Bradford) protein assay 
kit with bovine serum albumin as a standard protein. Homogeneity of purified AdhD and the 
mutants were determined by using NuPAGE 4-12 % Bis-Tris Gels with a Novex Mini-Cell system 
using novex sharp pre-stained protein standards for molecular weight estimation.  Samples were 
prepared as described previously [12]. 
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2.3.5 Protein Denaturation Studies 
Thermal denaturation of wild-type AdhD and mutants was studied by measuring circular dichroic 
absorbance at 222 nm between 25°C and 90 °C with rate of 1 °C/min. Of note, 1 ml of 5 µM 
protein samples were made in 10 mM phosphate buffer, pH 8.0 and spectra were recorded using 
JascoJ-815 spectrometer. 
2.3.6 Homology Modeling 
A homology model of AdhD and its mutants were generated using SWISS MODEL [87] using 
Prostaglandin F synthase from Trypanosoma brucei (1VBJ, 40.26 % identities). The homology 
models were aligned with the structure of 2,5-DKGR from Cornybacterium (1A80 with bound 
NADPH, 1M9H with bound NADH) [81] and the interactions of cofactor with mutants were 
explored using PYMOL. Figure 2.1 was generated using PYMOL. 
2.3.7 Kinetic Parameter Estimation 
The full kinetic parameters of AdhD and the mutants were determined for the oxidation reaction 
with both NAD+ and NADP+ by using previously described methodology [17]. Briefly, initial rates 
at 45°C were measured using a SpectraMax M2 plate reader by following the production of 
NAD(P)H at 340 nm (ε = 6.22 per mM/cm). Initially, kinetics of all the mutants were studied by 
using reaction mixtures containing 1-100 mM 2,3 butanediol and an appropriate amount of enzyme 
in 50 mM Glycine-NaOH buffer (pH 8.8). Mixtures were incubated in a 96-well plate at 45 °C and 
the reactions were initiated by addition of 1-1,000 µM NAD(P)H. For some mutants (G211S, 
G211C, G211InsA, and G211InsS), with NAD+ as a cofactor, the KA or KB values were observed 
to be higher than the maximum concentration of substrate or cofactor utilized. So, for mutants 
G211S, G211C, G211InsA and G211InsS, kinetic data were also measured using assay reaction 
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mixtures containing 1-450 mM 2,3 butanediol and 1-5500 µM NAD+. Control reactions in the 
absence of enzyme confirmed that cofactor degradation was insignificant at 45°C over the 
timescale used. Data was collected in at least triplicate and was fit to the ordered bi-bi rate equation 
(Equation 2.1) [18, 88] using nonlinear least-squares regression (Igor Pro, Wavemetrics, Inc., 
Portland, OR, USA). Errors are reported as standard errors. 
2.3.8 Fluorescence Titrations 
Dissociations constants for cofactor binding were determined using fluorescence titrations [17, 
89]. Briefly, 1 ml of 3 µM enzyme (in 50 mM glycine-NaOH buffer, pH 8.8) was stirred in a 1 cm 
quartz cuvette at 45 °C in a J-815 Spectrometer (Jasco, Inc., Easton, MD, USA) equipped with a 
Peltier junction temperature control and titrated with NAD(P)+ in solution. Samples were excited 
at 280 nm and fluorescence changes were monitored at 330 nm. Concentrations of cofactor were 
chosen so that total volume of cofactor added was <2 % (v/v) of the total reaction volume. 
Experiments were performed in triplicate and data were fit to a saturation adsorption isotherm 
(Equation 2.2) using Igor Pro. 
𝜙𝜙 =
[𝑁𝑁𝑁𝑁𝑁𝑁(𝑃𝑃)]




𝐾𝐾𝐷𝐷𝐾𝐾𝐵𝐵 +  𝐾𝐾𝐴𝐴𝐴𝐴 + 𝐾𝐾𝐵𝐵𝑁𝑁 + 𝑁𝑁𝐴𝐴
(2.1) 
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2.3.9  Cofactor Binding Energies 
Changes in the cofactor binding energies in the ground-state (ΔΔGb) and transition-state (ΔΔGb≠) 
were calculated from equations 2.3 and 2.4 [90] utilizing cofactor dissociation constants and 
steady-state kinetic parameters. R is the gas constant (1.9872041 cal/mol/K) and T is temperature 
(318 K). 
∆∆𝐺𝐺𝑏𝑏 =  −𝑅𝑅𝑅𝑅 ln[(𝐾𝐾𝑑𝑑)𝑤𝑤𝑡𝑡 (𝐾𝐾𝑑𝑑)𝑚𝑚𝑚𝑚𝑡𝑡⁄ ] (2.3) 










� � (2.4) 
2.4 Results 
2.4.1 Expression, Purification, and Thermostability of AdhD and Mutants 
Six different mutants were created by single amino acid mutations or insertions in the AdhD gene. 
The mutations were G211C and G211S (Figure 2.1C). The insertion mutants were G211InsA, 
G211InsG, G211InsC, and G211InsS (Figure 2.1D). After expression in E. coli, proteins were 
first purified by incubation at high temperature in order to exploit the thermostability of the AdhD 
structure. Following gel filtration chromatography, the proteins were purified to greater than 98% 
as observed on SDS-PAGE (Figure 2.3). The effect of the mutations on the thermostability of 
AdhD were studied by monitoring far UV circular dichroic spectra at 25°C and 80°C (Figure 2.4). 
Just as is observed with the wild-type, no apparent structural unfolding was observed for any of 
the mutants at 80°C. 
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2.4.2 Homology Modeling 
Homology models of AdhD and the mutants were generated and interactions with the cofactors 
were analyzed by aligning homology models with the crystal structure of a similar AKR (2,5-
DKGR) containing bound NADP(H) using PYMOL. Lys249 and His255 of AdhD are known to 
have favorable interactions with 2’phosphate group of NADP(H) [17]. Analysis of the homology 
models of all mutants suggested that interactions with these amino acids are not affected by the 
mutations or insertions at loop B (Figure 2.1B-D). 
2.4.3 Fluorescence Titrations 
Fluorescence titration measurements were performed at 45 °C to determine cofactor dissociation 
constants (KD’s) for the oxidized cofactors by the AdhD mutants. Fluorescence quenching of 
tryptophan located at the 92nd position in AdhD following cofactor binding was monitored. 
Titration curves for AdhD and the mutants with NAD+ and NADP+ are shown in Figure 2.5 and 
Figure 2.6. Dissociation constants were calculated using equation 2.2 and are shown in Table 2.1 
and Table 2.2 for NAD+ and NADP+. Only minor differences in KD’s for both NAD+ and NADP+ 
were observed between wild-type AdhD and the mutants (Table 2.1 and Table 2.2).  The KD 
values of wild-type AdhD and mutants varied between 8.6 - 37 µM and 56 - 78 µM, for NAD+ and 
NADP+ respectively, indicating that the mutations led to only marginal changes in affinity for the 
cofactor molecules. This is in contrast to results obtained with the K249G/H255R mutant where 
the KD for NAD+ increased to 45 µM while the KD for NADP+ decreased to 0.66 µM [17]. 
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Table 2.1 Steady-state kinetic parameters for wild-type AdhD and mutants with NAD+.  Full 
parameters with NAD+ as a cofactor for oxidation reactions. 
Enzyme KD (µM) kcat (s-1) KA (µM) KB (mM) 
11 ± 1 2.6 ± 0.4 230 ± 50 12 ± 6 
19 ± 1 4.0 ± 0.6 100 ± 40 100 ± 20 
37 ± 4 1.1 ± 0.1 480 ± 70 240 ± 40 
23 ± 3 6.5 ± 0.5 290 ± 50 110 ± 10 
33 ± 6 0.43 ± 0.02 97 ± 13 76 ± 6 
31 ± 5 1.7 ± 0.3 120 ± 10 260 ± 110 





































Wild-type  0.011 ± 0.003 0.12 ± 0.04 0.21 ± 0.11 20 ± 11 
G211S 0.040 ± 0.017 0.76 ± 0.32 0.040 ± 0.010 2.1 ± 0.5 
G211C 0.0023 ± 0.0004 0.087 ± 0.017 0.0046 ± 0.0009 0.12 ± 0.02 
G211InsG 0.022 ± 0.004 0.51 ± 0.15 0.059 ± 0.007 2.6 ± 0.5 
G211InsC 0.0044 ± 0.0006 0.15 ± 0.03 0.0057 ± 0.0005 0.17 ± 0.04 
G211InsA 0.014 ± 0.003 0.44 ± 0.11 0.0065 ± 0.0030 0.21 ± 0.10 
G211InsS 0.0042 ± 0.0022 0.036 ± 0.019 0.0061 ± 0.0035 0.71 ± 0.41 
K249G/H255a 0.033 ± 0.006 1.5 ± 0.3 0.022 ± 0.004 0.48 ± 0.09 
Oxidation reactions were performed at 45°C in 50 mM glycine-NaOH buffer (pH 8.8) with 2,3-butanediol as a 
substrate. KD is the cofactor dissociation constant as determined by fluorescence titrations, KA and KB are Michaelis 
constants for cofactor and substrate, respectively. For mutants G211S, G211C, G211InsA and G211InsS, kinetics 
data were measured using higher substrate and cofactor concentrations as described in the ‘Materials and Methods’ 
section. Reactions were performed in at least triplicate, and errors shown are standard errors of at least three 
independent measurements. 
Rate constants calculated from relationships: k1SS = kcat/KA , k2ss = kcat/KD, k3ss = kcat/KB
aThe K249G/H255R mutant data were determined by Campbell et.al (2010) under identical conditions. 
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Table 2.2 Steady-state kinetic parameters for wild-type AdhD and mutants with NADP+.  Full 
parameters with NADP+ as a cofactor for oxidation reactions. 
Enzyme KD (µM) kcat (s-1) KA (µM) KB (mM) 
Wild-type 64 ± 2 0.073 ± 0.002 7.4 ± 0.9 0.44 ± 0.10 
G211S 67 ± 4 0.29 ± 0.01 15 ± 2 0.91 ± 0.16 
G211C 65 ± 3 0.92 ± 0.07 25 ± 9 9.6 ± 2.5 
G211InsG 75 ± 5 0.52 ± 0.10 33 ± 29 1.5 ± 0.5 
G211InsC 78 ± 6 0.86 ± 0.09 120 ± 40 5.5 ± 1.2 
G211InsA 56 ± 4 2.1 ± 0.2 360 ± 90 90 ± 4 
G211InsS 59 ± 5 2.1 ± 0.1    66 ± 24 17 ± 2 
K249G/H255Ra 0.66 ± 0.10 4.7 ± 0.2 78 ± 5 200 ± 10 




Wild-type 0.0098 ± 0.0012 0.63 ± 0.08 0.16 ± 0.04 2.6 ± 0.6 
G211S 0.019 ± 0.02    1.3 ± 0.2 0.31 ± 0.06 4.7 ± 0.9 
G211C 0.037 ± 0.013 2.4 ± 0.9 0.096 ± 0.026 1.5 ± 0.4 
G211InsG 0.016 ± 0.014 1.2 ± 1.0 0.34 ± 0.12 4.5 ± 1.8 
G211InsC 0.0074 ± 0.0025 0.58 ± 0.20 0.16 ± 0.04 2.0 ± 0.5 
G211InsA 0.0057 ± 0.0015 0.32 ± 0.09 0.023 ± 0.002 0.41 ± 0.05 
G211InsS 0.032 ± 0.012 1.9 ± 0.70 0.12 ± 0.02 2.1 ± 0.3 
K249G/H255Ra 0.060 ± 0.005 0.040 ± 0.007 0.024 ± 0.002 36 ± 6 
Oxidation reactions were performed at 45°C in 50 mM glycine-NaOH buffer (pH 8.8) with 2,3-butanediol as a 
substrate. KD  is the cofactor dissociation constant as determined by fluorescence titrations, KA and KB are Michaelis 
constants for cofactor and substrate, respectively. Reactions were performed in at least triplicate, and errors shown are 
standard deviations. 
Rate constants calculated from relationships: 𝑘𝑘1𝑠𝑠𝑠𝑠=kcat/KA, 𝑘𝑘2𝑠𝑠𝑠𝑠=kcatKD/KA , 𝑘𝑘3𝑠𝑠𝑠𝑠=kcat/KB
aThe K249G/H255R mutant data was determined by Campbell et al (2010) under identical conditions. 
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2.4.4 Steady State Kinetic Analyses 
Steady state kinetic experiments were carried out in the oxidative direction for all the 
mutants and wild-type AdhD using either NAD+ or NADP+ as a cofactor (Table 2.1 and Table 
2.2). With NAD+, three mutants G211S, G211InsG, and G211InsS exhibited improvement in kcat 
over the wild-type enzyme. G211InsG and G211InsS mutant exhibited 2.5-fold enhancement in 
the kcat value and mutant G211S showed 1.5-fold enhancement over wild-type. The mutant with 
Cys insertion, G211InsC, exhibited the lowest kcat value with a 6-fold decrease as compared to the 
wild-type AdhD. The impact on the activity with NADP+ was even greater, as all the mutants 
exhibited improvement over wild-type. Mutants with Ala and Ser insertion showed a 29-fold 
increase in kcat, respectively (Table 2.2). An order of magnitude improvement was observed for 
other mutants as well. The KA varied from 97 to 1600 µM for NAD+ and from 7.4 to 360 µM for 
NADP+ in the wild-type and mutants. Similarly, variations observed for KB ranged from 12 to 
1100 mM for NAD+ and 0.44 to 90 mM for NADP+ in the wild-type and mutants. This is also in 
contrast to results obtained with the K249G/H255R mutant where the KB for NADP+ exhibited 
the largest increase observed, 200 mM [17].  
In order to simplify the comparison of the impacts of the mutations on the steady-state 
kinetics, the individual microscopic rate constants for the reaction mechanism were calculated 
according to Equation 2.5 (Table 2.1 and Table 2.2).  In the case of NAD+, the on-rate of cofactor 
(k1ss) was found to decrease in all of the mutants except for the G211S and insertion of Gly 
(G211InsG), which was measured to be 0.04 and 0.022 µM-1s-1, respectively, as compared to 0.011 
µM-1s-1 for wild-type AdhD. The mutant with the Ala insertion (G211InsA) showed a similar 𝑘𝑘1𝑠𝑠𝑠𝑠 
as that of wild-type. The off-rate (𝑘𝑘2𝑠𝑠𝑠𝑠) increased for all the mutants except G211C and G211InsS. 
The off-rate value for the mutant with the Cys insertion (G211InsC) was measured to be similar 
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to that of the wild-type enzyme. An approximately 6-fold enhancement was observed for mutant 
G211S and 3 to 4-fold for the Ala (G211InsA) and Gly insertion (G211InsG) mutants. All of the 
mutants demonstrated decreases in the on-rate of the substrate (𝑘𝑘3𝑠𝑠𝑠𝑠) after binding NAD+ as a 
cofactor, with decreases between 32-fold and 46-fold for mutants, G211InsA, G211InsS, 
G211InsC, and G211C. The highest decrease of 46-fold was shown by G211C. The composite rate 
constant (k1k3/k2)ss is a useful parameter that can be used to compare the catalytic performances 
of ordered bi-bi enzymes [76]. All of the mutants resulted in substantial decreases in catalytic 
performance with NAD+ (Table 2.1). The catalytic performance decreased by two orders of 
magnitude for G211C and G211InsC. Mutants, G211InS and G211InsA exhibited 28-fold and 
100-fold decreases, respectively. The G211InsG exhibited the highest catalytic performance
among mutants, but the value was still only 13% of the wild-type value. 
With NADP+ as a cofactor, all of the mutants produced an increase in both the on-rate (𝑘𝑘1𝑠𝑠𝑠𝑠) 
and the off-rate constants (𝑘𝑘2𝑠𝑠𝑠𝑠) for the cofactor, except mutant G211InsC and G211InsA, which 
showed a decrease in values compared to the wild-type (Table 2.2). Mutants G211S, G211C, 
G211InsS, and G211InsG exhibited between 2-fold to 4-fold enhancement for both k1ss and k2ss 
(Table 2.2). The net on-rate of the substrate following NADP+-binding (k3ss) increased by 
approximately 2-fold for mutants G211S and G211InsG and decreased by 7-fold for G211InsA. 
The G211InsC and G211InsS mutants showed similar net on-rates as that of wild-type, whereas 
G211C showed a 40% decrease. The mutants that showed an increase in the net on-rate of substrate 
with NADP+ were G211S and G211InsG, both with 0.31 x 10-3 µM-1s-1 compared to 0.16 x 10-3 
µM-1s-1 for the wild-type. G211S also exhibited a 2-fold improvement in overall catalytic 
performance (k1k3/k2)ss. In terms of catalytic performance with NADP+, the least active mutant 
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was G211InsA, which decreased 6-fold compared to wild-type AdhD. The catalytic performances 
of G211InsC and G211InsS were similar to that of wild-type. 






 𝐸𝐸𝑁𝑁  𝐸𝐸𝑁𝑁 + 𝐴𝐴 
𝑘𝑘3𝑠𝑠𝑠𝑠�� 𝐸𝐸𝑁𝑁𝐴𝐴
(2.5) 
Wild-type AdhD is able to use both cofactors in both directions, but it exhibits a strong 
preference for NADH over NADPH in the reductive direction [17] and a slight preference for 
NAD+ over NADP+ in the oxidative direction. The ratio of kcat(NADP+)/kcat(NAD+) for wild-type 
AdhD was 0.028 (Table 2.3). All of the mutants showed higher kcat(NADP+)/kcat(NAD+) ratios 
compared to wild-type AdhD. Mutants G211S and G211InsG showed an enhancement of 
approximately 3-fold and mutants G211InsS, G211C, and G211InsA, the enhancement observed 
was 11-, 30-, and 43-fold,respectively. The G211InsC mutant possessed the highest 
kcat(NADP+)/kcat(NAD+) ratio of 2.0, which is 71 times higher than the wild-type enzyme and more 
than 6-fold higher than the K249G/H255R mutant (Table 2.3). In contrast to the large changes 
seen in the kcat values, all of the Kd(NADP+)/Kd(NAD+) ratios were of the same order of 
magnitude as the wild-type enzyme. The Michaelis constants for the enzymes were more affected 
by the mutations. G211C and G211InsS had KA(NADP+)/KA(NAD+) values similar to the wild-
type with a ratio of 0.032 for wild-type AdhD. G211InsC and G211InsA had 38-fold and 94-fold 
increases in the KA(NADP+)/KA(NAD+) ratio, respectively. The wild-type enzyme had a 
KB(NADP+)/KB(NAD+) ratio of 0.037, which was similar to the G211C mutant value of 0.040. 
The values for G211InsG and G211InsS were approximately 40% of the wild-type value while the 
values for G211InsC and G211InsA were 2- and 9-fold higher than the wild-type. 
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Table 2.3 Ratio of steady-state parameters and composite microscopic rates for Wt AdhD and 
mutants. Studies with NAD+ versus NADP+ as cofactors for oxidation reactions. 










Wild-type 5.8 ± 0.7 0.028 ± 0.004 0.032 ± 0.080 0.037 ± 0.020 
G211S 3.5 ± 0.3 0.072 ± 0.011 0.15 ± 0.06 0.0091 ± 0.0024 
G211C 1.7 ± 0.2 0.83 ± 0.09 0.052 ± 0.020 0.040 ± 0.012 
G211InsG 3.3 ± 0.5 0.081 ± 0.017 0.12 ± 0.10 0.014 ± 0.005 
G211InsC 2.4 ± 0.5 2.0 ± 0.2 1.2 ± 0.4 0.072 ± 0.017 
G211InsA 1.8 ± 0.3 1.2 ± 0.2 3.0 ± 0.8 0.35 ± 0.15 
G211InsS 6.9 ± 1.0 0.31 ± 0.11 0.041 ± 0.022 0.016 ± 0.007 
K249G/H255Ra 0.015 ± 0.002 0.31 ± 0.04 0.17 ± 0.02 0.29 ± 0.04 
Enzyme (𝑘𝑘R1𝑘𝑘R3/𝑘𝑘R2)ss (NADP+)/(𝑘𝑘R1𝑘𝑘R3/𝑘𝑘R2)ss (NAD+) 
Wild-type 0.13 ± 0.08 
G211S 2.2 ± 0.7 
G211C 12 ±4 
G211InsG 1.7 ± 0.7 
G211InsC 12 ± 4 
G211InsA 2.0 ± 1.0 
G211InsS 2.9 ± 1.8 
K249G/H255Ra 74 ±18 
The (k1k3/k2)ss(NADP+)/(k1k3/k2)ss(NAD+) provides a clear comparison of the catalytic 
efficiencies of ordered bi-bi enzymes with the different cofactors. Cofactor specificity reversal was 
observed with every mutant explored (Table 2.3). The value for the wild-type is 0.13 and this 
increased for every mutant explored with the biggest changes seen with the G211C and G211InsC 
mutants exhibiting a two order of magnitude increase with a value of 12 for each ( Table 2.3 and 
Figure 2.2) 
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Figure 2.2 Catalytic performance of wild-type AdhD and mutants.  Comparison of catalytic 
performance (k1k3/k2)ss of wild-type AdhD and mutants with NAD+ and NADP+ in the oxidation 
reaction. Error bars shown are standard errors of at least three independent 
measurements.
2.4.5 Cofactor Binding Energies 
Changes in the ground-state and transition-state binding energies of the cofactors and the 
mutants compared to the wild-type enzyme were calculated from cofactor dissociation constants 
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and kinetic data using equations 2.3 and 2.4, respectively (Table 2.4 and Table 2.5).  With NAD+ 
as a cofactor, all of the mutants lost ground-state binding energy ranging from 0.35 to 0.76 
kcal/mol except for G211InsS, which gained 0.15 kcal/mol. The transition-state binding energies 
with NAD+ were more variable, with G211S, G211InsG, and G211InsA gaining energies and 
G211C, G211InsC, and G211InsS losing binding energies with the biggest changes in ground-
state and transition-state binding energies observed for G211C (0.76 and 1.0 kcal/mol, 
respectively). Similar results were seen with the previously described K249G/H255R mutant [19], 
which lost 0.88 kcal/mol of ground-state binding energy, but gained 0.67 kcal/mol transition-state 
binding energy (Table 2.4). 
Table 2.4 Change in the ground- and transition-state binding energies with NAD+ as a cofactor 








aThe K249G/H255R mutant data was determined by Campbell et al (2010) under identical 
conditions 
With NADP+, the G211InsC mutant showed the maximum change of 0.12 kcal/mol in the 
ground-state binding energy. With NADP+ as a cofactor, the changes in ground-state binding 
energy were smaller, with G211InsG and G211InsC exhibiting the largest losses of 0.10 and 0.12 
kcal/mol. The transition-state binding energy changes were larger, with G211C and G211InsS 
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showing the highest gains of 0.84 and 0.74 kcal/mol, respectively (Table 2.5). These results are 
much different from what was observed with the K249G/H255R mutant [19], which gained 2.9 
kcal/mol of ground-state binding energy and gained 1.1 kcal/mol transition-state binding energy 
(Table 2.5).  
Table 2.5 Change in the ground- and transition-state binding energies with NADP+ as a cofactor 




G211InsC 0.12 0.20 
G211InsA -0.084 0.33 
G211InsS -0.051 -0.74
K249G/H255Ra -2.9 -1.1
aThe K249G/H255R mutant data was determined by Campbell et al (2010) under identical 
conditions 
2.5 Discussion 
Enzymes of the AKR superfamily generally exhibit cofactor specificities and there have 
been a number of reports aiming to explore the basis of this molecular recognition [75-77, 80, 91].  
The general approach in all of these reports has been to apply site-directed mutagenesis to the 
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amino acids interacting with the cofactor, especially those that interact with the 2’-phosphate group 
of NADP+. 
While studying the structural differences between a mesophilic AKR (human aldose 
reductase) and the thermophilic AdhD, our group found that there is a truncation of loops A and 
B and an absence of loop C in AdhD [19] and that the insertion of these loops in AdhD altered the 
substrate specificity along with a concomitant alteration in cofactor specificity in the oxidative 
direction. This motivated further investigation into the minimum insertion length required to alter 
the cofactor specificity of AdhD in the loop regions as opposed to the amino acids directly 
interacting with the 2’-phosphate group of NADP(H). Loop B is located at the back side of the 
adenine binding site of cofactor binding pocket and has no apparent interaction with the 2’-
phosphate group of NADP(H) (Figure 2.1A). Thus, we decided to study the effect of mutations 
and single amino acid insertions at the loop B position. Homology models of AdhD and the 
mutants with NADP+ suggest that the distance between loop B of AdhD and the 2’-phosphate 
group of NADP+ is greater than 10 Å (Figure 2.1B-D). Yet surprisingly, these conservative 
changes led to increased activity in some and alteration of cofactor preference in all of the mutants 
evaluated.   
Similar effects have been reported upon mutation of side chains away from the 2’-
phosphate group of NADP(H) in other nicotinamide cofactor-dependent dehydrogenase enzymes 
[86]. Cahn et al. explored engineering cofactor-specificity in NAD(P)(H)-dependent enzymes with 
different folds and identified a position on a helix (within 5 Å of the N6 atom of the NAD(P)H 
adenine moiety) that runs parallel to the cofactor adenine moiety. Mutations at this position led to 
changes in catalytic activity and cofactor specificity.  However, this approach was ineffective for 
an enzyme with a TIM-barrel fold, as is found in the AKRs. 
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Based on previous mutagenesis work from our group in AKR enzymes, we made single 
mutations at loop B, which begins at 211th amino acid of AdhD. A homology model of AdhD 
shows that the distance between from N6 atom of the adenine moiety and amino acid 211 is 7-8 Å 
and the distance to amino acid 212 is 5-6 Å. The largest impacts on cofactor specificity were 
observed when G211 was mutated to cysteine (G211C) and when cysteine was inserted between 
the 211 and 212 amino acids (G211InsC) of AdhD.  
When mutations are made in the cofactor binding pocket at amino acid side chains 
interacting with the 2’-phosphate group of NADP(H), changes in the dissociation constant (KD, 
Table 2.3) and the ground- and transition-state binding energies can be observed as can be seen in 
the K249G/H255R mutant [19] (Table 2.5). The mutants created in this work also resulted in a 
substantial change in cofactor specificity in the oxidative direction (Figure 2.2); however, these 
changes are not due to large changes in the dissociation constants for the cofactors (KD, Table 2.3) 
or in the ground- or transition-state binding energies of either cofactor (Table 2.4 and Table 2.5). 
These results indicate that the mutations are instead affecting the interactions of the ternary 
enzyme/cofactor/substrate transition state. This is evidenced by the full steady-state kinetic 
behavior of all the mutants in the forward direction in the absence of products for the oxidation 
reaction using NAD+ or NADP+ as cofactors (Table 2.1, Table 2.2, and Table 2.3). The mutations 
led to many changes in the kinetic parameters, but there was a striking increase (6-fold up to 90-
fold) in every Michaelis constant for substrate (KB), when NAD+ was used as a cofactor. The 
results were more mixed when NADP+ was used, where the KB values also increased for very 
mutant, but some of the mutants exhibited only 2- to 4-fold differences. And, there was a consistent 
increase in the kcat value for every mutant with NADP+, which was not observed when NAD+ was 
used as a cofactor.  
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There are several ways to compare the catalytic performance of mutant enzymes.  For the 
ordered bi-bi enzymes, there are two Michaelis constant (Km) values, thus complicating the 
comparison of the traditional kcat/Km. An alternative choice is to use the steady-state kinetic 
parameters to calculate on- and off-rates of the individual reaction steps and compare a ratio such 
as k1k3/k2. All of the mutants created exhibited a decrease in overall catalytic performance 
(k1k3/k2)ss with NAD+ as compared to wild-type (Table 2.1). With NADP+, several mutants 
exhibited similar or decreased performance, while mutants, G211S and G211InsG, had a 1.8- and 
1.7-fold increase in this parameter, respectively. By comparing the ratio of this parameter between 
NADP+ and NAD+ as a cofactor, every mutant investigated resulted in a reversal of cofactor 
specificity. Two of the mutants (G211S and G211InsG) demonstrated activity with NADP+ that 
exceeds that of the wild-type, and two of the mutants (G211C and G211InsC) exhibit almost 
complete reversals in cofactor specificity (Table 2.3, Figure 2.2). 
The fact that single amino acid mutations or insertions at a site away from the 2’-phosphate 
group of NADP(H) affect cofactor specificity as dramatically as mutations within the cofactor 
binding pocket is useful. There are many reports of cofactor specificity engineering in the AKR 
family, but there are only few reports where reversal of cofactor specificity is achieved with 
retention or enhanced catalytic efficiency as compared to the wild-type. Furthermore, in all these 
reports at least triple or quadruple mutations of amino acids involved in the binding of the 2’-
phosphate group were required for switch in cofactor specificity [92-94]. There have been reports 
on effects of distal single mutation on various NAD(P)H-dependent enzymes with different folds; 
however, they could not find beneficial mutation for enzymes with TIM barrel fold. Here, we have 
discovered a position in AdhD, an enzyme with TIM barrel fold, distal to the 2’phosphate group, 
which can create mutants with activities with the non-preferred cofactor that exceeds the parental 
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activity and can lead to mutants with reversal of the cofactor specificity. This represents an 
extended approach for cofactor engineering in the AKR enzyme family with the TIM barrel fold. 
2.6 Conclusion 
There are well-established locations for mutagenesis to alter cofactor specificity in the aldo-
keto reductases. We identified a position on the other side of the cofactor binding pocket where 
point mutations or single amino acid insertions produced increased activities and every mutant 
exhibited altered cofactor specificity. This mutation site may be useful in related enzymes.  
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2.7 Supporting Information 
AdhD amino acid sequence: 
MGDYKDDDDK AKRVNAFNDL KRIGDDKVTA IGMGTWGIGG RETPDYSRDK ESIEAIRYGL        60 
ELGMNLIDTA EFYGAGHAEE IVGEAIKEFE REDIFIVSKV WPTHFGYEEA KKAARASAKR       120 
LGTYIDLYLL HWPVDDFKKI EETLHALEDL VDEGVIRYIG VSNFNLELLQ RSQEVMRKYE       180 
IVANQVKYSV KDRWPETTGL LDYMKREGIA LMAYTPLEKG TLARNECLAK IGEKYGKTAA       240 
QVALNYLIWE ENVVAIPKAS NKEHLKENFG AMGWRLSEED REMARRCVED PNSSSVD 297 
Oligonucleotides used for site-directed mutagenesis (mutation in italics) 
G211S: 
Forward primer: ACGCCTCTAGAAAAATCCACCCTGGCGCGTAAC - 3’ 
Reverse primer: GTTACGCGCCAGGGTGGATTTTTCTAGAGGCGT - 3’ 
G211C: 
Forward primer: ACGCCTCTAGAAAAATGCACCCTGGCGCGTAAC - 3’ 
Reverse primer: GTTACGCGCCAGGGTGCATTTTTCTAGAGGCGT - 3’ 
Glycine inserted between 211 & 212: 
Forward primer: CCTCTAGAAAAAGGTGGCACCCTGGCG - 3’ 
Reverse primer: CGCCAGGGTGCCACCTTTTTCTAGAGG - 3’ 
Alanine inserted between 211 & 212: 
Forward primer: GAAAAAGGTGCCACCCTGGCG - 3’ 
Reverse primer: CGCCAGGGTGGCACCTTTTTC - 3’ 
Serine inserted between 211 & 212: 
Forward primer: GAAAAAGGTTCCACCCTGGCG - 3’ 
Reverse primer: CGCCAGGGTGGAACCTTTTTC - 3’ 
Cysteine inserted between 211 & 212: 
Forward primer: CTAGAAAAAGGTTGCACCCTGGCG - 3’ 
Reverse primer: CGCCAGGGTGCAACCTTTTTCTAG - 3’ 
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Figure 2.3 SDS-PAGE of wild-type AdhD and mutants.  SDS-PAGE of wild-type AdhD and 
mutants after purification using gel filtration column (for details see materials and methods). 
Lane 1: molecular weight ladder, lane 2: wild-type AdhD, lane 3: G211S, lane 4: G211C, lane 5: 
G211InsA, lane 6: G211InsG, lane 7: G211InsC, and lane 8: G211InsS. A single band is 
observed at ~34 KDa, consistent with the calculated molecular mass of AdhD.
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Figure 2.4 Circular dichroic absorbance spectra of wild-type AdhD and mutants.  Far UV CD 
spectra of wild-type AdhD and mutants in 10 mM sodium phosphate buffer (pH 8.0) by 




Figure 2.5 Fluorescence titrations of wild-type AdhD and mutants with NAD+.  These were used 
for KD determination. 3 µM of enzyme was titrated with NAD+ at 45 °C in a J-815 spectrometer 
equipped with a Peltier junction temperature control. Samples were excited at 280 nm and 
fluorescence change at 330 nm was monitored.
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Figure 2.6 Fluorescence titrations of wild-type AdhD and mutants with NADP+.  These were 
used for KD determination. 3 µM of enzyme was titrated with NADP+ at 45 °C in a J-815 
spectrometer equipped with a Peltier junction temperature control. Samples were excited at 280 
nm and fluorescence change at 330 nm was monitored.  
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Chapter 3 
Insertion of a Calcium-Responsive Beta Roll Domain 
into a Thermostable Alcohol Dehydrogenase 
Enables Tunable Control over Cofactor Selectivity 
Project Collaborators: Walaa Abdallah, Kusum Solanki, and Scott Banta 
A version of this chapter entitled “Insertion of a calcium-responsive β-roll domain into a 
thermostable alcohol dehydrogenase enables tunable control over cofactor selectivity” was 
published in ACS Catalysis in 2018 in volume 8, pages 1602-1613. WA was responsible for 
molecular cloning and protein expression and characterization, including terbium studies, 
enzyme kinetics (with KS), circular dichroism studies (with KS), and kinetic model derivations. 
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3.1 Abstract 
The RTX domains found in some secreted proteins fold into the β-roll secondary structure 
motif upon calcium binding, which enables folding to be localized extracellularly. We inserted an 
RTX domain from the adenylate cyclase of Bordetella pertussis into a loop near the catalytic active 
site of the thermostable alcohol dehydrogenase D (AdhD) from Pyrococcus furiosus. The resultant 
chimera, β-AdhD, gained the calcium-binding ability of the β-roll, retained the thermostable 
activity of AdhD, and exhibited reduced overall alcohol dehydrogenase activity. However, the 
addition of calcium to β-AdhD preferentially inhibited NAD+-dependent activity in comparison to 
NADP+-dependent activity. Calcium was found to be a competitive inhibitor of AdhD and the 
addition of the RTX domain introduced calcium-dependent non-competitive inhibition to β-AdhD 
affecting NAD+-dependent activity. Thus, the insertion of an intrinsically disordered calcium-
binding domain into a key loop in a cofactor-dependent enzyme results in an enzyme with tunable 
cofactor selectivity, reminiscent of a calcium-controlled cofactor selectivity rheostat switch. 
3.2 Introduction 
Nicotinamide cofactors are critical electron donors and acceptors necessary for the 
biocatalysis of a wide range of redox reactions essential for life. The ubiquitous NAD(H) and 
NADP(H) cofactors have similar redox potentials and only differ by a 2’-phosphate group on the 
adenosine ribose of the molecule. This difference is exploited so that NAD(H) is often involved in 
catabolic reactions, while NADP(H) is used in anabolic reactions.  Most enzymes have evolved a 
selectivity for only one cofactor, allowing oxidation and reduction reactions to take place 
simultaneously in the same compartment without cross-reaction.       
There has been almost three decades of research in protein engineering aimed at altering 
or reversing the cofactor selectivity of nicotinamide-dependent enzymes. Early pioneering work 
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by Scrutton et al. [22] demonstrated how amino acids in the “Rossman fold” could be mutated to 
reverse cofactor selectivity in glutathione reductase. Often the engineering of cofactor specificity 
in an enzyme is driven by the desire to enable the enzyme to use NAD(H) as opposed to NADP(H) 
since NAD(H) is more abundant, more stable, and less expensive [95]. In the aldo-keto reductases 
(AKRs), mutations have been identified in the 2,5-diketo-D-gluconic acid reductase (2,5-DKGR) 
to broaden cofactor specificity to use NAD(H) for the production of vitamin C [76, 96]. Ketol-acid 
reductoisomerases involved in the biosynthesis of branched amino acids have been engineered for 
increased NAD(H)-dependent activity [79]. Formate dehydrogenases are useful for the 
regeneration of cofactors driven by formate oxidation. Mutations were identified in the cofactor 
binding pocket to engineer the enzyme to use NADP(H) [97]. More recently, there have been 
efforts to use computational approaches to predict mutations needed to alter cofactor specificity in 
dehydrogenases and reductases [82, 98].  
A central goal of biochemical engineering is the development of new biocatalysts that can 
be used to create novel biological processes. There has been a great deal of research aimed at 
designing and characterizing genetic circuit elements for dynamic and programmable control over 
protein expression [99]. In addition, there has been decades of research aimed at the development 
of inhibitors and other molecules that can be used for tunable control over enzymatic activity. We 
hypothesize that dynamic control over the cofactor selectivity of an enzyme could produce new 
biocatalytic capabilities. For in vivo applications, this could facilitate balancing of redox 
requirements under different growth conditions or it can enable dynamic control over the metabolic 
fluxes. Similarly, in in vitro systems, dynamic control over cofactor selectivity would enable 
control over pathway fluxes, energy utilization, and redox potential.  
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Figure 3.1 Structures of AdhD and the β-roll domain. Homology model of AdhD with bound 
cofactor highlighted in red and insertion sites in blue (A) looking down the α/β barrel and (B) 
rotated 90° with insertion sites in loop A indicated. (C) Homology model of ternary complex of 
AdhD with cofactor in red, 2,3-butanediol in yellow, and insertion site in blue. (D) Crystal 
structure of the fifth block β-roll domain from the adenylate cyclase protein with calcium ions in 
yellow (PDB ID 5CVW, Bumba et al., 2016).  
We have a long-standing interest in engineering the activity of the alcohol dehydrogenase 
D (AdhD) isolated from Pyrococcus furiosus (Figure 3.1) [11, 17, 19, 20, 25]. This enzyme is a 
monomeric member of the AKRs, has a preference for NAD(H) in the reductive direction, and 
follows an ordered bi-bi rate mechanism where the cofactor binds first followed by the binding of 
the substrate [18]. It has activity with many substrates and is most active with 2,3-butanediol [12]. 
Mobile loops on the top of the barrel (loops A, B and C) are thought to be responsible substrate 
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specificity [14]. We have engineered just about every aspect of this enzyme including the use of 
two site-directed mutations in the cofactor binding pocket in AdhD to broaden cofactor selectivity 
and enhance catalysis [17]. Substrate specificity was engineered by swapping the three mobile 
loops in the substrate binding pocket with loops from human aldose reductase (hAR). Interestingly, 
this loop-switching approach also resulted in a reversal of cofactor selectivity from NAD(H) to 
NADP(H) [19]. More recently, mutations and insertions in one of the mobile loop positions, loop 
B on the back side of the cofactor binding pocket, resulted in an enzyme with broadened or 
reversed cofactor selectivity [25]. Therefore, we have created versions of this enzyme with varying 
cofactor selectivities. However, as with all other protein engineering approaches to altering 
cofactor utilization, these selectivities are not dynamically controllable. 
It is becoming increasingly clear that nature uses conformationally dynamic peptides to 
regulate biomolecular functions [100]. Intrinsically disordered proteins (IDPs) can toggle between 
ordered and disordered structures, sometimes serving as regulatory elements. IDPs can be 
classified in two categories: systems that exploit entropic disorder (such as elastin-like peptides), 
and those which are involved in conditional molecular recognition (such as the N-terminal domain 
of the p53 transcription factor) [101]. Binding events by IDPs can be transient or irreversible, 
where transient binding allows IDPs to function as chaperones and permanent binding allows for 
modifications such as inhibition and activation [101]. We have been characterizing and exploring 
various applications using the β-roll secondary structure motif, which also seems to function 
physiologically as an IDP [102-108]. Specifically, we have been exploring the fifth block of the 
repeats-in-toxin (RTX) domain from the adenylate cyclase toxin of Bordetella pertussis, which is 
disordered in the absence of calcium and folds into the β-roll domain upon calcium binding [103]. 
The β-roll secondary structure domain is a flattened spiral shape with two parallel facing β-sheet 
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faces with turn regions in between that bind calcium via canonical aspartic acid side chains (Figure 
3.1D) [102, 104]. β-roll domains fold through a polarized mechanism that begins on the C-terminal 
side of the peptide. The C-terminal capping group stabilizes the initial calcium-dependent folding 
of β-roll domain via an entropic stabilization. It is thought that the β-roll domain serves as a natural 
switching mechanism so that pathogenic proteins with the RTX domain are inactive inside of cells, 
and β-roll domains fold outside of the cell where calcium is more abundant [109]. Thus, the 
RTX/β-roll transition serves as a dynamic protein switch to localize activity to extracellular, 
calcium rich environments. 
We hypothesized that the disordered to ordered transition of the RTX domain could be 
exploited for tunable, calcium-dependent modulation of enzymatic activity if it were inserted in 
the appropriate location of an enzyme. In this work, the RTX domain DNA sequence was cloned 
into a substrate binding loop (Loop A) of the AdhD sequence (Figure 3.1), resulting in the 
chimeric fusion protein β-AdhD. The Loop A site in AdhD was chosen as the insertion site because 
it is near the cofactor binding pocket and yet it can be substantially mutated without ablating 
enzymatic activity [19]. We explored the impact of calcium on the activity of the new β-AdhD 
fusion protein and found that calcium inhibited NAD+-dependent activity while far less of an 
impact was observed for NADP+-dependent activity. Thus, the introduction of the RTX domain 
into AdhD enables calcium addition to be used to regulate the cofactor selectivity of the new β-
AdhD enzyme.  
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3.3 Materials and Methods 
3.3.1 Materials 
Oligonucleotides were purchased from Integrated DNA technologies (Coralville, IA). 
Phusion high fidelity DNA polymerase and E. coli BL21(DE3) expression cells were from New 
England Biolabs (Ipswich, MA). Isopropyl β-D-1-thiogalactopyranoside and ampicillin were from 
Promega (Madison, WI).  NuPAGE SDS-PAGE gels, MOPS running buffer, and NOVEX Sharp 
pre-stained proteins standards were from Invitrogen (Carlsbad. CA). The gel filtration column, 
Superdex 16/200, was purchased from GE Healthcare (Piscataway, NJ). Molecular weight 
centrifugal filters were from EMD Millipore (Billerica, MA). All other chemicals were from Sigma 
Aldrich (St. Louis, MO). 
3.3.2 Cloning, Expression, and Purification 
The DNA sequence of the RTX domain from the fifth block of the RTX motifs in the CyaA 
toxin of Bordetella pertussis was cloned into the adhD gene from Pyrococcus furiosus in the pET-
20b(+) vector, plasmid pWUR85 [12]. The plasmid was restriction digested with SalI, so that the 
valine at the 125th position of AdhD was replaced with glycine followed by the DNA sequence of 
the fifth block of RTX and this was followed by phenylalanine, resulting in the final construct 
pWUR85-β-roll (complete sequences can be found in the Supporting Information). Final 
sequences were verified by DNA sequencing.  
The pWUR85 and pWUR85-β-roll plasmids were transformed into E. coli BL21(DE3) 
expression cells and plated onto Luria Broth (LB) plates supplemented with 0.1 mg/ml ampicillin. 
Single colonies were inoculated overnight in LB supplemented with 0.1 mg/ml ampicillin. 
Expression was performed at 37 °C in 1 L flasks containing the same medium. Induction was 
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performed with 0.5 mM final concentration Isopropyl β-D-1-thiogalactopyranoside (IPTG) at OD 
0.6 and cultures were kept shaking at 200 rpm overnight. 
 The cells were harvested, re-suspended in 20 mM Tris-HCl buffer (pH 7.8, with 100 mM 
NaCl), and lysed at 80 °C for one hour to denature all proteins except for thermophilic AdhD. Cell 
debris was removed by centrifugation for 30 minutes at 9560 rpm and was concentrated using 
centrifugal filters (30 kDa MWCO) and purified using gel filtration chromatography (Superdex 
16/200, GE Healthcare, Piscataway, NJ) using the lysis buffer of 20 mM Tris-HCl, 100 mM NaCl, 
pH 7.8. Samples were collected and pooled, and purity was ensured by electrophoresis on 
NuPAGE 4-12 % Bis-tris gels in MES running buffer (Invitrogen). Samples used were greater than 
95% pure and were concentrated in 30 kDa MWCO centrifugal filters before use. The β-AdhD 
protein was purified by the same method, but a final buffer exchange was performed into 50 mM 
tris (pH 7.5) by centrifugation at 5560 rpm for 10 minutes three times. This was done to decrease 
the effect of ionic strength on the conformational change in the β-roll [104]. Protein concentrations 
were determined by measuring absorbances at 280 nm on a SpectraMax M2 plate reader and using 
the extinction coefficients of 53,985 and 58,455 M-1 cm-1 for AdhD and β-AdhD, respectively 
[110].  
3.3.3 Circular Dichroic Absorbance 
Circular dichroic absorbance measurements were performed to determine the thermal 
denaturation curves for AdhD and β-AdhD by monitoring the absorbance at 222 nm while heating 
from 45 to 90 °C in a Jasco J-815 spectrometer at a rate of 1 ºC/min. Protein samples were dialyzed 
into water with and without 2.5 mM CaCl2 and a final concentration of 2 ml of 1.25 µM protein 
was used. Data were converted to mean residue ellipticities (Equation 3.1) and scans were 
performed in at least duplicate.  
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𝜃𝜃 (𝑑𝑑𝑑𝑑𝑑𝑑 𝑐𝑐𝑐𝑐2 𝑑𝑑𝑐𝑐𝑑𝑑𝑑𝑑−1) =
𝑑𝑑𝑑𝑑𝑑𝑑𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑐𝑐𝑒𝑒𝑒𝑒𝑒𝑒(𝑐𝑐𝑑𝑑𝑑𝑑𝑑𝑑)  × 106
𝑒𝑒𝑝𝑝𝑒𝑒ℎ𝑑𝑑𝑑𝑑𝑙𝑙𝑑𝑑𝑒𝑒ℎ(𝑐𝑐𝑐𝑐) ×  [𝑒𝑒𝑝𝑝𝑑𝑑𝑒𝑒𝑑𝑑𝑒𝑒𝑙𝑙](𝜇𝜇𝜇𝜇)  ×  𝑙𝑙
 
(3.1) 
Full length protein scans of AdhD and β-AdhD were also performed at 45 °C from 195 to 
260 nm. Data were converted to mean residue ellipticities (Equation 3.1) and experiments were 
performed in at least triplicate. 
3.3.4 Terbium Förster Resonance Energy Transfer 
Terbium binding assays were conducted to probe for the presence of calcium-binding sites 
as terbium is a fluorescent calcium analog with a similar ionic radius. 5 µM protein was incubated 
at 25 °C for 30 minutes in 20 mM PIPES (pH 6.8) supplemented with 120 mM NaCl and 10 mM 
KCl and varying terbium chloride hexahydrate concentrations in the same buffer. The samples 
were excited at 282 nm and emission at 545 nm was measured using a Spectramax M2 Plate 
Reader. Data were fit to a saturation adsorption isotherm (Equation 3.3). 
3.3.5 Intrinsic Tryptophan Fluorescence Experiments 
Cofactor dissociation constants (Kd or Kia values) were determined by fluorescence 
titrations in a J-815 Spectrometer (Jasco, Inc., Easton, MD). Fluorescence titrations were 
performed by incubating 2 mL of a 3 µM enzyme solution in glycine-NaOH buffer (pH 9.3) in 
one-centimeter path-length cuvettes at 45 °C. Samples were excited at 280 nm and emission was 
recorded at 330 nm to detect NAD(P)+ cofactor binding. Cofactors were titrated in and the total 
volume of the cofactor added was less than two percent of the total volume to avoid dilution effects. 





1 +  𝐾𝐾𝑑𝑑−1[𝑁𝑁𝑁𝑁𝑁𝑁(𝐻𝐻)]
 
(3.2) 
Dissociation constants were determined with varying calcium concentrations from 0 to 200 mM 
final concentrations (in 50 mM increments and at 25 mM).  
3.3.6 Kinetic Activity Assays 
Initial rate date for oxidation reactions in the forward direction were determined by 
conducting activity assays at 45 °C in 96-welled plates where substrate (2,3-butanediol), enzyme, 
and glycine buffer (pH 9.3) were initially incubated for 20 minutes. Cofactor (NAD+ or NADP+) 
was added and absorbance at 340 nm was measured continuously for 20 minutes. The initial 
alcohol concentrations ranged from 2 mM to 100 mM and the initial cofactor concentrations 
ranged from 1 µM to 1000 µM. Studies were performed with calcium (or other salt) concentrations 
ranging from 0 and 200 mM. The final reaction volumes were 250 µL. To ensure initial rates were 
collected, data was only used within the first 10% of the conversion of the added cofactor.  The 
absorbance values were converted to cofactor concentrations, and linear regression was used to 
calculate initial rates. These rates were divided by the enzyme concentration to obtain initial 
specific rates (Table 3.7 - Table 3.16).  All measurements were made in at least triplicate. 
3.3.7 Kinetic Rate Data Fitting 
 To determine parameters for various kinetic rate equations, nonlinear regression was 
performed using fits to the entire data sets using least squares curve fitting in MATLAB.  Measured 
dissociation constants were used for the Kia values in the equations.  Parameters were estimated 
and 95% confidence intervals were reported.  For the fit of the full β-AdhD data set to the derived 
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equation with competitive and non-competitive inhibition (Equation 3.10) several of the 
parameters were not well fit leading to error bars at least 3 orders of magnitude larger than values 
and thus these parameters were reported without error bars (Table 3.5).   
3.3.8 Statistical Analysis 
One-way and two-way analysis of variance (ANOVA) as well as Student’s t-test were 
completed using Microsoft Excel. At least three data sets were used per study. Statistical 
significance was indicated by p<0.05.  
3.4 Results and Discussion 
3.4.1 Expression and Purification of AdhD and β-AdhD 
The DNA sequence corresponding to the RTX peptide in the fifth block of the RTX motif 
in the CyaA toxin of Bordetella pertussis was cloned into plasmid pWUR85, which contains the 
AdhD gene from thermostable Pyrococcus furiosus. The 84-amino acid insertion began with an 
added glycine, ended with a phenylalanine, and replaced a valine at position 125 in the AdhD gene, 
resulting in the construct, pWUR85-β-roll. This site in AdhD (Loop A) was chosen for insertion 
as it has previously been shown that this loop region could be swapped with a loop from a related 
enzyme (hAR) without eliminating AdhD activity [19]. The pWUR85 and pWUR85-β-roll 
plasmids were transformed into BL21(DE3) cells and both proteins were expressed. Cloning of 
the RTX domain into Loop A of AdhD resulted in the formation of a new 42 kDa fusion protein, 
β-AdhD, with the parent enzyme, AdhD, having a molecular weight of around 34 kDa. The full 
amino acid and DNA sequences of AdhD and β-AdhD can be found in the Supporting Information. 
The resulting proteins, AdhD and β-AdhD, were routinely produced at 50-100 mg of 
protein per liter of E. coli culture. After induction, the pelleted cells were re-suspended and heat-
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treated for cell lysis and to denature endogenous mesostable E. coli proteins. The whole cell lysates 
were centrifuged and both proteins were found in the soluble fractions. This suggests the insertion 
of the RTX domain did not drastically affect the intrinsic thermostability of AdhD. The soluble 
fractions were concentrated, and the proteins were further purified using size exclusion 
chromatography and yielded the expected molecular masses to greater than 95% purity as seen on 
SDS-PAGE (Figure 3.9). 
3.4.2 Effect of RTX Domain on Protein Thermal Stability 
To further characterize the thermal stability of β-AdhD, denaturation studies were 
conducted where unfolding was monitored by measuring the circular dichroic absorbance at 222 
nm, where a prominent negative signal for alpha helices is observed.  The absorbance signals for 
AdhD and β-AdhD with and without 2.5 mM calcium chloride in water were found to be relatively 
constant up to 90°C, confirming that the insertion did not dramatically perturb native AdhD 
thermostability (Figure 3.10).  
3.4.3 Terbium Förster Resonance Energy Transfer (FRET) Studies to Probe 
the Presence of Calcium-Binding Sites in β-AdhD 
The ability of the β-roll to bind calcium after its insertion into the AdhD protein was 
assessed using FRET upon Tb3+ binding (Figure 3.2). Terbium was used to probe for the presence 
of calcium-binding sites in the RTX domain as it has a similar ionic radius to calcium and can be 
observed via fluorescence. When the RTX domain folds into the β-roll structure, tyrosine residues 
are localized close to the calcium-binding sites, allowing energy transfer between tyrosine and 




1 +  𝐾𝐾𝑑𝑑−1[𝑅𝑅𝑇𝑇3+]
 
(3.3) 
For additions up to 100 µM Tb3+, the change in fluorescence was similar for AdhD and β-
AdhD. At concentrations above 100 µM, the fluorescence signal continued to increase for β-AdhD 
but stayed relatively constant for AdhD. This suggests the β-roll domain in AdhD binds Tb3+ 
beyond what is bound by AdhD alone, indicating the presence of new Tb3+ binding sites. By two-
way ANOVA, the changes in fluorescence as a function of Tb3+ concentration and the interaction 
parameter were statistically significant for AdhD and β-AdhD, indicating the enzymes interact 
differently with Tb3+. These results are similar to what has previously been reported for Tb3+ 
binding by RTX peptide fusions to maltose binding protein [103].  
Figure 3.2 Fluorescence emission measurements at 545 nm as a function of terbium 
concentrations for the RTX domain inserted into AdhD (β-AdhD). The signal for β-AdhD (□) 
continues to increase at higher terbium concentrations as compared to AdhD alone (■), 
indicating calcium binding by the RTX domain beyond the calcium interactions with the AdhD 
protein alone.  
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Although the terbium binding data of the fusion protein, β-AdhD, is consistent with the 
folding of the RTX domain into the β-roll structure upon cation binding, 3-D structure 
determination will be required to definitively determine whether the β-roll structure is the same as 
observed when the same sequence is expressed recombinantly without insertion into another 
protein.   
3.4.4 Impact of Calcium on Cofactor Binding Affinities 
Dissociation constants (Kd values) for AdhD and β-AdhD binding cofactors were 
measured by fluorescence titration where the intrinsic fluorescence of the tryptophan in the 92nd 
position, in the cofactor binding pocket, was quenched by the addition of cofactor (NAD+ or 
NADP+) in the absence and presence of 50 mM Ca2+ (Table 3.1 and Figure 3.13).  This calcium 
concentration was chosen as this is well above the calcium concentration needed for the isolated 
RTX domain to fold into the β-roll structure. 
Table 3.1 Dissociation constants (Kd values, µM) for AdhD and β-AdhD.  Data collected with 
NAD+ and NADP+ in the presence and absence of 50 mM calciuma. 
The Kd values in the absence of calcium show that the insertion of the RTX domain 
improved the binding of NADP+, but changes in the binding of NAD+ were not statistically 
significant. Upon the addition of calcium, the Kd values increased for AdhD and β-AdhD with 
Kd with 0 mM Ca2+ Kd with 50 mM Ca2+ 
AdhD, NAD+ 12 ± 2 18 ± 3 
AdhD, NADP+ 67 ± 6*,† 44 ± 1† 
β-AdhD, NAD+ 12 ± 3⁑ 19 ± 2⁑
β-AdhD, NADP+ 38 ± 3* 48 ± 4 
aAll data were collected in at least triplicate.  Error bars represent standard deviations. 
Statistically significant differences by one-way ANOVA are denoted with *, †, and⁑ 
(p<0.05)  
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NAD+. The Kd of AdhD for NAD+ increased by 50%, while that of β-AdhD increased by 58%, 
but only the change for β-AdhD reached statistical significance. Two-way ANOVA with both 
proteins at 0 and 50 mM calcium revealed that the calcium concentration influenced the 
dissociation constants, whereas the effect of RTX domain insertion was not significant.  
With NADP+ as a cofactor, the Kd values increased for both AdhD and β-AdhD compared 
to NAD+, but the trend for cofactor affinities upon calcium addition were different between the 
enzymes. The Kd values for AdhD decreased by 34% in the presence of calcium but increased by 
26% for β-AdhD.  Only the change for AdhD reached statistical significance.  Two-way ANOVA 
revealed that the effect of the calcium concentration was insignificant, but the effects of the RTX 
domain insertion and the interaction parameter were significant. 
A significant change was observed when comparing enzyme binding affinities to NAD+ 
and NADP+ in the presence and absence of calcium. Two-way ANOVA comparing the Kd values 
for AdhD with NAD+ and NADP+ demonstrate that the type cofactor, as well as the interaction 
parameter, are significantly different, whereas the effect of the calcium concentration was not. The 
same was done for β-AdhD and it was determined that the effects of the cofactor type and the 
calcium concentrations are significant, but the interaction parameter was not. 
Overall these results indicate that the insertion of the RTX domain into AdhD and the 
addition of 50 mM calcium resulted in some significant impacts on the binding of the cofactors, 
but these changes were modest (not reaching an order of magnitude) indicating relatively minor 
impacts on the functions of the cofactor binding pockets. 
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3.4.5 Effect of the RTX Domain on Enzyme Activity in the Absence of 
Calcium 
AdhD follows the ordered bi-bi kinetic mechanism, where cofactor binding necessarily 
occurs before substrate (2,3-butanediol) to form a ternary enzyme/cofactor/substrate complex. 
Initial rate data were collected at varying cofactor (A, 1 - 1000 µM) and 2,3-butanediol substrate 
(B, 2 - 100 mM) concentrations. There are four parameters in the ordered bi-bi rate Equation (3.4). 
The dissociation constants (Kd or Kia values) were measured independently using fluorescence 
titration (as previously described, Table 3.1), so three parameters were used to fit the data (Table 
3.7, Table 3.9, Table 3.11, and Table 3.13). Experiments were performed with either NAD+ and 
NADP+ in the absence of calcium and the data were used to estimate the kinetic parameters (Table 
3.2) using non-linear least squares regression.   
The insertion of the RTX domain into AdhD in the absence of calcium resulted in a substantial 
overall reduction in AdhD activity. The rate data also indicated that substrate saturation was not 
reached for β-AdhD, which prevented the data from being accurately fitted by the ordered bi-bi 
rate equation (Figure 3.16 and Figure 3.17). Therefore, only AdhD kinetic parameters were 
determined at 0 mM calcium with NAD+ and NADP+ (Table 3.2, Table 3.7, and Table 3.11). The 
parameters are consistent with previously published results [17]. 
𝑣𝑣 =
𝐸𝐸𝑡𝑡𝑘𝑘𝑐𝑐𝑐𝑐𝑡𝑡𝑁𝑁𝐴𝐴
𝐾𝐾𝑖𝑖𝑐𝑐𝐾𝐾𝐵𝐵 +  𝐾𝐾𝐴𝐴𝐴𝐴 + 𝐾𝐾𝐵𝐵𝑁𝑁 + 𝑁𝑁𝐴𝐴
(3.4) 
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Table 3.2 Ordered bi-bi kinetic parameters for AdhD (Equation 3.4).  Data collected in the 
oxidation reaction with 2,3–butanediol and NAD(P)+ in the presence and absence of 50 mM 
calciuma. 
3.4.6 Effect of Calcium on Steady-State Kinetic Parameters of AdhD with 
NAD+ and NADP+ as Cofactors 
Steady state kinetic data were measured for AdhD and β-AdhD in the presence of 50 mM 
calcium, as this should be a sufficient calcium concentration to transition the RTX domain into the 
β-roll fold [103]. β-AdhD activity was affected by calcium addition. However, as was seen in the 
absence of calcium, the data with either cofactor could not be accurately fit to Equation 3.4 as 
substrate saturation was not reached (Figure 3.16 and Figure 3.17). 
The dissociation constants (Kd or Kia values) from Table 3.1 were used, and the remaining 
kinetic parameters for AdhD with NAD+ as a cofactor were fit and found to change slightly in the 
presence of calcium (Table 3.2). The KA and KB increased by an order of magnitude, but none of 
the changes reached statistical significance. The same studies were also conducted with NADP+ 
(Table 3.2, Table 3.8, and Table 3.12). Unlike with NAD+, the KA and KB values for AdhD with 









AdhD NAD+ 12 ± 2 1.5 ± 0.2 44 ± 56 5.8 ± 4.0 
AdhD w/50 mM Ca2+ NAD+ 18 ± 3 2.0 ± 0.8 140 ± 140 
AdhD NADP+  67 ± 6* 0.039 ± 0.003† 31 ± 35 
AdhD w/50 mM Ca2+ NADP+  44 ± 1* 0.24 ± 0.01† 23 ± 12 
71 ± 47 
1.1 ± 0.5⁑
5.1 ± 0.6⁑
aKia values were obtained from fluorescence titrations (Table 3.1). All data were collected in 
at least triplicate. Error bars represent 95% confidence intervals. Statistically significant 
differences by t-test of calcium addition are denoted with *, †, and ⁑ (p<0.05).
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the presence of 50 mM calcium. In the presence of calcium, the kcat value increased by around 
500%, the KA decreased by almost 30% and the KB value increased by almost 400%, but only the 
change in kcat and KB reached statistical significance. Therefore, the maximum turnover rate of 
the wild type enzyme increased in the presence of 50 mM calcium when NADP+ was used as a 
cofactor. These results suggest that the addition of calcium increases the turnover rate of the 
enzyme/NADP+/substrate complex into products. The reason for this calcium-induced 
enhancement of NADP+-dependent activity are not clear.  
To shed some light on the structural impact of the calcium addition, circular dichroic 
absorbance studies were performed in the presence and absence of 10 µM NAD(P)+ with and 
without 2.5 mM calcium at 45 °C, the temperature at which the kinetic assays were performed. 
Those concentrations were the highest that could be used, as the spectra became noisy at higher 
concentrations. The addition of cofactor with and without calcium had no effect on the secondary 
structure of AdhD (Figure 3.3A). Similarly, the addition of NAD+ had no effect on the β-AdhD 
secondary structure.  However, the addition of NADP+, calcium, or both resulted in significant 
upward shifts in the spectra (Figure 3.3B).  Further 3-D structural studies of the enzymes in the 
presence of calcium and cofactors would need to be performed to understand how calcium affects 
the formation of the enzyme/cofactor complexes. 
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Figure 3.3 Circular dichroic absorbance at 45 °C for (A) AdhD and (B) β-AdhD.  Spectra were 
measured in the absence of calcium and cofactor (red), and in the presence of 2.5 mM Ca2+ 
(black), 10 µM NAD+ (yellow), 10 µM NAD+ with 2.5 mM Ca2+ (green), 10 µM NADP+ (blue), 
and 10 µM NADP+ with 2.5 mM Ca2+ (purple). All measurements were made in triplicate and 
average values are shown. 
3.4.7 Effect of Calcium on Steady-State Kinetic Parameters Using a 
Simplified Rate Equation for β-AdhD with NAD+ and NADP+ as 
Cofactors 
To obtain a meaningful analysis of the kinetic data for the β-AdhD, the ordered bi-bi rate 
equation (Equation 3.4) was simplified to Equation 3.5 by dividing by the KB term and assuming 
that the substrate values (B) were small as compared to the KB value.  Thus, the equation captures 
activity where the reaction is first order with respect to substrate (B) and the data could be more 
readily fit using this equation. This approach has previously been used for exploring mutations in 
a similar AKR enzyme (2,5-DKGR) [96] and is appropriate for exploring kinetic behavior of an 
enzyme operating below the saturation conditions of the substrate (B<<KB). 
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The fitted apparent Kia value for β-AdhD was an order of magnitude lower than the 
measured Kd value and the fitted value for β-AdhD with 50 mM calcium was an order of 
magnitude higher than the measured Kd value (Table 3.1). As can be seen (Table 3.3), the lumped 
kinetic parameters indicate the overall activity of AdhD decreased by an order of magnitude with 
calcium addition, while β-AdhD decreased by three orders of magnitude in the presence of 50 mM 
calcium with NAD+. By Student’s t-test, the changes in these parameters for AdhD were 
insignificant, while changes in β-AdhD reached statistical significance. Thus, the addition of 50 
mM calcium significantly reduced activity with NAD+ as a cofactor in the β-AdhD enzyme. 
Table 3.3 Kinetic parameters fit to simplified rate equation (Equation 3.5) for AdhD and β-
AdhD with NAD+.  Data collected in the oxidation reaction with 2,3–butanediol and NAD+ in the 







aAdhD (2.6  ± 1.8) x 10-4  12 ± 2 (2.2 ± 1.6) x 10-5  
aAdhD w/50 mM Ca2+ (2.8  ± 2.2) x 10-5   18 ± 3 (1.6 ± 1.2) x 10-6  
β-AdhD (2.0 ± 0.1) x 10-7* 0.63 ± 1.10† (3.2 ± 5.6) x 10-7  
β-AdhD w/50 mM Ca2+ (1.3 ± 0.2) x 10-7*  630 ± 190† (2.1 ± 0.7) x 10-10 
aKia values were obtained from fluorescence titrations (Table 3.1) and kcat/KB data were 
obtained from Table 3.2.  All data were collected in at least triplicate. Error bars represent 
95% confidence intervals. Statistically significant differences by t-test of calcium addition are 
denoted with * and † (p<0.05).     
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The NADP+ data were also fit to the modified rate Equation 3.5. The fitted apparent Kia 
value for β-AdhD was an order of magnitude higher than the measured Kd value and the fitted 
value for β-AdhD with 50 mM calcium was similar to the measured Kd value (Table 3.1). With 
NADP+ as a cofactor, the addition of calcium increased the catalytic efficiency of AdhD by an 
order of magnitude, while the catalytic efficiency of β-AdhD doubled.  However, these changes 
did not reach statistical significance (Table 3.4).  Overall the addition of 50 mM calcium increased 
the activity with NADP+ as a cofactor. 
Table 3.4 Kinetic parameters fit to simplified rate equation (Equation 3.5) for AdhD and β-
AdhD with NADP+.  Data collected in the oxidation reaction with 2,3–butanediol and NADP+ in 
the presence and absence of calcium.  
Taken together, these results indicate that calcium addition (50 mM) has much different 
effects on AdhD versus β-AdhD activity. For AdhD, calcium increases activity with NADP+. 
When the β-roll domain is inserted into AdhD, calcium was also found to increase NADP+-
dependent activity. However, the more dramatic observation is the significant reduction in NAD+-
dependent activity that was seen for β-AdhD and not AdhD alone. Therefore, the calcium-induced 








aAdhD (3.6 ± 1.5) x 10-5  67 ± 6*  (5.3 ± 2.3) x 10-7  
aAdhD w/50 mM Ca2+  (4.7 ± 0.6) x 10-5   44 ± 1* (1.1 ± 0.1) x 10-6 
β-AdhD (5.1 ± 0.8) x 10-7   160 ± 100 (3.3 ± 2.1) x 10-9  
β-AdhD w/50 mM Ca2+ (4.7 ± 0.2) x 10-7  70 ± 20 (6.7 ± 1.9) x 10-9 
a Kia values were obtained from fluorescence titrations (Table 3.1) and kcat/KB data were 
obtained from Table 3.2. All data were collected in at least triplicate. Error bars represent 95% 
confidence intervals. Statistically significant differences by t-test of calcium addition are 
denoted with * (p<0.05).     
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Studies were performed with different salts to confirm the selectivity of this system with 
calcium (Figure 3.18). Magnesium, which has the same cationic charge as calcium, was even more 
inhibitory to AdhD activity with NAD+ than was observed for calcium, and thus magnesium was 
not used as a control for the β-AdhD. Sodium chloride, like calcium, has no significant effects on 
AdhD activity at 50 mM or less with NAD+. With AdhD and NADP+, calcium and sodium chloride 
have a similar effect on AdhD, making it an appropriate control. Although calcium and sodium 
chloride have a similar effect on β-AdhD in the presence of NAD+ and NADP+, the calcium-
induced inhibition of β-AdhD with NAD+ was greater than what was observed sodium chloride, 
which is consistent with the calcium selectivity of the RTX- β-roll transition. 
3.4.8 Effect of Calcium Titration on Cofactor Specificity of β-AdhD 
In order to further explore the impact of calcium on β-AdhD activity, additional kinetic 
rate experiments were performed with varying cofactor and a wider range of calcium 
concentrations (10 - 200 mM), but with constant substrate concentrations (100 mM 2,3–
butanediol) (Figure 3.4). At lower concentrations of calcium, the rates were generally found to 
increase, and then as the calcium concentration was increased further (especially above the 50 mM 
concentration used before), the rates for β-AdhD further decreased in the presence of NAD+ 
(Figure 3.4A). A pseudo-exponential decay as a function of calcium concentration was observed, 
which resulted in the rate decreasing by an order of magnitude at high calcium concentrations. The 
same study was conducted with NADP+; as the calcium concentration increased the rates either 
increased or stayed the same, except for 200 µM NADP+, where a slight decrease in activity was 
observed at around 100 mM calcium or higher (Figure 3.4B). However, unlike NAD+, none of 
these effects altered the rate by an order of magnitude. This is consistent with the observation that 
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calcium has a much larger effect on NAD+-dependent activity in β-AdhD, whereas calcium has a 
mixed effect on NADP+-dependent activity (which is mostly beneficial).    
The insertion of the RTX domain led to a decrease in the affinity of the enzyme/cofactor 
complex for substrate, as evidenced by the fact that the kinetic data collected before were below 
the saturation levels for the enzyme with the substrate, 2,3-butanediol. Therefore, data from Figure 
3.4 were fit to the ordered bi-bi rate equation (Equation 3.4) where the concentration of substrate 
(B) is held constant (but not saturating), which produces an apparent Michaelis Menton type
equation (Equation 3.6). 












Figure 3.4 Specific rates as a function of calcium concentration for β-AdhD with varying 
NAD(P)+. 200 (•), 500 (▲), 750 (-), and 1000 (■) µM cofactor were used all at 100 mM 2,3–
butanediol. (A) Specific rates decrease with NAD+ as a cofactor as calcium concentration 
increases. (B) Specific rates generally are affected differently with NADP+ as a cofactor as 
calcium concentration increases. All measurements were made in triplicate and error bars 
represent 95% confidence intervals. 
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These apparent catalytic efficiencies (kcat,app/KA,app) for AdhD and β-AdhD (at 100 mM 
2,3–butanediol and varying cofactor) were determined as a function of varying calcium 
concentrations (Figure 3.5A, Figure 3.5B, and Figure 3.11). Changes in the apparent catalytic 
efficiencies of AdhD with NAD+ were insignificant at calcium concentrations below 100 mM 
calcium, and a significant decrease in activity was only seen at 200 mM calcium. For β-AdhD, 
decreases in the apparent catalytic efficiencies with NAD+ were significant for all calcium 
concentrations except for 10 mM calcium. Upon the addition of 20 mM calcium, the apparent 
catalytic efficiency decreased by 43% and decreased continuously so that the efficiency decreased 
by 93% with 200 mM calcium.  These results extend the striking trend that was observed before, 
where the addition of calcium dramatically inhibits NAD+-dependent activity in β-AdhD, but not 
AdhD. 
The same study was conducted with NADP+ for both AdhD and β-AdhD (Figure 3.5A, 
Figure 3.5B, and Figure 3.12). Here, calcium addition had much less of an impact. All changes 
in apparent catalytic efficiency for AdhD were insignificant. The same was true for β-AdhD, with 
the exception of 200 mM calcium, where a significant decrease was observed. 
Thus, Figure 3.5A shows that the addition of calcium does not have a large impact on the 
apparent catalytic efficiency of either NAD+ or NADP+ for AdhD, but Figure 3.5B shows there is 
large effect on the catalytic efficiency of β-AdhD for NAD+, which is not seen for NADP+. The 
addition of calcium had a small, but significant effect on the binding of NAD+ by β-AdhD (Table 
3.1), but this data suggests the dominant effect of calcium addition on β-AdhD is the perturbation 
of the ternary complex formed between enzyme/NAD+/substrate.   
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Figure 3.5 Apparent catalytic efficiencies, cofactor dissociation constants, and binding energies 
for AdhD and β-AdhD.  Apparent catalytic efficiencies (kcat,app/KA,app) for AdhD (A) and β-
AdhD (B) with NAD+ (♦) and NADP+ (■) as a function of calcium concentrations with 100 mM 
2,3 – butanediol as the substrate. Insignificant changes were observed for AdhD with NAD+ at 
calcium concentrations lower than 100 mM, while insignificant changes observed with NADP+ 
at all calcium concentrations. A significant decrease in catalytic efficiencies is observed with β-
AdhD with NAD+, but not NADP+, as a function of increasing calcium concentration. Error bars 
represent 95% confidence intervals. Cofactor dissociation constants for NAD+ as a function of 
calcium concentration for AdhD (C) and β-AdhD (D). Data were fit to the saturation adsorption 
isotherm and calculated by equation 10. Error bars represent standard deviations. Changes in 
ground-state and transition state binding energies between AdhD and β- AdhD as a function of 
calcium concentrations. The differences in the ground state binding energy increase as a function 
of calcium concentration (E), while changes in transition-state binding energy as a function of 
calcium concentration (F) plateau after an increase upon calcium addition. The changes in 
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ground state and transition state binding energies were calculated by equations 3.7 and 3.8.  Error 
bars represent standard deviations. 
3.4.9 Effect of Calcium on Changes in Ground State and Transition State 
Binding Energies Between AdhD and β-AdhD 
Steady state kinetic experiments with AdhD and β-AdhD revealed that the addition of the 
RTX domain significantly reduced the activity under all conditions. The apparent kinetic 
parameters obtained from the modified ordered bi-bi rate equation when the substrate is held 
constant (Equation 3.6) can be used to calculate the effect of the mutations and calcium on the 
thermodynamic binding energies of the enzyme/cofactor binary complex (ground state) and the 
enzyme/cofactor/substrate ternary complex (transition state) [90].  
Since the activity of the β-AdhD enzyme was most affected with NAD+ as a cofactor, the 
majority of the analysis was focused on these reactions. Additional dissociation constants for 
NAD+ were determined at varying calcium concentrations (Table 3.6 and Figure 3.13) for 
AdhD and β-AdhD. A sigmoidal relationship between calcium concentration and dissociation 
constants was observed for β-AdhD, but not AdhD (Figure 3.5C and Figure 3.5D). Fitting the 
NAD+ dissociation constant data for β-AdhD as a function of calcium suggests a dissociation 
constant for calcium of 63±1 mM (Figure 3.19). This is larger than the Kd values for calcium 
that we have previously reported using circular dichroism [108], FRET using fluorescent 
proteins appended to the ends of the RTX domain [104], and by following the RTX folding using 
a quartz crystal microbalance (QCM) [105]. However, we have observed Kd values for calcium 
of this magnitude and even higher when the RTX domain repeats were rearranged into non-
native orderings, likely leading to perturbations in the polarized folding mechanism of the β-roll 
domain [102]. Since AdhD is a very stable scaffold, perhaps the insertion of the domain into 
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Loop A of AdhD also adds steric hindrance to the folding of the RTX domain, resulting in an 
increase in the calcium needed to enable folding into the β-Roll structure.  
These dissociation constants (as a function of calcium) were used to calculate changes in 
the ground-state binding energies between the proteins and cofactors at different calcium 
concentrations (Equation 3.7) [90].  
∆∆𝐺𝐺𝑏𝑏 =  −𝑅𝑅𝑅𝑅 ln[(𝐾𝐾𝑑𝑑)𝑤𝑤𝑡𝑡 (𝐾𝐾𝑑𝑑)𝑚𝑚𝑚𝑚𝑡𝑡⁄ ] (3.7) 
The insertion of the RTX domain into AdhD resulted in almost no change in the ground state 
binding energy of NAD+ and this continued up to 50 mM calcium.  However, as more calcium was 
added to the system, surpassing the apparent Kd for calcium, the β-AdhD binary complex lost 
ground state binding energy as compared to the wild type protein (Figure 3.5E). This suggests a 
modulation of the cofactor binding pocket leading to the observed calcium-dependent loss of 
activity with NAD+. Two-way ANOVA revealed the impact of the calcium concentration on the 
ground state binding energies was significant between the two proteins. 
Using the apparent catalytic efficiencies (kcat,app/KA,app) for NAD+ at varying calcium 
concentrations (Figure 3.5A and Figure 3.5B), the changes in the transition-state binding energies 
between the protein/cofactor/substrate complexes were determined using equation (3.8) [90].  










� � (3.8) 
The addition of the RTX domain significantly reduced the transition state binding energy of the β-
AdhD/NAD+/2,3-butanediol ternary complex as compared to the wild type suggesting the addition 
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perturbs the ability of the enzyme to create this complex. However, this was not further affected 
by the addition of calcium (Figure 3.5F). Two-way ANOVA analysis determined that the effect 
of the mutation is significant, whereas the effect of the calcium concentration is insignificant. 
These data suggest that the addition of the RTX sequence into AdhD perturbs the transition 
state with NAD+ as a cofactor under all calcium conditions. As calcium is added above the Kd of 
the RTX domain for calcium, the binding of the calcium also impacts the ground state binding of 
the NAD+ cofactor as well.  The reason why this effect occurs with NAD+ as a cofactor while far 
less of an impact with NADP+ is observed is not clear.  Crystal studies of the apo- and holo- forms 
of other members of the AKR superfamily suggest a rearrangement of these enzymes upon cofactor 
binding [14]. The catalytic tetrad residues are highly conserved in the AKR superfamily, including 
2,5-DKGR [23]. In particular, regions of 2,5-DKGR near the catalytic tetrad lack electron density 
suggesting a poorly defined structure, which becomes well-defined upon the binding of cofactor. 
This suggests the binding of cofactor facilitates the organization of the active site [14]. On the 
other hand, the residues that comprise the cofactor-binding pocket undergo minimal changes upon 
cofactor binding, suggesting the enzyme is always ready to interact with the cofactor. This implies 
that the cofactor does not only undergo hydride ion transfer with the substrate, but is also 
responsible for the orientation of the residues in the catalytic tetrad and substrate-binding pocket 
[14]. Therefore, we can speculate that when NADP+ is used as a cofactor, the active site 
organization is less affected by calcium as compared to when NAD+ is used.  This is consistent 
with the circular dichroism data where NADP+ and calcium affected the β-AdhD secondary 
structure differently than NAD+ alone (Figure 3.3), but structural studies of β-AdhD with cofactors 
and calcium would shed more light on these interactions.  
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Another interesting feature of AKR enzymes is the fact that many are NADP(H)-dependent 
and it has been shown that a canonical arginine residue (R276 in rat 3α- hydroxysteroid 
dehydrogenase) makes an ionic interaction with the phosphate group of NADP(H). This coincides 
with a conformational change where a salt bridge is able to form over the bound NADP(H) 
molecule, which is thought to enhance the kinetic mechanism [23]. We have previously studied 
these features in AdhD, which has a histidine (H255) at the position corresponding to R276 and 
the putative salt bridge is missing [17]. Despite these differences, pre-steady state kinetics showed 
a range of conformational dynamics in the wild type and an H255R mutant with both NAD(H) and 
NADP(H). Most interestingly, we observed a difference in the conformational dynamics between 
the cofactors, and this could also explain the asymmetry of the effect of calcium addition to the β-
AdhD enzyme [17]. The two different cofactors require different protein conformational changes 
during cofactor binding, and the insertion and calcium-dependent folding of the β-roll may affect 
these dynamics differently.   
3.4.10 Inhibition Analyses Suggest Calcium Acts as a Competitive Inhibitor in 
AdhD and a Mixed Inhibitor in β-AdhD 
We combined all the steady state kinetic data collected to attempt to complete the full 
forward kinetic analysis of the impacts of calcium on AdhD and β-AdhD activity. Therefore, 
Lineweaver-Burk plots were used to qualitatively evaluate the calcium inhibition mechanisms 
using the data collected over the wide range of calcium concentrations. The inverse of specific 
activity as a function of inverse cofactor concentration depicts similar y-intercepts for AdhD at 
varying calcium concentrations with an increase in slope, suggesting calcium acts as a competitive 
inhibitor of AdhD (Figure 3.6A). To quantify the inhibition constant, the data were fit to the 
ordered bi-bi rate equation with competitive inhibition of cofactor (Equation 3.9) [111].  
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Data with zero calcium (no inhibition) and varying cofactor and substrate were combined with 
data obtained with varying calcium and cofactor and 100 mM 2,3-butanediol and all of the data 
collected (254 reaction rates over a range of cofactor, substrate, and calcium concentrations, Table 
3.15) were fit by Equation 7 using least square regression to determine the kinetic constants (Table 
3.5, Figure 3.6B). The measured values of the dissociation constants at each calcium concentration 
were input as constants. The calcium inhibition constant, KI, was found to be 7.6 ± 7.4 mM (Table 
3.5, Figure 3.6B). The remainder of the parameters provided a good fit to the data, and the kcat, 
KA, and KB values from the global fit (Table 3.5) were not statistically significantly different from 
the same values obtained with zero calcium (Table 3.2).  However, it was clear by observing the 
fits of the data at different calcium and substrate conditions that this equation did not fully capture 
all the features in the data (Figure 3.6C). This suggests that the interactions of AdhD with calcium 
may be more complex than just competitive inhibition in the active site. This is not surprising 
given the fact that calcium seemed to accelerate AdhD activity with NADP+ as a cofactor and thus, 
it is unlikely that calcium just acts as a classic competitive inhibitor. Lineweaver-Burk plots were 
created for NADP+, but no obvious qualitative trend was observed (Figure 3.14). 
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Figure 3.6 AdhD calcium inhibition study. (A) Double reciprocal plot showing inverse AdhD 
specific activity vs inverse NAD+ with 100 mM 2,3-butanediol with increasing calcium 
concentrations as slope increases with inset of higher NAD+ concentrations depicted on top-left. 
This shows qualitatively that calcium acts as a competitive inhibitor with AdhD. (B) The same 
experimental rate data from panel (A) for AdhD with constant 100 mM 2,3-butanediol and 
varying NAD+ with 0 (•), 25 (■), 50 (♦), 100 (▲), 150 (▬), and 200 (x) mM calcium depicted as 
data points. The least squares fitted rate equation at these concentrations using equation 3.9 and 
the parameters from Table 3.5 are depicted as solid lines. (C) AdhD with 40 and 60 mM 2,3-
butanediol and varying NAD+ with 0 (•) and 50 (°) mM calcium. The least squares fitted rate 
equation at these concentrations using equation 3.9 and the parameters from Table 3.5 are 























































We assumed that the addition of the RTX domain into AdhD would add an orthogonal 
inhibition site, and since this was located away from the cofactor binding pocket, this could 
introduce a different inhibition mechanism. The Lineweaver-Burk plot for β-AdhD over a range 
of calcium concentrations shows an increasing slope at increasing calcium concentrations 
qualitatively suggesting competitive inhibition. However, a large change in the y-intercept is also 
observed suggesting non-competitive inhibition (Figure 3.7A). Calcium binding to the active site 
of AdhD is most likely contributing to competitive inhibition, while calcium binding to the β-roll 
and decreasing the affinity of the substrate to β-AdhD leads to an orthogonal non-competitive 
inhibition effect.  Calcium inhibition of β-AdhD in the presence of NADP+ was also explored using 
Lineweaver Burke plots, but like AdhD, no clear qualitative trend was observed (Figure 3.15). 
A mixed inhibition equation was derived (Supporting Information) for the ordered bi-bi 
mechanism (Equation 3.10). Although only one inhibitor is present (calcium), it acts in two 
different locations in the protein and thus, the rate equation was derived to accommodate 
competitive inhibition by calcium (I) in the active site of β-AdhD and non-competitive inhibition 
in the RTX site by calcium (J), so that two different inhibition constants could be determined.  
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Using a global least squares fit, all kinetic parameters were determined, with the exception of 
Kia, which was set to the Kd values from fluorescence titrations (Figure 3.13). Despite fitting 
331 reaction rates (Table 3.16) at varying cofactor, substrate, and calcium concentrations, the 
error bars for several of the parameters were orders of magnitude larger than the values. This 
suggests that despite the large data set used, additional data would be necessary to fully 
determine the remaining kinetic parameters. Pre-steady state or other methods may be necessary 
to determine these parameters with acceptable precision. In addition, it is also likely that calcium 
has other effects or interactions with the enzyme that may not be captured by just competitive 
and non-competitive inhibition. However, the values provide a reasonable fit to the experimental 
data (Figure 3.7B).  
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Figure 3.7 β-AdhD calcium inhibition study. (A) Double reciprocal plot showing inverse β-
AdhD specific activity vs inverse NAD+ with 100 mM 2,3-butanediol with increasing calcium 
concentrations as slope increases with inset of higher NAD+ concentrations depicted on top-left. 
This shows qualitatively that calcium acts as a mixed inhibitor with β-AdhD. (B) The same 
experimental rate data from panel (A) for β-AdhD with constant 100 mM 2,3-butanediol and 
varying NAD+ with experimental rates depicted as data points. The least squares fitted rate 
equation at these concentrations using equation 3.10 and the parameters from Table 3.5 are 
depicted as solid lines. (C) β-AdhD with 40 and 60 mM 2,3-butanediol and varying NAD+ with 0 
(•) and 50 (°) mM calcium. The least squares fitted rate equation at these concentrations using 
equation 3.10 and the parameters from Table 3.5 are depicted as solid lines for 0 mM calcium 
and dashed lines for 50 mM calcium. 
The kcat/KB value from the global fit (Table 3.5) was found to be similar to the same parameters 
from the modified rate equation fit to the data in the absence of calcium (Table 3.3). And a 

























































inhibit the system non-competitively is much less than the calcium required to inhibit AdhD 
competitively. 
Table 3.5 Calcium inhibition constants for AdhD and β-AdhD. Competitive inhibition constants 
(Equation 3.9) for AdhD and mixed inhibition constants (Equation 3.10) for β-AdhD with 100 
mM 2,3–butanediol, 1 to 1000 µM NAD+ and 0 to 200 mM calciuma.  
aAll data was collected in at least triplicate. Error bars represent 95% confidence intervals. 
bConfidence intervals are at least 3 orders of magnitude larger than values and thus are omitted 
for clarity. 
There are several figures of merit that could be used to compare the different enzymes at 
different calcium concentrations. The modified rate equation where the substrate concentration is 
low (Equation 3.5) provides a good fit to the data at 0 and 50 mM calcium, and this equation can 
be used to calculate an apparent kcat/KM for the two enzymes (Figure 3.8). The wild type protein 
is affected by calcium such that its activity with NAD+ is reduced but its activity with NADP+ is 
increased. The cofactor selectivity is broadened, but the preference for NAD+ remains. The 









AdhD 1.4 ± 0.2 34 ± 34 7.7 ± 4.7 7.6 ± 7.4 











AdhD N/A N/A N/A N/A N/A 
β-AdhD 0.038 b 1.1b 1.1 b 85 b 86 b
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of calcium, the β-AdhD enzyme has a strong preference for NAD+ over NADP+. However, as 
calcium is increased, the NADP+-dependent activity is enhanced, while the NAD+-dependent 
activity is dramatically inhibited. Thus, the addition of the RTX domain introduces calcium-
dependent control over the cofactor selectivity of AdhD.  
Figure 3.8 Apparent catalytic efficiency of (A) AdhD and (B) β-AdhD with NAD+ and NADP+ 
at 0 and 50 mM calcium.  Cofactor specificity of β-AdhD reverses upon the addition of calcium. 
The catalytic efficiency of β-AdhD in the absence of calcium is greater with NAD+, while in the 
presence of 50 mM Ca2+, activity is greater with NADP+. 
This new IDP/enzyme chimera, whose activity and relative cofactor selectivity can be 
controlled externally through the addition or removal of calcium, is reminiscent of a protein switch. 
In these systems, protein structures change in response to input signals (ligands, pH, etc.) leading 
to outputs such as altered ligand affinities or enzymatic activities [112-114]. Examples of protein 
switches include a barnase/ubiquitin system and a maltose binding protein/beta-lactamase system 
where catalytic activity is modulated by maltose [113, 115-119]. These switches can be used in 
applications including biosensors, therapeutic agents, and smart biomaterials.   
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3.5 Conclusion 
In conclusion, the insertion of a conformationally dynamic IDP domain into a loop near 
the active site of an enzyme, β-AdhD, resulted in a novel thermostable chimera. The RTX 
domain introduces a new non-competitive calcium-binding inhibition site that preferentially 
impacts NAD+-dependent activity. Thus, in the new protein, calcium functions as a novel 
“rheostat”-like switching mechanism, where cofactor selectivity can be tuned with calcium.  This 
approach should be modular and could be used to introduce calcium-dependent modulation of 
activity in any other member of the AKR superfamily, which are ubiquitous and are known to 
participate in many physiological roles [120]. The use of IDP domains to dynamically modify 
enzymatic activity, especially cofactor selectivity, is an important new approach in biocatalyst 
development. 
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3.6 Supporting Information 
AdhD and β-AdhD amino acid sequences 
AdhD 
MGDYKDDDDK AKRVNAFNDL KRIGDDKVTA IGMGTWGIGG RETPDYSRDK ESIEAIRYGL 60 
ELGMNLIDTA EFYGAGHAEE IVGEAIKEFE REDIFIVSKV WPTHFGYEEA KKAARASAKR       120 
LGTYIDLYLL HWPVDDFKKI EETLHALEDL VDEGVIRYIG VSNFNLELLQ RSQEVMRKYE       180 
IVANQVKYSV KDRWPETTGL LDYMKREGIA LMAYTPLEKG TLARNECLAK IGEKYGKTAA       240 
QVALNYLIWE ENVVAIPKAS NKEHLKENFG AMGWRLSEED REMARRCVED PNSSSVD 297 
β-AdhD 
MGDYKDDDDK AKRVNAFNDL KRIGDDKVTA IGMGTWGIGG RETPDYSRDK ESIEAIRYGL 60 
ELGMNLIDTA EFYGAGHAEE IVGEAIKEFE REDIFIVSKV WPTHFGYEEA KKAARASAKR       120 
LGTYIDLYLL HWPGGSARDD VLIGDAGANV LNGLAGNDVL SGGAGDDVLL GDEGSDLLSG       180 
DAGNDDLFGG QGDDTYLFGV GYGHDTIYES GGGHDTIRFD DFKKIEETLH ALEDLVDEGV       240 
IRYIGVSNFN LELLQRSQEV MRKYEIVANQ VKYSVKDRWP ETTGLLDYMK REGIALMAYT       300 
PLEKGTLARN ECLAKIGEKY GKTAAQVALN YLIWEENVVA IPKASNKEHL KENFGAMGWR       360 
LSEEDREMAR RCVEDPNSSS VD 382 
AdhD and β-AdhD DNA sequences 
AdhD 
ATGGGGGACT ACAAAGACGA TGACGACAAG GCAAAACGCG TGAATGCATT TAACGACCTG 60     
AAACGTATTG GTGATGACAA AGTAACCGCT ATCGGCATGG GTACTTGGGG CATCGGTGGT       120 
CGTGAAACCC CGGATTACAG CCGCGACAAA GAGTCCATCG AGGCGATCCG TTATGGCCTG       180 
GAGCTGGGTA TGAACCTGAT TGACACGGCG GAGTTTTATG GTGCCGGCCA CGCTGAAGAG       240 
ATTGTCGGTG AAGCCATCAA AGAGTTCGAA CGCGAGGACA TCTTCATTGT TTCGAAGGTC       300 
TGGCCGACCC ACTTTGGTTA TGAAGAGGCG AAGAAAGCTG CACGCGCCAG CGCGAAGCGT       360 
CTGGGCACCT ACATTGATCT GTACCTGTTG CATTGGCCGG TCGACGACTT TAAAAAGATT       420 
GAAGAAACCC TGCACGCACT CGAGGATTTG GTGGATGAGG GTGTCATTCG CTACATCGGC       480 
GTTTCCAATT TCAATCTGGA GTTGCTGCAA CGTAGCCAGG AAGTGATGCG TAAGTACGAG       540 
ATCGTGGCGA ACCAGGTCAA ATACAGCGTG AAGGACCGTT GGCCAGAAAC GACCGGCCTG       600 
CTGGACTATA TGAAACGTGA GGGTATCGCG CTGATGGCCT ATACGCCTCT AGAAAAAGGT       660 
ACCCTGGCGC GTAACGAGTG CCTGGCAAAG ATCGGTGAGA AGTACGGTAA GACGGCGGCA       720 
CAAGTTGCCC TGAATTACCT GATTTGGGAA GAGAATGTTG TGGCGATTCC GAAGGCGAGC       780 
AACAAAGAGC ATCTGAAAGA GAACTTCGGC GCGATGGGCT GGCGCCTGAG CGAAGAAGAT       840 
CGTGAGATGG CGCGCCGGTG TGTTGAGGAT CCGAATTCGA GCTCCGTGGA C 891 
β-AdhD 
ATGGGGGACT ACAAAGACGA TGACGACAAG GCAAAACGCG TGAATGCATT TAACGACCTG 60 
AAACGTATTG GTGATGACAA AGTAACCGCT ATCGGCATGG GTACTTGGGG CATCGGTGGT       120 
CGTGAAACCC CGGATTACAG CCGCGACAAA GAGTCCATCG AGGCGATCCG TTATGGCCTG       180 
GAGCTGGGTA TGAACCTGAT TGACACGGCG GAGTTTTATG GTGCCGGCCA CGCTGAAGAG       240 
ATTGTCGGTG AAGCCATCAA AGAGTTCGAA CGCGAGGACA TCTTCATTGT TTCGAAGGTC       300 
TGGCCGACCC ACTTTGGTTA TGAAGAGGCG AAGAAAGCTG CACGCGCCAG CGCGAAGCGT       360 
CTGGGCACCT ACATTGATCT GTACCTGTTG CATTGGCCGG GGGGCAGCGC GCGTGATGAC       420 
GTGCTGATCG GCGACGCAGG CGCCAACGTC CTCAATGGCC TGGCGGGCAA CGACGTGCTG       480 
TCCGGCGGCG CTGGCGACGA TGTGCTGCTG GGCGACGAGG GCTCGGACCT GCTCAGCGGC       540 
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GATGCGGGCA ACGACGATCT GTTCGGCGGG CAGGGCGATG ATACTTATCT GTTCGGGGTC       600 
GGGTACGGGC ACGACACGAT CTACGAATCG GGCGGCGGCC ATGACACCAT CCGCTTCGAC       660 
GACTTTAAAA AGATTGAAGA AACCCTGCAC GCACTCGAGG ATTTGGTGGA TGAGGGTGTC       720 
ATTCGCTACA TCGGCGTTTC CAATTTCAAT CTGGAGTTGC TGCAACGTAG CCAGGAAGTG       780 
ATGCGTAAGT ACGAGATCGT GGCGAACCAG GTCAAATACA GCGTGAAGGA CCGTTGGCCA       840 
GAAACGACCG GCCTGCTGGA CTATATGAAA CGTGAGGGTA TCGCGCTGAT GGCCTATACG       900 
CCTCTAGAAA AAGGTACCCT GGCGCGTAAC GAGTGCCTGG CAAAGATCGG TGAGAAGTAC       960 
GGTAAGACGG CGGCACAAGT TGCCCTGAAT TACCTGATTT GGGAAGAGAA TGTTGTGGCG      1020 
ATTCCGAAGG CGAGCAACAA AGAGCATCTG AAAGAGAACT TCGGCGCGAT GGGCTGGCGC      1080 
CTGAGCGAAG AAGATCGTGA GATGGCGCGC CGGTGTGTTG AGGATCCGAA TTCGAGCTCC      1140 
GTGGAC                                                                 1146 
Figure 3.9 SDS-PAGE of AdhD and β-AdhD after gel filtration. Lane 1: molecular weight 
marker, lane 2: AdhD, lane 3: β-AdhD. Samples were lysed by heating for 1 h at 80°C prior to 
purification. A distinct band at approximately 34 kDa for AdhD and 42 kDa for β-AdhD is 
observed, consistent with the theoretical molecular masses. 
 1   2     3 
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Figure 3.10 Thermal denaturation curves for AdhD and β-AdhD. Studies were done in the 
absence and presence of calcium as measured by the circular dichroic absorbance at 222 nm as 
temperature was varied from 25 to 90 °C. 1.25 µM samples were prepared in water and runs 
were performed in at least duplicate. 
Figure 3.11 Rate versus NAD+ at varying calcium concentrations for β-AdhD.  Data were 




























AdhD with 2.5 mM Ca2+
β-AdhD




























Figure 3.12 Rate versus NADP+ at varying calcium concentrations for β-AdhD.  Data were 




























Figure 3.13 Fluorescence titrations for AdhD and β-AdhD. From 0 to 200 mM calcium with NAD+ 
and at zero and 50 mM calcium with NADP+. Data were collected in at least triplicate. 
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Table 3.6 Dissociation constants for cofactor (NAD+) for AdhD and β-AdhD at various calcium 
concentrations. 
Figure 3.14 Double reciprocal plot of inverse specific activity for AdhD vs inverse NADP+. 
Reactions run with 100 mM 2,3-butanediol with increasing calcium concentrations. There is no 
clear tend as a function of increasing calcium concentration, indicating a mixed inhibition.  








0 12 ± 2 12 ± 3 
10 14 ± 4 
20 14 ± 4 
25 21 ± 3 17 ± 3 
30 19 ± 5 
40 15 ± 4 
50 18 ± 3 19 ± 2 
60 29 ± 6 
70 27 ± 4 
80 36 ± 5 
90 40 ± 7 
100 36 ± 5 57 ± 6 
150 24 ± 3 58 ± 7 
200 31 ± 4 60 ± 8 
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Figure 3.15 Double reciprocal plot of inverse specific activity for β-AdhD vs NADP+. Reactions 
run with 100 mM 2,3-butanediol with increasing calcium concentrations. There is no clear trend 
as a function of increasing calcium concentration, indicating a mixed inhibition.   
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β-AdhD, 0 Ca2+, NAD+ 
β-AdhD, 50 Ca2+, NAD+ 
Figure 3.16 Steady state kinetic rate data for β-AdhD at 0 and 50 mM calcium with NAD+.  Data 
were collected in at least triplicate. 
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β-AdhD, 0 Ca2+, NADP+ 
β-AdhD, 50 Ca2+, NADP+
Figure 3.17 Steady state kinetic rate data for β-AdhD at 0 and 50 mM calcium with NADP+. 
Data were collected in at least triplicate. 
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Figure 3.18 Specific rates for AdhD and β-AdhD with 0, 10, 50, and 100 mM salts with NAD+ 
and NADP+ as cofactors.  Magnesium has a strong inhibitor effect on the activity of AdhD with 
NAD+, and therefore was not an appropriate control. NaCl was used as a control to compare with 
CaCl2 with β-AdhD. Stars indicate statistically significant rates (*p<0.05, **p<0.005) compared 
to the protein in the absence of the salt (red bars). Data were collected in at least triplicate.  
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Ordered Bi Bi Derivations 
Case 1: varying [B] 
V = Et * kcat * A * B / (Kia*Kb + Ka*B + A*Kb + AB) 
Case 2: Constant [B] 
- Ordered bi-bi rate equation
V = Et * kcat * A * B / (Kia*Kb + Ka*B + A*Kb + AB) 
- Constant B so can divide by B and Kb (both constants)
V = [(Et * kcat * A * B)/(Kb*B)] / (Kia*Kb/(Kb*B) + Ka*B/(B*Kb) + A*Kb/(B*Kb) + 
AB/(Kb*B) 
V = (Et * (kcat *B/Kb + B) * A) / ((KiaKb + KaB)/(Kb + B) + A) 
V = Et * kcat,app * A / (Ka,app + A) 
** Same form as Michaelis-Menton Equation; used to determine apparent parameters 
Case 3: Kb >> B 
V = Et * kcat * A * B / (Kia*Kb + Ka*B + A*Kb + AB) 
- Divide by Kb (Kb values exceed B)
V = (Et * kcat * A * B / Kb) / (Kia*Kb/Kb + Ka*B/Kb + A* Kb/Kb + AB/Kb) 
V = (Et * kcat * A * B / Kb) / (Kia + 0 [kb >> B] + A + 0 [kb >> B]) 
V = (Et*kcat*A*B /kb) / (Kia + A) 
Mixed competitive and non-competitive inhibition derivation for β-AdhD 
- The following script was entered into DynaFit
   reaction A + B  ---> P + Q 
   modifiers I, J 
   E + A  <==> EA       :     k1  k-1 
   EA + B <=> EAB      :     k2  k-2 
   EAB   <=> EPQ        :     kp  k-p 
   EPQ  <=> EQ + P    :     k3  k-3 
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   EQ  <=> E + Q         :     k4  k-4 
   E + I  <=> EI             :     k5  k-5   
   E + J  <=> EJ            :     k6  k-6 
   EJ + I <=> EJI           :     k7  k-7 
   EJ + A  <=> EJA       :     k8  k-8 
   EJA + B <=> EJAB   :     k9  k-9 
   EJAB <=> EJPQ       :     k10 k-10 
   EJPQ <=> EJQ + P   :     k11 k-11 
   EJQ <=> EJ + Q       :     k12 k-12 
Notes: 
- Competitive inhibition, where calcium competes with the substrate, was previously
shown to be true for AdhD
- Non-competitive inhibition, where calcium binds at a site other than the active site and
decreases the affinity of the enzyme for the substrate, is assumed to represent the β-roll
binding sites
- “I” represents calcium binding to AdhD
- “J” represents calcium binding to the β-roll
- There are no steps following the EJI complex because it is a dead end complex with
calcium binding to the β-roll and the active site of AdhD. “I” is competing with cofactor
so the calcium attachment is reversible. When calcium binds the β-roll it is not reversible.
Therefore, EJI is used as opposed to EIJ.
- The following model output was obtained (based on the King-Altman method):
Rate Equation 
V = [E]0 N/D = d[P]/dt = + k3 [EPQ] - k-3 [EQ] [P] + k11 [EJPQ] - k-11 [P] [EJQ] 
N = n1 [P][Q] + n2 [A][B] + n3 [P][Q][J] - n4 [P]2[Q] - n5 [B][P][Q] + n6 [A][B][J] + n7 
[A][B][P] + n8 [A][B]2 - n9 [P]2[Q][J] - n10 [B][P][Q][J] + n11 [A][B][P][J] + n12 [A][B]2[J] 
D = d1 + d2 [J] + d3 [I] + d4 [Q] + d5 [P] + d6 [B] + d7 [A] + d8 [I][J] + d9 [Q][J] + d10 [P][J] 
+ d11 [P][I] + d12 [P][Q] + d13 [P]2 + d14 [B][J] + d15 [B][I] + d16 [B][Q] + d17 [B][P] + d18
[B]2 + d19 [A][J] + d20 [A][P] + d21 [A][B] + d22 [P][I][J] + d23 [P][Q][J] + d24 [P]2[J] + d25
[P]2[I] + d26 [P]2[Q] + d27 [B][I][J] + d28 [B][Q][J] + d29 [B][P][J] + d30 [B][P][I] + d31
[B][P][Q] + d32 [B]2[J] + d33 [B]2[I] + d34 [B]2[Q] + d35 [A][P][J] + d36 [A][P]2 + d37
[A][B][J] + d38 [A][B][P] + d39 [A][B]2 + d40 [P]2[I][J] + d41 [P]2[Q][J] + d42 [B][P][I][J] +
d43 [B][P][Q][J] + d44 [B][P]2[Q] + d45 [B]2[I][J] + d46 [B]2[Q][J] + d47 [B]2[P][Q] + d48
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[A][P]2[J] + d49 [A][B][P][J] + d50 [A][B][P]2 + d51 [A][B]2[J] + d52 [A][B]2[P] + d53 
[B][P]2[Q][J] + d54 [B]2[P][Q][J] + d55 [A][B][P]2[J] + d56 [A][B]2[P][J] 
Terms: 
n1 = k-1 k-2 k-p k-3 k-4 k-5 k-6 k-7 k-8 k12 ( - k-9 k-10 - k-9 k11 - k10 k11 ) 
n2 = k1 k2 kp k3 k4 k-5 k-6 k-7 k-8 k12 ( + k-9 k-10 + k-9 k11 + k10 k11 ) 
n3 = k-1 k4 k-5 k6 k-7 k-8 k-9 k-10 k-11 k-12 ( - k-2 k-p - k-2 k3 - kp k3 ) 
n4 = - k-1 k-2 k-p k-3 k-4 k-5 k-6 k-7 k-8 k-9 k-10 k-11 
n5 = - k-1 k-2 k-p k-3 k-4 k-5 k-6 k-7 k9 k10 k11 k12 
n6 = k-1 k4 k-5 k6 k-7 k8 k9 k10 k11 k12 ( + k-p k-2 + kp k3 ) 
n7 = + k1 k2 kp k3 k4 k-5 k-6 k-7 k-8 k-9 k-10 k-11 
n8 = + k1 k2 kp k3 k4 k-5 k-6 k-7 k9 k10 k11 k12 
n9 = - k-1 k-2 k-p k-3 k-5 k6 k-7 k-8 k-9 k-10 k-11 k-12 
n10 = - k2 kp k3 k4 k-5 k6 k-7 k-8 k-9 k-10 k-11 k-12 
n11 = + k-1 k-2 k-p k-3 k-5 k6 k-7 k8 k9 k10 k11 k12 
n12 = + k2 kp k3 k4 k-5 k6 k-7 k8 k9 k10 k11 k12 
d1 = k-1 k4 k-5 k-6 k-7 k-8 k12 ( k-2 k-p k-9 k-10 + k-2 k-p k-9 k11 + k-2 k-p k10 k11 + k-2 k3 
k-9 k-10 + k-2 k3 k-9 k11 + k-2 k3 k10 k11 + kp k3 k-9 k-10 + kp k3 k-9 k11 + kp k3 k10 k11 )
d2 = k-1 k4 k-5 k6 k-7 k-8 k12 ( k-2 k-p k-9 k-10 + k-2 k-p k-9 k11 + k-2 k-p k10 k11 + k-2 k3
k-9 k-10 + k-2 k3 k-9 k11 + k-2 k3 k10 k11 + kp k3 k-9 k-10 + kp k3 k-9 k11 + kp k3 k10 k11 )
d3 = k-1 k4 k5 k-6 k-7 k-8 k12 ( k-2 k-p k-9 k-10 + k-2 k-p k-9 k11 + k-2 k-p k10 k11 + k-2 k3
k-9 k-10 + k-2 k3 k-9 k11 + k-2 k3 k10 k11 + kp k3 k-9 k-10 + kp k3 k-9 k11 + kp k3 k10 k11 )
d4 = k-1 k-4 k-5 k-6 k-7 k-8 k12 ( k-2 k-p k-9 k-10 + k-2 k-p k-9 k11 + k-2 k-p k10 k11 + k-2 k3
k-9 k-10 + k-2 k3 k-9 k11 + k-2 k3 k10 k11 + kp k3 k-9 k-10 + kp k3 k-9 k11 + kp k3 k10 k11 )
d5 = k-1 k-5 k-6 k-7 k-8 ( k-2 k-p k4 k-9 k-10 k-11 + k-2 k-p k-3 k-9 k-10 k12 + k-2 k-p k-3 k-9 
k11 k12 + k-2 k-p k-3 k10 k11 k12 + k-2 k3 k4 k-9 k-10 k-11 + kp k3 k4 k-9 k-10 k-11 ) 
d6 = k4 k-5 k-6 k-7 k12 ( k-1 k-2 k-p k9 k10 k11 + k-1 k-2 k3 k9 k10 k11 + k-1 kp k3 k9 k10 
k11 + k2 kp k3 k-8 k-9 k-10 + k2 kp k3 k-8 k-9 k11 + k2 kp k3 k-8 k10 k11 ) 
d7 = k1 k4 k-5 k-6 k-7 k-8 k12 ( k-2 k-p k-9 k-10 + k-2 k-p k-9 k11 + k-2 k-p k10 k11 + k-2 k3 
k-9 k-10 + k-2 k3 k-9 k11 + k-2 k3 k10 k11 + kp k3 k-9 k-10 + kp k3 k-9 k11 + kp k3 k10 k11 )
d8 = k-1 k4 k-5 k6 k7 k-8 k12 ( k-2 k-p k-9 k-10 + k-2 k-p k-9 k11 + k-2 k-p k10 k11 + k-2 k3
k-9 k-10 + k-2 k3 k-9 k11 + k-2 k3 k10 k11 + kp k3 k-9 k-10 + kp k3 k-9 k11 + kp k3 k10 k11 )
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d9 = k-1 k4 k-5 k6 k-7 k-8 k-12 ( k-2 k-p k-9 k-10 + k-2 k-p k-9 k11 + k-2 k-p k10 k11 + k-2 k3 
k-9 k-10 + k-2 k3 k-9 k11 + k-2 k3 k10 k11 + kp k3 k-9 k-10 + kp k3 k-9 k11 + kp k3 k10 k11 )
d10 = k-1 k-5 k6 k-7 k-8 ( k-2 k-p k4 k-9 k-10 k-11 + k-2 k-p k-3 k-9 k-10 k12 + k-2 k-p k-3 k-9 
k11 k12 + k-2 k-p k-3 k10 k11 k12 + k-2 k3 k4 k-9 k-10 k-11 + kp k3 k4 k-9 k-10 k-11 ) 
d11 = k-1 k5 k-6 k-7 k-8 ( k-2 k-p k4 k-9 k-10 k-11 + k-2 k-p k-3 k-9 k-10 k12 + k-2 k-p k-3 k-9 
k11 k12 + k-2 k-p k-3 k10 k11 k12 + k-2 k3 k4 k-9 k-10 k-11 + kp k3 k4 k-9 k-10 k-11 ) 
d12 = k-4 k-5 k-6 k-7 k-8 ( k-2 k-p k-3 k-9 k-10 k12 + k-2 k-p k-3 k-9 k11 k12 + k-2 k-p k-3 k10 
k11 k12 + k-1 k-p k-3 k-9 k-10 k12 + k-1 k-p k-3 k-9 k11 k12 + k-1 k-p k-3 k10 k11 k12 + k-1 
k-2 k-3 k-9 k-10 k12 + k-1 k-2 k-3 k-9 k11 k12 + k-1 k-2 k-3 k10 k11 k12 + k-1 kp k-3 k-9 k-10
k12 + k-1 kp k-3 k-9 k11 k12 + k-1 kp k-3 k10 k11 k12 + k-1 k-2 k-p k-9 k-10 k-11 + k-1 k-2 k3
k-9 k-10 k-11 + k-1 kp k3 k-9 k-10 k-11 )
d13 = k-1 k-2 k-p k-3 k-5 k-6 k-7 k-8 k-9 k-10 k-11
d14 = k4 k-5 k6 k-7 k12 ( k-1 k-2 k-p k9 k10 k11 + k-1 k-2 k3 k9 k10 k11 + k-1 kp k3 k9 k10 
k11 + k2 kp k3 k-8 k-9 k-10 + k2 kp k3 k-8 k-9 k11 + k2 kp k3 k-8 k10 k11 ) 
d15 = k4 k5 k-6 k-7 k12 ( k-1 k-2 k-p k9 k10 k11 + k-1 k-2 k3 k9 k10 k11 + k-1 kp k3 k9 k10 
k11 + k2 kp k3 k-8 k-9 k-10 + k2 kp k3 k-8 k-9 k11 + k2 kp k3 k-8 k10 k11 ) 
d16 = k-4 k-5 k-6 k-7 k12 ( k-1 k-2 k-p k9 k10 k11 + k-1 k-2 k3 k9 k10 k11 + k-1 kp k3 k9 k10 
k11 + k2 kp k3 k-8 k-9 k-10 + k2 kp k3 k-8 k-9 k11 + k2 kp k3 k-8 k10 k11 ) 
d17 = k-5 k-6 k-7 ( k-1 k-2 k-p k-3 k9 k10 k11 k12 + k2 kp k3 k4 k-8 k-9 k-10 k-11 ) 
d18 = k2 kp k3 k4 k-5 k-6 k-7 k9 k10 k11 k12 
d19 = k-1 k4 k-5 k6 k-7 k8 k12 ( k-2 k-p k-9 k-10 + k-2 k-p k-9 k11 + k-2 k-p k10 k11 + k-2 k3 
k-9 k-10 + k-2 k3 k-9 k11 + k-2 k3 k10 k11 + kp k3 k-9 k-10 + kp k3 k-9 k11 + kp k3 k10 k11 )
d20 = k1 k-5 k-6 k-7 k-8 ( k-2 k-p k4 k-9 k-10 k-11 + k-2 k-p k-3 k-9 k-10 k12 + k-2 k-p k-3 k-9 
k11 k12 + k-2 k-p k-3 k10 k11 k12 + k-2 k3 k4 k-9 k-10 k-11 + kp k3 k4 k-9 k-10 k-11 ) 
d21 = k1 k-5 k-6 k-7 k12 ( k-2 k-p k4 k9 k10 k11 + k-2 k3 k4 k9 k10 k11 + kp k3 k4 k9 k10 k11 
+ k2 k-p k4 k-8 k-9 k-10 + k2 k-p k4 k-8 k-9 k11 + k2 k-p k4 k-8 k10 k11 + k2 k3 k4 k-8 k-9 k-
10 + k2 k3 k4 k-8 k-9 k11 + k2 k3 k4 k-8 k10 k11 + k2 kp k4 k-8 k-9 k-10 + k2 kp k4 k-8 k-9
k11 + k2 kp k4 k-8 k10 k11 + k2 kp k3 k-8 k-9 k-10 + k2 kp k3 k-8 k-9 k11 + k2 kp k3 k-8 k10
k11 )
d22 = k-1 k-5 k6 k7 k-8 ( k-2 k-p k4 k-9 k-10 k-11 + k-2 k-p k-3 k-9 k-10 k12 + k-2 k-p k-3 k-9 
k11 k12 + k-2 k-p k-3 k10 k11 k12 + k-2 k3 k4 k-9 k-10 k-11 + kp k3 k4 k-9 k-10 k-11 ) 
d23 = k-1 k-5 k6 k-7 k-12 ( k-2 k-p k4 k-9 k-10 k-11 + k-2 k3 k4 k-9 k-10 k-11 + kp k3 k4 k-9 
k-10 k-11 + k-2 k-p k4 k-8 k-10 k-11 + k-2 k3 k4 k-8 k-10 k-11 + kp k3 k4 k-8 k-10 k-11 + k-2
k-p k4 k-8 k-9 k-11 + k-2 k-p k4 k-8 k10 k-11 + k-2 k3 k4 k-8 k-9 k-11 + k-2 k3 k4 k-8 k10 k-11
+ kp k3 k4 k-8 k-9 k-11 + kp k3 k4 k-8 k10 k-11 + k-2 k-p k-3 k-8 k-9 k-10 + k-2 k-p k-3 k-8 k-
9 k11 + k-2 k-p k-3 k-8 k10 k11 )
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d24 = k-1 k-2 k-p k-3 k-5 k6 k-7 k-8 k-9 k-10 k-11 
d25 = k-1 k-2 k-p k-3 k5 k-6 k-7 k-8 k-9 k-10 k-11 
d26 = k-3 k-4 k-5 k-6 k-7 k-8 k-9 k-10 k-11 ( k-2 k-p + k-1 k-p + k-1 k-2 + k-1 kp ) 
d27 = k4 k-5 k6 k7 k12 ( k-1 k-2 k-p k9 k10 k11 + k-1 k-2 k3 k9 k10 k11 + k-1 kp k3 k9 k10 
k11 + k2 kp k3 k-8 k-9 k-10 + k2 kp k3 k-8 k-9 k11 + k2 kp k3 k-8 k10 k11 ) 
d28 = k4 k-5 k6 k-7 k-12 ( k-1 k-2 k-p k9 k10 k11 + k-1 k-2 k3 k9 k10 k11 + k-1 kp k3 k9 k10 
k11 + k2 kp k3 k-8 k-9 k-10 + k2 kp k3 k-8 k-9 k11 + k2 kp k3 k-8 k10 k11 ) 
d29 = k-5 k6 k-7 ( k-1 k-2 k-p k-3 k9 k10 k11 k12 + k2 kp k3 k4 k-8 k-9 k-10 k-11 ) 
d30 = k5 k-6 k-7 ( k-1 k-2 k-p k-3 k9 k10 k11 k12 + k2 kp k3 k4 k-8 k-9 k-10 k-11 ) 
d31 = k-4 k-5 k-6 k-7 ( k-2 k-p k-3 k9 k10 k11 k12 + k-1 k-p k-3 k9 k10 k11 k12 + k2 k-p k-3 k-
8 k-9 k-10 k12 + k2 k-p k-3 k-8 k-9 k11 k12 + k2 k-p k-3 k-8 k10 k11 k12 + k-1 k-2 k-3 k9 k10 
k11 k12 + k-1 kp k-3 k9 k10 k11 k12 + k2 kp k-3 k-8 k-9 k-10 k12 + k2 kp k-3 k-8 k-9 k11 k12 
+ k2 kp k-3 k-8 k10 k11 k12 + k2 kp k3 k-8 k-9 k-10 k-11 )
d32 = k2 kp k3 k4 k-5 k6 k-7 k9 k10 k11 k12
d33 = k2 kp k3 k4 k5 k-6 k-7 k9 k10 k11 k12
d34 = k2 kp k3 k-4 k-5 k-6 k-7 k9 k10 k11 k12
d35 = k-1 k-5 k6 k-7 k8 ( k-2 k-p k4 k-9 k-10 k-11 + k-2 k-p k-3 k-9 k-10 k12 + k-2 k-p k-3 k-9 
k11 k12 + k-2 k-p k-3 k10 k11 k12 + k-2 k3 k4 k-9 k-10 k-11 + kp k3 k4 k-9 k-10 k-11 ) 
d36 = k1 k-2 k-p k-3 k-5 k-6 k-7 k-8 k-9 k-10 k-11 
d37 = k4 k-5 k6 k-7 k8 ( k2 kp k3 k-9 k-10 k12 + k2 kp k3 k-9 k11 k12 + k2 kp k3 k10 k11 k12 
+ k-1 k-2 k-p k9 k-10 k12 + k-1 k-2 k-p k9 k11 k12 + k-1 k-2 k3 k9 k-10 k12 + k-1 k-2 k3 k9
k11 k12 + k-1 kp k3 k9 k-10 k12 + k-1 kp k3 k9 k11 k12 + k-1 k-2 k-p k9 k10 k12 + k-1 k-2 k3
k9 k10 k12 + k-1 kp k3 k9 k10 k12 + k-1 k-2 k-p k9 k10 k11 + k-1 k-2 k3 k9 k10 k11 + k-1 kp
k3 k9 k10 k11 )
d38 = k1 k-5 k-6 k-7 ( k-2 k-p k-3 k9 k10 k11 k12 + k2 k-p k4 k-8 k-9 k-10 k-11 + k2 k-p k-3 k-
8 k-9 k-10 k12 + k2 k-p k-3 k-8 k-9 k11 k12 + k2 k-p k-3 k-8 k10 k11 k12 + k2 k3 k4 k-8 k-9 k-
10 k-11 + k2 kp k4 k-8 k-9 k-10 k-11 + k2 kp k-3 k-8 k-9 k-10 k12 + k2 kp k-3 k-8 k-9 k11 k12 
+ k2 kp k-3 k-8 k10 k11 k12 + k2 kp k3 k-8 k-9 k-10 k-11 )
d39 = k1 k2 k-5 k-6 k-7 k9 k10 k11 k12 ( k-p k4 + k3 k4 + kp k4 + kp k3 )
d40 = k-1 k-2 k-p k-3 k-5 k6 k7 k-8 k-9 k-10 k-11
d41 = k-1 k-2 k-p k-3 k-5 k6 k-7 k-11 k-12 ( k-9 k-10 + k-8 k-10 + k-8 k-9 + k-8 k10 )
d42 = k-5 k6 k7 ( k-1 k-2 k-p k-3 k9 k10 k11 k12 + k2 kp k3 k4 k-8 k-9 k-10 k-11 )
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d43 = k-5 k6 k-7 k-12 ( k2 kp k3 k4 k-9 k-10 k-11 + k-1 k-2 k-p k4 k9 k-10 k-11 + k-1 k-2 k3 k4 
k9 k-10 k-11 + k-1 kp k3 k4 k9 k-10 k-11 + k2 kp k3 k4 k-8 k-10 k-11 + k-1 k-2 k-p k4 k9 k10 
k-11 + k-1 k-2 k3 k4 k9 k10 k-11 + k-1 kp k3 k4 k9 k10 k-11 + k2 kp k3 k4 k-8 k-9 k-11 + k2
kp k3 k4 k-8 k10 k-11 + k-1 k-2 k-p k-3 k9 k10 k11 )
d44 = k2 k-3 k-4 k-5 k-6 k-7 k-8 k-9 k-10 k-11 ( k-p + kp ) 
d45 = k2 kp k3 k4 k-5 k6 k7 k9 k10 k11 k12 
d46 = k2 kp k3 k4 k-5 k6 k-7 k9 k10 k11 k-12 
d47 = k2 k-3 k-4 k-5 k-6 k-7 k9 k10 k11 k12 ( k-p + kp ) 
d48 = k-1 k-2 k-p k-3 k-5 k6 k-7 k8 k-9 k-10 k-11 
d49 = k-5 k6 k-7 k8 ( k2 kp k3 k4 k-9 k-10 k-11 + k-1 k-2 k-p k4 k9 k-10 k-11 + k-1 k-2 k-p k-3 
k9 k-10 k12 + k-1 k-2 k-p k-3 k9 k11 k12 + k-1 k-2 k3 k4 k9 k-10 k-11 + k-1 kp k3 k4 k9 k-10 
k-11 + k-1 k-2 k-p k4 k9 k10 k-11 + k-1 k-2 k-p k-3 k9 k10 k12 + k-1 k-2 k3 k4 k9 k10 k-11 +
k-1 kp k3 k4 k9 k10 k-11 + k-1 k-2 k-p k-3 k9 k10 k11 )
d50 = k1 k2 k-3 k-5 k-6 k-7 k-8 k-9 k-10 k-11 ( k-p + kp )
d51 = k2 kp k3 k4 k-5 k6 k-7 k8 k9 ( k-10 k12 + k11 k12 + k10 k12 + k10 k11 )
d52 = k1 k2 k-3 k-5 k-6 k-7 k9 k10 k11 k12 ( k-p + kp )
d53 = k-1 k-2 k-p k-3 k-5 k6 k-7 k9 k-11 k-12 ( k-10 + k10 )
d54 = k2 kp k3 k4 k-5 k6 k-7 k9 k-11 k-12 ( k-10 + k10 )
d55 = k-1 k-2 k-p k-3 k-5 k6 k-7 k8 k9 k-11 ( k-10 + k10 )
d56 = k2 kp k3 k4 k-5 k6 k-7 k8 k9 k-11 ( k-10 + k10 )
Simplification #1:
- All terms with P and Q are cancelled as reactions were performed in the absence of
products
N = n2 [A][B] + n6 [A][B][J] + n8 [A][B] + n12 [A][B]2[J] 
D = d1 + d2 [J] + d3 [I] + d6 [B] + d7 [A] + d8 [I][J] + d14 [B][J] + d15 [B][I] + d18 [B]2 + d19 
[A][J] + d21 [A][B] + d27 [B][I][J] + d32 [B]2[J] + d33 [B]2[I] + d37 [A][B][J] + d39 [A][B]2 + 
d45 [B]2[I][J] + d51 [A][B]2[J] 
Simplification #2: 
- All terms were simplified by canceling terms that contained k-2, k-p, k-9, and k-10 as we
assume enzyme is irreversible
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Simplification #3: 







- Kpk3k4 are part of kcat term in ordered bi bi derivation, analogously, k10k11k12 are part






- Re-write all terms into kinetic parameters (Equation 3.10)
𝑣𝑣 =  
𝐸𝐸𝑒𝑒 �
𝑘𝑘𝑐𝑐𝑝𝑝𝑒𝑒𝐾𝐾𝑒𝑒𝑝𝑝𝑖𝑖𝐾𝐾𝐴𝐴𝑖𝑖𝐾𝐾𝐼𝐼
𝐾𝐾𝑖𝑖𝐾𝐾𝑖𝑖𝐼𝐼[𝑁𝑁][𝐴𝐴] + 𝑘𝑘𝑐𝑐𝑝𝑝𝑒𝑒𝐾𝐾𝑁𝑁𝑖𝑖𝐾𝐾𝐼𝐼𝐾𝐾𝑖𝑖𝐾𝐾𝑖𝑖𝐼𝐼 [𝑁𝑁][𝐴𝐴]2 +

















+�𝐾𝐾𝑒𝑒𝑝𝑝𝐾𝐾𝑁𝑁𝑖𝑖𝐾𝐾𝐴𝐴 + 𝐾𝐾𝑒𝑒𝑝𝑝𝑖𝑖𝐾𝐾𝑁𝑁𝐾𝐾𝐴𝐴𝑖𝑖�𝐾𝐾𝑖𝑖𝐾𝐾𝐼𝐼𝐾𝐾𝑖𝑖𝐼𝐼[𝐴𝐴]  + 𝐾𝐾𝑁𝑁𝐾𝐾𝑁𝑁𝑖𝑖𝐾𝐾𝐼𝐼𝐾𝐾𝑖𝑖𝐾𝐾𝑖𝑖𝐼𝐼[𝐴𝐴]
2
+ 𝐾𝐾𝑖𝑖𝐾𝐾𝐼𝐼𝐾𝐾𝑖𝑖𝐼𝐼�𝐾𝐾𝐴𝐴𝐾𝐾𝑁𝑁𝑖𝑖 + 𝐾𝐾𝑒𝑒𝑝𝑝𝑖𝑖𝐾𝐾𝐴𝐴𝑖𝑖�[𝑁𝑁][𝐴𝐴] + �𝐾𝐾𝑁𝑁𝑖𝑖𝐾𝐾𝑖𝑖𝐾𝐾𝐼𝐼𝐾𝐾𝑖𝑖𝐼𝐼� [𝑁𝑁][𝐴𝐴]2
+ 𝐾𝐾𝑒𝑒𝑝𝑝 𝐾𝐾𝐴𝐴𝐾𝐾𝐴𝐴𝑖𝑖𝐾𝐾𝐼𝐼𝐾𝐾𝑖𝑖𝐼𝐼[𝑁𝑁][𝑖𝑖] + �𝐾𝐾𝑒𝑒𝑝𝑝𝐾𝐾𝑁𝑁𝑖𝑖𝐾𝐾𝐴𝐴 + 𝐾𝐾𝑒𝑒𝑝𝑝𝑖𝑖𝐾𝐾𝑁𝑁𝐾𝐾𝐴𝐴𝑖𝑖�𝐾𝐾𝐼𝐼𝐾𝐾𝑖𝑖𝐼𝐼[𝐴𝐴][𝑖𝑖]
+�𝐾𝐾𝑒𝑒𝑝𝑝𝐾𝐾𝑁𝑁𝑖𝑖𝐾𝐾𝐴𝐴 + 𝐾𝐾𝑒𝑒𝑝𝑝𝑖𝑖𝐾𝐾𝑁𝑁𝐾𝐾𝐴𝐴𝑖𝑖�𝐾𝐾𝑖𝑖𝐾𝐾𝑖𝑖𝐼𝐼[𝐴𝐴][𝐼𝐼] +
�𝐾𝐾𝑒𝑒𝑝𝑝𝐾𝐾𝑁𝑁𝑖𝑖𝐾𝐾𝐴𝐴𝐾𝐾𝐼𝐼 + 𝐾𝐾𝑒𝑒𝑝𝑝𝑖𝑖𝐾𝐾𝑁𝑁𝐾𝐾𝐴𝐴𝑖𝑖𝐾𝐾𝐼𝐼�[𝐴𝐴][𝐼𝐼][𝑖𝑖] + �𝐾𝐾𝑁𝑁𝐾𝐾𝑁𝑁𝑖𝑖𝐾𝐾𝑖𝑖𝐾𝐾𝑖𝑖𝐼𝐼�[𝐴𝐴]2[𝐼𝐼] + 
𝐾𝐾𝑁𝑁𝐾𝐾𝑁𝑁𝑖𝑖𝐾𝐾𝐼𝐼𝐾𝐾𝑖𝑖𝐼𝐼[𝐴𝐴]2[𝑖𝑖]  + 𝐾𝐾𝐼𝐼𝐾𝐾𝑁𝑁𝐾𝐾𝑁𝑁𝑖𝑖 [𝐴𝐴]2[𝐼𝐼][𝑖𝑖]+ 𝐾𝐾𝐼𝐼𝐾𝐾𝑖𝑖𝐼𝐼𝐾𝐾𝑁𝑁𝐾𝐾𝐴𝐴𝑖𝑖[𝑁𝑁][𝐴𝐴][𝑖𝑖] + 
 𝐾𝐾𝐼𝐼𝐾𝐾𝑖𝑖𝐼𝐼𝐾𝐾𝑒𝑒𝑝𝑝𝐾𝐾𝐴𝐴[𝑁𝑁][𝐴𝐴][𝑖𝑖] + 𝐾𝐾𝐼𝐼𝐾𝐾𝑖𝑖𝐼𝐼𝐾𝐾𝑁𝑁 [𝑁𝑁][𝐴𝐴]2[𝑖𝑖] +













- Note: Setting I and J equal to zero and re-arranging the equation results in the ordered bi-
bi rate equation
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Figure 3.19 Sigmoidal relationship between calcium concentration and Kia values for β-AdhD. 
The following values were obtained for the sigmoidal fit to the Log data: 
𝑒𝑒 = 𝑇𝑇𝑝𝑝𝑏𝑏𝑑𝑑 +  
𝑐𝑐𝑝𝑝𝑚𝑚
1 + exp((𝑚𝑚ℎ𝑐𝑐𝑎𝑎𝑎𝑎 − 𝑚𝑚)/𝑝𝑝𝑝𝑝𝑒𝑒𝑑𝑑))
(3.11) 
base = 1.2 ± 0.085 
max   = 0.63 ± 0.16 
xhalf  = 4.8 ± 0.072 
rate  = 0.10 ± 0.067 
The concentration at the inflection point is 63±1 mM calcium. 
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Specific Initial Rate Kinetic Data 
Table 3.7 Specific rate data for AdhD at varying NAD+ and 2,3-butanediol concentration with 
zero calcium  
AdhD, NAD, No Ca2+ 
Rate (1/s) NAD+ (µM) 2,3-butanediol (µM) 
0.228 200 2000 
0.292 500 2000 
0.496 750 2000 
0.474 500 4000 
0.488 750 4000 
0.524001 1000 4000 
1.223938 200 20000 
1.676643 500 20000 
1.946813 750 20000 
1.23562 500 60000 
1.310444 750 60000 
1.456876 1000 60000 
1.448604 750 80000 
1.636246 1000 80000 
1.713312 200 100000 
1.727727 500 100000 
1.818645 750 100000 
1.849095 1000 100000 
0.302 500 2000 
0.592 750 2000 
0.698 1000 2000 
0.496 500 4000 
0.508 750 4000 
0.617999 1000 4000 
1.766582 200 20000 
1.830731 500 20000 
2.071161 750 20000 
1.683814 750 100000 
1.917748 1000 100000 
0.592759 200 20000 
0.636689 500 20000 
0.803461 500 40000 
0.935139 750 40000 
1.020002 200 60000 
1.110001 500 60000 
1.142002 750 60000 
1.224537 200 80000 
1.273342 500 80000   
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1.373617 750 80000 
1.362036 200 100000 
1.47894 500 100000 
1.588096 750 100000 
0.64492 500 40000 
0.756061 750 40000 
0.773461 1000 40000 
0.99004 500 60000 
1.00014 750 60000 
1.033138 1000 60000 
1.082943 500 80000 
1.170837 750 80000 
1.230739 1000 80000 
1.419003 750 100000 
1.43736 1000 100000 
0.442706 750 20000 
0.443198 1000 20000 
0.729999 200 40000 
0.776181 500 40000 
0.788581 750 40000 
1.008822 500 60000 
1.028658 750 60000 
1.086478 1000 60000 
0.881679 200 80000 
1.216183 500 80000 
1.249922 750 80000 
1.308541 1000 80000 
1.413497 500 100000 
1.474165 750 100000 
1.531077 1000 100000 
0.640921 200 40000 
0.667481 500 40000 
0.820001 200 60000 
0.822 500 60000 
0.998582 200 80000 
1.013223 500 80000 
0.13214 1 100000 
0.87 20 100000 
1.426005 200 100000 
1.560002 500 100000 
1.419003 750 100000 
1.437205 1000 100000 
0.195601 20 100000 
1.465996 200 100000 
1.413398 500 100000 
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1.474002 750 100000 
1.529999 1000 100000 
0.037948 20 100000 
1.178002 200 100000 
1.242321 500 100000 
1.179997 750 100000 
1.102317 1000 100000 
0.652554 200 100000 
0.860045 500 100000 
0.925549 750 100000 
0.953284 1000 100000 
0.650656 200 100000 
0.856788 500 100000 
1.193766 750 100000 
0.927007 1000 100000 
Table 3.8 Specific rate data for AdhD at varying NAD+ and 2,3-butanediol concentration with 
50 mM calcium  
AdhD, NAD, 50 mM Ca2+ 
Rate (1/s) NAD+ (µM) 2,3-butanediol (µM) 
0.50854 200 40000 
0.5253 750 40000 
0.76278 750 60000 
0.84206 1000 60000 
0.89546 200 100000 
1.12294 1000 100000 
0.36778 200 20000 
0.420476 500 20000 
0.55962 750 40000 
0.70824 200 60000 
0.7542 500 60000 
0.77412 750 60000 
0.79434 1000 60000 
0.78166 200 80000 
0.92974 500 80000 
0.95674 1000 80000 
0.82382 200 100000 
0.986 750 100000 
0.60926 500 20000 
0.31936 200 40000 
0.40178 500 40000 
0.52294 750 40000 
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0.54642 1000 40000 
0.5941 200 80000 
0.92448 500 80000 
0.97788 1000 80000 
0.86766 500 100000 
1.04338 750 100000 
0.4427 750 20000 
0.44352 1000 20000 
0.73 200 40000 
0.77618 500 40000 
0.78858 750 40000 
1.00882 500 60000 
1.02866 750 60000 
1.08648 1000 60000 
Table 3.9 Specific rate data for β-AdhD at varying NAD+ and 2,3-butanediol concentration with 
zero calcium  
β-AdhD, NAD+, No Ca2+ 
Rate (1/s) NAD+ (µM) 2,3-butanediol (µM) 
0.003551 200 20000 
0.005748 500 20000 
0.005706 750 20000 
0.007289 200 40000 
0.009838 500 40000 
0.011242 750 40000 
0.013043 1000 40000 
0.016202 500 60000 
0.016557 750 60000 
0.018727 1000 60000 
0.013388 200 80000 
0.020021 500 80000 
0.022265 750 80000 
0.024566 1000 80000 
0.016243 200 100000 
0.028195 500 100000 
0.036482 750 100000 
0.017567 1000 100000 
0.001316 1000 4000 
0.003814 200 20000 
0.005521 500 20000 
0.00628 750 20000 
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0.006711 1000 20000 
0.006007 200 40000 
0.010515 500 40000 
0.011997 750 40000 
0.013062 1000 40000 
0.016818 750 60000 
0.016002 1000 60000 
0.012743 200 80000 
0.020559 500 80000 
0.023007 750 80000 
0.025038 1000 80000 
0.036113 1000 100000 
0.000926 750 4000 
0.000787 1000 4000 
0.003197 200 20000 
0.003906 500 20000 
0.004166 750 20000 
0.002904 1000 20000 
0.005436 200 40000 
0.0067 500 40000 
0.007611 750 40000 
0.008042 1000 40000 
0.007304 200 60000 
0.01196 750 60000 
0.012279 750 60000 
0.009195 200 80000 
0.013052 500 80000 
0.015533 750 80000 
0.015404 1000 80000 
0.011577 200 80000 
0.017643 500 100000 
0.020965 750 100000 
0.022091 1000 100000 
0.003064 200 20000 
0.003718 500 20000 
0.004141 750 20000 
0.006109 200 40000 
0.007321 500 40000 
0.008048 750 40000 
0.010879 500 60000 
0.011969 750 60000 
0.012213 1000 60000 
0.012069 200 80000 
0.015293 500 80000 
0.016579 750 80000 
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0.017172 1000 80000 
0.014175 200 100000 
0.020174 500 100000 
0.021676 750 100000 
0.022 1000 100000 
0.003283 200 20000 
0.003777 500 20000 
0.004508 750 20000 
0.004846 1000 20000 
0.006692 200 40000 
0.007362 500 40000 
0.008042 750 40000 
0.009131 1000 40000 
0.009007 200 60000 
0.011069 500 60000 
0.012638 750 60000 
0.013356 1000 60000 
0.011827 200 80000 
0.015403 500 80000 
0.016776 750 80000 
0.018456 1000 80000 
0.014671 200 100000 
0.019759 500 100000 
0.021211 750 100000 
0.023069 1000 100000 
0.003195 200 20000 
0.003231 500 20000 
0.003687 750 20000 
0.006048 200 40000 
0.007091 500 40000 
0.007404 750 40000 
0.007546 1000 40000 
0.009051 200 60000 
0.011157 500 60000 
0.011447 750 60000 
0.012146 1000 60000 
0.011857 200 80000 
0.014639 500 80000 
0.015882 750 80000 
0.015938 1000 80000 
0.01504 200 100000 
0.018651 500 100000 
0.020409 750 100000 
0.020926 1000 100000 
0.000971 1 100000 
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0.000971 1 100000 
0.004243 20 100000 
0.015191 200 100000 
0.020147 500 100000 
0.021618 750 100000 
0.021985 1000 100000 
0.00475 20 100000 
0.015882 200 100000 
0.019706 500 100000 
0.021176 750 100000 
0.023015 1000 100000 
0.003235 20 100000 
0.015882 200 100000 
0.018603 500 100000 
0.020409 750 100000 
0.020926 1000 100000 
0.002029 20 100000 
0.007941 200 100000 
0.009191 500 100000 
0.009679 750 100000 
0.010382 1000 100000 
0.001809 20 100000 
0.007721 200 100000 
0.009117 500 100000 
0.009835 1000 100000 
Table 3.10 Specific rate data for β-AdhD at varying NAD+ and 2,3-butanediol concentration 
with 50 mM calcium  
β-AdhD, NAD+, 50 mM Ca2+ 
Rate (1/s) NAD+ (µM) 2,3-butanediol (µM) 
0.001063 750 20000 
0.00136 1000 20000 
0.001959 200 40000 
0.002225 500 40000 
0.002742 750 40000 
0.003213 1000 40000 
0.003252 500 60000 
0.004366 750 60000 
0.004574 1000 60000 
0.002464 200 80000 
0.004871 500 80000 
0.006048 750 80000 
0.00714 1000 80000 
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0.003432 200 100000 
0.005335 500 100000 
0.006971 750 100000 
0.00841 1000 100000 
0.001121 750 20000 
0.001317 1000 20000 
0.001219 200 40000 
0.002135 500 40000 
0.002831 750 40000 
0.003345 1000 40000 
0.00202 200 60000 
0.003429 500 60000 
0.002273 750 60000 
0.005646 1000 60000 
0.002724 200 80000 
0.004474 500 80000 
0.006119 750 80000 
0.006916 1000 80000 
0.004925 200 100000 
0.005505 500 100000 
0.007375 750 100000 
0.008517 1000 100000 
0.001849 500 40000 
0.00204 750 40000 
0.002447 1000 40000 
0.001563 200 60000 
0.002577 500 60000 
0.003232 750 60000 
0.003635 1000 60000 
0.002078 200 80000 
0.003971 500 80000 
0.0074 750 80000 
0.002566 200 100000 
0.005324 500 100000 
0.005176 750 100000 
0.006866 1000 100000 
0.001367 750 20000 
0.001571 1000 20000 
0.001375 200 40000 
0.001935 500 40000 
0.003136 750 40000 
0.003417 1000 40000 
0.003175 500 60000 
0.004657 750 60000 
0.005201 1000 60000 
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0.002721 200 80000 
0.004078 500 80000 
0.006307 750 80000 
0.007479 1000 80000 
0.003461 200 100000 
0.005269 500 100000 
0.008423 750 100000 
0.001263 500 20000 
0.001554 750 20000 
0.001684 1000 20000 
0.001284 200 40000 
0.002489 500 40000 
0.003196 750 40000 
0.003605 1000 40000 
0.002034 200 60000 
0.003946 500 60000 
0.004785 750 60000 
0.005288 1000 60000 
0.002422 200 80000 
0.005231 500 80000 
0.006566 750 80000 
0.007457 1000 80000 
0.000682 200 20000 
0.00126 500 20000 
0.001408 750 20000 
0.002095 1000 20000 
0.001168 200 40000 
0.002236 500 40000 
0.002719 750 40000 
0.0034 1000 40000 
0.00195 200 60000 
0.003624 500 60000 
0.004809 750 60000 
0.006033 1000 60000 
0.002493 200 80000 
0.004568 500 80000 
0.006704 750 80000 
0.007706 1000 80000 
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Table 3.11 Specific rate data for AdhD at varying NADP+ and 2,3-butanediol concentration with 
zero calcium  
AdhD, NADP, No Ca2+ 
Rate (1/s) NAD+ (µM) 2,3-butanediol (µM) 
0.020594 500 2000 
0.024027 750 2000 
0.022797 200 4000 
0.026127 500 4000 
0.030825 500 40000 
0.034249 750 40000 
0.033239 500 80000 
0.034313 750 80000 
0.038253 500 100000 
0.036685 750 100000 
0.0271 200 2000 
0.027408 500 2000 
0.028176 500 4000 
0.029764 750 4000 
0.033008 200 40000 
0.034649 500 40000 
0.030174 200 60000 
0.033049 500 60000 
0.034174 200 80000 
0.034626 500 80000 
0.034137 750 100000 
0.038213 1000 100000 
0.033043 500 20000 
0.030072 750 20000 
0.032028 750 40000 
0.046321 1000 40000 
0.039991 500 100000 
0.042613 750 100000 
0.042589 200 40000 
0.039216 500 40000 
0.038748 750 40000 
0.032766 1000 40000 
0.022442 200 60000 
0.039449 500 60000 
0.038206 750 60000 
0.034613 500 80000 
0.037133 750 80000 
0.036543 500 100000 
0.040179 750 100000 
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0.038322 200 20000 
0.042783 500 20000 
0.03626 750 40000 
0.038465 1000 40000 
0.037345 750 60000 
0.039647 1000 60000 
0.037691 750 100000 
0.038607 1000 100000 
0.033998 1000 40000 
0.040369 500 60000 
Table 3.12 Specific rate data for AdhD at varying NADP+ and 2,3-butanediol concentration with 
50 mM calcium  
AdhD, NADP+, 50 mM Ca2+ 
Rate (1/s) NAD+ (µM) 2,3-butanediol (µM) 
0.007223 200 2000 
0.094775 500 2000 
0.093238 750 2000 
0.103996 1000 2000 
0.030576 200 60000 
0.236363 500 60000 
0.224841 750 60000 
0.21481 1000 60000 
0.213012 200 80000 
0.249488 500 80000 
0.246737 750 80000 
0.230379 1000 80000 
0.023924 200 100000 
0.258811 500 100000 
0.265215 750 100000 
0.24166 1000 100000 
0.081967 200 2000 
0.09375 500 2000 
0.098873 750 2000 
0.121414 200 4000 
0.139344 500 4000 
0.154713 750 4000 
0.181865 200 20000 
0.199621 500 20000 
0.196834 750 20000 
0.202049 1000 20000 
0.244826 200 40000 
0.236901 500 40000 
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0.226947 750 40000 
0.232418 1000 40000 
0.224027 200 60000 
0.239933 500 60000 
0.232121 750 60000 
0.24772 1000 60000 
0.237613 200 80000 
0.250415 500 80000 
0.247111 750 80000 
0.256522 1000 80000 
0.228586 200 100000 
0.260963 500 100000 
0.267587 750 100000 
0.253519 1000 100000 
0.049488 200 2000 
0.078381 500 2000 
0.095287 750 2000 
0.13627 200 20000 
0.018955 500 20000 
0.019416 750 20000 
0.194672 200 40000 
0.214139 500 40000 
0.145492 200 60000 
0.222848 500 60000 
0.230533 750 60000 
0.194672 200 80000 
0.215164 500 80000 
0.220287 750 80000 
0.189549 200 100000 
0.240779 500 100000 
0.306352 750 100000 
0.056352 200 4000 
0.079918 750 4000 
0.060451 1000 4000 
0.167008 200 20000 
0.169057 500 20000 
0.172643 750 20000 
0.185963 500 40000 
0.193135 750 40000 
0.024744 200 60000 
0.196209 500 60000 
0.196721 750 60000 
0.204918 500 80000 
0.204918 750 80000 
0.209529 200 100000 
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0.209529 500 100000 
0.210041 750 100000 
0.090164 200 4000 
0.098361 500 4000 
0.177254 200 20000 
0.177766 500 20000 
0.190574 750 40000 
0.197234 1000 40000 
0.197746 750 60000 
0.207403 1000 60000 
0.206455 200 100000 
0.211066 750 100000 
0.218238 1000 100000 
0.082992 500 4000 
0.085041 750 4000 
0.162398 500 20000 
0.165471 750 20000 
0.179303 500 40000 
0.189549 750 40000 
0.186988 500 60000 
0.196209 750 60000 
0.204406 1000 60000 
0.199795 500 80000 
0.194672 750 80000 
0.194672 200 100000 
0.199795 500 100000 
0.199795 750 100000 
Table 3.13 Specific rate data for β-AdhD at varying NADP+ and 2,3-butanediol concentration 
with zero calcium  
β-AdhD, NADP+, No Ca2+ 





















0.016176 500 40000 
0.016176 750 40000 
0.004559 200 60000 
0.019485 500 60000 
0.019191 200 80000 
0.022206 500 80000 
0.020588 200 100000 
0.023529 500 100000 
0.024191 750 100000 
0.003397 200 4000 
0.00375 500 4000 
0.004338 750 4000 
0.010662 200 20000 
0.011176 500 20000 
0.011176 750 20000 
0.012059 1000 20000 
0.013529 200 40000 
0.016471 500 40000 
0.017647 200 60000 
0.019118 500 60000 
0.019485 750 60000 
0.019265 200 80000 
0.021471 750 80000 
0.021471 1000 80000 
0.018382 200 100000 
0.024265 500 100000 
0.024265 750 100000 
0.024265 1000 100000 
0.001471 200 2000 
0.002279 750 2000 
0.000846 1000 2000 
0.002868 500 4000 
0.003456 750 4000 
0.010956 200 20000 
0.01125 500 20000 
0.013309 200 40000 
0.015588 500 40000 
0.015735 1000 40000 
0.017279 200 60000 
0.018603 500 60000 
0.019853 200 80000 
0.020882 500 80000 
0.020882 200 100000 
0.022279 500 100000 
0.001684 200 2000 
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0.001838 500 2000 
0.003559 200 4000 
0.003618 500 4000 
0.01375 500 20000 
0.014265 750 20000 
0.022059 200 40000 
0.024779 500 40000 
0.025368 1000 40000 
0.004412 200 60000 
0.031838 500 60000 
0.033015 750 60000 
0.033088 1000 60000 
0.039706 500 80000 
0.038235 750 80000 
0.039706 1000 80000 
0.041618 200 100000 
0.044118 500 100000 
0.044853 750 100000 
0.047059 1000 100000 
0.003632 200 4000 
0.003662 500 4000 
0.012059 200 20000 
0.014338 500 20000 
0.014265 1000 20000 
0.022279 200 40000 
0.025221 500 40000 
0.026471 1000 40000 
0.032353 500 60000 
0.033088 750 60000 
0.036029 1000 60000 
0.038603 500 80000 
0.038971 750 80000 
0.044118 1000 80000 
0.043382 500 100000 
0.047059 750 100000 
0.048529 1000 100000 
0.001618 200 2000 
0.001838 500 2000 
0.003699 500 4000 
0.003743 750 4000 
0.004779 1000 4000 
0.013897 200 20000 
0.015221 500 20000 
0.016176 1000 20000 
0.023897 200 40000 
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0.025441 500 40000 
0.0275 1000 40000 
0.031765 200 60000 
0.032574 500 60000 
0.033088 750 60000 
0.038529 500 80000 
0.038235 750 80000 
0.038971 1000 80000 
0.040441 200 100000 
0.043382 500 100000 
0.045221 750 100000 
0.045588 1000 100000 
Table 3.14 Specific rate data for β-AdhD at varying NADP+ and 2,3-butanediol concentration 
with 50 mM calcium  
β-AdhD, NADP+, 50 mM Ca2+ 
Rate (1/s) NAD+ (µM) 2,3-butanediol (µM) 
0.000632 500 2000 
0.000882 750 2000 
0.000904 1000 2000 
0.001412 200 4000 
0.003074 500 4000 
0.008824 200 20000 
0.010588 750 20000 
0.014412 200 40000 
0.019118 500 40000 
0.020221 750 40000 
0.025 500 60000 
0.028676 750 60000 
0.028676 1000 60000 
0.026691 200 80000 
0.031618 500 80000 
0.036691 750 80000 
0.036765 1000 80000 
0.040441 500 100000 
0.045956 750 100000 
0.001029 200 2000 
0.001397 200 4000 
0.002353 500 4000 
0.008603 200 20000 
0.010588 500 20000 
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0.010662 750 20000 
0.013897 200 40000 
0.020074 500 40000 
0.017794 200 60000 
0.025368 500 60000 
0.02875 750 60000 
0.024926 200 80000 
0.032132 500 80000 
0.036471 750 80000 
0.038235 200 100000 
0.045588 500 100000 
0.046471 1000 100000 
0.001669 750 4000 
0.002397 1000 4000 
0.011838 200 40000 
0.014706 500 40000 
0.015441 750 40000 
0.016176 1000 40000 
0.016544 200 60000 
0.021912 500 60000 
0.022279 1000 60000 
0.019779 200 80000 
0.027353 500 80000 
0.030809 750 80000 
0.030882 1000 80000 
0.024559 200 100000 
0.031765 500 100000 
0.040368 750 100000 
0.048456 1000 100000 
0.000824 200 2000 
0.000949 500 2000 
0.001074 750 2000 
0.001809 500 4000 
0.001772 750 4000 
0.002743 1000 4000 
0.015074 200 40000 
0.017794 500 40000 
0.024559 500 60000 
0.025809 750 60000 
0.026397 1000 60000 
0.028529 200 80000 
0.03125 500 80000 
0.035294 750 80000 
0.035882 1000 80000 
0.033382 200 100000 
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0.040368 500 100000 
0.045294 750 100000 
0.047353 1000 100000 
0.000853 200 2000 
0.001037 500 2000 
0.001397 750 2000 
0.001838 500 4000 
0.002404 750 4000 
0.004044 1000 4000 
0.008456 750 20000 
0.011618 1000 20000 
0.015 200 40000 
0.016985 500 40000 
0.017059 750 40000 
0.01875 1000 40000 
0.020956 200 60000 
0.025294 500 60000 
0.026397 750 60000 
0.028676 1000 60000 
0.027868 200 80000 
0.031176 500 80000 
0.034191 750 80000 
0.036985 1000 80000 
0.031544 200 100000 
0.040441 500 100000 
0.045 750 100000 
0.001265 1000 2000 
0.001478 200 4000 
0.001735 500 4000 
0.001882 1000 4000 
0.008676 200 20000 
0.009118 500 20000 
0.000956 1000 20000 
0.015735 200 40000 
0.017941 500 40000 
0.017941 750 40000 
0.018456 1000 40000 
0.023088 200 60000 
0.026471 500 60000 
0.027426 750 60000 
0.02875 1000 60000 
0.036397 200 100000 
0.043088 500 100000 
0.047353 750 100000 
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Table 3.15 Complete specific rate data for AdhD at varying NAD+ and 2,3-butanediol 
concentration with varying calcium  
AdhD, varying calcium 
Rate (1/s) NAD+ (µM) 2,3-Butandediol (µM) Ca2+ (µM) 
0.228 200 2000 0 
0.292 500 2000 0 
0.496 750 2000 0 
0.474 500 4000 0 
0.488 750 4000 0 
0.524 1000 4000 0 
1.224 200 20000 0 
1.6766 500 20000 0 
1.9468 750 20000 0 
1.2356 500 60000 0 
1.3104 750 60000 0 
1.4568 1000 60000 0 
1.4486 750 80000 0 
1.6362 1000 80000 0 
1.7134 200 100000 0 
1.7278 500 100000 0 
1.8186 750 100000 0 
1.849 1000 100000 0 
0.302 500 2000 0 
0.592 750 2000 0 
0.698 1000 2000 0 
0.496 500 4000 0 
0.508 750 4000 0 
0.618 1000 4000 0 
1.7666 200 20000 0 
1.8308 500 20000 0 
2.0712 750 20000 0 
1.6838 750 100000 0 
1.9178 1000 100000 0 
0.5928 200 20000 0 
0.6366 500 20000 0 
0.8034 500 40000 0 
0.9352 750 40000 0 
1.02 200 60000 0 
1.11 500 60000 0 
1.142 750 60000 0 
1.2246 200 80000 0 
1.2734 500 80000 0 
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1.3736 750 80000 0 
1.362 200 100000 0 
1.479 500 100000 0 
1.588 750 100000 0 
0.645 500 40000 0 
0.756 750 40000 0 
0.7734 1000 40000 0 
0.99 500 60000 0 
1.0002 750 60000 0 
1.0332 1000 60000 0 
1.083 500 80000 0 
1.1708 750 80000 0 
1.2308 1000 80000 0 
1.419 750 100000 0 
1.4374 1000 100000 0 
0.4428 750 20000 0 
0.4432 1000 20000 0 
0.73 200 40000 0 
0.7762 500 40000 0 
0.7886 750 40000 0 
1.0088 500 60000 0 
1.0286 750 60000 0 
1.0864 1000 60000 0 
0.8816 200 80000 0 
1.2162 500 80000 0 
1.25 750 80000 0 
1.3086 1000 80000 0 
1.4134 500 100000 0 
1.4742 750 100000 0 
1.531 1000 100000 0 
0.641 200 40000 0 
0.6674 500 40000 0 
0.82 200 60000 0 
0.822 500 60000 0 
0.9986 200 80000 0 
1.0132 500 80000 0 
0.43 20 100000 25000 
1.042 200 100000 25000 
1.206 500 100000 25000 
1.238 750 100000 25000 
1.24 1000 100000 25000 
0.36 20 100000 25000 
0.944 200 100000 25000 
1.102 750 100000 25000 
1.192 1000 100000 25000 
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0.358 20 100000 25000 
0.958 200 100000 25000 
1.136 500 100000 25000 
1.1822 750 100000 25000 
0.9726 20 100000 25000 
1.226 500 100000 25000 
1.2056 750 100000 25000 
1.384 1000 100000 25000 
0.366 20 100000 25000 
0.932 200 100000 25000 
1.19 500 100000 25000 
1.252 750 100000 25000 
1.405 1000 100000 25000 
0.39 200 100000 50000 
0.47 750 100000 50000 
0.494 1000 100000 50000 
1.4134 500 100000 50000 
1.474 750 100000 50000 
1.531 1000 100000 50000 
0.2152 200 100000 50000 
0.238 750 100000 50000 
0.2266 1000 100000 50000 
0.7722 200 100000 50000 
1.16 500 100000 50000 
1.1938 750 100000 50000 
1.2094 1000 100000 50000 
0.7722 200 100000 50000 
1.0992 500 100000 50000 
1.1858 750 100000 50000 
1.223 1000 100000 50000 
0.386 200 100000 100000 
0.618 500 100000 100000 
0.6634 750 100000 100000 
0.7706 1000 100000 100000 
0.378 200 100000 100000 
0.624 500 100000 100000 
0.722 750 100000 100000 
0.746 1000 100000 100000 
0.428 200 100000 100000 
0.622 500 100000 100000 
0.758 750 100000 100000 
0.8332 1000 100000 100000 
0.5854 200 100000 100000 
0.962 500 100000 100000 
1.1314 750 100000 100000 
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1.2248 1000 100000 100000 
0.6176 200 100000 100000 
0.9664 500 100000 100000 
1.1548 750 100000 100000 
1.216 1000 100000 100000 
0.1906 200 100000 150000 
0.342 500 100000 150000 
0.466 750 100000 150000 
0.596 1000 100000 150000 
0.1034 20 100000 150000 
0.174 200 100000 150000 
0.304 500 100000 150000 
0.348 750 100000 150000 
0.478 1000 100000 150000 
0.181 200 100000 150000 
0.306 500 100000 150000 
0.42 750 100000 150000 
0.476 1000 100000 150000 
0.8306 500 100000 150000 
0.997 750 100000 150000 
1.0802 1000 100000 150000 
0.5008 200 100000 150000 
0.835 500 100000 150000 
0.9986 750 100000 150000 
1.1402 1000 100000 150000 
0.386 200 100000 200000 
0.46 500 100000 200000 
0.834 750 100000 200000 
1.022 1000 100000 200000 
0.165 200 100000 200000 
0.272 500 100000 200000 
0.4 750 100000 200000 
0.658 1000 100000 200000 
0.128 200 100000 200000 
0.2722 500 100000 200000 
0.3758 750 100000 200000 
0.467 1000 100000 200000 
0.3824 200 100000 200000 
0.6876 500 100000 200000 
0.857 750 100000 200000 
0.949 1000 100000 200000 
0.3474 200 100000 200000 
0.708 500 100000 200000 
0.8672 750 100000 200000 
0.9782 1000 100000 200000 
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0.296 1000 80000 50000 
0.5086 200 40000 50000 
0.5252 750 40000 50000 
0.7628 750 60000 50000 
0.842 1000 60000 50000 
0.8954 200 100000 50000 
1.123 1000 100000 50000 
0.3678 200 20000 50000 
0.4204 500 20000 50000 
0.3944 200 40000 50000 
0.5596 750 40000 50000 
0.7082 200 60000 50000 
0.7542 500 60000 50000 
0.7742 750 60000 50000 
0.7944 1000 60000 50000 
0.7816 200 80000 50000 
0.9298 500 80000 50000 
0.9568 1000 80000 50000 
0.8238 200 100000 50000 
0.986 750 100000 50000 
1.2636 1000 100000 50000 
0.3582 200 20000 50000 
0.6092 500 20000 50000 
0.3194 200 40000 50000 
0.4018 500 40000 50000 
0.523 750 40000 50000 
0.5464 1000 40000 50000 
0.594 200 80000 50000 
0.9244 500 80000 50000 
0.9778 1000 80000 50000 
0.8676 500 100000 50000 
1.0434 750 100000 50000 
0.292 500 40000 50000 
0.3096 500 60000 50000 
0.3246 750 60000 50000 
0.3408 200 80000 50000 
0.382 500 80000 50000 
0.3848 750 80000 50000 
0.387 1000 80000 50000 
0.3902 200 100000 50000 
0.4716 750 100000 50000 
0.4956 1000 100000 50000 
0.4428 750 20000 50000 
0.4436 1000 20000 50000 
0.73 200 40000 50000 
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0.7762 500 40000 50000 
0.7886 750 40000 50000 
1.0088 500 60000 50000 
1.0286 750 60000 50000 
1.0864 1000 60000 50000 
1.2078 200 80000 50000 
1.2162 500 80000 50000 
1.25 750 80000 50000 
1.3086 1000 80000 50000 
1.4674 200 100000 50000 
1.4742 750 100000 50000 
1.531 1000 100000 50000 
0.1322 1 100000 0 
0.87 20 100000 0 
1.426 200 100000 0 
1.56 500 100000 0 
1.419 750 100000 0 
1.4372 1000 100000 0 
0.1956 20 100000 0 
1.466 200 100000 0 
1.4134 500 100000 0 
1.474 750 100000 0 
1.53 1000 100000 0 
0.038 20 100000 0 
1.178 200 100000 0 
1.2424 500 100000 0 
1.18 750 100000 0 
1.1024 1000 100000 0 
0.6526 200 100000 0 
0.86 500 100000 0 
0.9256 750 100000 0 
0.9532 1000 100000 0 
0.6506 200 100000 0 
0.8568 500 100000 0 
1.1938 750 100000 0 
0.927 1000 100000 0 
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Table 3.16 Complete specific rate data for β-AdhD at varying NAD+ and 2,3-butanediol 
concentration with varying calcium  
β-AdhD, varying calcium 
Rate (1/s) NAD+ (µM) 2,3-butanediol (µM) Ca2+ (µM) 
0.000971 1 100000 0 
0.004243 20 100000 0 
0.015191 200 100000 0 
0.020147 500 100000 0 
0.021618 750 100000 0 
0.021985 1000 100000 0 
0.00475 20 100000 0 
0.015882 200 100000 0 
0.019706 500 100000 0 
0.021176 750 100000 0 
0.023015 1000 100000 0 
0.003235 20 100000 0 
0.015882 200 100000 0 
0.018603 500 100000 0 
0.020409 750 100000 0 
0.020926 1000 100000 0 
0.002029 20 100000 0 
0.007941 200 100000 0 
0.009191 500 100000 0 
0.009679 750 100000 0 
0.010382 1000 100000 0 
0.001809 20 100000 0 
0.007721 200 100000 0 
0.009117 500 100000 0 
0.009835 1000 100000 0 
0.003551 200 20000 0 
0.005748 500 20000 0 
0.005706 750 20000 0 
0.007289 200 40000 0 
0.009838 500 40000 0 
0.011242 750 40000 0 
0.013043 1000 40000 0 
0.016202 500 60000 0 
0.016557 750 60000 0 
0.018727 1000 60000 0 
0.013388 200 80000 0 
0.020021 500 80000 0 
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0.022265 750 80000 0 
0.024566 1000 80000 0 
0.016243 200 100000 0 
0.028195 500 100000 0 
0.036482 750 100000 0 
0.001316 1000 4000 0 
0.003814 200 20000 0 
0.005521 500 20000 0 
0.00628 750 20000 0 
0.006711 1000 20000 0 
0.006007 200 40000 0 
0.010515 500 40000 0 
0.011997 750 40000 0 
0.013062 1000 40000 0 
0.016818 750 60000 0 
0.016002 1000 60000 0 
0.012743 200 80000 0 
0.020559 500 80000 0 
0.023007 750 80000 0 
0.025038 1000 80000 0 
0.036113 1000 100000 0 
0.000926 750 4000 0 
0.000787 1000 4000 0 
0.003197 200 20000 0 
0.003906 500 20000 0 
0.004166 750 20000 0 
0.005436 200 40000 0 
0.0067 500 40000 0 
0.007611 750 40000 0 
0.008042 1000 40000 0 
0.007304 200 60000 0 
0.01196 750 60000 0 
0.012279 750 60000 0 
0.009195 200 80000 0 
0.013052 500 80000 0 
0.015533 750 80000 0 
0.015404 1000 80000 0 
0.011577 200 80000 0 
0.017643 500 100000 0 
0.020965 750 100000 0 
0.022091 1000 100000 0 
0.003064 200 20000 0 
0.003718 500 20000 0 
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0.004141 750 20000 0 
0.006109 200 40000 0 
0.007321 500 40000 0 
0.008048 750 40000 0 
0.010879 500 60000 0 
0.011969 750 60000 0 
0.012213 1000 60000 0 
0.012069 200 80000 0 
0.015293 500 80000 0 
0.016579 750 80000 0 
0.017172 1000 80000 0 
0.014175 200 100000 0 
0.020174 500 100000 0 
0.021676 750 100000 0 
0.022 1000 100000 0 
0.003283 200 20000 0 
0.003777 500 20000 0 
0.004508 750 20000 0 
0.004846 1000 20000 0 
0.006692 200 40000 0 
0.007362 500 40000 0 
0.008042 750 40000 0 
0.009131 1000 40000 0 
0.009007 200 60000 0 
0.011069 500 60000 0 
0.012638 750 60000 0 
0.013356 1000 60000 0 
0.011827 200 80000 0 
0.015403 500 80000 0 
0.016776 750 80000 0 
0.018456 1000 80000 0 
0.014671 200 100000 0 
0.019759 500 100000 0 
0.021211 750 100000 0 
0.023069 1000 100000 0 
0.003195 200 20000 0 
0.003231 500 20000 0 
0.003687 750 20000 0 
0.006048 200 40000 0 
0.007091 500 40000 0 
0.007404 750 40000 0 
0.007546 1000 40000 0 
0.009051 200 60000 0 
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0.011157 500 60000 0 
0.011447 750 60000 0 
0.012146 1000 60000 0 
0.011857 200 80000 0 
0.014639 500 80000 0 
0.015882 750 80000 0 
0.015938 1000 80000 0 
0.01504 200 100000 0 
0.018651 500 100000 0 
0.020409 750 100000 0 
0.020926 1000 100000 0 
0.000324 1 100000 10000 
0.007773 20 100000 10000 
0.018483 200 100000 10000 
0.029027 500 100000 10000 
0.030228 750 100000 10000 
0.030134 1000 100000 10000 
0.007125 20 100000 10000 
0.018218 200 100000 10000 
0.02784 500 100000 10000 
0.030228 750 100000 10000 
0.031929 1000 100000 10000 
0.005911 20 100000 10000 
0.019648 200 100000 10000 
0.02761 500 100000 10000 
0.031659 750 100000 10000 
0.032091 1000 100000 10000 
0.005182 20 100000 20000 
0.01483 200 100000 20000 
0.023602 500 100000 20000 
0.028407 750 100000 20000 
0.030863 1000 100000 20000 
0.005571 20 100000 20000 
0.014813 200 100000 20000 
0.023575 500 100000 20000 
0.027206 750 100000 20000 
0.031497 1000 100000 20000 
0.000162 1 100000 20000 
0.004426 20 100000 20000 
0.015341 200 100000 20000 
0.023548 500 100000 20000 
0.029648 750 100000 20000 
0.027529 1000 100000 20000 
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0.00384 20 100000 30000 
0.012226 200 100000 30000 
0.020944 500 100000 30000 
0.025208 750 100000 30000 
0.027448 1000 100000 30000 
0.003644 20 100000 30000 
0.011606 200 100000 30000 
0.020094 500 100000 30000 
0.025654 750 100000 30000 
0.003401 20 100000 30000 
0.011889 200 100000 30000 
0.020256 500 100000 30000 
0.02537 750 100000 30000 
0.026585 1000 100000 30000 
0.00332 20 100000 40000 
0.017462 500 100000 40000 
0.022725 750 100000 40000 
0.022725 1000 100000 40000 
0.003167 20 100000 40000 
0.010108 200 100000 40000 
0.017705 500 100000 40000 
0.021727 750 100000 40000 
0.026949 1000 100000 40000 
0.003279 20 100000 40000 
0.006626 200 100000 40000 
0.018339 500 100000 40000 
0.023683 750 100000 40000 
0.026801 1000 100000 40000 
7.2E-05 1 100000 50000 
0.002785 20 100000 50000 
0.008056 200 100000 50000 
0.014682 500 100000 50000 
0.018339 750 100000 50000 
0.019932 1000 100000 50000 
4.05E-05 1 100000 50000 
0.002562 20 100000 50000 
0.007935 200 100000 50000 
0.014534 500 100000 50000 
0.018339 750 100000 50000 
0.020323 1000 100000 50000 
4.22E-05 1 100000 50000 
0.002321 20 100000 50000 
0.007611 200 100000 50000 
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0.013832 500 100000 50000 
0.016423 750 100000 50000 
0.018312 1000 100000 50000 
0.001965 20 100000 60000 
0.006963 200 100000 60000 
0.013427 500 100000 60000 
0.017192 750 100000 60000 
0.020013 1000 100000 60000 
0.002321 20 100000 60000 
0.007517 200 100000 60000 
0.014372 500 100000 60000 
0.017773 750 100000 60000 
0.020823 1000 100000 60000 
0.002402 20 100000 60000 
0.007975 200 100000 60000 
0.014912 500 100000 60000 
0.01807 750 100000 60000 
0.022779 1000 100000 60000 
0.002143 20 100000 70000 
0.006181 200 100000 70000 
0.011228 500 100000 70000 
0.014345 750 100000 70000 
0.015357 1000 100000 70000 
0.00471 200 100000 70000 
0.009176 500 100000 70000 
0.012051 750 100000 70000 
0.014183 1000 100000 70000 
0.001534 20 100000 70000 
0.005101 200 100000 70000 
0.010283 500 100000 70000 
0.012213 750 100000 70000 
0.015047 1000 100000 70000 
0.001822 20 100000 80000 
0.005762 200 100000 80000 
0.011606 500 100000 80000 
0.014331 750 100000 80000 
0.016167 1000 100000 80000 
0.001457 20 100000 80000 
0.004494 200 100000 80000 
0.008353 500 100000 80000 
0.01116 750 100000 80000 
0.015141 1000 100000 80000 
0.001547 20 100000 80000 
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0.005115 200 100000 80000 
0.009716 500 100000 80000 
0.012037 750 100000 80000 
0.014439 1000 100000 80000 
0.001483 20 100000 80000 
0.004966 200 100000 80000 
0.010108 500 100000 80000 
0.012577 750 100000 80000 
0.015101 1000 100000 80000 
0.001373 20 100000 90000 
0.004129 200 100000 90000 
0.008623 500 100000 90000 
0.010364 750 100000 90000 
0.01336 1000 100000 90000 
0.001342 20 100000 90000 
0.004318 200 100000 90000 
0.008056 500 100000 90000 
0.011754 750 100000 90000 
0.012915 1000 100000 90000 
0.00108 20 100000 90000 
0.004386 200 100000 90000 
0.008529 500 100000 90000 
0.011916 750 100000 90000 
0.013373 1000 100000 90000 
0.001342 20 100000 90000 
0.004683 200 100000 90000 
0.009082 500 100000 90000 
0.011525 750 100000 90000 
0.013792 1000 100000 90000 
0.001281 20 100000 90000 
0.004642 200 100000 90000 
0.008866 500 100000 90000 
0.011619 750 100000 90000 
0.014318 1000 100000 90000 
0.001266 20 100000 100000 
0.004278 200 100000 100000 
0.007503 500 100000 100000 
0.010634 750 100000 100000 
0.011363 1000 100000 100000 
0.0015 20 100000 100000 
0.004615 200 100000 100000 
0.008434 500 100000 100000 
0.012105 750 100000 100000 
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0.013549 1000 100000 100000 
0.000162 1 100000 100000 
0.0015 20 100000 100000 
0.004656 200 100000 100000 
0.008002 500 100000 100000 
0.011147 500 100000 100000 
0.01336 1000 100000 100000 
0.000864 20 100000 150000 
0.003077 200 100000 150000 
0.006167 500 100000 150000 
0.008083 750 100000 150000 
0.009406 1000 100000 150000 
0.001012 20 100000 150000 
0.003225 200 100000 150000 
0.006086 500 100000 150000 
0.008259 750 100000 150000 
0.009109 1000 100000 150000 
0.000958 20 100000 150000 
0.003144 200 100000 150000 
0.006302 500 100000 150000 
0.007759 750 100000 150000 
0.009622 1000 100000 150000 
0.000621 20 100000 200000 
0.001835 200 100000 200000 
0.00332 500 100000 200000 
0.004021 750 100000 200000 
0.003981 1000 100000 200000 
0.000526 20 100000 200000 
0.001835 200 100000 200000 
0.00363 500 100000 200000 
0.00448 750 100000 200000 
0.004534 1000 100000 200000 
0.000513 20 100000 200000 
0.001903 200 100000 200000 
0.003738 500 100000 200000 
0.004764 750 100000 200000 
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Chapter 4 
Site-specific Incorporation of the tempo organic 
catalyst into a thermostable alcohol 
dehydrogenase produces a selective bio/organo-
hybrid catalyst 
Project Collaborators: Walaa Abdallah, Louis Lancaster, David Hickey, Ian Wheeldon, Shelley 
Minteer, and Scott Banta 
WA was responsible for molecular cloning work and all enzyme work, including protein 
expression, protein purification, unnatural amino acid incorporation, and enzyme kinetics. 
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4.1 Abstract 
Amber stop codons were introduced at three different positions in the thermostable alcohol 
dehydrogenase D, AdhD, from Pyrococcus furiosus. This enabled the incorporation of the 
unnatural amino acid, para-azidophenylalanine, to replace the initiation methionine (M1TAG), the 
catalytic tyrosine 64 (Y64TAG), and tyrosine 205 near the cofactor binding pocket (Y205TAG). 
The addition of the unnatural amino acid rendered Y64TAG inactive as its hydroxyl group, which 
participates in catalysis, was replaced with an azide group. The remaining mutants, M1TAG and 
Y205TAG, retained AdhD activity with 2,3-butanediol, its preferred substrate, and cofactor, 
NAD+. An amber stop codon was also introduced into a hydrogel containing AdhD, HS-AdhD-H, 
to allow for the incorporation of the para-azidophenylalanine. This mutant retained the activity of 
AdhD. The azide in AdhD and HS-AdhD-H allowed for the site-specific attachment of an alkyne 
modified TEMPO organic catalyst via click chemistry. This resulted in an AdhD/TEMPO hybrid. 
AdhD prefers the oxidation of secondary alcohols with a specificity for medium carbon chain 
lengths while TEMPO prefers to oxidize primary alcohols of varying chain length. The bio/organo-
hybrid catalysts demonstrate that enzymatic selectivity can be transferred to an organic catalyst by 
this approach. And this specificity can be altered by standard protein engineering methods.   
4.2 Introduction 
Biological and organic catalysts are two different classes of catalysts with varying properties. 
Enzymes are known for their enantioselectivity, substrate specificity, no byproduct formation, and 
their ability to be mass produced recombinantly [8]. Additionally, their ability to be engineered to 
increase stability and broaden potential applications makes them a desirable platform. Organic 
catalysts can be used homogenously or heterogeneously, can be modified to work in extreme 
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conditions, and can be synthesized with various functional groups. However, they lack the 
selectivity found in enzymes [7]. 
Bio-organo catalytic hybrids combines the properties of both classes, which was studied here. 
The enzyme chosen was alcohol dehydrogenase D, AdhD, from archaea Pyrococcus furiosus, 
which we have worked with extensively in our group [11, 17-20, 25]. It displays extreme 
thermostability, can be easily engineered, and exhibits substrate selectivity. AdhD prefers 
secondary alcohols over primary and works well with those with a medium carbon chain length 
[12]. The organic catalyst, TEMPO (2,2,6,6-tetramethylpiperidine-1-oxyl), prefers primary 
alcohols over secondary and works well with any chain length [7].  
To expand the potential applications of a bio-organo hybrid, work was also done with an AdhD 
chimera. Chimeric fusion proteins allow for the functionalities of various protein domains to be 
combined into one system. Examples of these systems include fusion proteins designed to develop 
switches, study human drug therapy, drug targeting, production of antibodies, and much more 
[117, 121-123]. Previously, the Banta Lab fused a structural domain, hydrogel HSH, and an active 
domain, AdhD, to develop a chimeric fusion protein, HS-AdhD-H. HSH is a hydrogel forming 
triblock polypeptide with two-alpha helical leucine zipper domains (H), which reversibly cross-
link resulting in a supramolecular hydrogel and are separated by a randomly coiled domain (S) 
[18, 37-40, 124]. HS-AdhD-H is a “novel bioactive material” that allowed AdhD to retain its 
activity while gaining the ability to form hydrogels [18].  
 We hypothesized that merging AdhD or HS-AdhD-H and TEMPO will result in selective 
alcohol oxidation (Figure 4.1). It can also allow for the selectivity of enzymes to be imparted onto 
organic catalysts. In the AdhD/TEMPO pathway, the alcohol being oxidized depends on which 
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catalyst can proceed. AdhD requires a cofactor and TEMPO must be regenerated, as the 
oxoammonium ion is the reactive species [45].  
 Figure 4.1 Alcohol oxidation reaction scheme with TEMPO and AdhD. 
The AdhD-TEMPO and HS-AdhD-H/TEMPO hybrids were developed using azide-alkyne 
click chemistry. The reaction between azides and alkynes can be done in the presence or absence 
of copper. The use of copper requires a terminal alkyne, speeds up the reaction around seven orders 
of magnitude, and is selective [47]. However, the presence of copper can be toxic to some cells. 
The second pathway is referred to as strain-promoted cycloaddition, which occurs between a 
cyclooctyne and an azide. Since the reaction occurs through ring strain, this removes the need for 
toxic copper, however, two regioisomers result [47]. Both methods were studied. 
To enable click chemistry, both AdhD and TEMPO required functional groups. Different 
versions of alkyne TEMPO (both terminal and internal) were synthesized by our collaborators. 
The azide group was incorporated into AdhD through site-specific unnatural amino acid 
incorporation, specifically through amber stop codon suppression. Unnatural amino acid 
incorporation has been utilized to study protein structure and activity, develop a responsive photo-
switching mechanism, fuse the properties of metal catalysts and enzymes, and much more [34, 35, 
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125]. Here, we are using the azide functionality provided by the unnatural amino acid to develop 
site-selective hybrids. A TEMPO-AdhD hybrid has previously been made, but the sites of 
attachment were not selective [45]. 
In this work, three AdhD mutants were studied, each with a different location of the azide. 
The azide designates where TEMPO will attach. The following sites were mutated to an amber 
stop codon: initiation methionine (M1TAG), catalytic tyrosine (Y64TAG), and tyrosine near the 
cofactor binding pocket (Y205TAG) (Figure 4.2).  
Figure 4.2 Homology model of AdhD with amber stop codon positions highlighted. Looking 
down the AdhD (α/β)8 barrel with mutations highlighted as blue sticks and cofactor, NAD+, 
highlighted as red spheres. Figure generated using PYMOL. 
M1TAG AdhD-TEMPO and Y205TAG AdhD-TEMPO may allow for the selective oxidation of 
primary and secondary alcohols, with Y205 providing steric hindrance. Y64TAG AdhD-TEMPO 
gained the substrate selectivity of AdhD suggesting enzymatic selectivity can be imparted onto 
organic catalysts.  
The same techniques will be used to develop a three-component system containing TEMPO, 
HSH, and HS-AdhD-H to both selectively oxidize alcohols and form hydrogels.  
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4.3 Materials and Methods 
4.3.1 Materials 
Oligonucleotides were purchased from Integrated DNA Technologies (Coralville, IA). 
Phusion high fidelity DNA polymerase and E. coli BL21(DE3) and BL21-AI expression cells were 
from New England Biolabs (Ipswich, MA). NuPAGE SDS-PAGE gels, MOPS running buffer, 
and Novex sharp pre-stained protein standards were from Invitrogen (Carlsbad, CA). BugBuster 
protein extraction reagent was purchased from Millipore Sigma (Burlington, MA). Histidine 
purification Nickel-NTA resin and TAMRA was purchased from ThermoFisher Scientific 
(Waltham, MA). Chromatography columns were from Bio-Rad (Hercules, CA). Molecular weight 
centrifugal filters were from EMD Millipore (Billerica, MA). All other chemicals, including 
kanamycin and spectinomycin, were from Sigma Aldrich (St. Louis, MMO). 
4.3.2 Cloning, Expression, and Purification of AdhD with Unnatural Amino 
Acids 
The adhD gene from Pyrococcus furiosus in the pET-20b(+) vector, plasmid pWUR85, was 
re-cloned into the pET-28a(+) vector [12, 26]. The pET-28a(+) vector was restriction digested with 
NdeI such that the gene was preceded by the poly-histidine tag and the thrombin site. The resulting 
plasmid, AdhD-pet28a, was verified by DNA sequencing (complete sequence can be found in the 
Supporting Information). Site-directed mutagenesis was then used to introduce the amber stop 
codon (TAG) at the desired position for unnatural amino acid incorporation. Three different 
constructs were made: M1TAG (start methionine mutated to the amber stop codon), Y64TAG 
(catalytic tyrosine 64 mutated to the amber stop codon), and Y205TAG (tyrosine 205, which 
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participates in catalysis, mutated to the amber stop codon). Final sequences were verified by DNA 
sequencing (primers can be found in the Supporting Information). 
The AdhD-pET-28a(+) plasmid, as well as the three different mutants (M1TAG, Y64TAG, 
Y205TAG), were co-transformed with aminoacyl-tRNA synthetase/tRNA pDule2 pCNF RS from 
Methanocaldococcus jannaschii into E. coli BL21-AI expression cells and plated onto Luria Broth 
(LB) plates supplemented with 0.1 mg/ml spectinomycin and 0.035 mg/ml kanamycin [126]. The 
pDule2 plasmid was a gift from Ryan Mehl. Prior to expression, media component stocks were 
prepared. 50x5052 solution was prepared by dissolving 125 g glycerol, 12.5 g glucose, and 50 g 
α-lactose in 365 mL water. 1 M MgSO4 was prepared by dissolving 60.18 g of MgSO4 in 500 mL 
water. 40% glucose contained 20 g of D-(+)-glucose for every 30 mL of water. 20% arabinose was 
prepared by dissolving 2 g L-arabinose in 8 mL water and was sterile filtered and aliquoted into -
20 °C. 25xM solution contained 44.36 g Na2HPO4, 42.55 g KH2PO4, 33.5 g NH4Cl, and 8.9 g 
Na2SO4 in 500 mL water. ZY media contained 5 g N-Z amine AS (bovine casein enzymatic 
hydrolysate) and 2.5 g yeast extract in 500 mL water [126]. 200x trace metal solution contains the 
following in grams per liter: 0.5 EDTA, 3 MgSO4-7H2O, 0.5 MnSO4-H2O, 1 NaCl, 0.1 FeSO4-
7H2O, 0.1 Co(NO3)2-6H2O, 0.1 anhydrous CaCl2, 0.1 ZnSO4-7H2O, anhydrous 0.01 AlK(SO4)2, 
0.01 H3BO3, 0.01 Na2MoO4-2H2O, 0.001 anhydrous Na2SeO3, 0.01 Na2WO4-2 H2O, and 0.02 
NiCl2-6H2O.  
Single colonies were inoculated overnight in noninducing media, which contained the 
following for every 150 ml ZY media: 2 mM 1 M MgSO4, 6 mL 25xM media, 750 µL of 200x 
trace metals, and 1.875 mL 40% glucose. Expression was performed the next day at 37 °C in 1L 
flasks containing 200 mL ZY media with 2 mL of the inoculated colonies. This media was then 
supplemented with autoinducing media containing the following for every 150 mL ZY media: 2 
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mM 1 M MgSO4, 6 mL 25xM media, 750 µL of 200x trace metals, 3 mL 50x5052, and 375 uL 
20% arabinose. The flasks were kept shaking at 200 rpm while the unnatural amino acid (UAA), 
para-azidophenylalanine, was prepared. 20 mg UAA per every 50 mL of media was added to each 
flask (M1TAG, Y64TAG, and Y205TAG positive controls) by pre-dissolving it in 0.5 M NaOH. 
Flasks containing the wild-type protein (AdhD-pET28a(+)) and negative controls (amber stop 
codon mutants) were not supplemented with the unnatural amino acid. The flasks were then 
returned to 37 °C and kept shaking overnight at 200 rpm. 
The cells were harvested for purification with a portion resuspended in tris-buffer and lysed at 
80 °C for 1 hour to denature all proteins except for thermophilic AdhD. This was done to confirm 
the presence of the protein, but was not used as a purification step as the unnatural amino acid is 
sensitive and although not studied at higher temperatures, it is known to photodegrade [127]. 
Therefore, the remainder of the cells were resuspended in 6 mL BugBuster protein extraction 
reagent and kept shaking at room temperature at 60 rpm for 20 minutes. The cells that were 
previously supplemented with para-azidophenylalanine were covered in foil to prevent azide 
degradation. Cell debris was removed by centrifugation for 30 minutes for the samples heated at 
80 °C and for 1 hour at 7000xg for the samples treated with BugBuster. The clarified lysate from 
both the heated samples and the BugBuster samples were loaded onto NuPAGE 4-12% Bis-tris 
gels to confirm the expression of full-length protein in the wild-type and mutants 
supplemented with para-azidophenylalanine (Figure 4.8). The negative controls, mutants not 
supplemented with unnatural amino acid were also run on the gel to confirm the expression of 
the truncated protein. To confirm the expression of AdhD, the full-length protein for the wild-
type and positive controls must have been present in the BugBuster samples (suggesting the 
incorporation of the UAA) and the supernatant of the 80 °C samples (suggesting the expression 
of AdhD as it is thermophilic). 
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Full-length proteins (wild-type and mutants with the UAA) that were lysed with BugBuster 
were loaded onto previously prepared chromatography columns containing 4 mL Ni-NTA resin. 
The resin was previously equilibrated with 20 mM sodium phosphate buffer with 500 mM NaCl, 
pH 7.4. The flow-through was collected and the column was washed with varying immidizole 
concentrations (75-500 mM immidizole) in 20 mM tris-HCl with 200 mM NaCl pH 7.4. Fractions 
were run on NuPAGE 4-12% Bis-tris gels in MES running buffer and those with 95% purity or 
more were pooled together and concentrated in 10 kDa MWCO centrifugal filters. The proteins 
were then buffer exchanged in 100 mM sodium phosphate buffer pH 7.4. Protein concentrations 
was measured by reading the absorbance at 280 nm on a SpectraMax M2 plate reader using an 
extinction coefficient of  52495 M-1 cm-1 for AdhD and M1TAG and 51005 M-1 cm-1  for Y64TAG 
and Y205TAG as the tyrosine is not present in the incorporated protein [110]. 
4.3.3 Cloning, Expression, and Purification of HSH, HS-AdhD-H, and HSH 
M1TAG 
HSH and HS-AdhD-H (previously prepared in the Banta Lab) were cloned into pET28a(+) at 
NdeI (complete sequences can be found in supporting information) [18]. An amber stop codon was 
introduced at the initiation methionine of HSH, resulting in HSH M1TAG (primer can be found in 
supporting information). After verification of the sequences, constructs were co-transformed with 
the helper plasmid used for unnatural amino acid incorporation. The helper plasmid, pULTRA-
CNF from Methanocaldococcus jannaschii, was prepared by the Schultz Lab and was ordered 
from Addgene (plasmid #48215). pULTRA was used instead of the previously used pDule2 
because this helper plasmid has been shown to increase incorporation yields [30]. 
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HSH, HSH M1TAG, and HS-AdhD-H were each co-transformed with pULTRA into E. coli 
BL21(DE3) cells onto Luria Broth (LB) plates supplemented with 0.035 mg/ml kanamycin and 
0.1 mg/ml spectinomycin. Single colonies were inoculated at 37 ºC overnight in Terrific Broth 
(TB) supplemented with 0.035 mg/ml kanamycin and 0.1 mg/ml spectinomycin. Expression was 
performed the next day in the same media at 37 °C. When the cells reached on O.D. of 
approximately 1.0, induction was performed with 1 mM isopropyl β-D-1-thiogalactopyranoside 
(IPTG) and the cells were shaken at 200 rpm overnight at 27 °C. Cultures containing HSH M1TAG 
were supplemented with para-azidophenylalanine (20 mg of unnatural amino acid per 50 mL 
expression) during induction. A negative control was also done where HSH M1TAG was not 
supplemented with para-azidophenylalanine but was induced with IPTG. 
The cells were harvested and resuspended in BugBuster and kept shaking at 60 rpm for 20 
minutes. Those containing the unnatural amino acid were covered in foil. Cell debris was removed 
by centrifuging at 7000xg for 1 hour. The clarified lysate for the wild-type enzymes (HSH and 
HS-AdhD-H) and those containing the unnatural amino acid (HSH M1TAG with UAA) were 
loaded onto chromatography columns containing Ni-NTA resin previously equilibrated with 20 
mM sodium phosphate buffer with 500 mM NaCl, pH 7.4. The clarified lysate of the negative 
control (HSH M1TAG without UAA) was run on SDS-PAGE to ensure no wild-type protein was 
expressed through read-through expression. Once this was confirmed, the columns incubated with 
clarified lysates were used to purify the proteins. The flow-through was collected and the column 
was washed with varying immidizole concentrations (75-500 mM immidizole) in 20 mM tris-
HCl with 200 mM NaCl pH 7.4 (Figure 4.11 and Figure 4.12). Fractions were run on NuPAGE 
4-12% Bis-tris gels in MES running buffer and those containing protein greater than 95%
pure were pooled together and concentrated in 20 kDa MWCO filters for HSH and 30 kDa 
MWCO filters 
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for HS-AdhD-H. It should be noted that the theoretical molecular weight of HSH is 24 kDa, but it 
runs at approximately 35 kDa, which matches previous work done in the Banta Lab [18]. The 
proteins were then buffer exchanged in 100 mM sodium phosphate buffer pH 7.4. A portion of 
HS-AdhD-H was buffer exchanged into 50 mM glycine (pH 9.3) for activity assays. 
4.3.4 Kinetic Activity Assays 
Kinetic assays were done with proteins that showed expression of the full-length protein and 
those containing the unnatural amino acid, para-azidophenylalanine. Specific activities for wild-
type AdhD and its three mutants was determined by conducting assays at 45 °C in 96-well plates 
where enzyme, 100 mM substrate (2,3-butanediol), and 100 mM sodium phosphate buffer (pH 
7.4) were incubated for 20 minutes. 100 µM cofactor (NAD+) was then added and the absorbance 
at 340 nm was measured continuously for 20 minutes. Absorbance was converted to concentration 
using an extinction coefficient of 6.22 mM-1 cm-1. The final reaction volume was 250 µL. To 
ensure initial rates, only data within the first 10% of the conversion of the added cofactor was used. 
Using enzyme concentration, rates were converted to initial specific rates. All measurements were 
made in at least triplicate. 
The specific rate of wild-type AdhD with various alcohols, other than 2,3-butanediol, and 
sugars was measured at the exact same conditions.  
Kinetic assays with HS-AdhD-H were performed to confirm the activity of AdhD in this 
chimeric fusion protein. Briefly, 100 mM 2,3-butanediol was incubated with enzyme and 50 mM 
glycine (pH 9.3) at 45 °C for approximately 20 minutes. 100 µM cofactor, NAD+, was then added 
and the absorbance at 340 nm of NADH production was monitored. Specific rates were not 
determined as these were preliminary assays done only to ensure that HS-AdhD-H is active. 
159 
4.3.5 Click Chemistry with TAMRA 
To further confirm the incorporation of the UAA (besides purification and activity assays), 
AdhD and the three mutants (M1TAG, Y64TAG, and Y205TAG) supplemented with para-
azidophenylalanine were clicked to alkyne TAMRA. Steps 3.1 to 3.3 and 5.1 to 5.4 from protocol 
number MP33368 from ThermoFisher and steps 1.1 to 2.7 from protocol number MP33370 were 
followed. The samples were run on NuPAGE 4-12% Bis-tris gels in MES running buffer and prior 
to staining were observed under UV light.  
HSH (as a control) and HSH M1TAG containing unnatural amino acid para-
azidophenylalanine were also clicked to alkyne TAMRA to confirm incorporation and the ability 
to click onto HSH (same protocol as that used for AdhD). The samples were run on NuPAGE 4-
12% Bis-tris gels in MES running buffer and prior to staining were observed under UV light (as 
the alkyne used for click chemistry is fluorescent). Once again, HSH should be observed at 
approximately 35 kDa, inconsistent with its theoretical molecular weight.  
4.4 Results and Discussion 
4.4.1 Expression and Purification of AdhD, M1TAG AdhD, Y64TAG AdhD, 
and Y205TAG AdhD and HSH, HSH TAG, and HS-AdhD-H 
The DNA sequence corresponding to the AdhD gene from Pyrococcus furiosus was cloned 
into the pET28a(+) vector, resulting in the construct AdhD-pET28a(+). This same plasmid was 
used to introduce three unique amber stop codons in positions: methionine 1, tyrosine 64, and 
tyrosine 205. AdhD-pET28a(+) and the three mutants (M1TAG, Y64TAG, and Y205TAG) were 
co-transformed with pDule2 pCNF RS from Methanocaldococcus jannaschii into BL21-AI cells 
and all proteins were expressed. The wild-type enzyme and the three mutants had a molecular 
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weight of around 34 kDa consistent with its theoretical molecular weight. The full DNA and amino 
acid sequence of AdhD and the mutants can be found in the Supporting Information. 
The resulting proteins, wild-type AdhD and the three mutants supplemented with para-
azidophenylalanine, were routinely produced at 12 mg of protein per 200 mL E. coli culture. After 
expression and auto-induction, the pelleted cells were resuspended and extracted with BugBuster 
protein extraction reagent. The whole cell lysates were centrifuged, and the proteins were found 
in the soluble portion (Figure 4.8). The clarified lysate was purified using nickel-column 
chromatography and yielded the expected molecular masses with a purity of greater than 95% 
(Figure 4.9 and Figure 4.10). 
HSH and HS-AdhD-H (previously prepared in the Banta Lab) were cloned into pET28a(+), 
resulting in the plasmids HSH-pET28 and HS-AdhD-H pET28 (full DNA and amino acid 
sequences can be found in Supporting Information) [18]. The plasmids were co-transformed into 
E. coli BL21(DE3) cells with pULTRA-CNF. The proteins were purified on nickel resin to greater 
than 95% purity (Figure 4.11 and Figure 4.12). The theoretical molecular weights are 24 kDa and 
56 kDa for HSH and HS-AdhD-H, respectively, but HSH runs slightly higher at around 35 kDa, 
which was previously observed [18].  
HSH and HS-AdhD-H were produced at around 10 to 15 mg of protein per liter of E. coli 




4.4.2 Effect of the Unnatural Amino Acid, para-azidophenylalanine, on AdhD 
Specific Activity 
The specific activity of AdhD and the three mutants, with para-azidophenylalanine replacing 
the amber stop codon, was determined with AdhD’s preferred substrate, 2,3-butanediol (100 mM), 
and its cofactor NAD+ (100 µM) (Table 4.1). 
Table 4.1 Specific activity of AdhD and mutants (with para-azidophenylalanine) with 2,3- 
butanediol and NAD+  Oxidation reaction with 100 mM 2,3 - butanediol and 100 µM NAD+ in 
100 mM sodium phosphate buffer pH 7.4. All data was collected in at least triplicate. 
Mutant Specific Activity (µmol min-1 mg-1) 
AdhD 1.3 ± 0.05 
M1TAG 1.0 ± 0.05 
Y64TAG Inactive 
Y205TAG 0.62 ± 0.024 
The activity of M1TAG AdhD was similar to that of AdhD, which was expected as the 
insertion was made at the N-terminus of the enzyme, away from the active site. The Y64TAG 
mutant was inactive. This was expected as the hydroxyl group of tyrosine 64, which participates 
in catalysis, was replaced with the functional azide group from para-azidophenylalanine [11]. The 
final mutant, Y205TAG was active, but less active than the wild-type enzyme. The benzene ring 
in Y205 is thought to participate in catalysis so the fact that the enzyme retained its activity is not 
unusual [11]. However, the decrease in activity could be due to insertion of a unique functional 
group previously not present. 
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4.4.3 Specific Activity of AdhD with Primary, Secondary, and Other Alcohols 
AdhD prefers secondary alcohols over primary alcohols and works well with medium carbon 
chains. The preference of AdhD towards various alcohols, both with a varying number of hydroxyl 
groups and positions, and with varying carbon chain lengths was tested (Figure 4.3). 
 
 
Figure 4.3 Specific activity of AdhD with various alcohols.  Activity tested with 100 µM NAD+ 
in 100 mM sodium phosphate buffer pH 7.4 
 
Primary and secondary alcohols were varied from three to six carbon chains. AdhD 
consistently preferred the secondary alcohols over the primary regardless of chain length. Within 
the secondary alcohols, the maximum activity peaked at five carbon chains and then decreased, 
signifying AdhD’s preference for secondary alcohols with medium chain length. The “other” 
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alcohols tested included methanol, ethanol, 2,3-butanediol, glucose, D-arabinose, and L-arabinose 
(list can be found in Supporting Information Table 4.2). AdhD showed minimal activity with most, 
except for arabinose and 2,3-butanediol. D-arabinose was more active than L-arabinose and the 
maximum activity was achieved with 2,3-butanediol, which is in accordance with previously 
published results [12]. 
4.4.4 HS-AdhD-H Activity Assay 
One advantage of chimeric fusion proteins is their dual-functionality - HS-AdhD-H has the 
ability to form a hydrogel and retains the activity of AdhD [18]. To ensure HS-AdhD-H activity, 
assays with AdhD’s preferred substrate 2,3-butanediol was done. Enzyme along with 100 mM 
substrate and 100 µM NAD+ was incubated and monitored at 340 nm at 45 °C (Figure 4.4). 
Figure 4.4 Rate of NADH production with HS-AdhD-H.  HS-AdhD-H was incubated at 45 ºC 
with 2,3-butanediol and NAD+ in 50 mM glycine (pH 9.3) and production of NADH at 340 nm 




The enzymatic activity of HS-AdhD-H and its ability to form a hydrogel suggests a tri-
functional system, that will have the ability to selectively oxidize secondary alcohols (AdhD) and 
primary alcohols (TEMPO), is possible.  
4.4.5 Click Chemistry with TAMRA 
AdhD and the three mutants, M1TAG, Y64TAG, and Y205TAG were clicked to alkyne-
functionalized TAMRA to ensure the presence of para-azidophenylalanine and to test the 
accessibility of those sites for click chemistry. The use of copper ensures the formation of solely 
the 1,4-disubstituted 1,2,3-triazole [47]. After the reaction, the samples were run on SDS-PAGE 
and exposed to UV light (Figure 4.5). All three mutants labeled with para-azidophenylalanine 
were able to react with alkyne TAMRA and ran at the expected molecular weight of 34 kDa. AdhD 
alone was unable to form a bond with TAMRA as it does not contain the azide functional group 
required to react. 
 
Figure 4.5 SDS-PAGE of azide-alkyne cycloaddition with AdhD. Protein gel exposed to UV 
light after copper-catalyzed azide-alkyne cycloaddition between para-azidophenylalanine labeled 
AdhD mutants M1TAG, Y64TAG, and Y205TAG and TAMRA (tetramethylrhodamine) 
fluorescent alkyne. Lane: (1) molecular weight ladder, (2) AdhD, (3) UAA labeled M1TAG, (4) 
UAA labeled Y64TAG, (5) UAA labeled Y205TAG. Expected bands observed at theoretical 
molecular weight, 34 kDa. 
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To ensure the incorporation of para-azidophenylalanine in HSH and to make sure the site 
is accessible for click chemistry, HSH para-azidophenylalanine was clicked to fluorescent- 
TAMRA (Figure 4.6). HSH without the unnatural amino acid was tested as a negative control. 
Figure 4.6 SDS-PAGE of HSH and HSH M1TAG with TAMRA.  Protein gel exposed to UV 
light after click chemistry between HSH containing para-azidophenylalanine and alkyne 
TAMRA. Lane 1: molecular weight marker lane 2: HSH UAA, lane 3: HSH. An expected band 
at 35 kDa was observed for HSH with the unnatural amino acid. 
HSH M1TAG (with the unnatural amino acid) lit up on SDS-PAGE under UV light. It ran at 
approximately the same size it normally runs on SDS-PAGE and a single band was fluorescent 
indicating HSH contains the unnatural amino acid and click chemistry was successful at this site. 
HSH alone does not have a band at the same molecular weight indicating the wild-type protein 
does not react with TAMRA alkyne. 
4.4.6 Y64TAG AdhD-TEMPO Imparts AdhD Selectivity Onto TEMPO 
Y64TAG AdhD was clicked to TEMPO via strain-promoted cycloaddition.  Prior to the fusion, 
TEMPO preferred 1-propanol over 2,3-butanediol. After clicking TEMPO in the cofactor binding 
pocket of AdhD at Y64, the preference switched to 2,3-butanediol, a secondary alcohol (Figure 
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4.7). This suggests that selectivity can be imparted from one catalyst to another and that hybrids 














Figure 4.7 Activity of TEMPO before and after AdhD attachment at Y64.  Collaborators 
performed electrochemical assay with TEMPO alone and AdhD-TEMPO after click chemistry at 
position Y64. 
 
4.5  Conclusion  
The ability to impart substrate selectivity onto an organic catalyst provides us with an extra 
tool we can use to develop multi-step cascades and merge different classes of catalysts. Here, we 
developed a technique that allows us to selectively oxidize a mixture of alcohols and in some cases, 
impart the selectivity of an enzyme, AdhD, onto an organic catalyst, TEMPO. The protein 
engineering methods used here can be readily applied to other systems. Work is still being 
completed on the other two mutants, M1TAG AdhD and Y205TAG AdhD. Additionally, work is 
being done with other organic catalysts besides TEMPO. 
TEMPO                 AdhD-TEMPO HYBRID  
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4.6  Future Work 
Work with the three different mutants of AdhD and other alkyne modified moieties are 
currently being studied and tested by our collaborators. 
Preliminary work has been done with new mutants of AdhD: hAR AdhD and hAR Y64TAG 
AdhD. Here, the AdhD gene containing human aldose reductase (hAR) loops A and B was 
synthesized, matching the protein sequence of a previous version of this fusion [19]. This construct 
was cloned into pET28a(+) using the same primers as those used when AdhD was cloned into this 
same vector. hAR is active with DL-glyceraldehyde and NADP(H), while AdhD is inactive with 
DL-glyceraldehyde. However, when hAR substrate loops A and B were grafted onto AdhD, hAR
AdhD was found to be active with NADPH and DL-glyceraldehyde [19]. Its activity with 2,3-
butanediol was still intact. However, hAR AdhD reversed cofactor specificity where now NADP+ 
is preferred over NAD+ [19].  
Site-directed mutagenesis was performed on this new construct, hAR AdhD, to introduce an 
amber stop codon in the same position as tyrosine 64 in AdhD (sequence in Supporting 
Information).  
Expression of hAR AdhD and incorporation of para-azidophenylalanine in Y64TAG hAR 
AdhD was achieved, as well as the ability to purify this protein on the nickel column (Figure 4.13). 
Preliminary TAMRA assays indicates the ability to click in the active site (Figure 4.14). 
Additionally, preliminary activity assays with hAR AdhD and Y64TAG hAR AdhD indicate the 
chimeric protein is active while the one lacking the hydroxyl group of tyrosine 64 is not (mutant 
with para-azidophenylalanine). Additionally, the enzyme is active with L-glyceraldehyde, but not 
D-glyceraldehyde. This chiral specificity gives us the ability to click TEMPO into the active site
168 
of AdhD and impart not only its substrate selectivity, but its ability to distinguish between 
enantiomers as well. 
4.7  Supporting Information 
Primers to clone AdhD into pET28a(+) at NdeI 
FWD: CCGCGCGGCAGCCATATGGCAAAAAGGGTAAATGCATTCAACGACCTTAAGCGTA 
REV: AGTCATGCTAGCCATTCACACACACCTCCTTGCCATCTCTCTATCCTC 
AdhD-pET28a(+) DNA sequence: 
ATGGGCAGCA GCCATCATCA TCATCATCAC AGCAGCGGCC TGGTGCCGCG CGGCAGCCAT 60 
ATGGCAAAAA GGGTAAATGC ATTCAACGAC CTTAAGCGTA TAGGAGATGA TAAGGTAACG 120 
GCAATTGGAA TGGGAACATG GGGAATAGGA GGGAGAGAGA CCCCAGACTA TTCTAGGGAT 180 
AAGGAAAGCA TAGAAGCAAT AAGATATGGA CTTGAATTAG GAATGAATTT AATCGACACA 240 
GCGGAATTCT ATGGAGCTGG TCATGCTGAG GAAATAGTTG GAGAGGCCAT TAAAGAATTC 300 
GAACGTGAGG ACATCTTCAT AGTGAGCAAG GTCTGGCCAA CTCACTTTGG GTATGAGGAA 360 
GCAAAGAAGG CTGCTAGAGC AAGTGCTAAA AGGTTAGGAA CTTATATTGA CCTTTATTTG 420 
TTGCACTGGC CCGTTGATGA CTTCAAGAAG ATAGAGGAGA CACTTCACGC TTTGGAAGAC 480 
CTCGTAGATG AGGGAGTGAT AAGGTACATT GGAGTTAGCA ACTTCAATCT GGAACTTCTC 540 
CAGCGCTCCC AGGAGGTCAT GAGGAAGTAT GAGATTGTAG CAAATCAAGT TAAATACTCA 600 
GTGAAAGACC GCTGGCCCGA AACTACAGGA CTTCTCGACT ACATGAAGCG TGAAGGAATA 660 
GCATTAATGG CGTACACACC TCTAGAAAAG GGAACTCTTG CAAGGAATGA ATGTCTAGCT 720 
AAAATTGGAG AAAAATACGG AAAAACAGCT GCTCAAGTGG CTTTAAACTA CCTGATTTGG 780 
GAGGAAAATG TTGTAGCAAT TCCAAAAGCA AGCAACAAGG AACACCTCAA AGAAAACTTT 840 
GGAGCTATGG GATGGAGGCT TTCAGAGGAG GATAGAGAGA TGGCAAGGAG GTGTGTGTGA 900 
AdhD Amino Acid Sequence 
MGSSHHHHHH SSGLVPRGSH MAKRVNAFND LKRIGDDKVT AIGMGTWGIG GRETPDYSRD 60 
KESIEAIRYG LELGMNLIDT AEFYGAGHAE EIVGEAIKEF EREDIFIVSK VWPTHFGYEE 120 
AKKAARASAK RLGTYIDLYL LHWPVDDFKK IEETLHALED LVDEGVIRYI GVSNFNLELL 180 
QRSQEVMRKY EIVANQVKYS VKDRWPETTG LLDYMKREGI ALMAYTPLEK GTLARNECLA 240 
KIGEKYGKTA AQVALNYLIW EENVVAIPKA SNKEHLKENF GAMGWRLSEE DREMARRCV 299 
AdhD Amino Acid Sequence with Mutations Highlighted in Red 
MGSSHHHHHH SSGLVPRGSH MAKRVNAFND LKRIGDDKVT AIGMGTWGIG GRETPDYSRD 60 
KESIEAIRYG LELGMNLIDT AEFYGAGHAE EIVGEAIKEF EREDIFIVSK VWPTHFGYEE 120 
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AKKAARASAK RLGTYIDLYL LHWPVDDFKK IEETLHALED LVDEGVIRYI GVSNFNLELL 180 
QRSQEVMRKY EIVANQVKYS VKDRWPETTG LLDYMKREGI ALMAYTPLEK GTLARNECLA 240 
KIGEKYGKTA AQVALNYLIW EENVVAIPKA SNKEHLKENF GAMGWRLSEE DREMARRCV 299 










** mutations highlighted in red in amino acid sequence 
Primers for Hydrogels: 
Primers to clone HSH and HS-AdhD-H into pET28a(+) 
Forward: CCGCGCGGCAGCCATATGGGATCCGATGACGATGACAAATGGGCTAGCGGTGACCTGG 
Reverse: AGTCATGCTAGCCATTTAGCAGCCACCCATACTAGTGTCTCGAGGCGCCACATGGTCA 






ATGGGCAGCA GCCATCATCA TCATCATCAC AGCAGCGGCC TGGTGCCGCG CGGCAGCCAT 60 
ATGGGATCCG ATGACGATGA CAAATGGGCT AGCGGTGACC TGGAAAACGA AGTGGCCCAG 120 
CTGGAAAGGG AAGTTAGATC TCTGGAAGAT GAAGCGGCTG AACTGGAACA AAAAGTCTCG 180 
AGACTGAAAA ATGAAATCGA AGACCTGAAA GCCGAAATTG GTGACCATGT GGCGCCTCGA 240 
GACACTAGCT ATCGCGATCC GATGGGTGCC GGCGCTGGTG CGGGCCCGGA AGGTGCAGGC 300 
GCTGGTGCGG GCCCGGAAGG TGCCGGCGCT GGTGCGGGCC CGGAAGGTGC AGGCGCTGGT 360 
GCGGGCCCGG AAGGTGCCGG CGCTGGTGCG GGCCCGGAAG GTGCAGGCGC TGGTGCGGGC 420 
CCGGAAGGTG CCGGCGCTGG TGCGGGCCCG GAAGGTGCAG GCGCTGGTGC GGGCCCGGAA 480 
GGTGCCGGCG CTGGTGCGGG CCCGGAAGGT GCAGGCGCTG GTGCGGGCCC GGAAGGTGCC 540 
CGCATGCCGA CTAGCGGTGA CCTGGAAAAC GAAGTGGCCC AGCTGGAAAG GGAAGTTAGA 600 
TCTCTGGAAG ATGAAGCGGC TGAACTGGAA CAAAAAGTCT CGAGACTGAA AAATGAAATC 660 
GAAGACCTGA AAGCCGAAAT TGGTGACCAT GTGGCGCCTC GAGACACTAG TATGGGTGGC 720 
TGCTAA 726 
HS-AdhD-H: 
ATGGGCAGCA GCCATCATCA TCATCATCAC AGCAGCGGCC TGGTGCCGCG CGGCAGCCAT 60 
ATGGGATCCG ATGACGATGA CAAATGGGCT AGCGGTGACC TGGAAAACGA AGTGGCCCAG 120 
CTGGAAAGGG AAGTTAGATC TCTGGAAGAT GAAGCGGCTG AACTGGAACA AAAAGTCTCG 180 
AGACTGAAAA ATGAAATCGA AGACCTGAAA GCCGAAATTG GTGACCATGT GGCGCCTCGA 240 
GACACTAGCT ATCGCGATCC GATGGGTGCC GGCGCTGGTG CGGGCCCGGA AGGTGCAGGC 300 
GCTGGTGCGG GCCCGGAAGG TGCCGGCGCT GGTGCGGGCC CGGAAGGTGC AGGCGCTGGT 360 
GCGGGCCCGG AAGGTGCCGG CGCTGGTGCG GGCCCGGAAG GTGCAGGCGC TGGTGCGGGC 420 
CCGGAAGGTG CCGGCGCTGG TGCGGGCCCG GAAGGTGCAG GCGCTGGTGC GGGCCCGGAA 480 
GGTGCCGGCG CTGGTGCGGG CCCGGAAGGT GCAGGCGCTG GTGCGGGCCC GGAAGGTGCC 540 
CGCATGCCGC ATGGAATGGC AAAAAGGGTA AATGCATTCA ACGACCTTAA GCGTATAGGA 600 
GATGATAAGG TAACGGCAAT TGGAATGGGA ACATGGGGAA TAGGAGGGAG AGAGACCCCA 660 
GACTATTCTA GGGATAAGGA AAGCATAGAA GCAATAAGAT ATGGACTTGA ATTAGGAATG 720 
AATTTAATCG ACACAGCGGA ATTCTATGGA GCTGGTCATG CTGAGGAAAT AGTTGGAGAG 780 
GCCATTAAAG AATTCGAACG TGAGGACATC TTCATAGTGA GCAAGGTCTG GCCAACTCAC 840 
TTTGGGTATG AGGAAGCAAA GAAGGCTGCT AGAGCAAGTG CTAAAAGGTT AGGAACTTAT 900 
ATTGACCTTT ATTTGTTGCA CTGGCCCGTT GATGACTTCA AGAAGATAGA GGAGACACTT 960 
CACGCTTTGG AAGACCTCGT AGATGAGGGA GTGATAAGGT ACATTGGAGT TAGCAACTTC 1020 
AATCTGGAAC TTCTCCAGCG CTCCCAGGAG GTCATGAGGA AGTATGAGAT TGTAGCAAAT 1080 
CAAGTTAAAT ACTCAGTGAA AGACCGCTGG CCCGAAACTA CAGGACTTCT CGACTACATG 1140 
AAGCGTGAAG GAATAGCATT AATGGCGTAC ACACCTCTAG AAAAGGGAAC TCTTGCAAGG 1200 
AATGAATGTC TAGCTAAAAT TGGAGAAAAA TACGGAAAAA CAGCTGCTCA AGTGGCTTTA 1260 
AACTACCTGA TTTGGGAGGA AAATGTTGTA GCAATTCCAA AAGCAAGCAA CAAGGAACAC 1320 
CTCAAAGAAA ACTTTGGAGC TATGGGATGG AGGCTTTCAG AGGAGGATAG AGAGATGGCA 1380 
AGGAGGTGTG TGGGCATGCC GACTAGCGGT GACCTGGAAA ACGAAGTGGC CCAGCTGGAA 1440 
AGGGAAGTTA GATCTCTGGA AGATGAAGCG GCTGAACTGG AACAAAAAGT CTCCAGACTG 1500 
AAAAATGAAA TCGAAGACCT GAAAGCCGAA ATTGGTGACC ATGTGGCGCC TCGAGACACT 1560 




MGSSHHHHHH SSGLVPRGSH MGSDDDDKWA SGDLENEVAQ LEREVRSLED EAAELEQKVS 60 
RLKNEIEDLK AEIGDHVAPR DTSYRDPMGA GAGAGPEGAG AGAGPEGAGA GAGPEGAGAG 120 
AGPEGAGAGA GPEGAGAGAG PEGAGAGAGP EGAGAGAGPE GAGAGAGPEG AGAGAGPEGA 180 
RMPTSGDLEN EVAQLEREVR SLEDEAAELE QKVSRLKNEI EDLKAEIGDH VAPRDTSMGG 240 
C 241 
• Initiation methionine (in red) mutated to amber stop codon in
M1TAG construct
HS-AdhD-H: 
MGSSHHHHHH SSGLVPRGSH MGSDDDDKWA SGDLENEVAQ LEREVRSLED EAAELEQKVS 60 
RLKNEIEDLK AEIGDHVAPR DTSYRDPMGA GAGAGPEGAG AGAGPEGAGA GAGPEGAGAG 120 
AGPEGAGAGA GPEGAGAGAG PEGAGAGAGP EGAGAGAGPE GAGAGAGPEG AGAGAGPEGA 180 
RMPHGMAKRV NAFNDLKRIG DDKVTAIGMG TWGIGGRETP DYSRDKESIE AIRYGLELGM 240 
NLIDTAEFYG AGHAEEIVGE AIKEFEREDI FIVSKVWPTH FGYEEAKKAA RASAKRLGTY 300 
IDLYLLHWPV DDFKKIEETL HALEDLVDEG VIRYIGVSNF NLELLQRSQE VMRKYEIVAN 360 
QVKYSVKDRW PETTGLLDYM KREGIALMAY TPLEKGTLAR NECLAKIGEK YGKTAAQVAL 420 
NYLIWEENVV AIPKASNKEH LKENFGAMGW RLSEEDREMA RRCVGMPTSG DLENEVAQLE 480 
REVRSLEDEA AELEQKVSRL KNEIEDLKAE IGDHVAPRDT SMGGC 525 
Figure 4.8 SDS-PAGE of AdhD and mutant cell lysates.  Samples include M1TAG, Y64TAG, 
and Y205TAG with and without unnatural amino acid para-azidophenylalanine supplementation 
after heat treatment at 80 °C and after lysing with BugBuster detergent. 80 °C samples: (1) 
molecular weight marker, (2) AdhD, (3) M1TAG, (4) UAA labeled M1TAG, (5) Y64TAG, (6) 
UAA labeled Y64TAG, (7) Y205TAG, (8) UAA labeled Y205TAG. BugBuster samples: (2b) 
AdhD, (4b) UAA labeled M1TAG, (6b) UAA labeled Y64TAG, (8b) UAA labeled Y205TAG. 
A distinct band at approximately 34 kDa is observed for AdhD and mutants with UAA, 
consistent with calculated molecular weights. 
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Figure 4.9 SDS-PAGE after nickel column purification of AdhD and mutants.  Mutants 
M1TAG, Y64TAG, and Y205TAG supplemented with unnatural amino acid para-
azidophenylalanine. Lane 1: molecular weight marker, lane 2: flow-through, lane 3: 75 mM 
immidizole, lane 4: 100 mM immidizole, lane 5: 150 mM immidizole, lane 6: 300 mM 
immidizole, lane 7: 400 mM immidizole, lane 8: 500 mM immidizole. Samples were lysed using 
BugBuster detergent for 20 minutes at room temperature and purified by exploiting the poly-
histidine tag at the N-terminus of the proteins. Proteins were eluted off the nickel column with 
increasing immidizole concentrations. Distinct bands at approximately 34 kDa are observed for 
AdhD and mutants with UAA, consistent with calculated molecular weights. 
Figure 4.10 SDS-PAGE of AdhD and mutants. Lane 1: molecular weight marker, lane 2: AdhD, 
lane 3: M1TAG AdhD, lane 4: Y64TAG AdhD, and lane 5: Y205TAG AdhD. Bands are 
observed at the theoretical molecular weight, 34 kDa. 
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Figure 4.11 SDS-PAGE of HSH purification on nickel column.  HSH and HSH M1TAG with 
para-azidophenylalanine. Protein was eluted off the column with increasing immidizole 
concentrations and purified protein boxed in red. Lane 1: molecular weight ladder, Lane 2-8: 
increasing immidizole concentrations. Protein runs at around 35 kDa, higher than the theoretical 
molecular weight of 24 kDa. 
Figure 4.12 SDS-PAGE of HS-AdhD-H purification on nickel column.  Protein was eluted off 
the column with increasing immidizole concentrations and purified protein boxed in red. Lane 1: 
molecular weight ladder, Lane 2-11: increasing immidizole concentrations. Band observed at 56 
kDa, consistent with theoretical molecular weight. 
Table 4.2 Specific activities of alcohols with AdhD 
Alcohol Specific Activity (µmol min-1 mg-1) x 10-2 
1-propanol 0.32 ± 0.08 
1-butanol 0.76 ± 0.14 
1-pentanol 1.3 ± 0.6 
1-hexanol 0.67 ± 0.09 
2-propanol 1.2 ± 0.3 
2-butanol 4.0 ± 0.7 
2-pentanol 14 ± 2.0 
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2-hexanol 7.8 ± 0.9 
2,3-butanediol 130 ± 4 
L-arabinose 5 ± 0.2 
D-arabinose 78 ± 10 
D-Glucose 0.43 ± 0.04 
Methanol 0.33 ± 0.02 
Ethanol 0.19 ± 0.04 
hAR AdhD DNA Sequence 
ATGGGCAGCA GCCATCATCA TCATCATCAC AGCAGCGGCC TGGTGCCGCG CGGCAGCCAT 60 
ATGGCAAAAA GGGTAAATGC ATTCAACGAC CTTAAGCGTA TAGGAGATGA TAAGGTAACG 120 
GCAATTGGAA TGGGAACATG GGGAATAGGA GGGAGAGAGA CCCCAGACTA TTCTAGGGAT 180 
AAGGAAAGCA TAGAAGCAAT AAGATATGGA CTTGAATTAG GAATGAATTT AATCGACACA 240 
GCGGAATTCT ATGGAGCTGG TCATGCTGAG GAAATAGTTG GAGAGGCCAT TAAAGAATTC 300 
GAACGTGAGG ACATCTTCAT AGTGAGCAAG GTCTGGCCAA CTCACTTTGG GTATGAGGAA 360 
GCAAAGAAGG CTGCTAGAGC AAGTGCTAAA AGGTTAGGAA CTTATATTGA CCTTTATTTG 420 
TTGCACTGGC CCACCGGCTT CAAACCAGGC AAAGAGTTCT TTCCGCTGGA TGAAAGCGGT 480 
AACGTGCCGT CGGACAAGAA GATAGAGGAG ACACTTCACG CTTTGGAAGA CCTCGTAGAT 540 
GAGGGAGTGA TAAGGTACAT TGGAGTTAGC AACTTCAATC TGGAACTTCT CCAGCGCTCC 600 
CAGGAGGTCA TGAGGAAGTA TGAGATTGTA GCAAATCAAG TTAAATACTC AGTGAAAGAC 660 
CGCTGGCCCG AAACTACAGG ACTTCTCGAC TACATGAAGC GTGAAGGAAT AGCATTAATG 720 
GCGTACACAC CTCTAGAAAA GCCGGATCGC CCGTGGGCGA AACCGGAAGA CCCGTCTCTT 780 
GCAAGGAATG AATGTCTAGC TAAAATTGGA GAAAAATACG GAAAAACAGC TGCTCAAGTG 840 
GCTTTAAACT ACCTGATTTG GGAGGAAAAT GTTGTAGCAA TTCCAAAAGC AAGCAACAAG 900 
GAACACCTCA AAGAAAACTT TGGAGCTATG GGATGGAGGC TTTCAGAGGA GGATAGAGAG 960 
ATGGCAAGGA GGTGTGTGTG A 981 
hAR AdhD Protein Sequence 
MGSSHHHHHH SSGLVPRGSH MAKRVNAFND LKRIGDDKVT AIGMGTWGIG GRETPDYSRD 60 
KESIEAIRYG LELGMNLIDT AEFYGAGHAE EIVGEAIKEF EREDIFIVSK VWPTHFGYEE 120 
AKKAARASAK RLGTYIDLYL LHWPTGFKPG KEFFPLDESG NVPSDKKIEE TLHALEDLVD 180 
EGVIRYIGVS NFNLELLQRS QEVMRKYEIV ANQVKYSVKD RWPETTGLLD YMKREGIALM 240 
AYTPLEKPDR PWAKPEDPSL ARNECLAKIG EKYGKTAAQV ALNYLIWEEN VVAIPKASNK 300 
EHLKENFGAM GWRLSEEDRE MARRCV 326 
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Figure 4.13 SDS-PAGE of hAR AdhD and Y64TAG hAR AdhD.  (1) Molecular weight marker, 
(2) hAR AdhD, and (3) Y64TAG AdhD.
Figure 4.14 SDS PAGE of azide-alkyne cycloaddition with hAR AdhD. Protein gel exposed to 
UV light after copper-catalyzed azide-alkyne cycloaddition between hAR AdhD containing 
unnatural amino acid para-azidophenylalanine and fluorescent alkyne, tetramethylrhodamine 
(TAMRA). Lane: (1) molecular weight ladder, (2) hAR AdhD, and (3) UAA labeled Y64TAG. 
1   2   3 
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The chemical microenvironment near the active site of an enzyme can impact biocatalytic 
activity, however these effects can be difficult to investigate as mutations and fusions made near 
enzymatic active sites can introduce multiple variables and overlapping effects. Here we 
investigate the complexes made between the  thermostable alcohol dehydrogenase D (AdhD) from 
Pyrococcus furiosus and superfolding green fluorescent protein (sfGFP) mutants that have extreme 
surface charges. Three charged sfGFP variants, -30, 0, and +36 were covalently attached to AdhD 
via the SpyCatcher/SpyTag system.  Specific rates for the conversion of  2,3-butanediol and NAD+ 
to acetoin and NADH were significantly increased in the -30 sfGFP complex, a mixed effect was 
seen for the 0 sfGFP complexes and the rates were unaffected by +36 sfGFP complexation. The 
effects of varying pH (7.8, 8.8 and 9.8) and salt (7.75 mM, 200 mM and 500mM) showed that 
there was a complex interplay between these effects which was consistent with fusion proteins 
affecting the local ionic strength near the AdhD active site as opposed to the local pH. A more 
complete steady state kinetic analysis was performed with of -30 and 0 AdhD-sfGFP complexes. 
The apparent kcat and KM parameters were affected by both salt and pH, but the overall catalytic 
efficiency was dependent on the charge of the fused sfGFP variant, and the -30 sfGFP fusions 
exhibited the largest beneficial effects at pH 8.8. The fusion of a supercharged protein is a facile 
means to alter the biocatalytic microenvironment of an enzyme and this approach could be used in 
in vivo catalytic cascades. The impact of the fusion protein on the apparent ionic strength of the 
active enzyme provides further insight into the potential effects charged patches observed on many 




There have been decades of protein engineering research efforts aimed towards altering the 
active sites of enzymes to enhance catalytic performance [128-130]. Amino acid substitutions are 
frequently explored to alter the active site chemistry leading to changes in binding affinities, 
binding specificities, catalytic activities, and overall molecular stabilization. For example, site-
directed mutations made in the cofactor binding pocket of the thermostable alcohol dehydrogenase 
D (AdhD) from Pyrococcus furiosus [11] were explored to broaden its cofactor specificity from 
NADH to enable activity with NADPH [17]. These mutations focused on interactions with the 2’-
phosphate group of NADP(H).  In a complimentary approach, amino acid mutations were made 
on the other side of the cofactor binding pocket, distal to the phosphate group in NADP(H), and 
this also resulted in broadened cofactor specificity [25]. These types of studies demonstrate the 
power of protein engineering, where mutations can be frequently found to create enzymes with 
improvements in reactant binding and/or transition state stabilization, leading to enhanced catalytic 
performance. However, a limitation of this approach is that it is time consuming and the 
engineering must generally be performed on a case by case basis for each new enzyme. Therefore, 
there is interest in developing strategies to potentially enhance enzyme performance characteristics 
without needing to perform a mutational analysis for every protein.   
There has been recent interest in exploring the engineering of the enzyme microenvironments 
as a means to enhance catalytic activity. Protein immobilization efforts have demonstrated that the 
chemical environment of the supporting medium could influence biocatalytic activity [131-133].  
Protein immobilization has been frequently investigated on charged resins to exploit 
electrostatic/ionic interaction with oppositely charged proteins [134]. For example, the 
immobilization of amyloglucosidase has been explored on cationic resins and when 
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amyloglucosidase conjugated to negative copolymers was immobilized, the enzyme was stabilized 
at higher temperatures, however the activity was found to decrease [135]. When invertase was 
immobilized on a DOWEX resin, the KM of the enzyme was unaffected but an increase in the 
maximum velocity was reported [136]. The immobilization of enzymes on charged materials may 
result in the useful modulation of the local chemical microenvironment during in vitro 
biotransformations, however this approach will be limited for other applications including in vivo 
use.   
Several molecular-scale approaches to modulating the microenvironment have also been 
reported which have led to desirable impacts on catalytic activity. The local pH of an active site is 
thought to be an important factor in the enzyme microenvironment as enzymatic activity is often 
pH-dependent. This effect has been used as an explanation for increased activity in the glucose 
oxidase (GOx)–horseradish peroxidase (HRP) cascade upon immobilized on a DNA scaffold [65]. 
The presence of the DNA reduces the local pH near the active sites, allowing the enzymes to 
operate closer to their optimal values. A similar effect was observed for a D-amino acid oxidase 
(DAAO) and Cytochrome C (Cyt c) cascade [137]. DAAO is active at alkaline pH values, while 
Cyt c is active at more acidic pH values. When a negative polyelectrolyte was fused to Cyt c, the 
local pH decreased which supported increased activity. Another means to modulate the catalytic 
microenvironment is through altering protein conformation. This was observed when a repeats-in-
toxin (RTX) domain from the adenylate cyclase protein from Bordetella pertussis was inserted 
into a substrate binding look of AdhD [26]. The RTX domain is disordered in the absence of 
calcium and folds into the β-roll secondary structure upon calcium addition [138]. The fusion 
protein, β-AdhD, preferred NADP+ in the presence of calcium and NAD+ in the absence of 
calcium, which  allows for tunable regulation of cofactor selectivity via addition of calcium as an 
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uncompetitive inhibitor. The microenvironment of an active site can also be modified to increase 
the local concentration of substrates. By concentrating reactants near the enzyme higher reaction 
rates can be achieved. This was observed with a modified version of AdhD that can accept 
nicotinamide mononucleotide NMN(H) as a cofactor [139]. dsDNA has a micromolar affinity for 
nicotinamide mono nucleotide (NMN(H)) so when dsDNA strands were conjugated to AdhD, the 
local concentration of NMN+ was increased, enhancing the overall activity of the enzyme with this 
non-natural cofactor. A recently published review article discusses other approaches in 
engineering the microenvironment of enzymes [1]. 
In this report, we explore the fusion of supercharged proteins as a means to alter the 
microenvironment of an enzyme. We use the thermostable AdhD from Pyrococcus furiosus as a 
model enzyme (Figure 5.1A). AdhD is a monomeric member of the aldo-keto reductase 
superfamily and has the ability reversibly convert alcohols to aldehydes/ketones along with the 
concomitant reduction of NAD(P)+ to NAD(P)H [11, 12]. It is enantioselective, highly 
thermostable, and has broad substrate specificity making it an interesting and useful potential 
industrial catalyst. The native enzyme has the highest activity with 2,3-butanediol which, in the 
presence of NAD+, is converted to acetoin and NADH following an ordered bi-bi kinetic 
mechanism with the cofactor binding first [17, 18]. AdhD has been engineered to exhibit 
broadened cofactor specificity [17, 25], altered substrate specificity [19], activity with the non-
natural cofactor NMN(H) [20], binding of a small molecule explosive molecule [140], and it has 
been engineered to form self-assembling catalytic hydrogels [18]. In order to rationally alter the 
microenvironment of AdhD without making site-directed mutations in the enzyme, we explored 
the fusion of the wild type enzyme to supercharged superfolder green fluorescent (sfGFP) proteins. 
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The supercharged sfGFP collection provides a set of well-characterized molecules that are 
structurally similar, yet have a wide range of calibrated surface charges (Figure 5.1B) [61]. The 
wild type GFP from Aequorea victoria consists of 11 β-strands wrapped around a central helix 
(PDB 1EMA) [56]. Several mutations have been made to enhance expression, folding and 
fluorescence [57]. The superfolder variant was used to create supercharged versions, where surface 
mutations were made, leading to remarkable increases in stability [61]. Here we explored a neutral 
GFP variant along with a mutant with 30 negative surface charges (-30) and a mutant with 36 
positive charges (+36).  The effective functional surface charge will depend on the solution pH.  
We hypothesized that fusions of the supercharged sfGFP proteins to AdhD would lead to 
altered microenvironments, producing to altered kinetic activities. The nicotinamide cofactor 
NAD(H) is negatively charged and the AdhD enzyme has been reported to have an alkaline pH-
optimum in the oxidative direction. Therefore, altering the charge near the active site should 
present an opportunity to enhance activity without making site directed mutations in the active 
site. To make the protein fusions, the SpyCatcher protein/SpyTag peptide system [141] (Figure 
5.1C) was used to form a covalent bond between AdhD and sfGFP. This leads to the formation of 
tri-domain proteins where the sfGFP proteins and AdhD are fused by the SpyCatcher/SpyTag 
protein bridges (Figure 5.1D). The effects of different charges on the sfGFP on the kinetics of 
AdhD were explored and it was found that the addition of the negative charges leads to significant 
improvements in AdhD activity as compared to fusions made with the neutral and positively 




Figure 5.1 Structures of AdhD, sfGFP, and SpyTag/SpyCatcher.  (A) Homology model of AdhD 
looking down the barrel with NAD+ in blue and 2,3-butanediol in yellow. (B) Electrostatic 
surface potentials of -30, 0, and +36 sfGFP (PDB ID 2B3P). (C) SpyCatcher/SpyTag with 
catcher in purple and tag in yellow (PDB ID 4MLI). (D) Schematic of SpyCatcher-AdhD and 
SpyTag-sfGFP complexes. 
 
5.3 Materials and Methods 
5.3.1 Materials 
DNA Oligonucleotides and ultramers were purchased from Integrated DNA Technologies 
(Coralville, IA). Phusion high fidelity DNA polymerase, Hi-Fi DNA assembly Master Mix, Q5 
site-directed mutagenesis kit, and E. coli BL21(DE3) expression cells were from New England 
Biolabs (Ipswich, MA). In-Fusion cloning kit was from Takara Bio (Mountain View, CA). 
NuPAGE SDS-PAGE gels, MOPS running buffer, and Novex sharp pre-stained protein standards 
were from Invitrogen (Carlsbad, CA). Histidine purification Nickel-NTA resin was purchased 













(Hercules, CA). Molecular weight centrifugal filters were from EMD Millipore (Billerica, MA). 
All other chemicals, including kanamycin, were from Sigma Aldrich (St. Louis, MMO). 
5.3.2  Cloning, Expression, Purification 
Plasmids encoding for -30 and +36 sfGFP from jellyfish Aequorea victoria were a kind gift 
from the laboratory of David R. Liu [61] while the 0 sfGFP gene was a kind gift from the laboratory 
of Allie Obermeyer.  A plasmid encoding the SpyCatcher gene was a kind gift from the laboratory 
of David Baker. The genes corresponding to sfGFPs flanked by SpyTag at their C-termini were 
produced by cloning into the Hind III linearized pET-28a(+) vector using ultramers containing the 
C-terminus sequence of sfGFP followed by the SpyTag sequence (see Supporting Information).
This resulted in constructs -30 sfGFP SpyTag, 0 sfGFP SpyTag, and +36 sfGFP SpyTag. The 
genes were verified by DNA sequencing (complete sequences can be found in Supporting 
Information). The final charges on the sfGFP mutants were increased by 3 upon addition of the 
polyhistidine purification tag and thrombin site, artifacts of the cloning, and the SpyTag sequence. 
Control sfGFP proteins lacking the C-terminal SpyTag, were prepared via site-directed 
mutagenesis by designing primers to insert a stop codon before the SpyTag (primers can be found 
in Supporting Information). This resulted in constructs -30, 0, and +36 sfGFP. 
The sfGFP expression plasmids were transformed into E. coli BL21(DE3) cells and plated onto 
Luria Broth (LB) plates supplemented with 0.035 mg/ml kanamycin. Single colonies were 
inoculated overnight in LB media with 0.035 mg/ml kanamycin and kept shaking at 200 rpm at 37 
°C. Expression was performed at 37 °C in the same media. Once the OD600 reached approximately 
0.6, the cells were induced with 0.5 mM isopropyl β-D-1-thiogalactopyranside (IPTG) and kept 
shaking at 200 rpm at 25 °C overnight. 
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The cells were harvested and resuspended in 10 mM tris pH 7.5 with 1 M NaCl and sonicated. 
The crude lysate was then incubated at 70 °C for 10 minutes followed by centrifugation at 7000xg 
for 1 hour. The clarified lysate was loaded onto a pre-packed column containing nickel resin 
equilibrated with the resuspension buffer. The lysate with the resin was continuously rotated at 4 
°C for 30 minutes. Following the collection of the flow-through, the column was washed with 10 
column volumes of wash buffer (resuspension buffer with 20 mM immidizole, pH 7.5). The protein 
was eluted from the column with 500 mM immidizole.  
Samples were loaded onto NuPAGE SDS-PAGE 4-12% Bis-tris gels in MES running buffer. 
Fractions containing protein greater than 95% pure were pooled together and briefly concentrated 
in 10 kDa MWCO filters. They were then dialyzed in 20 kDa MWCO cassettes in 50 mM glycine 
pH 8.8. 
The AdhD gene from Pyrococcus furiosus in the pET-20b(+) vector, plasmid pWUR85, was 
cloned into the NdeI-digested pET-28a(+) vector (primers can be found in Supporting Information) 
[12]. The resulting plasmid (pET28a-AdhD), with a poly-histidine tag and the thrombin site, was 
verified by DNA sequencing (see Supporting Information).  
To clone in SpyCatcher, the pET28a-AdhD plasmid was linearized via PCR prior to the 
initiation methionine of AdhD, between His20 and Met21 (primers can be found in Supporting 
Information). The SpyCatcher gene was  amplified using PCR with another set of primers to clone 
it in at the N-terminus of AdhD (primers can be found in Supporting Information), resulting in 
pET28a-SpyCatcher-AdhD plasmid. A construct was also made with a short linker region (GGGS) 
inserted between the C-terminus of SpyCatcher (Ile136) and the N-terminus of AdhD (Met137)  
(primers can be found in Supporting Information), resulted in the pET28a-SpyCatcher-GGGS-
AdhD plasmid (final sequences can be found in Supporting Information). 
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The pET28a-SpyCatcher-AdhD and pET28a-SpyCatcher-GGGS-AdhD plasmids were 
transformed into E. coli BL21(DE3) expression cells and plated onto Luria Broth (LB) plates 
supplemented with 0.035 mg/ml kanamycin. A single colony was inoculated overnight in LB 
supplemented with kanamycin. This was expressed at 37 ºC in a 1 L flask containing LB with 
0.035 mg/ml kanamycin. When the cells reached an OD of approximately 0.6, they were induced 
with 0.5 mM IPTG and kept shaking at 37 ºC overnight. 
Cells containing pET28a-SpyCatcher-AdhD were harvested in 20 mM tris-HCl (pH 7.8) buffer 
with 100 mM NaCl and lysed at 80 ºC for 1 hour to denature endogenous proteins. Crude lysate 
was spun down at 7000xg for 1 hour to remove cell debris. The clarified lysate was then 
concentrated in 30 kDa MWCO centrifugation filters. This was purified via gel filtration 
chromatography on a Superdex 16/200 (GE Healthcare, Piscataway, NJ) column using the lysis 
buffer. Samples were collected, and purity was ensured by running NuPAGE 4-12% Bis-tris gels 
in MES running buffer (Invitrogen). Samples containing protein greater than 95% pure was pooled 
together, concentrated in 30 kDa MWCO filters, and buffer exchanged into 50 mM glycine pH 
8.8. 
Cells containing pET28a-SpyCatcher-GGGS-AdhD were harvested and resuspended in 20 
mM sodium phosphate buffer with 500 mM NaCl, pH 7.5. The cells were sonicated and 
centrifuged at 7000xg for 1 hour to remove cell debris. The clarified lysate was loaded onto a 
prepacked Ni column equilibrated with 20 mM Tris with 200 mM NaCl, pH 7.4. Following the 
collection of the flow-through, the column was washed with 4 column volumes of 20 mM sodium 
phosphate buffer with 500 mM NaCl, pH 7.5. The protein was then eluted off the column with 
steps of imidazole ranging from 50 to 500 mM imidazole, pH 7.5. Samples were loaded onto 
NuPAGE SDS-PAGE 4-12% Bis-tris gels in MES running buffer (Invitrogen). Fractions 
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containing protein with greater than 95% purity were pooled together and concentrated in 30 kDa 
MWCO filters and buffer exchanged into 50 mM glycine pH 8.8. 
SpyCatcher-AdhD and SpyCatcher-GGGS-AdhD protein concentrations were determined by 
absorbance 280 nm on a SpectraMax M2 plate reader using an extinction coefficient of  63,955 M-
1 cm-1 [142]. 
5.3.3 Determining sfGFP/ sfGFP SpyTag Concentrations 
Spectral absorbance scans of different sfGFP proteins (in 50 mM glycine pH 8.8) were 
measured from 250 to 600 nm at 5 nm increments in triplicate and background was subtracted, 
revealing, an absorbance maximum of 485 nm, similar to what has been previously reported [61]. 
Beer’s Law can be used to determine the protein concentration from the absorbance at 485 nm, 
however the extinction coefficient at 485 nm is needed. Using the ratio of the absorbance values 
at 485 nm and 280 nm, as well as the extinction coefficient at 280 nm (determined from ExPASy, 
19,035 M-1cm-1 for sfGFP and 20,525 M-1cm-1 for sfGFP SpyTag) [142], the extinction coefficient 
at 485 nm can be calculated using equation 5.1 [143]. 





To confirm the accuracy of the measurements, protein concentrations were normalized and 
the samples were scanned from 280 to 600 nm in triplicate. The absorbances at 485 nm were 
confirmed to be within 10% of each other (Figure 5.6). Equal concentrations of the sfGFP variants 
(-30, 0, and +36) were also run on NuPAGE 4-12% Bis-tris gels to ensure equal purity and 
concentration (Figure 5.7). The sfGFP-SpyTag proteins were treated similarly.  
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5.3.4 Complexation of sfGFP SpyTag and SpyCatcher-GGGS-AdhD 
Equal concentrations of sfGFP or sfGFP-SpyTag and SpyCatcher-GGGS-AdhD were 
incubated together in the presence of 387.5 mM NaCl and 10 mM tris pH 7.5. Samples were 
vortexed and placed in a rotator at 4 °C overnight. Samples run on NuPAGE SDS-PAGE 4-12% 
Bis-tris gels in MES running buffer to follow the formation of a covalent bond between sfGFP-
SpyTag and SpyCatcher-GGGS-AdhD and to ensure equal concentrations of the complexes were 
formed between the different charged sfGFP. 
5.3.5 Kinetic Assays 
Enzymes samples were taken directly from the complexation reaction for the kinetic assays to 
ensure equal concentration of SpyCatcher-GGGS-AdhD and each supercharged sfGFP. For 
specific rate data, equal concentrations from each reaction (between SpyCatcher-GGGS-AdhD 
and charged sfGFP tagged and untagged) was incubated with 50 mM glycine buffer and 100 mM 
substrate (2,3-butanediol) in 96-well plates at 45 °C for 15 minutes. Following incubation, 100 
µM NAD+ was added and absorbance at 340 nm was monitored. For pH studies, glycine buffers 
and 2,3-butanediol stocks were made at different pH values: 7.8, 8.8 or 9.8. For the salt studies, 1 
M NaCl stocks were made in various 50 mM glycine buffers (pH 7.8, 8.8, and 9.8). The final 
reaction volume in the well was 250 µL. Initial rate data for the oxidation reaction was obtained 
by only using data within 10% of the conversion of NAD+. Absorbance at 340 nm was converted 
to cofactor concentration (ɛ = 6.22 mM-1 cm-1) and the rates were divided by enzyme concentration 
to determine initial specific rates. All measurements were made in at least triplicate. 
To determine the ordered bi-bi kinetic parameters of the different proteins, enzyme 
(SpyCatcher-GGGS-AdhD, -30 sfGFP-SpyTag + SpyCatcher-GGGS-AdhD, or 0 sfGFP-SpyTag 
+ SpyCatcher-GGGS-AdhD) was incubated in 50 mM glycine buffer pH 7.8 or 8.8 with either
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7.75 mM or 200 mM NaCl with substrate (2,3-butanediol) ranging from 2 to 30 mM. Following 
incubation, 1 to 200 µM NAD+ was added bringing the final reaction volume to 250 µL. Initial 
rate data for the oxidation reaction was obtained by only using data within 10% of the conversion 
of NAD+. Absorbance at 340 nm was converted to cofactor concentration and divided by enzyme 
concentration to determine initial specific rates. All measurements were made in at least triplicate. 
5.3.6 Kinetic Rate Data Fitting 
Kinetic parameters for simplified ordered bi-bi kinetic rate equation (5.3) were determined 
using nonlinear regression and least-squares in MATLAB. Parameters are reported with 95% 
confidence intervals. 
5.3.7 Statistical Analysis 
Three-way analysis of variance (ANOVA), two-factor interactions, and post-hoc analyses 
were done using MATLAB. To perform 3-way ANOVA with replicate for the simplified ordered 
bi-bi rate equation, individual data sets were used to determine three sets of parameters at one set 
of conditions (Table 5.3) and these values were used in the statistical analysis. Averages of the 
individual fits were confirmed to be similar to the global fit (Table 5.4). Student’s t-test was 
completed using Microsoft Excel. Statistical significance was indicated by p < 0.05. 
5.4 Results and Discussion 
5.4.1 Expression and Purification of sfGFP, sfGFP SpyTag, and SpyCatcher-
GGGS-AdhD 
Supercharged sfGFP mutants (-30, 0 and +36) were expressed with and without an N-
terminal SpyTag, resulting in 33 kDa proteins. The AdhD gene was expressed with an N-terminal 
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SpyCatcher domain, resulting in a 47 kDa protein.  All of the proteins were expressed and purified 
to greater than 95% purity as seen on SDS-PAGE (Figure 5.7, Figure 5.8, and Figure 5.9). 
5.4.2 Effect of SpyCatcher on AdhD Activity 
To determine the effect of the SpyCatcher fusion on AdhD activity, kinetic assays with 100 
mM 2,3-butanediol and 100 µM NAD+ were conducted. Initial rate data was used to determine 
specific rates for the oxidation reaction (Table 5.1). The kinetic activity of the protein under these 
conditions with the SpyCatcher on the N-terminus was an order of magnitude lower than the wild 
type enzyme. 
To obtain activity comparable to the wild type AdhD enzyme, a Gly-Gly-Gly-Ser (GGGS) 
linker was inserted between SpyCatcher and AdhD. The insertion of the linker reduced the fusion-
induced inhibition, resulting in an order of magnitude increase in activity, making the difference 
in the specific rates between SpyCatcher-GGGS-AdhD and wild type AdhD insignificant by 
Student’s t-test. Thus, the linker domain was included between SpyCatcher and AdhD in all 
subsequent experiments. 
Table 5.1 Specific rate of AdhD and SpyCatcher-AdhD Variants.  Rates collected from the 
oxidation reaction with 100 mM 2,3-butanediol and 100 µM NAD+ 
Protein Specific Rate (1/s) 
AdhD 0.34 ± 0.01 
SpyCatcher-AdhD 0.025 ± 0.002 
SpyCatcher-GGGS-AdhD 0.39 ± 0.08 
All data were collected in at least triplicate. Errors bars 
represent standard deviation.  
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5.4.3 Effect of Salt on sfGFP SpyTag and SpyCatcher-GGGS-AdhD 
Conjugation Reaction 
Spectral scans of sfGFP proteins indicate a maximum absorbance at 485 nm (Figure 5.6), 
similar to previous reports [61]. Absorbance at 485 nm can be used as an indicator of the 
fluorescent protein concentration [144]. SDS-PAGE of normalized protein concentrations at 485 
nm shows sfGFP variants with comparable concentrations (Figure 5.7). Normalizing proteins at 
this absorbance also showed similar absorbances at 280 nm, which is indicative of the total protein 
present, suggesting highly pure samples [144]. 
Mixing equimolar sfGFP-SpyTag proteins with SpyCatcher-GGGS-AdhD overnight at 4 ºC 
resulted in incomplete covalent bond formation (Figure 5.8A). The reaction with -30 sfGFP-
SpyTag was unsuccessful, 0 sfGFP-SpyTag went to completion, and +36 sfGFP-SpyTag was 
partially reacted. The fact that the proteins with surface charge were less successful suggests a 
charge effect on the SpyTag/SpyCatcher reaction. To shield the charges, the reaction was repeated 
in the presence of approximately 400 mM NaCl. The reactions went to apparent completion in all 
three cases with SpyCatcher-GGGS-AdhD being fully consumed resulting in the formation of 
sfGFP-SpyTag/SpyCatcher-GGGS-AdhD and excess sfGFP-SpyTag (Figure 5.8B). SDS-PAGE 
analysis of the proteins suggested a similar concentration of SpyTag-SpyCatcher in all three cases. 
The same reactions were repeated with sfGFP without the SpyTag and no apparent complexes 
were formed, as expected (Figure 5.9). 
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5.4.4 Effect of Salt and pH on SpyCatcher-GGGS-AdhD Activity and Effect of 
pH on Net Charge of SpyCatcher-GGGS-AdhD and sfGFP-SpyTag 
Previous work with AdhD has shown that the optimal pH for the oxidation of alcohols is 
pH 8.8 [12]. SpyCatcher-GGGS-AdhD activity was evaluated with 100 mM 2,3-butanediol and 
100 µM NAD+ with 0 – 500 mM NaCl at the reported optimal pH (Figure 5.2A). The addition of 
salt increased the specific rates until a maximum value was obtained at 125 mM NaCl. At higher 
salt concentrations the rates were found to plateau followed by a downward trend at the highest 
salt concentration of 0.5 M.  
To test the effect of pH on SpyCatcher-GGGS-AdhD, additional assays were performed 
at one unit above and one unit below the optimal of 8.8 (Figure 5.2B). The specific activity with 
7.75 mM NaCl was found to increase as the pH increased. Therefore, the observed optimal pH at 
low salt is pH 9.8 or higher. The same assay was repeated with 200 mM NaCl. Here, the rates at 
pH 7.8 and 8.8 were increased while at pH 9.8 a decrease was observed. The specific rates at 
each pH were significantly different from one another, with pH 8.8 being the optimal, as 
previously reported. Assays were performed at 500 mM NaCl, and the rate at pH 9.8 was again 
decreased compared to the lower salt concentrations, resulting in pH 8.8 being the optimal pH. 
The rates at the different pH values at the same salt concentration were significantly different by 
Student t-test. These results demonstrate a previously unreported interplay between salt and pH 
where an increase in ionic strength leads to a reduction in the pH-optima of the enzymatic 
activity (Figure 5.2C).  Or conversely, the effect of salt on the activity at a given pH transitions 
from enhancing at low pH to inhibitory at high pH (Figure 5.2B). 
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Figure 5.2 Specific rates for SpyCatcher-GGGS-AdhD with 100 mM 2,3-butanediol and 100 µM 
NAD+.  Assay performed at: (a) pH 8.8 as a function of varying salt concentrations, (b) varying 
salt as a function of pH and (c) varying pH as a function of salt. Statistically significant 
differences by Student’s t-test denoted with  ٭ , ‡, and † (p <0.05). (d) Net charge of SpyCatcher-
GGGS-AdhD and sfGFP-SpyTag as a function of pH.  
Along with changes in activity, pH also affects the net charge of SpyCatcher-GGGS-
AdhD and sfGFP-SpyTag (Figure 5.2D). At pH 7.8, close to physiological pH, SpyCatcher-
GGGS-AdhD has a net charge of approximately -17, while the sfGFP variants have a net charge 
approximately equivalent to the net charge calculated from the positive and negative residues. As 
the pH increases to 8.8, each protein is slightly more negative. This results in sfGFP-SpyTag 
variants with charges of -32, -2, and +32 and SpyCatcher-GGGS-AdhD with a net charge of -22. 
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As the pH increases to 9.8, the trend of becoming more negative continues, but the change is 
more drastic. SpyCatcher-GGGS-AdhD and -30 sfGFP have a net charge of approximately -41 
while 0 sfGFP is now -16 and +36 sfGFP is 13. Therefore, as the pH increases, side chains are 
deprotonated resulting in a more negative net charge. From pH 7.8 to 9.8, 0 sfGFP attains a 
negative net charge, SpyCatcher-GGGS-AdhD and -30 stay negative while +36 remains 
positively charged. 
5.4.5 Effect of sfGFP Complexation on AdhD Specific Activity 
Kinetic rate experiments were performed in the presence of 100 mM 2,3-butanediol 
(substrate) and 100 µM NAD+ (cofactor) and initial rates were collected to determine the effect of 
the charged sfGFP complexation on AdhD activity. The enzyme samples were added directly from 
the complexation reaction mixtures without further purification to ensure equal concentrations of 
active enzyme, SpyCatcher-GGGS-AdhD. Studies were performed with tagged and untagged 
sfGFP to determine the effect of the covalent bond formation on the catalytic efficiency.  
Assays were first performed at pH 8.8, the reported optimal pH for the oxidation reaction 
[12] in the presence of 200 mM NaCl (Figure 5.3D-F). The conjugation of -30 sfGFP to the AdhD
enzyme led to a significant increase in activity at 7.75 mM NaCl as compared to the untagged and 
mixed sfGFP control (Figure 5.3D). At higher NaCl concentrations, the rates for both the 
conjugated complexes and unconjugated mixtures significantly increased compared to 7.75 mM 
NaCl, but their differences between the conjugated and unconjugated proteins were statistically 
insignificant by a paired t-test. This increase in activity upon the addition of salt is similar to 
SpyCatcher-GGGS-AdhD at the same conditions (Figure 5.2B). The 0 sfGFP complex samples at 
pH 8.8 follow the same trend as both -30 sfGFP complexes and SpyCatcher-GGGS-AdhD, with 
an increase in rate upon salt addition followed by a slight decrease at the higher salt concentration 
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(Figure 5.3E). Like -30 sfGFP, AdhD conjugated with 0 sfGFP is significantly more active than 
the mixed proteins at 7.75 mM NaCl. However, the mixed versions are significantly more active 
than the conjugates at 200 and 500 mM NaCl. The +36 sfGFP samples followed a similar trend, 
however, none of the activities between the conjugated and mixed control versions reached 
statistical significance by a paired t-test (Figure 5.3F). 
At pH 8.8, the complexation of -30 GFP and 0 GFP to AdhD appears to be similar to the 
addition of salt to unconjugated AdhD. At pH 8.8, both -30 and 0 sfGFP have a negative net charge, 
while +36 has a positive net charge. It is possible that the localization of negative charge near the 
enzyme introduces an increase in the apparent ionic strength, which increases the activity of 
SpyCatcher-GGGS-AdhD and then further salt addition leads to decreased activity at pH 8.8. With 
-30 sfGFP, the complexation at low salt increases the activity by 65 percent, and there was no
effect of complexation at higher salt concentrations. With 0 sfGFP, a mixed effect was observed 
where at low salt the complexation with 0 sfGFP increased the activity by ~25 percent. 
Furthermore, although an increase in activity at higher salt is observed, the complexation of 0 
sfGFP at 200 and 500 mM NaCl inhibited activity by ~30 percent compared to the untagged sfGFP. 
This inhibition is similar to what was observed with SpyCatcher-GGGS-AdhD where above 125 
mM NaCl, inhibition was observed (Figure 5.2A). The effect is only observed for the addition of 
negative charges, as complexation of the +36 sfGFP protein have no effect on activity.   
The effect of ionic strength on the activity of the uncomplexed AdhD was pH-dependent 
and thus the results were repeated at higher and lower pH values.  At the lower pH 7.8, the addition 
of salt to AdhD led to increased activity, and inhibition at high salt was not observed (Figure 
5.2B). When -30 sfGFP was conjugated to AdhD, no effect was seen at low salt, but at the higher 
salt concentrations the conjugation of sfGFP led to significant increases in the activity as compared 
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to the unconjugated mixed protein controls (Figure 5.3A). With 0 sfGFP, a similar trend was 
observed where, as the salt concentration increased, the activity increased and then plateaued. 
However, at 7.75 mM NaCl, the conjugated proteins were less active than the mixed proteins 
controls. A decrease was also seen at higher salt concentrations, but the effect of the complexation 
was statistically significant. The +36 sfGFP followed the same trend where the addition of salt 
increased activity, however, none of the differences between the conjugated and mixes protein 
controls were statistically significant by Student’s t-test. 
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Figure 5.3 Specific rates of AdhD-sfGFP conjugates at varying pH as a function of NaCl. Rates 
collected at pH 7.8 (A-C), 8.8 (D-F), and 9.8 (G-I) as a function of NaCl. Conjugated proteins 
are shown with grey bars and controls consisting of unconjugated and mixed SpyCatcher-GGGS-
AdhD and sfGFP are shown as  white bars.  All reactions were performed in triplicate with 100 
mM 2,3-butanediol and 100 µM NAD+. Statistically significant differences by Student’s t-test of 
mixed sfGFP to conjugated sfGFP denoted with ٭ (p < 0.05). 
-30  0  +36
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At a pH of 7.8, the results for the complexation of the -30 sfGFP were qualitatively similar 
to what was observed pH 8.8 where the addition of the negative charges were consistent with an 
increase in the local ionic strength. However, the 0 sfGFP results were markedly different as the 
complexation of 0 sfGFP led to either an inhibition at low salt and no effect at higher salt. This is 
likely due to the fact that at pH 7.8 the net charge of 0 sfGFP transitions to an apparent positive 
charge (Figure 5.2D). When -30 sfGFP was conjugated to AdhD, the largest impacts were seen 
where at 200 and 500 mM NaCl, the conjugation of the -30 sfGFP led an increase in activity of 50 
and 70 percent, respectively.  
Kinetic assays were then performed at pH 9.8. At this pH, increasing salt had a consistently 
inhibitory effect on SpyCatcher-GGGS-AdhD (Figure 5.2B). However, this is a more optimal pH 
for activity in lows salt (7.75 mM NaCl or lower) (Figure 5.2C). A similar salt trend was observed 
with all three sfGFPs. Tethering the sfGFPs at 7.75 mM NaCl led to increased activity for all 3 
sfGFP proteins but statistical significance was only reacted for -30 sfGFP as compared to the 
mixed protein controls.  At higher salt, the tethering of the charged protein had no effect or was 
inhibitory, and this inhibition reached statistical significance for 0 sfGFP at 500 mM NaCl.  As 
before, the tethering of +36 sfGFP had no effect on AdhD activity. 
At pH 9.8, the 0 sfGFP protein has a net negative charge.  At higher salt concentrations, 
the complexation of the charged proteins is consistent with an increase in ionic strength, and at 
this pH that effect is inhibitor. However, this effect only reached statistical significance for the 0 
sfGFP at 500 mM salt, where a 45% reduction in activity was observed. The observation of 
increased activity upon complexation of all of the sfGFP proteins at low salt is not consistent with 
the ionic strength model.   
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Overall, these assays suggest that pH, salt, and the net charge of complexed sfGFP can all 
affect kinetic activity. However, these factors are not independent of each other and there is a 
complex the interplay between these effects. Previous work has shown that appending polymers 
with substantial negative or positive charges to enzymes can change the local pH, which can affect 
activity [133, 145].  Under this hypothesis, the complexation of -30 sfGFP should attract H+ ions 
decreasing the local pH whereas complexation of +36 sfGFP should attract -OH ions increasing 
the local pH. If this were the case, the -30 sfGFP complexes would be most active at pH 9.8, as 
this would decrease the local pH and approach the optimum pH of 8.8 at higher salt concentrations. 
Similarly, the +36 sfGFP complexes would be most active at pH 7.8 as this would increase the 
local pH and approach the optimum pH of 8.8 at higher salt concentrations. However, no 
significant changes were observed upon tethering +36 sfGFP to SpyCatcher-GGGS-AdhD, 
suggesting the modulation of the local pH may not be occurring in this system. Instead, the results 
above are more consistent with the hypothesis that the appending of the negatively charged sfGFP 
proteins leads to local changes in ionic strength which can increase or decrease activity depending 
on the pH. 
5.4.6 Effect of sfGFP-SpyTag on SpyCatcher-GGGS-AdhD Kinetics 
In addition to affecting the apparent ionic strength, the appending of charged domains near 
enzyme active sites may also lead to changes in the local chemical environment that may impact 
different steps in the catalytic mechanism, such as the binding kinetics of the charged cofactor, 
NAD(H).  To explore this, further kinetic assays were performed with 2,3-butanediol ranging from 
2 to 30 mM and NAD+ ranging from 1 to 200 µM NAD+.  Initial rates were measured at pH 7.8 
and 8.8 with 7.75 and 200 mM NaCl.  These pH values were chosen as pH 8.8 is the optimal pH 
for AdhD at the intermediate salt concentration, and experiments at pH 7.8 exhibited the greatest 
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differences between the uncharged 0 sfGFP and -30 sfGFP.  The studies were completed with -30 
sfGFP  and 0 sfGFP complexes as the appending of -30 sfGFP significantly increased the activity 
at pH 7.8 and 8.8 while no significant effect was  observed upon complexation with +36 sfGFP. 
The AdhD enzyme follows an ordered bi-bi mechanism where cofactor (NAD+) binds before 
substrate (2,3-butanediol) followed by the release of the product preceding that of the reduced 
cofactor (NADH). The ordered bi-bi rate law (Equation 5.2) has four parameters: kcat, KA, KB, 
and Kia, where KA and KB are Michaelis constants for cofactor and substrate, respectively, and 
Kia is the dissociation constant for the cofactor. 
Initial rates were collected with varying NAD+ (A) and 2,3-butanediol (B) concentrations 
to determine the kinetic parameters. The range of substrate used were near or below the previously 
published KB value of the wild type enzyme (29 mM) [17]. Under these conditions the 2,3-
butanediol concentrations did not reach saturation (Figure 5.10 and Table 5.5). Therefore, as 
published previously [17, 25, 26, 76] we assume the rates will first order with respect to the 
substrate concentration (B) which leads to a simplified form of the ordered bi-bi rate equation, 
Equation 5.3. This equation retains saturating behavior with respect to the cofactor (A).   








𝐾𝐾𝑖𝑖𝑐𝑐𝐾𝐾𝐵𝐵 +  𝐾𝐾𝐴𝐴𝐴𝐴 + 𝐾𝐾𝐵𝐵𝑁𝑁 + 𝑁𝑁𝐴𝐴
(5.2) 
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The fitting of data to this equation results in the determination of an apparent kcat term 
(kcat/KB), and an apparent KM term (Kia). An apparent catalytic efficiency term can also be 
calculated  ((kcat/KB)/Kia) (Table 5.2). In some cases, small decreases in activity were observed 
at high cofactor concentrations, and the data were also fit using a version of Equation 5.3 with a 
cofactor inhibition term. However, this resulted in similar kinetic parameters and no significant 
reduction in the error estimates. Thus, all data were fit with Equation 5.3.   
Initial rates were first collected for uncomplexed SpyCatcher-GGGS-AdhD at pH 8.8 and 
7.75 mM NaCl (Table 5.2) to ensure the measured activity was comparable to previous reported 
kinetic parameters of AdhD [17, 25, 26]. The catalytic parameters were found to be similar to 
previous reports, suggesting that any change in catalytic efficiency upon being fused to sfGFP are 
solely due to the complexation of the sfGFP variants and not an effect of the SpyCatcher domain 
or the GGGS linker. 
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Table 5.2 Kinetic Parameters fit to Simplified Ordered Bi-Bi Rate Equation for complexes.  Data 
fit to (Eq 5.3) for the Oxidation Reaction with 2,3-butanediol and NAD+ for -30 sfGFP-AdhD 
and 0 sfGFP-AdhD Complexes 
Protein pH Salt (mM) kcat/KB (µM-1 s-1) Kia (µM) 
SpyCatcher-GGGS-AdhD 8.8 7.75 (8.5 ± 0.8) x 10-6 ‡ 30 ± 10 
-30 sfGFP- AdhD Complexes 7.8 7.75 (2.3 ± 0.2) x 10-6* 35 ± 9 
0 sfGFP- AdhD Complexes 7.8 7.75 (1.5 ± 0.2) x 10-6* 21 ± 10 
-30 sfGFP –AdhD Complexes 7.8 200 (7.1 ± 0.6) x 10-6 110 ± 18 
0 sfGFP –AdhD Complexes 7.8 200 (3.7 ± 0.8) x 10-6 76 ± 39 
-30 sfGFP –AdhD Complexes 8.8 7.75 (1.3 ± 0.09) x 10-5‡ 38 ± 9 
0 sfGFP –AdhD Complexes 8.8 7.75 (1.2 ± 0.1) x 10-5‡ 47 ± 12 
-30 sfGFP – AdhD Complexes 8.8 200 (2.0 ± 0.2) x 10-5 56 ± 12* 
0 sfGFP – AdhD Complexes 8.8 200 (2.4 ± 0.2) x 10-5 83 ± 14* 
Protein pH Salt (mM) (kcat/KB)/Kia (µM-2 s-1) 
SpyCatcher-GGGS-AdhD 8.8 7.75 (2.8 ± 1.0) x 10-7 
-30 sfGFP- AdhD Complexes 7.8 7.75 (6.6 ± 1.8) x 10-8 
0 sfGFP- AdhD Complexes 7.8 7.75 (7.1 ± 3.5) x 10-8 
-30 sfGFP –AdhD Complexes 7.8 200 (6.5 ± 1.2) x 10-8 
0 sfGFP –AdhD Complexes 7.8 200 (4.9 ± 2.7) x 10-8 
-30 sfGFP –AdhD Complexes 8.8 7.75 (3.4 ± 0.8) x 10-7* 
0 sfGFP –AdhD Complexes 8.8 7.75 (2.6 ± 0.7) x 10-7* 
-30 sfGFP – AdhD Complexes 8.8 200 (3.6 ± 0.8) x 10-7* 
0 sfGFP – AdhD Complexes 8.8 200 (2.9 ± 0.5) x 10-7* 
Data was collected in at least triplicate. Errors bars represent 95% confidence intervals. 
‡ Indicates significant difference from SpyCatcher-GGGS-AdhD by Student’s t-test 
*Indicates significant difference between 0 sfGFP and -30sfGFP at the same salt and pH by
Student’s t-test
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The activity of the complexes formed by the addition of the 0 and -30 sfGFP proteins can 
be compared to the unfused SpyCatcher-GGGS-AdhD protein at pH 8.8 and a salt concentration 
of 7.75 mM.  The fusion of both sfGFP proteins led to significant increases in the apparent kcat 
values and this was consistent with the previous observations made at the fixed substrate 
concentrations (Figure 5.3). NAD(H) is negatively charged, however the apparent KM values were 
found to increase with both of the sfGFP fusions, independent of charge, although this did not 
reach statistical significance. The increases in the apparent kcat and apparent KM values for the 
sfGFP fusions led to apparent kcat/KM values that were statistically unchanged compared to the 
free SpyCatcher-GGGS-AdhD protein. However, the apparent kcat/KM for –30 sfGFP was 
significantly increased compared to the 0 sfGFP complex. This indicates that the addition of the 
sfGFP proteins affects the binding of the reactants and the formation of the catalytic transition 
states which cannot be captured by making measurements at a single reactant and cofactor 
concentration.     
More complete kinetic measurements were made for 0 and the -30 GFP complexes with 
varying salt and pH concentrations. Overall, pH has a large impact on the catalytic efficiency of 
the enzyme. The catalytic efficiency of -30 sfGFP complex with 7.75 and 200 mM NaCl increased 
by 415% and 450% when the pH was increased from 7.8 to pH 8.8.  For the 0 sfGFP complexes, 
the catalytic efficiency also increased at pH to 8.8 as compared to pH 7.8.  In 7.75 mM NaCl, the 
activity increased 260% and at 200 mM NaCl the activity increased 500%.   
To untangle the global effect of the charge addition from the impacts of pH and ionic 
strength on the kinetic parameters, an N-way ANOVA was performed with all of the kinetic 
parameters (Table 5.2). Overall, the apparent kcat of the enzymes (kcat/KB) increased by an order 
of magnitude at pH 8.8 compared to pH 7.8. The N-way ANOVA revealed that the salt and pH 
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significant affect the apparent kcat and the effect of the sfGFP charge was not significant (Figure 
5.4A and Figure 5.4D). The higher the pH, the greater the apparent turnover rate of the enzyme. 
The addition of salt also increased the apparent turnover rate of the enzyme. Two-factor 
interactions indicate that the protein charge and pH interaction is significant as is the salt and pH 
interaction. Post-hoc analysis revealed that an increase in pH increased the apparent catalytic 
turnover regardless of the charge of the sfGFP. This can be observed in the increase by an order 
of magnitude of the turnover rate at both -30 and 0 sfGFP complexes. The different combinations 
of low salt and high salt at pH 7.8 and 8.8 are all significantly different. Therefore, it can be 
concluded that the increased pH and salt concentrations alone lead to increases in the apparent kcat 
of the AdhD enzyme. 
Figure 5.4 Kinetic parameters for oxidation reaction with 2,3-butanediol and NAD+.  Data fit to 
simplified ordered bi-bi rate equation (5.3) at (A-C) pH 7.8 and (D-F) pH 8.8. Error bars 
represent 95% confidence intervals. N-way ANOVA was used to explore the impact of pH, 
salt, and surface charge on the global data set as discussed in the text. 
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The apparent KM, (Kia), is the cofactor dissociation constant of the enzyme for the charged 
NAD+ cofactor. N-way ANOVA over the entire data set revealed that this parameter is a function 
of the salt concentration (Figure 5.4B and E). This suggests that the addition of salt decreases the 
affinity of enzyme for the cofactor. The Kia for -30 sfGFP at pH 7.8 increased by 215% upon the 
addition of salt (from 7.75 to 200 mM NaCl). The Kia for 0 sfGFP increased by 260%. The changes 
at pH 8.8 were less drastic. For -30 sfGFP, the Kia increased by 50% while it increased 75% for 0 
sfGFP. Two-factor interactions revealed that salt and pH interactions are also 
significant. Interestingly, the effect of the charge of the sfGFP did not reach significance by N-
way ANOVA.  At low pH, the addition of the -30 sfGFP tended to increase the apparent KM 
value and at the higher pH the addition of the -30 sfGFP tended to decrease the apparent KM 
value, and this became significant by the Student’s t-test only at 200 mM NaCl.  Thus, the 
introduction of the charge can affect the binding of the charged cofactor, but the effect of pH 
and ionic strength are more dominant. 
The apparent catalytic efficiency parameter, ((kcat/KB)/Kia), was found to be a function of 
pH and the charge of the sfGFP protein in complexation by N-way ANOVA (Figure 5.4C and 
4F). The two factor interactions between sfGFP protein and pH and salt and pH were found to 
be significant. The post-hoc analysis revealed that at a given pH, the effect of the salt is not 
significant, suggesting that although it was significant in the turnover of the enzyme and 
the cofactor dissociation constant, the salt effects largely cancel out when comparing 
apparent catalytic efficiencies. However, the apparent catalytic efficiency is a function of fusion 
protein charge as -30 and 0 sfGFP-AdhD complexes at pH 8.8 were significantly more active 
than the complexes at pH 7.8. Furthermore, -30 sfGFP-AdhD is significantly more active than 0 
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sfGFP-AdhD at pH 8.8. This suggests that complexation of AdhD with -30 sfGFP affects the 
microenvironment differently than fusions to 0 sfGFP, thereby significantly increasing the 
apparent catalytic efficiency of AdhD. 
5.4.7 Effect of sfGFP-SpyTag on Ground-State and Transition-State Binding 
Energies 
The apparent kcat and KM values can be used to estimate the impact of the sfGFP charge (-
30 versus 0) on the thermodynamic binding energies of the AdhD enzyme. The apparent KM values 
can be used to explore the impact on the ground state binding energy, which shows the effect of 
the sfGFP charge on the formation of the enzyme/cofactor complexes (Equation 5.4).  And the 
apparent catalytic efficiencies (kcat/KM) can be used to estimate the impact on the transition state 
binding energies, which shows the effect of the sfGFP charge on the formation of the 
enzyme/cofactor/substrate transition state complexes (Equation 5.5). 
∆∆𝐺𝐺𝑏𝑏 =  −𝑅𝑅𝑅𝑅 ln�(𝐾𝐾𝑑𝑑)0 𝑠𝑠𝑎𝑎𝑠𝑠𝑠𝑠𝑠𝑠−𝑆𝑆𝑎𝑎𝑆𝑆𝑆𝑆𝑐𝑐𝑆𝑆 (𝐾𝐾𝑑𝑑)−30 𝑠𝑠𝑎𝑎𝑠𝑠𝑠𝑠𝑠𝑠−𝑆𝑆𝑎𝑎𝑆𝑆𝑆𝑆𝑐𝑐𝑆𝑆⁄ � (5.4) 










� � (5.5) 
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Figure 5.5 Change in (a) ground-state and (b) transition-state binding energies.  Energies 
calculated with -30 and 0 sfGFP-SpyTag at pH 7.8 and 8.8 at 7.75 and 200 mM NaCl. 
At low pH, the -30 charge leads to an increase in the transition-state binding energy, a 
decrease in the substrate binding energy, and the effect of salt is minor (Figure 5.5). At pH 8.8, 
the -30 charge on the sfGFP leads to an increase in the ground-state binding energy while the 
transition-state binding energy is reduced. At the higher pH, increased salt decreases the transition-
state binding energy even further (Figure 5.5). The biggest synergistic impact happens at neutral 
pH and low salt, where the addition of -30 GFP leads to improvements in both the ground and 
transition state binding energies, thus improving the catalytic microenvironment.   
Overall the effects of fusing supercharged sfGFP proteins to AdhD were unexpected.  Prior 
research would suggest that the addition of charge near the active site should influence the local 
pH and the addition of the +36 sfGFP protein should increase the local pH while the addition of 
the -30 sfGFP protein should decrease the local pH. This was not observed; rather the tethering of 
-30 sfGFP leads to increases in activity while no significant effects were observed with the +36
sfGFP complexes.  Further analysis of these results suggests that the addition of the -30 charges to 
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the sfGFP reduces affinity for cofactor but increases the stabilization of the catalytic transition 
state at low pH. At high pH and high salt, the reverse trend is seen where the addition of the 
-30 charges to the sfGFP increases the binding energy for the cofactor, but a transition 
state destabilization is observed. Interestingly, at the optimal pH of the enzyme (8.8) and 
most physiological salt concentration, the addition of the -30 negative charge on the sfGFP leads 
to both a stabilization of both the ground and transition states, leading to significant 
improvements in biocatalysis.     
Nature uses charged patches on proteins to affect biocatalytic rates, termed electrostatic 
guidance, where the surface charge limits the diffusion of charged intermediates, thus preventing 
their equilibration with the bulk solution. There has been a good deal of interest in exploring this 
and other substrate channeling mechanisms in natural and engineered protein systems [63]. The 
surface charge effect have been observed in the metabolon complex formed with citrate synthase 
and malate dehydrogenase enzymes in the citric acid cycle [146]. To prove the importance of this 
channeling effect, a single site-directed mutation was made to disrupt the positively charged patch 
on the protein complexes and this lead to a measurable loss in the substrate channeling between 
the two active sites [64]. The results obtained in current work suggest that the charged patches 
observed near the active sites of many proteins may also affect the local microenvironment of the 
enzymes through in interplay of local pH and local ionic strength effects. This opens up the 
possibility of using supercharged protein domains to introduce electrostatic guidance capabilities 




In conclusion, the covalent complexation of -30 sfGFP to AdhD using the 
SpyCatcher/SpyTag fusion technology at pH 8.8 resulted in a protein that is significantly more 
active than the AdhD protein complexed with an uncharged sfGFP. And the covalent bond between 
the proteins was required as the mixing of the unfused domains did not introduce a kinetic benefit.  
Both salt and pH significantly affect the activity of AdhD and at low pH, the addition of the -30 
sfGFP fusion appears to influence the local ionic strength more than the local pH. This leads to an 
improvement in both cofactor binding as well as the formation of the catalytic transition state.  The 
appending of supercharged domains to proteins may be useful technique for modulating 
biocatalytic microenvironments and this may be especially valuable in in vivo applications as there 











5.6 Supporting Information 
Ultramers to clone sfGFP with SpyTag at C-terminus into pET-28a(+) 
-30 sfGFP-SpyTag
















ATGGGCAGCA GCCATCATCA TCATCATCAC AGCAGCGGCC TGGTGCCGCG CGGCAGCCAT 60 
ATGGCTAGCA TGACTGGTGG ACAGCAAATG GGTCGCGGAT CCGAATTCGA GCTCCGTCGA 120 
CAAATGGGTG GCGCTAGCAA AGGTGAAGAG CTGTTTGACG GTGTAGTACC GATCTTAGTG 180 
GAATTAGACG GCGACGTGAA CGGTCACGAA TTTAGCGTGC GCGGCGAGGG CGAAGGTGAC 240 
GCTACCGAGG GTGAATTGAC CCTGAAGTTT ATTTGCACAA CAGGCGAATT ACCCGTTCCG 300 
TGGCCCACCT TAGTGACCAC CCTGACCTAT GGCGTTCAGT GCTTCAGTGA TTACCCAGAT 360 
CATATGGATC AACACGATTT TTTCAAATCA GCCATGCCTG AAGGATATGT TCAAGAGCGT 420 
ACAATCAGCT TCAAGGACGA TGGCACCTAT AAAACGCGTG CGGAAGTGAA ATTTGAAGGC 480 
GACACATTAG TAAACCGTAT CGAACTGAAA GGTATCGACT TCAAAGAAGA CGGCAACATT 540 
TTAGGCCATA AGCTGGAATA TAACTTTAAT TCTCATGACG TGTATATTAC GGCCGATAAA 600 
CAGGAAAACG GTATCAAGGC AGAATTTGAA ATTCGCCATA ACGTGGAGGA CGGCAGCGTT 660 
CAATTAGCGG ATCATTATCA ACAAAACACG CCGATTGGTG ATGGGCCTGT ACTGTTACCT 720 
GACGATCACT ACCTGAGCAC GGAGTCAGCC CTGAGCAAAG ATCCGAACGA AGACCGCGAT 780 
210 
 
CACATGGTTC TGTTAGAATT CGTGACCGCT GCAGGCATTG ATCATGGAAT GGACGAGCTG 840 
TACAAGGCCC ACATCGTGAT GGTGGACGCC TACAAGCCGA CGAAGTAA 888 
 
0 sfGFP-SpyTag 
ATGGGCAGCA GCCATCATCA TCATCATCAC AGCAGCGGCC TGGTGCCGCG CGGCAGCCAT 60 
ATGGCTAGCA TGACTGGTGG ACAGCAAATG GGTCGCGGAT CCGAATTCGA GCTCCGTCGA 120 
CAAATGGGTG GCGCTAGCAA AGGTGAACGT CTGTTTACTG GTGTAGTACC GATCTTAGTG 180 
GAATTAGACG GCGACGTGAA CGGTCATAAA TTTAGCGTGC GCGGCGAGGG CGAAGGTGAC 240 
GCTACCAATG GTAAATTGAC CCTGAAGTTT ATTTGCACAA CAGGCAAATT ACCCGTTCCG 300 
TGGCCCACCT TAGTGACCAC CCTGACCTAT GGCGTTCAGT GCTTCAGTCG TTACCCTGAT 360 
CATATGAAAC AACACGATTT TTTCAAATCA GCCATGCCTG AAGGATATGT TCAAGAGCGT 420 
ACAATCAGCT TCAAGGACGA TGGCACCTAT AAAACGCGTG CGGAAGTGAA ATTTGAAGGC 480 
GACACATTAG TAAATCGTAT CGAACTGAAA GGTCGTGACT TCAAAGAAGA CGGCAACATT 540 
TTAGGCCATA AACTGGAATA TAACTTTAAT TCTCATAACG TGTATATTAC GGCCGATAAA 600 
CAGAAGAATG GTATCAAGGC AAATTTCAAA ATTCGCCATA ACGTGGAGGA CGGCAGCGTT 660 
CAATTAGCGG ATCATTATCA ACAAAACACG CCGATTGGTG ATGGGCCTGT ACTGTTACCT 720 
CGCAACCACT ACCTGAGCAC CCAATCTGCC CTGAGCAAAG ATCCGAAAGA AAAACGCGAT 780 
CACATGGTTC TGTTAGAATT CGTGACCGCT GCAGGCATTA CGCACGGAAT GGACGAACGC 840 
TACAAGGCCC ACATCGTGAT GGTGGACGCC TACAAGCCGA CGAAGTAA 888 
 
+36 sfGFP-SpyTag 
ATGGGCAGCA GCCATCATCA TCATCATCAC AGCAGCGGCC TGGTGCCGCG CGGCAGCCAT 60 
ATGGCTAGCA TGACTGGTGG ACAGCAAATG GGTCGCGGAT CCGAATTCGA GCTCCGTCGA 120 
CAAATGGGTG GCGCTAGCAA AGGTGAACGT CTGTTTCGTG GTAAAGTACC GATCTTAGTG 180 
GAATTAAAGG GCGACGTGAA CGGTCATAAA TTTAGCGTGC GCGGCAAAGG CAAAGGTGAC 240 
GCTACCCGTG GTAAATTGAC CCTGAAGTTT ATTTGCACAA CAGGCAAATT ACCCGTTCCG 300 
TGGCCCACCT TAGTGACCAC CCTGACCTAT GGCGTTCAGT GCTTCAGTCG TTACCCTAAA 360 
CATATGAAAC GTCACGATTT TTTCAAATCA GCCATGCCTA AAGGATATGT TCAAGAGCGT 420 
ACAATCAGCT TCAAGAAGGA TGGCAAATAT AAAACGCGTG CGGAAGTGAA ATTTGAAGGC 480 
CGCACATTAG TAAATCGTAT CAAACTGAAA GGTCGTGACT TCAAAGAAAA AGGCAACATT 540 
TTAGGCCATA AACTGCGTTA TAACTTTAAT TCTCATAAGG TGTATATTAC GGCCGATAAA 600 
CGCAAGAATG GTATCAAGGC AAAATTCAAA ATTCGCCATA ACGTGAAAGA CGGCAGCGTT 660 
CAATTAGCGG ATCATTATCA ACAAAACACG CCGATTGGTC GCGGGCCTGT ACTGTTACCT 720 
CGCAACCACT ACCTGAGCAC CCGTTCTAAA CTGAGCAAAG ATCCGAAAGA AAAACGCGAT 780 
CACATGGTTC TGTTAGAATT CGTGACCGCT GCAGGCATTA AGCACGGACG CGACGAACGC 840 
TACAAGGCCC ACATCGTGAT GGTGGACGCC TACAAGCCGA CGAAGTAA 888 
 
Amino Acid Sequences 
-30 sfGFP-SpyTag: 
 
MGSSHHHHHH SSGLVPRGSH MASMTGGQQM GRGSEFELRR QMGGASKGEE LFDGVVPILV 60 
ELDGDVNGHE FSVRGEGEGD ATEGELTLKF ICTTGELPVP WPTLVTTLTY GVQCFSDYPD 120 
HMDQHDFFKS AMPEGYVQER TISFKDDGTY KTRAEVKFEG DTLVNRIELK GIDFKEDGNI 180 
LGHKLEYNFN SHDVYITADK QENGIKAEFE IRHNVEDGSV QLADHYQQNT PIGDGPVLLP 240 
DDHYLSTESA LSKDPNEDRD HMVLLEFVTA AGIDHGMDEL YKAHIVMVDA YKPTK 295 
211 
0 sfGFP-SpyTag: 
MGSSHHHHHH SSGLVPRGSH MASMTGGQQM GRGSEFELRR QMGGASKGER LFTGVVPILV 60 
ELDGDVNGHK FSVRGEGEGD ATNGKLTLKF ICTTGKLPVP WPTLVTTLTY GVQCFSRYPD 120 
HMKQHDFFKS AMPEGYVQER TISFKDDGTY KTRAEVKFEG DTLVNRIELK GRDFKEDGNI 180 
LGHKLEYNFN SHNVYITADK QKNGIKANFK IRHNVEDGSV QLADHYQQNT PIGDGPVLLP 240 
RNHYLSTQSA LSKDPKEKRD HMVLLEFVTA AGITHGMDER YKAHIVMVDA YKPTK 295 
+36 sfGFP-SpyTag:
MGSSHHHHHH SSGLVPRGSH MASMTGGQQM GRGSEFELRR QMGGASKGER LFRGKVPILV 60 
ELKGDVNGHK FSVRGKGKGD ATRGKLTLKF ICTTGKLPVP WPTLVTTLTY GVQCFSRYPK 120 
HMKRHDFFKS AMPKGYVQER TISFKKDGKY KTRAEVKFEG RTLVNRIKLK GRDFKEKGNI 180 
LGHKLRYNFN SHKVYITADK RKNGIKAKFK IRHNVKDGSV QLADHYQQNT PIGRGPVLLP 240 
RNHYLSTRSK LSKDPKEKRD HMVLLEFVTA AGIKHGRDER YKAHIVMVDA YKPTK 295 
Primers to clone AdhD into pET28a(+) at NdeI 
FWD: CCGCGCGGCAGCCATATGGCAAAAAGGGTAAATGCATTCAACGACCTTAAGCGTA 
REV: AGTCATGCTAGCCATTCACACACACCTCCTTGCCATCTCTCTATCCTC 
Primers to linearize AdhD pET28a(+): 
FWD: ATGGCAAAAAGGGTAAATG 
REV: ATGGCTGCCGCGCGGCAC 
Primers to clone SpyCatcher at N-terminus of AdhD pET28a(+): 
FWD: TGGTGCCGCGCGGCAGCCATGGCGCCATGGTTGATACC 
REV: GCATTTACCCTTTTTGCCATAATATGAGCGTCACCTTTAGTTGC 
Primers to insert Glycine-Glycine-Glycine-Serine (GGGS) Linker between C-terminus 
SpyCatcher and N-terminus AdhD 
FWD: GGAAGTATGGCAAAAAGGGTAAATG 
REV: TCCTCCAATATGAGCGTCACCTTTAG 
SpyCatcher-GGGS-AdhD DNA sequence: 
ATGGGCAGCA GCCATCATCA TCATCATCAC AGCAGCGGCC TGGTGCCGCG CGGCAGCCAT 60 
GGCGCCATGG TTGATACCTT ATCAGGTTTA TCAAGTGAGC AAGGTCAGTC CGGTGATATG 120 
ACAATTGAAG AAGATAGTGC TACCCATATT AAATTCTCAA AACGTGATGA GGACGGCAAA 180 
212 
 
GAGTTAGCTG GTGCAACTAT GGAGTTGCGT GATTCATCTG GTAAAACTAT TAGTACATGG 240 
ATTTCAGATG GACAAGTGAA AGATTTCTAC CTGTATCCAG GAAAATATAC ATTTGTCGAA 300 
ACCGCAGCAC CAGACGGTTA TGAGGTAGCA ACTGCTATTA CCTTTACAGT TAATGAGCAA 360 
GGTCAGGTTA CTGTAAATGG CAAAGCAACT AAAGGTGACG CTCATATTGG AGGAGGAAGT 420 
ATGGCAAAAA GGGTAAATGC ATTCAACGAC CTTAAGCGTA TAGGAGATGA TAAGGTAACG 480 
GCAATTGGAA TGGGAACATG GGGAATAGGA GGGAGAGAGA CCCCAGACTA TTCTAGGGAT 540 
AAGGAAAGCA TAGAAGCAAT AAGATATGGA CTTGAATTAG GAATGAATTT AATCGACACA 600 
GCGGAATTCT ATGGAGCTGG TCATGCTGAG GAAATAGTTG GAGAGGCCAT TAAAGAATTC 660 
GAACGTGAGG ACATCTTCAT AGTGAGCAAG GTCTGGCCAA CTCACTTTGG GTATGAGGAA 720 
GCAAAGAAGG CTGCTAGAGC AAGTGCTAAA AGGTTAGGAA CTTATATTGA CCTTTATTTG 780 
TTGCACTGGC CCGTTGATGA CTTCAAGAAG ATAGAGGAGA CACTTCACGC TTTGGAAGAC 840 
CTCGTAGATG AGGGAGTGAT AAGGTACATT GGAGTTAGCA ACTTCAATCT GGAACTTCTC 900 
CAGCGCTCCC AGGAGGTCAT GAGGAAGTAT GAGATTGTAG CAAATCAAGT TAAATACTCA 960 
GTGAAAGACC GCTGGCCCGA AACTACAGGA CTTCTCGACT ACATGAAGCG TGAAGGAATA 1020 
GCATTAATGG CGTACACACC TCTAGAAAAG GGAACTCTTG CAAGGAATGA ATGTCTAGCT 1080 
AAAATTGGAG AAAAATACGG AAAAACAGCT GCTCAAGTGG CTTTAAACTA CCTGATTTGG 1140 
GAGGAAAATG TTGTAGCAAT TCCAAAAGCA AGCAACAAGG AACACCTCAA AGAAAACTTT 1200 
GGAGCTATGG GATGGAGGCT TTCAGAGGAG GATAGAGAGA TGGCAAGGAG GTGTGTGTGA 1260 
SpyCatcher-GGGS-AdhD amino acid sequence: 
MGSSHHHHHH SSGLVPRGSH GAMVDTLSGL SSEQGQSGDM TIEEDSATHI KFSKRDEDGK 60 
ELAGATMELR DSSGKTISTW ISDGQVKDFY LYPGKYTFVE TAAPDGYEVA TAITFTVNEQ 120 
GQVTVNGKAT KGDAHIGGGS MAKRVNAFND LKRIGDDKVT AIGMGTWGIG GRETPDYSRD 180 
KESIEAIRYG LELGMNLIDT AEFYGAGHAE EIVGEAIKEF EREDIFIVSK VWPTHFGYEE 240 
AKKAARASAK RLGTYIDLYL LHWPVDDFKK IEETLHALED LVDEGVIRYI GVSNFNLELL 300 
QRSQEVMRKY EIVANQVKYS VKDRWPETTG LLDYMKREGI ALMAYTPLEK GTLARNECLA 360 
KIGEKYGKTA AQVALNYLIW EENVVAIPKA SNKEHLKENF GAMGWRLSEE DREMARRCV 419 
 
• Catcher highlighted in blue 











Figure 5.6 Spectral scans from 280 to 600 nm for sfGFP after normalizing sfGFP 
concentrations.  
Figure 5.7 SDS-PAGE of sfGFP after normalizing at 485 nm. Lane 1: molecular weight marker, 
lane 2: -30 sfGFP, lane 3: 0 sfGFP, and lane 4: +36 sfGFP. A band at approximately 33 kDa is 
observed, consistent with the theoretical molecular masses.  
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Figure 5.8 SDS-PAGE of sfGFP-SpyTag and SpyCatcher-GGGS-AdhD reaction. Lane 1: 
molecular weight maker, lane 2: -30 sfGFP-SpyTag + SpyCatcher-GGGS-AdhD, lane 3: 0 
sfGFP-SpyTag + SpyCatcher-GGGS-AdhD, lane 4: +36 sfGFP-SpyTag + SpyCatcher-GGGS-
AdhD in: (A) the absence of salt and (B) the presence of approximately 400 mM NaCl. A band 
at approximately 33 kDa is observed for sfGFP, 47 kDa for SpyCatcher-GGGS-AdhD, and 80 
kDa for the complex between SpyTag and SpyCatcher, consistent with the theoretical molecular 
weights. 
Figure 5.9 SDS-PAGE of reaction between sfGFP and SpyCatcher-GGGS-AdhD. Lane 1: 
molecular weight maker, lane 2: -30 sfGFP + SpyCatcher-GGGS-AdhD, lane 3: 0 sfGFP + 
SpyCatcher-GGGS-AdhD, and lane 4: +36 sfGFP + SpyCatcher-GGGS-AdhD. A band at 
approximately 33 kDa is observed for sfGFP and at 47 kDa for SpyCatcher-GGGS-AdhD, 






Figure 5.10 Specific rates as a function of 2,3-butanediol and NAD+ concentration.  Reactions 
performed with SpyCatcher-GGGS-AdhD, -30 and 0 sfGFP-SpyTag at pH 7.8 and 8.8 with 7.75 
and 200 mM NaCl. 
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Table 5.3 Kinetic parameters for oxidation reaction with 2,3-butanediol and NAD+ fit to 
simplified bi-bi rate equation (5.3) with three individual data sets. 
Protein pH NaCl (mM) kcat/KB (µM-1 s-1) Kia (µM) (kcat/KB)/Kia (µM-2 s-1) 
-30 7.8 7.75 2.10E-06 ± 3.30E-07 28 ± 16 7.50E-08 ± 4.44E-08 
-30 7.8 7.75 2.20E-06 ± 2.60E-07 29 ± 12 7.59E-08 ± 3.26E-08 
-30 7.8 7.75 2.40E-06 ± 3.40E-07 37 ± 17 6.49E-08 ± 3.12E-08  
0 7.8 7.75 1.50E-06 ± 3.60E-07 27 ± 25 5.56E-08 ± 5.31E-08 
0 7.8 7.75 1.70E-06 ±  3.60E-07 23 ± 20 7.39E-08 ± 6.62E-08 
0 7.8 7.75 1.60E-06 ± 2.50E-07 21 ± 15 7.62E-08 ± 5.57E-08 
-30 7.8 200 7.00E-06 ± 1.10E-06 120 ± 36 5.83E-08 ± 1.98E-08 
-30 7.8 200 7.70E-06 ± 9.30E-07 117 ± 28 6.58E-08 ± 1.76E-08 
-30 7.8 200 6.80E-06 ± 8.90E-07 94 ± 27 7.23E-08 ± 2.28E-08 
0 7.8 200 3.70E-06 ± 1.70E-06 82 ± 86 4.51E-08 ± 5.17E-08 
0 7.8 200 2.80E-06 ± 1.20E-06 49 ± 57 5.71E-08 ± 7.08E-08 
0 7.8 200 6.10E-06 ± 1.50E-06 161 ± 70 3.79E-08 ± 1.89E-08 
-30 8.8 7.75 1.20E-05 ± 1.70E-06 34 ± 16 3.53E-07 ± 1.73E-07 
-30 8.8 7.75 1.30E-05 ± 1.40E-06 34 ± 12 3.82E-07 ± 1.41E-07 
-30 8.8 7.75 1.50E-05 ± 1.70E-06 47 ± 16 3.19E-07 ± 1.15E-07 
0 8.8 7.75 1.20E-05 ± 1.90E-06 48 ± 23 2.50E-07 ± 1.26E-07 
0 8.8 7.75 1.10E-05 ± 1.80E-06 40 ± 20 2.75E-07 ± 1.45E-07 
0 8.8 7.75 1.30E-05 ± 2.10E-06 53 ± 23 2.45E-07 ± 1.14E-07 
-30 8.8 200 2.10E-05 ± 2.70E-06 61 ± 20 3.44E-07 ± 1.21E-07 
-30 8.8 200 2.10E-05 ± 3.70E-06 58 ± 26 3.62E-07 ± 1.74E-07 
-30 8.8 200 1.90E-05 ± 2.10E-06 48 ± 15 3.96E-07 ± 1.31E-07 
0 8.8 200 2.30E-05 ± 3.00E-06 74 ± 23 3.11E-07 ± 1.05E-07 
0 8.8 200 2.50E-05 ± 3.40E-06 81 ± 25 3.09E-07 ± 1.04E-07 
0 8.8 200 2.60E-05 ± 3.10E-06 94 ± 24 2.77E-07 ± 7.79E-08 
221 
Table 5.4 Average kinetic parameters for oxidation reaction with 2,3-butanediol and NAD+.  




Table 5.5 Raw data to determine kinetic parameters for oxidation reaction with 2,3-butanediol 
and NAD+. Data fit to simplified bi-bi rate equation (5.3). 
0 sfGFP-SpyTag, pH 7.8, 7.75 mM NaCl 
2,3-butanediol (µM) NAD+ (µM) Specific Rate (1/s) 
2000 1 0.00357 
2000 1 0.00185 
2000 1 0.00278 
2000 20 0.00561 
2000 20 0.00556 
2000 20 0.00784 
2000 40 0.00534 
2000 40 0.00486 
2000 40 0.00382 
2000 60 0.00388 
2000 60 0.00408 
2000 60 0.00357 
2000 80 0.00583 
2000 80 0.00534 
2000 80 0.00194 
2000 100 0.00534 
2000 100 0.00826 
2000 100 0.00340 
2000 150 0.00486 
2000 150 0.00583 
2000 150 0.00340 
2000 200 0.00534 
2000 200 0.00631 
2000 200 0.00561 
10000 1 0.00437 
10000 1 0.00437 
10000 1 0.00243 
10000 20 0.0107 
10000 20 0.00967 
10000 20 0.00874 
10000 40 0.0107 
10000 40 0.0286 
10000 40 0.0117 
10000 60 0.0123 
10000 60 0.0133 
10000 60 0.0143 
10000 80 0.0111 
10000 80 0.0111 
10000 80 0.00927 
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10000 100 0.0131 
10000 100 0.0146 
10000 100 0.0151 
10000 150 0.0165 
10000 150 0.0117 
10000 150 0.00850 
10000 200 0.0153 
10000 200 0.0158 
10000 200 0.0107 
20000 1 0.00194 
20000 1 0.00534 
20000 1 0.00146 
20000 20 0.0210 
20000 20 0.0160 
20000 20 0.0173 
20000 40 0.0181 
20000 40 0.0218 
20000 40 0.0371 
20000 60 0.0204 
20000 60 0.0209 
20000 60 0.0181 
20000 80 0.0190 
20000 80 0.0398 
20000 80 0.0222 
20000 100 0.0236 
20000 100 0.0329 
20000 100 0.0227 
20000 150 0.0264 
20000 150 0.0389 
20000 150 0.0297 
20000 200 0.0315 
20000 200 0.0374 
20000 200 0.0311 
30000 1 0.00340 
30000 1 0.00742 
30000 1 0.00291 
30000 20 0.0170 
30000 20 0.0214 
30000 20 0.0185 
30000 40 0.0243 
30000 40 0.0262 
30000 40 0.0260 
30000 60 0.0287 
30000 60 0.0262 
30000 60 0.0279 
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30000 80 0.0175 
30000 80 0.0354 
30000 80 0.0352 
30000 100 0.0427 
30000 100 0.0352 
30000 100 0.0374 
30000 150 0.0505 
30000 150 0.0371 
30000 150 0.0450 
30000 200 0.0246 
30000 200 0.0520 
30000 200 0.0487 
 
0 sfGFP-SpyTag, pH 7.8, 200 mM NaCl 
2,3-butanediol (µM) NAD+ (µM) Specific Rate (1/s) 
2000 1 0.00534 
2000 1 0.00243 
2000 1 0.00637 
2000 20 0.0102 
2000 20 0.00816 
2000 20 0.00918 
2000 40 0.0136 
2000 40 0.0121 
2000 40 0.0102 
2000 60 0.0199 
2000 60 0.0160 
2000 60 0.0180 
2000 80 0.0250 
2000 80 0.0151 
2000 80 0.0158 
2000 100 0.0209 
2000 100 0.0227 
2000 100 0.00850 
2000 150 0.0296 
2000 150 0.0214 
2000 150 0.00742 
2000 200 0.0301 
2000 200 0.0296 
2000 200 0.00918 
10000 1 0.00510 
10000 1 0.00204 
10000 1 0.00161 
10000 20 0.00923 
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10000 20 0.00825 
10000 20 0.00777 
10000 40 0.0185 
10000 40 0.0180 
10000 40 0.0165 
10000 60 0.0194 
10000 60 0.0199 
10000 60 0.0204 
10000 80 0.0243 
10000 80 0.0257 
10000 80 0.0238 
10000 100 0.0283 
10000 100 0.0297 
10000 100 0.0255 
10000 150 0.0315 
10000 150 0.0371 
10000 150 0.0334 
10000 200 0.0325 
10000 200 0.0384 
10000 200 0.0338 
20000 1 0.00612 
20000 1 0.0061 
20000 1 0.00612 
20000 20 0.0107 
20000 20 0.0136 
20000 20 0.0175 
20000 40 0.0255 
20000 40 0.0291 
20000 40 0.0306 
20000 60 0.0315 
20000 60 0.0324 
20000 60 0.0335 
20000 80 0.0403 
20000 80 0.0408 
20000 80 0.0423 
20000 100 0.0468 
20000 100 0.0496 
20000 100 0.0459 
20000 150 0.0630 
20000 150 0.0640 
20000 150 0.0621 
20000 200 0.0695 
20000 200 0.0122 
20000 200 0.0681 
30000 1 0.004370 
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30000 1 0.00388 
30000 1 0.00437 
30000 20 0.0223 
30000 20 0.00973 
30000 20 0.0185 
30000 40 0.0329 
30000 40 0.0452 
30000 40 0.0359 
30000 60 0.0399 
30000 60 0.0371 
30000 60 0.0398 
30000 80 0.0440 
30000 80 0.0399 
30000 80 0.0589 
30000 100 0.0352 
30000 100 0.0579 
30000 100 0.0663 
30000 150 0.0686 
30000 150 0.0607 
30000 150 0.0862 
30000 200 0.0695 
30000 200 0.0681 
30000 200 0.106 
 
 
-30 sfGFP-SpyTag, pH 7.8, 7.75 mM NaCl 
2,3-butanediol (µM) NAD+ (µM) Specific Rate (1/s) 
2000 1 0.00612 
2000 1 0.00437 
2000 1 0.00556 
2000 20 0.00357 
2000 20 0.00534 
2000 20 0.00235 
2000 40 0.00583 
2000 40 0.00194 
2000 40 0.00486 
2000 60 0.00486 
2000 60 0.00437 
2000 60 0.00291 
2000 80 0.00583 
2000 80 0.00765 
2000 80 0.00583 
2000 100 0.00631 
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2000 100 0.00874 
2000 100 0.00583 
2000 150 0.00825 
2000 150 0.00966 
2000 150 0.00971 
2000 200 0.00437 
2000 200 0.00680 
2000 200 0.00534 
10000 1 0.00113 
10000 1 0.00185 
10000 1 0.00232 
10000 20 0.00583 
10000 20 0.0126 
10000 20 0.0131 
10000 40 0.0195 
10000 40 0.0139 
10000 40 0.0165 
10000 60 0.0277 
10000 60 0.0199 
10000 60 0.0175 
10000 80 0.0159 
10000 80 0.0189 
10000 80 0.0194 
10000 100 0.0167 
10000 100 0.0189 
10000 100 0.0223 
10000 150 0.0282 
10000 150 0.0204 
10000 150 0.0257 
10000 200 0.0238 
10000 200 0.0218 
10000 200 0.0252 
20000 1 0.00649 
20000 1 0.00459 
20000 1 0.00534 
20000 20 0.0199 
20000 20 0.0199 
20000 20 0.0190 
20000 40 0.0273 
20000 40 0.0250 
20000 40 0.0311 
20000 60 0.0311 
20000 60 0.0301 
20000 60 0.0297 
20000 80 0.0338 
228 
 
20000 80 0.0320 
20000 80 0.0255 
20000 100 0.0278 
20000 100 0.0380 
20000 100 0.0389 
20000 150 0.0412 
20000 150 0.0454 
20000 150 0.0422 
20000 200 0.0418 
20000 200 0.0408 
20000 200 0.0384 
30000 1 0.00371 
30000 1 0.00583 
30000 1 0.00631 
30000 20 0.0241 
30000 20 0.0250 
30000 20 0.0148 
30000 40 0.0338 
30000 40 0.0350 
30000 40 0.0352 
30000 60 0.0394 
30000 60 0.0352 
30000 60 0.0385 
30000 80 0.0380 
30000 80 0.0431 
30000 80 0.0450 
30000 100 0.0436 
30000 100 0.0505 
30000 100 0.0520 
30000 150 0.0524 
30000 150 0.0533 
30000 150 0.0612 
30000 200 0.0587 
30000 200 0.0584 
30000 200 0.0584 
 
-30 sfGFP-SpyTag, pH 7.8, 200 mM NaCl 
2,3-butanediol (µM) NAD+ (µM) Specific Rate (1/s) 
2000 1 0.00408 
2000 1 0.00268 
2000 1 0.00268 
2000 20 0.00663 
2000 20 0.00663 
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2000 20 0.00388 
2000 40 0.00874 
2000 40 0.00714 
2000 40 0.00874 
2000 60 0.00971 
2000 60 0.00874 
2000 60 0.00631 
2000 80 0.0136 
2000 80 0.00816 
2000 80 0.00971 
2000 100 0.0112 
2000 100 0.0111 
2000 100 0.0111 
2000 150 0.0155 
2000 150 0.0121 
2000 150 0.0125 
2000 200 0.0126 
2000 200 0.0131 
2000 200 0.0112 
10000 1 0.00194 
10000 1 0.00486 
10000 1 0.00486 
10000 20 0.0141 
10000 20 0.0155 
10000 20 0.0146 
10000 40 0.0243 
10000 40 0.0238 
10000 40 0.0267 
10000 60 0.0286 
10000 60 0.0243 
10000 60 0.0283 
10000 80 0.0354 
10000 80 0.0324 
10000 80 0.0343 
10000 100 0.0371 
10000 100 0.0417 
10000 100 0.0426 
10000 150 0.0501 
10000 150 0.0570 
10000 150 0.0496 
10000 200 0.0491 
10000 200 0.0561 
10000 200 0.0547 
20000 1 0.00306 
20000 1 0.00243 
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20000 1 0.00510 
20000 20 0.0223 
20000 20 0.0246 
20000 20 0.0241 
20000 40 0.0338 
20000 40 0.0389 
20000 40 0.0374 
20000 60 0.0437 
20000 60 0.0515 
20000 60 0.0468 
20000 80 0.0524 
20000 80 0.0607 
20000 80 0.0598 
20000 100 0.0670 
20000 100 0.0751 
20000 100 0.0663 
20000 150 0.0806 
20000 150 0.0885 
20000 150 0.0820 
20000 200 0.0922 
20000 200 0.0913 
20000 200 0.0964 
30000 1 0.00612 
30000 1 0.00510 
30000 1 0.00612 
30000 20 0.0287 
30000 20 0.0371 
30000 20 0.0388 
30000 40 0.0468 
30000 40 0.0505 
30000 40 0.0675 
30000 60 0.0635 
30000 60 0.0723 
30000 60 0.0762 
30000 80 0.0783 
30000 80 0.0899 
30000 80 0.0779 
30000 100 0.0894 
30000 100 0.105 
30000 100 0.0945 
30000 150 0.115 
30000 150 0.127 
30000 150 0.127 
30000 200 0.129 
30000 200 0.146 
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30000 200 0.145 
0 sfGFP-SpyTag, pH 8.8, 7.75 mM NaCl 
2,3-butanediol (µM) NAD+ (µM) Specific Rate (1/s) 
2000 1 0.00631 
2000 1 0.00340 
2000 1 0.00534 
2000 20 0.0180 
2000 20 0.0185 
2000 20 0.0209 
2000 40 0.0218 
2000 40 0.0214 
2000 40 0.0241 
2000 60 0.0228 
2000 60 0.0238 
2000 60 0.0277 
2000 80 0.0233 
2000 80 0.0257 
2000 80 0.0316 
2000 100 0.0269 
2000 100 0.0248 
2000 100 0.0287 
2000 150 0.0325 
2000 150 0.0306 
2000 150 0.0264 
2000 200 0.0209 
2000 200 0.0345 
2000 200 0.0403 
10000 1 0.0126 
10000 1 0.00463 
10000 1 0.00680 
10000 20 0.0667 
10000 20 0.0538 
10000 20 0.0644 
10000 40 0.0340 
10000 40 0.0839 
10000 40 0.0811 
10000 60 0.0820 
10000 60 0.0936 
10000 60 0.0904 
10000 80 0.0881 
10000 80 0.0950 
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10000 80 0.0978 
10000 100 0.0987 
10000 100 0.103 
10000 100 0.127 
10000 150 0.102 
10000 150 0.118 
10000 150 0.101 
10000 200 0.159 
10000 200 0.147 
10000 200 0.136 
20000 1 0.0116 
20000 1 0.00881 
20000 1 0.0102 
20000 20 0.0881 
20000 20 0.0959 
20000 20 0.0955 
20000 40 0.126 
20000 40 0.126 
20000 40 0.131 
20000 60 0.145 
20000 60 0.159 
20000 60 0.147 
20000 80 0.160 
20000 80 0.167 
20000 80 0.156 
20000 100 0.151 
20000 100 0.184 
20000 100 0.186 
20000 150 0.185 
20000 150 0.202 
20000 150 0.193 
20000 200 0.230 
20000 200 0.199 
20000 200 0.243 
30000 1 0.0138 
30000 1 0.00971 
30000 1 0.0146 
30000 20 0.111 
30000 20 0.0955 
30000 20 0.103 
30000 40 0.146 
30000 40 0.152 
30000 40 0.147 
30000 60 0.159 
30000 60 0.185 
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30000 60 0.184 
30000 80 0.205 
30000 80 0.191 
30000 80 0.201 
30000 100 0.236 
30000 100 0.216 
30000 100 0.238 
30000 150 0.254 
30000 150 0.228 
30000 150 0.246 
30000 200 0.251 
30000 200 0.272 
30000 200 0.307 
0 sfGFP-SpyTag, pH 8.8, 200 mM NaCl 
2,3-butanediol (µM) NAD+ (µM) Specific Rate (1/s) 
2000 1 0.00728 
2000 1 0.00194 
2000 1 0.00291 
2000 20 0.0117 
2000 20 0.0131 
2000 20 0.0141 
2000 40 0.0158 
2000 40 0.0180 
2000 40 0.0155 
2000 60 0.0214 
2000 60 0.0167 
2000 60 0.0107 
2000 80 0.0228 
2000 80 0.0218 
2000 80 0.0287 
2000 100 0.0222 
2000 100 0.0180 
2000 100 0.0199 
2000 150 0.0255 
2000 150 0.0278 
2000 150 0.0278 
2000 200 0.0273 
2000 200 0.0252 
2000 200 0.0228 
10000 1 0.00971 
10000 1 0.00881 
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10000 1 0.00825 
10000 20 0.0746 
10000 20 0.0667 
10000 20 0.0700 
10000 40 0.118 
10000 40 0.110 
10000 40 0.104 
10000 60 0.141 
10000 60 0.139 
10000 60 0.0723 
10000 80 0.148 
10000 80 0.154 
10000 80 0.159 
10000 100 0.159 
10000 100 0.176 
10000 100 0.170 
10000 150 0.193 
10000 150 0.219 
10000 150 0.204 
10000 200 0.200 
10000 200 0.208 
10000 200 0.220 
20000 1 0.0131 
20000 1 0.0141 
20000 1 0.0112 
20000 20 0.103 
20000 20 0.108 
20000 20 0.105 
20000 40 0.172 
20000 40 0.185 
20000 40 0.171 
20000 60 0.209 
20000 60 0.210 
20000 60 0.219 
20000 80 0.244 
20000 80 0.261 
20000 80 0.245 
20000 100 0.260 
20000 100 0.283 
20000 100 0.272 
20000 150 0.339 
20000 150 0.342 
20000 150 0.328 
20000 200 0.377 
20000 200 0.382 
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20000 200 0.354 
30000 1 0.0126 
30000 1 0.0141 
30000 1 0.0162 
30000 20 0.127 
30000 20 0.126 
30000 20 0.132 
30000 40 0.224 
30000 40 0.239 
30000 40 0.231 
30000 60 0.293 
30000 60 0.282 
30000 60 0.288 
30000 80 0.336 
30000 80 0.333 
30000 80 0.339 
30000 100 0.375 
30000 100 0.390 
30000 100 0.377 
30000 150 0.425 
30000 150 0.466 
30000 150 0.477 
30000 200 0.458 
30000 200 0.478 
30000 200 0.520 
-30 sfGFP-SpyTag, pH 8.8, 7.75 mM NaCl
2,3-butanediol (µM) NAD+ (µM) Specific Rate (1/s) 
2000 1 0.00510 
2000 1 0.00534 
2000 1 0.00437 
2000 20 0.0214 
2000 20 0.0185 
2000 20 0.0209 
2000 40 0.0228 
2000 40 0.0227 
2000 40 0.0250 
2000 60 0.0248 
2000 60 0.0277 
2000 60 0.0316 
2000 80 0.0252 
2000 80 0.0316 
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2000 80 0.0354 
2000 100 0.0282 
2000 100 0.0379 
2000 100 0.0364 
2000 150 0.0345 
2000 150 0.0338 
2000 150 0.0379 
2000 200 0.0320 
2000 200 0.0195 
2000 200 0.0264 
10000 1 0.00867 
10000 1 0.00971 
10000 1 0.0107 
10000 20 0.0695 
10000 20 0.0728 
10000 20 0.0742 
10000 40 0.0973 
10000 40 0.0922 
10000 40 0.0964 
10000 60 0.111 
10000 60 0.106 
10000 60 0.112 
10000 80 0.119 
10000 80 0.109 
10000 80 0.117 
10000 100 0.134 
10000 100 0.116 
10000 100 0.133 
10000 150 0.134 
10000 150 0.130 
10000 150 0.140 
10000 200 0.0973 
10000 200 0.137 
10000 200 0.123 
20000 1 0.0140 
20000 1 0.0136 
20000 1 0.0136 
20000 20 0.101 
20000 20 0.116 
20000 20 0.106 
20000 40 0.141 
20000 40 0.153 
20000 40 0.151 
20000 60 0.174 
20000 60 0.178 
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20000 60 0.175 
20000 80 0.178 
20000 80 0.202 
20000 80 0.198 
20000 100 0.218 
20000 100 0.221 
20000 100 0.217 
20000 150 0.232 
20000 150 0.244 
20000 150 0.229 
20000 200 0.210 
20000 200 0.238 
20000 200 0.223 
30000 1 0.0136 
30000 1 0.0126 
30000 1 0.0151 
30000 20 0.114 
30000 20 0.142 
30000 20 0.130 
30000 40 0.168 
30000 40 0.183 
30000 40 0.182 
30000 60 0.204 
30000 60 0.219 
30000 60 0.215 
30000 80 0.246 
30000 80 0.250 
30000 80 0.256 
30000 100 0.257 
30000 100 0.285 
30000 100 0.293 
30000 150 0.298 
30000 150 0.294 
30000 150 0.318 
30000 200 0.270 
30000 200 0.313 
30000 200 0.384 
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-30 sfGFP-SpyTag, pH 8.8, 200 mM NaCl 
 
2,3-butanediol (µM) NAD+ (µM) Specific Rate (1/s) 
2000 1 0.00680 
2000 1 0.00437 
2000 1 0.00437 
2000 20 0.0238 
2000 20 0.0248 
2000 20 0.0250 
2000 40 0.0291 
2000 40 0.0329 
2000 40 0.0335 
2000 60 0.0388 
2000 60 0.0379 
2000 60 0.0357 
2000 80 0.0418 
2000 80 0.0440 
2000 80 0.0426 
2000 100 0.0635 
2000 100 0.0447 
2000 100 0.0544 
2000 150 0.0515 
2000 150 0.0565 
2000 150 0.0542 
2000 200 0.0384 
2000 200 0.0181 
2000 200 0.0603 
10000 1 0.00825 
10000 1 0.00971 
10000 1 0.00969 
10000 20 0.0793 
10000 20 0.0746 
10000 20 0.0695 
10000 40 0.111 
10000 40 0.102 
10000 40 0.109 
10000 60 0.140 
10000 60 0.141 
10000 60 0.131 
10000 80 0.148 
10000 80 0.146 
10000 80 0.146 
10000 100 0.161 
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10000 100 0.136 
10000 100 0.150 
10000 150 0.181 
10000 150 0.181 
10000 150 0.190 
10000 200 0.164 
10000 200 0.0612 
10000 200 0.137 
20000 1 0.0102 
20000 1 0.00971 
20000 1 0.0107 
20000 20 0.121 
20000 20 0.116 
20000 20 0.122 
20000 40 0.171 
20000 40 0.184 
20000 40 0.178 
20000 60 0.240 
20000 60 0.224 
20000 60 0.225 
20000 80 0.279 
20000 80 0.269 
20000 80 0.236 
20000 100 0.315 
20000 100 0.330 
20000 100 0.253 
20000 150 0.307 
20000 150 0.378 
20000 150 0.250 
20000 200 0.310 
20000 200 0.383 
20000 200 0.285 
30000 1 0.0121 
30000 1 0.0131 
30000 1 0.0121 
30000 20 0.147 
30000 20 0.146 
30000 20 0.140 
30000 40 0.228 
30000 40 0.216 
30000 40 0.219 
30000 60 0.278 
30000 60 0.296 
30000 60 0.294 
30000 80 0.340 
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30000 80 0.351 
30000 80 0.358 
30000 100 0.377 
30000 100 0.392 
30000 100 0.404 
30000 150 0.412 
30000 150 0.424 
30000 150 0.395 
30000 200 0.514 
30000 200 0.447 
30000 200 0.467 
 
SpyCatcher-GGGS-AdhD, pH 8.8, 7.75 mM NaCl 
2,3-butanediol (µM) NAD+ (µM) Specific Rate (1/s) 
2000 1 0.00388 
2000 1 0.00255 
2000 1 0.00510 
2000 20 0.0120 
2000 20 0.0116 
2000 20 0.0176 
2000 40 0.0125 
2000 40 0.0120 
2000 40 0.0118 
2000 60 0.0116 
2000 60 0.0148 
2000 60 0.0123 
2000 80 0.0181 
2000 80 0.0218 
2000 80 0.0255 
2000 100 0.0176 
2000 100 0.0204 
2000 100 0.0250 
2000 150 0.0167 
2000 150 0.0255 
2000 150 0.0264 
2000 200 0.0320 
2000 200 0.0223 
2000 200 0.0236 
10000 1 0.00742 
10000 1 0.0102 
10000 1 0.00973 
10000 20 0.0575 
10000 20 0.0584 
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10000 20 0.0751 
10000 40 0.0579 
10000 40 0.0723 
10000 40 0.0755 
10000 60 0.0686 
10000 60 0.0621 
10000 60 0.0742 
10000 80 0.0704 
10000 80 0.0857 
10000 80 0.0927 
10000 100 0.0626 
10000 100 0.0978 
10000 100 0.0918 
10000 150 0.0524 
10000 150 0.0932 
10000 150 0.100 
10000 200 0.0955 
10000 200 0.0950 
10000 200 0.0881 
20000 1 0.00927 
20000 1 0.0107 
20000 1 0.00834 
20000 20 0.0797 
20000 20 0.0871 
20000 20 0.0820 
20000 40 0.106 
20000 40 0.109 
20000 40 0.0793 
20000 60 0.119 
20000 60 0.108 
20000 60 0.0922 
20000 80 0.129 
20000 80 0.127 
20000 80 0.145 
20000 100 0.132 
20000 100 0.106 
20000 100 0.148 
20000 150 0.112 
20000 150 0.100 
20000 150 0.144 
20000 200 0.153 
20000 200 0.148 
20000 200 0.127 
30000 1 0.00534 
30000 1 0.0134 
242 
 
30000 1 0.0122 
30000 20 0.0473 
30000 20 0.137 
30000 20 0.110 
30000 40 0.144 
30000 40 0.0971 
30000 40 0.123 
30000 60 0.149 
30000 60 0.212 
30000 60 0.109 
30000 80 0.202 
30000 80 0.163 
30000 80 0.184 
30000 100 0.226 
30000 100 0.169 
30000 100 0.212 
30000 150 0.261 
30000 150 0.173 
30000 150 0.210 
30000 200 0.228 
30000 200 0.208 
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6.1 Abstract 
Substrate channeling can be used to increase efficiency in cascades by preventing the diffusion 
of intermediates into the bulk. In this work, we are engineering substrate channeling between 
recombinant human hexokinase II (HK2) and glucose-6-phosphate-dehydrogenase (G6PD) using 
a supercharged superfolder GFP (sfGFP) scaffold. Three different variants of sfGFP will be 
studied, -30, 0, and +36, as a means for electrostatic guidance. HK2 converts D-glucose and ATP 
to D-glucose-6-phosphate and ADP. G6PD converts D-glucose-6-phosphate and NADP+ to 6-
phospho-D-gluconate and NADPH. The channeling of the negative intermediate, D-glucose-6-
phosphate, along the surface of sfGFP between HK2 and G6PD will be studied. It is presumed that 
it can be guided along the positive patch provided by +36 sfGFP, while -30 sfGFP should repel 
the intermediate preventing channeling. The efficiency of channeling through electrostatic 
guidance will be studied through detailed kinetics. Complexes were made with orthogonal tags 
including SpyTag/SpyCatcher and SnoopTag/SnoopCatcher, as well as through click chemistry 
between azides and alkynes. 
6.2 Introduction 
Substrate channeling occurs when an intermediate is transferred from one enzymatic active 
site to the next without diffusing or reaching equilibrium with the bulk environment. There has 
been a lot of misconceptions on how to achieve substrate channeling as a way to increase efficiency 
in cascades. A lot of focus has been on proximity being the source of channeling, which is incorrect 
once a distance of one nanometer has been exceeded [63]. Studies have shown that to achieve 
channeling, there must be some sort of bounded diffusion or sequestration. Channeling is desirable 
as it decreases the chance of side reactions, protects the cells from unstable or toxic intermediates, 
can increase local substrate concentrations, and increases overall yields and efficiency [63].  
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Methods of substrate channeling include intramolecular tunnels, chemical swings arms, and 
electrostatic guidance. An example of an intramolecular tunnel includes the hydrophobic tunnel 
that channels indole in tryptophan synthase [147]. Chemical swing arms are found in the pyruvate 
dehydrogenase complex where the intermediate acetyl group is transferred between enzymes 
[148]. Electrostatic guidance is found in the TCA cycle between malate dehydrogenase and citrate 
synthase. Previous work with these enzymes has shown that mutations in the positive patch 
connecting the two enzymes results in a decrease in substrate channeling. This suggested the 
guidance of the negative intermediate, oxaloacetate, along the positive patch through electrostatic 
guidance [64]. 
In this work, we are engineering substrate channeling using supercharged superfolder GFP 
(sfGFP). The GFP used here is from jellyfish Aequorea Victoria which consists of 11 β-strands 
wrapped around a central helix (PDB 1EMA) [56]. The cycle three mutations, enhanced GFP 
mutations, and six new mutations resulted in sfGFP (PDB 2B3P) [57, 60]. Mutations along the 
surface allowed charged variants to be developed and increased the stability of supercharged 
sfGFP [61]. 
sfGFP will be used to electrostatically guide the intermediate between recombinant human 
hexokinase II (HK2) and human glucose-6-phosphate dehydrogenase (G6PD). HK2 is responsible 
for catalyzing the first step of glycolysis. It converts D-glucose and ATP to D-glucose-6-phosphate 
and ADP [67]. There are four isomers of hexokinase, with class two being around 100 kDa. It 
consists of two halves that are both catalytic [67]. HK2 is a dimer (PDB 2NZT) and follows the 
random bi-bi rate equation [149]. Human glucose-6-phosphate dehydrogenase (G6PD) is 
responsible for catalyzing the first step of the pentose phosphate pathway [68]. Specifically, it 
converts glucose-6-phosphate and NADP+, in the presence of magnesium chloride, to 6-phospho-
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D-gluconate and NADPH. It is also known to have both a structural and catalytic NADP+ binding 
site [69]. Its subunit is approximately 60 kDa, but is naturally a tetramer [150]. G6PD follows the 
random bi-bi rate equation [151]. 
The product of HK2, D-glucose-6-phosphate, is used by G6PD allowing for substrate 
channeling. As D-glucose-6-phosphate, the intermediate, is negatively charged, electrostatic 
guidance along a positively charged patch is possible (Figure 6.1). This will be demonstrated with 
superfolder GFP (sfGFP). Three different charges of sfGFP will be tested, -30, 0, and +36, where 
+36 is expected to provide substrate channeling, 0 is expected to allow for some channeling, while 
-30 sfGFP should direct the intermediate into the bulk. 
 
Figure 6.1 Schematic of engineered substrate channeling between HK2 and G6PD with sfGFP 
scaffold.  -30 sfGFP is shown in red (left), 0 sfGFP is shown in white (middle), +36 sfGFP is 
shown in blue (right). 
 
HK2 and G6PD will be complexed to sfGFP through two methods. The first involves HK2 and 
G6PD both being on top of the sfGFP barrel, as a result of the N and C-termini of sfGFP both 
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being on top of the barrel. This set-up will be accomplished through orthogonal tag systems 
SpyTag/SpyCatcher and SnoopTag/SnoopCatcher. The second method involves HK2 and G6PD 
on opposite sides of the sfGFP barrel through the previously mentioned tags, as well as through 
unnatural amino acid incorporation, allowing for click chemistry between azides and alkynes. 
These two set-ups will allow us to determine the effect of protein charge and enzyme location on 
the degree of substrate channeling in this three-enzyme system. 
6.3 Materials and Methods 
6.3.1 Materials 
Oligonucleotides were purchased from Integrated DNA Technologies (Coralville, IA). 
Phusion high fidelity DNA polymerase and E. coli BL21(DE3) expression cells were from New 
England Biolabs (Ipswich, MA). NuPAGE SDS-PAGE gels, MOPS running buffer, and Novex 
sharp pre-stained protein standards were from Invitrogen (Carlsbad, CA). Histidine purification 
Nickel-NTA resin and TAMRA was purchased from ThermoFisher Scientific (Waltham, MA). 
Chromatography columns were from Bio-Rad (Hercules, CA). Molecular weight centrifugal filters 
were from EMD Millipore (Billerica, MA). Para-azidophenylalanine was from Bachem 
(Bubendorf, Switzerland) and O-propargyl-L-tyrosine was from Psyclo Peptide (Shanghai, China). 
All other chemicals, including kanamycin and spectinomycin, were from Sigma Aldrich (St. Louis, 
MO). 
6.3.2 Cloning, Expression, Purification of SpyCatcher G6PD 
The DNA sequence corresponding to human glucose-6-phosphate dehydrogenase (G6PD) 
was cloned into pET-28a(+) at Nhe I. The DNA sequence was obtained from Addgene (#41521). 
The resulting construct, G6PD-pET28, was used to clone SpyCatcher at the N-terminus at Nde I, 
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resulting in SpyCatcher G6PD. Final sequences were verified by DNA sequencing (see Supporting 
Information). 
SpyCatcher G6PD was transformed into E. coli BL21(DE3) cells onto Luria Broth (LB) plates 
supplemented with 0.035 mg/ml kanamycin. Single colonies were inoculated at 37 ºC overnight 
in Luria Broth (LB) supplemented with 0.035 mg/ml kanamycin. Expression was performed the 
next day in the same media at 37 °C. When the cells reached on O.D. of approximately 0.60, 
induction was performed with 0.1 mM isopropyl β-D-1-thiogalactopyranoside (IPTG) and the cells 
were shaken at 200 rpm overnight at 37 °C.  
The cells were harvested and resuspended in 20 mM sodium phosphate buffer with 500 mM 
NaCl, pH 7.4. They were then sonicated and centrifuged for 1 hour at 7000xg to remove cell debris. 
The clarified lysate was loaded onto chromatography columns containing Ni-NTA resin previously 
equilibrated with 20 mM sodium phosphate buffer with 500 mM NaCl, pH 7.4. The flow-through 
was collected and the column was washed with varying immidizole concentrations (75-500 mM 
immidizole) in 20 mM tris-HCl with 200 mM NaCl pH 7.4. Fractions were run on NuPAGE 4-
12% Bis-tris gels in MES running buffer and protein bands at the expected molecular weight of 
approximately 75 kDa were observed. Fractions containing protein greater than 95% pure were 
pooled together and concentrated in 50 kDa MWCO centrifugal filters. They were then buffer 
exchanged into assay buffer 50 mM triethanolamine pH 7.6. 
6.3.3 Cloning of sfGFP SpyTag, SnoopTag sfGFP SpyTag, and sfGFP SpyTag 
T50TAG 
Different versions of sfGFP were made for different conjugation methods. sfGFP with 
SpyTag and SnoopTag will be used to attach HK2 and G6PD to the top of the sfGFP barrel. sfGFP 
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SpyTag with an amber stop codon will be used to attach HK2 and G6PD on opposite sides of the 
barrel. sfGFP SpyTag was used as the foundation for the constructs SnoopTag sfGFP SpyTag and 
sfGFP SpyTag T50TAG. 
Cloning of sfGFP SpyTag plasmids was previously described in chapter 5. Briefly, sfGFP 
SpyTag was produced by cloning the PCR product of ultramers, containing the C-terminus 
sequence of sfGFP followed by the SpyTag sequence, into pET-28a(+) linearized with Hind III 
(see Supporting Information). This resulted in constructs -30 sfGFP SpyTag, 0 sfGFP SpyTag, and 
+36 sfGFP SpyTag. The genes were verified by DNA sequencing (complete sequencing can be
found in Supporting Information). The final charges on the sfGFP mutants were increased by three 
upon addition of the poly-histidine purification tag and thrombin site, artifacts of the cloning, and 
the SpyTag sequence. 
SnoopTag sfGFP SpyTag was cloned into pET28 after linearizing at Hind III. Ultramers 
with SnoopTag at the N-terminus were used to amplify SnoopTag sfGFP SpyTag from sfGFP 
SpyTag pET28 (see Supporting Information). The genes were verified by DNA sequencing 
(complete sequencing can be found in Supporting Information). 
sfGFP SpyTag constructs were used to introduce an amber stop codon (TAG) at T50 to 
enable unnatural amino acid incorporation. The mutation was inserted using site-directed 
mutagenesis (see Supporting Information). The genes were verified by DNA sequencing (complete 
sequencing can be found in Supporting Information). 
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6.3.4 sfGFP SpyTag and SnoopTag sfGFP SpyTag Expression and 
Purification 
sfGFP SpyTag and SnoopTag sfGFP SpyTag were transformed into E. coli BL21(DE3) cells 
onto Luria Broth (LB) plates supplemented with 0.035 mg/ml kanamycin for sfGFP. Single 
colonies were inoculated at 37 ºC overnight in Luria Broth (LB) supplemented with 0.035 mg/ml 
kanamycin. Expression was performed the next day in the same media at 37 °C. When the cells 
reached on O.D. of approximately 0.60, induction was performed with 0.5 mM isopropyl β-D-1-
thiogalactopyranoside (IPTG). The cells were shaken at 200 rpm overnight at 25 °C. 
The cells were harvested and resuspended in 10 mM tris with 1 M NaCl, pH 7.5. The lysate 
was sonicated and cell debris was removed by centrifuging at 7000xg for 1 hour. The clarified 
lysates were loaded onto chromatography columns containing Ni-NTA resin previously 
equilibrated with 10 mM tris with 1 M NaCl, pH 7.5. The column was washed with 20 mM 
immidizole and eluted with 500 mM immidizole. Fractions were run on NuPAGE 4-12% Bis-tris 
gels in MES running buffer and those containing protein greater than 95% pure were pooled 
together and briefly concentrated in 10 kDa MWCO filters. They were then dialyzed into 50 mM 
triethanolamine pH 7.6.  
6.3.5 sfGFP SpyTag T50TAG Incorporation of para-azidophenylalanine and 
Purification 
sfGFP SpyTag T50TAG and helper plasmid pULTRA were transformed into E. coli 
BL21(DE3) cells onto Luria Broth (LB) plates supplemented with 0.035 mg/ml kanamycin and 
0.1 mg/ml spectinomycin. Single colonies were inoculated at 37 ºC overnight in Luria Broth (LB) 
supplemented with 0.035 mg/ml kanamycin and 0.1 mg/ml spectinomycin. Expression was 
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performed the next day in the same media at 37 °C. When the cells reached on O.D. of 
approximately 0.60, induction was performed with 0.5 mM isopropyl β-D-1-thiogalactopyranoside 
(IPTG). Cultures containing T50TAG were supplemented with para-azidophenylalanine (20 mg 
of unnatural amino acid per 50 mL expression) during induction. A negative control was also done 
where sfGFP SpyTag T50TAG was not supplemented with para-azidophenylalanine but was 
induced with IPTG. The cells were shaken at 200 rpm overnight at 25 °C. 
The same method of lysis and purification previously described for sfGFP was used here. 
Protein fractions were run on NuPAGE 4-12% Bis-tris gels in MES running buffer. The clarified 
lysate of the negative control (sfGFP SpyTag without UAA) was also run on SDS-PAGE to ensure 
no wild-type protein was expressed through read-through expression. Fractions containing 
unnatural amino acid labeled protein greater than 95% pure were pooled together and briefly 
concentrated in 10 kDa MWCO filters. They were then dialyzed into 50 mM triethanolamine pH 
7.6. 
6.3.6 Cloning of HK2 D19TAG and HK2 SnoopCatcher 
Two versions of HK2 were made – one with an amber stop codon for unnatural amino acid 
incorporation and the second with SnoopCatcher for conjugation to SnoopTag. HK2 containing 
unnatural amino acid can be used to click onto sfGFP SpyTag T50TAG resulting in HK2 and 
G6PD on opposite sides of the barrel. HK2 SnoopCatcher can be complexed with SnoopTag sfGFP 
SpyTag allowing HK2 and G6PD to attach through orthogonal tags on the top of the sfGFP barrel. 
The DNA sequence corresponding to human hexokinase II (HK2) in pET-28a(+) was 
purchased from Addgene (#25529) and verified by DNA sequencing. To enable unnatural amino 
acid incorporation, D19 in HK2 was mutated to amber stop codon TAG (see supporting 
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information for primers), resulting in HK2 D19TAG. This can be clicked onto sfGFP SpyTag 
T50TAG resulting in HK2 and G6PD on opposite sides of the sfGFP barrel. 
HK2 SnoopCatcher was made by restriction digesting HK2 pET28a with Hind III and 
ligating with amplified SnoopCatcher. Site-directed mutagenesis was then performed on the 
resulting construct to remove stop codons between HK2 and SnoopCatcher resulting in HK2 
SnoopCatcher (see Supporting Information for primers). This can be covalently complexed with 
SnoopTag sfGFP SpyTag resulting in HK2 and G6PD on top of the sfGFP barrel. 
HK2 D19TAG and HK2 SnoopCatcher were verified by DNA sequencing (see Supporting 
Information). 
6.3.7 Expression and Purification of HK2 and HK2 SnoopCatcher 
HK2 and HK2 SnoopCatcher were transformed into E. coli BL21(DE3) cells onto Luria Broth 
(LB) plates supplemented with 0.035 mg/ml kanamycin. Single colonies were inoculated at 37 ºC 
overnight in Luria Broth (LB) supplemented with 0.035 mg/ml kanamycin. Expression was 
performed the next day in the same media at 37 °C. When the cells reached on O.D. of 
approximately 0.60, induction was performed with 0.5 mM isopropyl β-D-1-thiogalactopyranoside 
(IPTG) and the cells were shaken at 200 rpm overnight at 18 °C.  
The cells were harvested and resuspended in 20 mM sodium phosphate buffer with 500 mM 
NaCl, pH 7.4. They were then sonicated and centrifuged for 1 hour at 7000xg to remove cell debris. 
The clarified lysate was loaded onto chromatography columns containing Ni-NTA resin previously 
equilibrated with 20 mM sodium phosphate buffer with 500 mM NaCl, pH 7.4. The flow-through 
was collected and the column was washed with varying immidizole concentrations (75-500 mM 
immidizole) in 20 mM tris-HCl with 200 mM NaCl pH 7.4. Fractions were run on NuPAGE 4-
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12% Bis-tris gels in MES running buffer and protein bands at the expected molecular weight of 
approximately 100 kDa were observed. Fractions containing protein greater than 95% pure were 
pooled together and concentrated in 50 kDa MWCO centrifugal filters. They were then buffer 
exchanged into 50 mM triethanolamine pH 7.6. 
6.3.8 HK2 D19TAG Unnatural Amino Acid Incorporation and Purification 
HK2 D19TAG and helper plasmid pULTRA were transformed into E. coli BL21(DE3) cells 
onto Luria Broth (LB) plates supplemented with 0.035 mg/ml kanamycin and 0.1 mg/ml 
spectinomycin. Single colonies were inoculated at 37 ºC overnight in Luria Broth (LB) 
supplemented with 0.035 mg/ml kanamycin and 0.1 mg/ml spectinomycin. Expression was 
performed the next day in the same media at 37 °C. When the cells reached on O.D. of 
approximately 0.60, induction was performed with 0.5 mM isopropyl β-D-1-thiogalactopyranoside 
(IPTG). Cultures containing D19TAG were supplemented with o-propargyl-tyrosine (20 mg of 
unnatural amino acid per 50 mL expression) during induction. A negative control was also done 
where HK2 D19TAG was not supplemented with o-propargyl-tyrosine but was induced with 
IPTG. The cells were shaken at 200 rpm overnight at 18 °C. 
The same method of lysis and purification previously described for HK2 was used here. The 
clarified lysate of the negative control (HK2 without UAA) was run on SDS-PAGE to ensure no 
wild-type protein was expressed through read-through expression. Fractions containing the 
unnatural amino acid were run on NuPAGE 4-12% Bis-tris gels in MES running buffer and those 
containing protein greater than 95% pure were pooled together and briefly concentrated in 50 kDa 
MWCO filters. They were then dialyzed into 50 mM triethanolamine pH 7.6. 
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6.3.9 Determining Protein Concentrations 
Concentrations of G6PD and HK2 as well as their modified variants were determined by 
reading the absorbances of the protein at 280 nm. The extinction coefficients of the monomers in 
M-1 cm-1 are as follows: G6PD 70290, SpyCatcher G6PD 81750, HK2 55360, and HK2 
SnoopCatcher 65790. Spectral scans to normalize sfGFP concentrations were done as previously 
described in chapter 5 (Figure 6.9).  
6.3.10  Kinetic Assays with HK2 and G6PD 
To test the activity of SpyCatcher G6PD, 100 mM D-glucose-6-phosphate, 10 mM magnesium 
chloride, and 1 mM NADP+ in 50 mM triethanolamine buffer (pH 7.6) were reacted in the presence 
of G6PD in a final volume of 250 µL. NADPH production was monitored at 340 nm. 
To confirm HK2 can produce D-glucose-6-phosphate and that SpyCatcher G6PD uses it, the 
two enzymes were mixed in solution without supplying D-glucose-6-phosphate. HK2 and 
SpyCatcher G6PD were reacted with 216 mM D-glucose, 0.74 mM ATP, 10 mM MgCl2, and 1 
mM NADP+ (final concentrations) in 50 mM triethanolamine buffer (pH 7.6). The final volume 
was 250 µL and the production of NADPH was monitored at 340 nm. 
6.3.11  SpyTag/SpyCatcher and SnoopTag/SnoopCatcher Reactions 
To test the ability of the SpyTag/SpyCatcher reaction, SpyCatcher G6PD was reacted with 
sfGFP SpyTag in 50 mM triethanolamine buffer (pH 7.6) in the presence of approximately 400 
mM NaCl. The reaction was kept rotating overnight in 4 ºC. SDS-PAGE was run the next day to 
check for the presence of a covalent bond between SpyTag and SpyCatcher. The reaction with 
sfGFP SpyTag (with unnatural amino acid) will allow SpyCatcher G6PD and HK2 (with unnatural 
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amino acid) to attach on opposite sides of the barrel. The attachment of HK2 via click chemistry 
will be addressed in the next section. 
To test the reaction between SnoopTag/SnoopCatcher, SnoopTag sfGFP SpyTag and HK2 
SnoopCatcher were mixed together in the presence of NaCl at 4 °C overnight. SDS-PAGE was 
run the next day to check for the presence of a covalent bond between SnoopTag and 
SnoopCatcher. The reaction with SnoopTag sfGFP SpyTag will allow SpyCatcher G6PD and HK2 
SnoopCatcher to attach on the top of the sfGFP barrel. 
Mixing SnoopTag sfGFP SpyTag with SpyCatcher G6PD and HK2 SnoopCatcher to test the 
formation of a 3-enzyme complex was tested by mixing all three components overnight in 4 °C in 
the presence of NaCl. This reaction has yet to be optimized. 
6.3.12 Click Chemistry Between sfGFP SpyTag T50TAG and HK2 D19TAG 
To confirm the incorporation of the unnatural amino acid para-azidophenylalanine, sfGFP 
SpyTag T50TAG was clicked to alkyne TAMRA while sfGFP SpyTag without the UAA was 
tested as a negative control. Steps 3.1 to 3.3 and 5.1 to 5.4 from protocol number MP33368 from 
ThermoFisher and steps 1.1 to 2.7 from protocol number MP33370 were followed. The samples 
were run on NuPAGE 4-12% Bis-tris gels in MES running buffer and were observed under UV 
light prior to staining. 
To confirm the incorporation of the unnatural amino acid o-propargyl-tyrosine in HK2 
D19TAG, click chemistry was tested with TAMRA azide. A literature protocol for click chemistry 
was used, specifically steps 1a-1e, however, the reaction was allowed to proceed overnight in 4 ºC 
[51]. The samples were run on NuPAGE 4-12% Bis-tris gels in MES running buffer and were 
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observed under UV light prior to staining. The same protocol was used to test the ability to click 
sfGFP SpyTag T50TAG with azide and HK2 D19TAG with alkyne [51]. 
6.4 Results and Discussion 
6.4.1 Cloning, Expression, and Purification of Proteins 
The DNA sequence corresponding to glucose-6-phosphate dehydrogenase (G6PD) was cloned 
into pET-28a(+) followed by the insertion of SpyCatcher at the N-terminus, resulting in 
SpyCatcher G6PD. SpyCatcher G6PD was expressed in E. coli BL21(DE3) cells and was purified 
on a nickel column. It runs at approximately 75 kDa, consistent with its theoretical molecular 
weight (Figure 6.8). 
sfGFP SpyTag and SnoopTag sfGFP SpyTag were cloned into pET-28a(+) and expressed in 
E. coli BL21(DE3) expression cells. The SnoopTag construct will be used to orthogonally attach
G6PD and HK2 on top of the sfGFP barrel. sfGFP SpyTag T50TAG was treated similarly but 
supplied with the unnatural amino acid para-azidophenylalanine. sfGFP with the SpyTag and 
unnatural amino acid will be used to attach G6PD and HK2 on opposite sides of the barrel. All 
proteins were purified on a nickel column and run at approximately 35 kDa, consistent with their 
theoretical molecular weight (Figure 6.9 and Figure 6.10). 
HK2 pET-28a(+) was purchased from Addgene and was used to clone in SnoopCatcher at the 
C-terminus. HK2 and HK2 SnoopCatcher were expressed in E. coli BL21(DE3) expression cells.
HK2 D19TAG was treated similarly but supplied with the unnatural amino acid o-propargyl-
tyrosine. All proteins were purified on a nickel column. HK2 with and without the amber stop 
codon was purified on the nickel column and runs at 100 kDa, consistent with its theoretical 
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molecular weight (Figure 6.11). HK2 SnoopCatcher runs at approximately 115 kDa, consistent 
with its theoretical molecular weight (Figure 6.12). 
6.4.2 Activity Assays with G6PD and HK2 
 To confirm G6PD and HK2 are active, activity assays were performed before setting up 
conjugation reactions. SpyCatcher G6PD activity was tested by reacting D-glucose-6-phosphate 
and NADP+ (in the presence of magnesium chloride) and monitoring NADPH production at 340 
nm. An increase in the slope was observed suggesting G6PD activity (Figure 6.2). Additionally, 
the rate doubled when the enzyme concentration doubled suggesting catalytic activity. 
Figure 6.2 SpyCatcher G6PD activity assay.  NADPH production was monitored at 340 nm 
upon reacting D-glucose-6-phosphate, MgCl2, and NADP+ in triethanolamine buffer (pH 7.6) 
with SpyCatcher G6PD. 
To test the ability of SpyCatcher G6PD to use the product (D-glucose-6-phosphate) supplied 
by HK2, activity assays with all required substrates for HK2 and G6PD (except for D-glucose-6-
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phosphate) were conducted (Figure 6.3). The ability of SpyCatcher G6PD to produce NADPH 
signifies that HK2 and SpyCatcher G6PD are active and that D-glucose-6-phopshate was produced 










Figure 6.3 HK2 and SpyCatcher G6PD activity assay.  HK2 with D-glucose and ATP was 
reacted with SpyCatcher G6PD with MgCl2 and NADP+ in triethanolamine buffer (pH 7.6) to 
monitor NADPH production. 
 
6.4.3 SpyTag/SpyCatcher and SnoopTag/SnoopCatcher Reactions 
Equimolar SpyCatcher G6PD was incubated with sfGFP SpyTag overnight in the presence of 
NaCl at 4 ºC. The formation of a higher molecular weight protein suggests the formation of a 







Figure 6.4 SDS-PAGE of sfGFP SpyTag - SpyCatcher G6PD complex.   Lane 1: molecular 
weight marker, lane 2: SpyCatcher G6PD, lane 3: sfGFP SpyTag, and lane 4: sfGFP SpyTag- 
SpyCatcher G6PD complex. SpyCatcher G6PD runs at around 75 kDa, sfGFP runs at around 35 
kDa, and the complex runs at around 110 kDa, consistent with the theoretical molecular weights. 
The same reaction was repeated with SnoopTag sfGFP SpyTag and SpyCatcher G6PD 
and a similar complex was observed.  
To test the ability of HK2 SnoopCatcher to attach onto SnoopTag sfGFP SpyTag, the two 
proteins were mixed together overnight in the presence of NaCl (Figure 6.5). Reactions were 
set-up prior to HK2 SnoopCatcher purification optimization (Figure 6.12). 
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Figure 6.5 SDS-PAGE of SnoopTag sfGFP SpyTag-HK2 SnoopCatcher complex. Lane 1: 
molecular weight marker, lane 2: SnoopTag sfGFP SpyTag, lane 3: HK2 SnoopCatcher fraction 
A, lane 4: HK2 SnoopCatcher fraction B, lane 5: SnoopTag sfGFP SpyTag – HK2 SnoopCatcher 
A complex, and lane 6: SnoopTag sfGFP SpyTag – HK2 SnoopCatcher B complex. SnoopTag 
sfGFP SpyTag runs at approximately 35 kDa, HK2 SnoopCatcher runs at around 110 kDa, and 
the complex runs at approximately 150 kDa, consistent with their theoretical molecular weights. 
Once again SnoopTag sfGFP SpyTag will be used to orthogonally attach SpyCatcher 
G6PD and HK2 SnoopCatcher on the top of the sfGFP barrel.  To test the ability to form a 3-
enzyme complex, all three proteins were mixed together in the presence of salt. A faint band at 
approximately 230 kDa corresponding the 3-enzyme complex was observed. However, the 
reaction has not been optimized and further work is required to separate unconjugated protein and 
impurities. Additionally, the formation of the complex cannot be confirmed until it is isolated and 
activity assays are performed. 
6.4.4 sfGFP SpyTag T50TAG and HK2 D19TAG Click Reactions 
To confirm unnatural amino acid incorporation in sfGFP SpyTag T50TAG and HK2 
D19TAG, both were clicked with TAMRA, a small fluorescent molecule. sfGFP SpyTag was 
incorporated with azide para-azidophenylalanine and clicked with TAMRA alkyne in the presence 
of copper. Prior to staining, the SDS-PAGE gel was placed under UV light and a band at the 
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expected molecular weight was observed (Figure 6.6). No change in the molecular weight of 
sfGFP was expected as TAMRA is less than 1 kDa. 
Figure 6.6 SDS-PAGE of sfGFP SpyTag T50TAG with para-azidophenylalanine clicked to 
TAMRA alkyne.  Lane 1: molecular weight marker, 2: click chemistry product of sfGFP SpyTag 
with para-azidophenylalanine and TAMRA alkyne. Product observed at 35 kDa, consistent with 
the theoretical molecular weight of sfGFP SpyTag. 
This suggests para-azidophenylalanine was successfully incorporated into sfGFP and the site is 
accessible. To test incorporation of alkyne o-propargyl-tyrosine in HK2, TAMRA azide was 
clicked on. Once again, a band at the expected molecular weight lit up, suggesting incorporation 
in HK2 was successful and the site is accessible (Figure 6.7). 
Figure 6.7 SDS-PAGE of HK2 D19TAG with o-propargyl-tyrosine clicked to TAMRA azide.  
Lane 1: molecular weight marker, 2: click chemistry product of HK2 D19TAG with o-propargyl-
tyrosine and TAMRA azide. Product observed at 100 kDa, consistent with the theoretical 
molecular weight. 
1  2 
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Attempts to click sfGFP SpyTag T50TAG with para-azidophenylalanine and HK2 D19TAG 
with o-propargyl-tyrosine were unsuccessful. As a result, future work involves clicking sfGFP 
SpyTag T50TAG para-azidophenylalanine with synthesized SnoopTag-alkyne. This will then be 
reacted with SpyCatcher G6PD (reacts with SpyTag) and HK2 SnoopCatcher (reacts with 
SnoopTag). The final construct will have SpyCatcher G6PD and SnoopCatcher HK2 on opposite 
sides of the sfGFP barrel. The kinetics of this system will be compared to SnoopTag sfGFP SpyTag 
with SpyCatcher G6PD and HK2 SnoopCatcher on top of the barrel.  
 
6.5  Conclusion/Future Work 
 
The development of a three-enzyme complex should enable substrate channeling between 
HK2 and G6PD. Since the intermediate, D-glucose-6-phosphate, is negatively charged, 
electrostatic guidance should be possible along the surface of supercharged sfGFP scaffolds. Three 
different variants will be tested including -30, 0, and +36. Substrate channeling is expected with 
+36, repulsion is expected with -30, and 0 is expected to fall somewhere in between. 
Two different set-ups of the complexes will be studied. In the first, HK2 and G6PD will be 
on top of the sfGFP barrel and will attach through orthogonal tagged systems, SpyTag/SpyCatcher 
and SnoopTag/SnoopCatcher. SDS-PAGE gels suggest the complex has been formed, but the 
yields are extremely low, and the unconjugated proteins are present in solution. As a result, the 
reaction needs to be optimized. Furthermore, isolating the three-enzyme complex will be required 
in order to test the efficiency of substrate channeling. In the second set-up, HK2 and G6PD will 
be on opposite sides of the sfGFP barrel and will attach through both the tagged systems as well 
as through click chemistry. Although incorporation of azides and alkynes has been successful in 
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sfGFP and HK2, the click reaction between the two has been unsuccessful. Therefore, future work 
includes clicking synthesized SnoopTag-alkyne onto sfGFP SpyTag T50TAG. This will allow 
HK2 to attach via SnoopCatcher. This method is being tested as we believe the click reaction might 
be unsuccessful due to the steric hindrance provided by the bulky sfGFP and HK2 proteins making 
the click sites between them inaccessible. Once this set-up is accomplished, HK2 and G6PD will 
be on opposite sides of the sfGFP barrel and the intermediate should be guided along the surface 
of sfGFP. Here HK2 and G6PD are not adjacent to one another, which is unlike the first set-up 
where there is a possibility that HK2 and G6PD are close enough to make sfGFP unnecessary. 
Kinetics will be tested by saturating one of the substrates in both HK2 and G6PD to study 
Michalis-Menton type kinetics. The reaction with HK2 will proceed by saturating ATP and the 
reaction with G6PD will be performed by saturating NADP+. This will allow the intermediate to 
be studied. Of course, the reactions will be performed with the different sfGFP variants as well as 
with the proteins mixed in solution and complexed together. 
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6.6  Supporting Information 
 
Primers to clone G6PD into pET-28a(+) at NheI 
FWD: GCGGCAGCCATATGGCTATGGCAGAGCAGGTGGCCCTGAGC 
REV: CACCAGTCATGCTAGTCAGAGCTTGTGGGGGTTCACCCACTTGTAGGT  




SpyCatcher G6PD pET-28a(+) DNA Sequence 
ATGGGCAGCA GCCATCATCA TCATCATCAC AGCAGCGGCC TGGTGCCGCG CGGCAGCCAT 60 
GGCGCCATGG TTGATACCTT ATCAGGTTTA TCAAGTGAGC AAGGTCAGTC CGGTGATATG 120 
ACAATTGAAG AAGATAGTGC TACCCATATT AAATTCTCAA AACGTGATGA GGACGGCAAA 180 
GAGTTAGCTG GTGCAACTAT GGAGTTGCGT GATTCATCTG GTAAAACTAT TAGTACATGG 240 
ATTTCAGATG GACAAGTGAA AGATTTCTAC CTGTATCCAG GAAAATATAC ATTTGTCGAA 300 
ACCGCAGCAC CAGACGGTTA TGAGGTAGCA ACTGCTATTA CCTTTACAGT TAATGAGCAA 360 
GGTCAGGTTA CTGTAAATGG CAAAGCAACT AAAGGTGACG CTCATATTGG TATGGCTATG 420 
GCAGAGCAGG TGGCCCTGAG CCGGACCCAG GTGTGCGGGA TCCTGCGGGA AGAGCTTTTC 480 
CAGGGCGATG CCTTCCATCA GTCGGATACA CACATATTCA TCATCATGGG TGCATCGGGT 540 
GACCTGGCCA AGAAGAAGAT CTACCCCACC ATCTGGTGGC TGTTCCGGGA TGGCCTTCTG 600 
CCCGAAAACA CCTTCATCGT GGGCTATGCC CGTTCCCGCC TCACAGTGGC TGACATCCGC 660 
AAACAGAGTG AGCCCTTCTT CAAGGCCACC CCAGAGGAGA AGCTCAAGCT GGAGGACTTC 720 
TTTGCCCGCA ACTCCTATGT GGCTGGCCAG TACGATGATG CAGCCTCCTA CCAGCGCCTC 780 
AACAGCCACA TGAATGCCCT CCACCTGGGG TCACAGGCCA ACCGCCTCTT CTACCTGGCC 840 
TTGCCCCCGA CCGTCTACGA GGCCGTCACC AAGAACATTC ACGAGTCCTG CATGAGCCAG 900 
ATAGGCTGGA ACCGCATCAT CGTGGAGAAG CCCTTCGGGA GGGACCTGCA GAGCTCTGAC 960 
CGGCTGTCCA ACCACATCTC CTCCCTGTTC CGTGAGGACC AGATCTACCG CATCGACCAC 1020 
TACCTGGGCA AGGAGATGGT GCAGAACCTC ATGGTGCTGA GATTTGCCAA CAGGATCTTC 1080 
GGCCCCATCT GGAACCGGGA CAACATCGCC TGCGTTATCC TCACCTTCAA GGAGCCCTTT 1140 
GGCACTGAGG GTCGCGGGGG CTATTTCGAT GAATTTGGGA TCATCCGGGA CGTGATGCAG 1200 
AACCACCTAC TGCAGATGCT GTGTCTGGTG GCCATGGAGA AGCCCGCCTC CACCAACTCA 1260 
GATGACGTCC GTGATGAGAA GGTCAAGGTG TTGAAATGCA TCTCAGAGGT GCAGGCCAAC 1320 
AATGTGGTCC TGGGCCAGTA CGTGGGGAAC CCCGATGGAG AGGGCGAGGC CACCAAAGGG 1380 
TACCTGGACG ACCCCACGGT GCCCCGCGGG TCCACCACCG CCACTTTTGC AGCCGTCGTC 1440 
CTCTATGTGG AGAATGAGAG GTGGGATGGG GTGCCCTTCA TCCTGCGCTG CGGCAAGGCC 1500 
CTGAACGAGC GCAAGGCCGA GGTGAGGCTG CAGTTCCATG ATGTGGCCGG CGACATCTTC 1560 
CACCAGCAGT GCAAGCGCAA CGAGCTGGTG ATCCGCGTGC AGCCCAACGA GGCCGTGTAC 1620 
ACCAAGATGA TGACCAAGAA GCCGGGCATG TTCTTCAACC CCGAGGAGTC GGAGCTGGAC 1680 
CTGACCTACG GCAACAGATA CAAGAACGTG AAGCTCCCTG ACGCCTATGA GCGCCTCATC 1740 
CTGGACGTCT TCTGCGGGAG CCAGATGCAC TTCGTGCGCA GCGACGAGCT CCGTGAGGCC 1800 
TGGCGTATTT TCACCCCACT GCTGCACCAG ATTGAGCTGG AGAAGCCCAA GCCCATCCCC 1860 
TATATTTATG GCAGCCGAGG CCCCACGGAG GCAGACGAGC TGATGAAGAG AGTGGGTTTC 1920 
CAGTATGAGG GCACCTACAA GTGGGTGAAC CCCCACAAGC TCTGA 1965 
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SpyCatcher G6PD Protein Sequence (SpyCatcher highlighted in blue) 
MGSSHHHHHH SSGLVPRGSH GAMVDTLSGL SSEQGQSGDM TIEEDSATHI KFSKRDEDGK 60 
ELAGATMELR DSSGKTISTW ISDGQVKDFY LYPGKYTFVE TAAPDGYEVA TAITFTVNEQ 120 
GQVTVNGKAT KGDAHIGMAM AEQVALSRTQ VCGILREELF QGDAFHQSDT HIFIIMGASG 180 
DLAKKKIYPT IWWLFRDGLL PENTFIVGYA RSRLTVADIR KQSEPFFKAT PEEKLKLEDF 240 
FARNSYVAGQ YDDAASYQRL NSHMNALHLG SQANRLFYLA LPPTVYEAVT KNIHESCMSQ 300 
IGWNRIIVEK PFGRDLQSSD RLSNHISSLF REDQIYRIDH YLGKEMVQNL MVLRFANRIF 360 
GPIWNRDNIA CVILTFKEPF GTEGRGGYFD EFGIIRDVMQ NHLLQMLCLV AMEKPASTNS 420 
DDVRDEKVKV LKCISEVQAN NVVLGQYVGN PDGEGEATKG YLDDPTVPRG STTATFAAVV 480 
LYVENERWDG VPFILRCGKA LNERKAEVRL QFHDVAGDIF HQQCKRNELV IRVQPNEAVY 540 
TKMMTKKPGM FFNPEESELD LTYGNRYKNV KLPDAYERLI LDVFCGSQMH FVRSDELREA 600 
WRIFTPLLHQ IELEKPKPIP YIYGSRGPTE ADELMKRVGF QYEGTYKWVN PHKL 654 
Ultramers to clone sfGFP with SpyTag at C-terminus into pET-28a(+) 
-30 sfGFP SpyTag










































ATGGGCAGCA GCCATCATCA TCATCATCAC AGCAGCGGCC TGGTGCCGCG CGGCAGCCAT 60 
ATGGCTAGCA TGACTGGTGG ACAGCAAATG GGTCGCGGAT CCGAATTCGA GCTCCGTCGA 120 
CAAATGGGTG GCGCTAGCAA AGGTGAAGAG CTGTTTGACG GTGTAGTACC GATCTTAGTG 180 
GAATTAGACG GCGACGTGAA CGGTCACGAA TTTAGCGTGC GCGGCGAGGG CGAAGGTGAC 240 
GCTACCGAGG GTGAATTGAC CCTGAAGTTT ATTTGCACAA CAGGCGAATT ACCCGTTCCG 300 
TGGCCCACCT TAGTGACCAC CCTGACCTAT GGCGTTCAGT GCTTCAGTGA TTACCCAGAT 360 
CATATGGATC AACACGATTT TTTCAAATCA GCCATGCCTG AAGGATATGT TCAAGAGCGT 420 
ACAATCAGCT TCAAGGACGA TGGCACCTAT AAAACGCGTG CGGAAGTGAA ATTTGAAGGC 480 
GACACATTAG TAAACCGTAT CGAACTGAAA GGTATCGACT TCAAAGAAGA CGGCAACATT 540 
TTAGGCCATA AGCTGGAATA TAACTTTAAT TCTCATGACG TGTATATTAC GGCCGATAAA 600 
CAGGAAAACG GTATCAAGGC AGAATTTGAA ATTCGCCATA ACGTGGAGGA CGGCAGCGTT 660 
CAATTAGCGG ATCATTATCA ACAAAACACG CCGATTGGTG ATGGGCCTGT ACTGTTACCT 720 
GACGATCACT ACCTGAGCAC GGAGTCAGCC CTGAGCAAAG ATCCGAACGA AGACCGCGAT 780 
CACATGGTTC TGTTAGAATT CGTGACCGCT GCAGGCATTG ATCATGGAAT GGACGAGCTG 840 
TACAAGGCCC ACATCGTGAT GGTGGACGCC TACAAGCCGA CGAAGTAA 888 
0 sfGFP SpyTag 
ATGGGCAGCA GCCATCATCA TCATCATCAC AGCAGCGGCC TGGTGCCGCG CGGCAGCCAT 60 
ATGGCTAGCA TGACTGGTGG ACAGCAAATG GGTCGCGGAT CCGAATTCGA GCTCCGTCGA 120 
CAAATGGGTG GCGCTAGCAA AGGTGAACGT CTGTTTACTG GTGTAGTACC GATCTTAGTG 180 
GAATTAGACG GCGACGTGAA CGGTCATAAA TTTAGCGTGC GCGGCGAGGG CGAAGGTGAC 240 
GCTACCAATG GTAAATTGAC CCTGAAGTTT ATTTGCACAA CAGGCAAATT ACCCGTTCCG 300 
TGGCCCACCT TAGTGACCAC CCTGACCTAT GGCGTTCAGT GCTTCAGTCG TTACCCTGAT 360 
CATATGAAAC AACACGATTT TTTCAAATCA GCCATGCCTG AAGGATATGT TCAAGAGCGT 420 
ACAATCAGCT TCAAGGACGA TGGCACCTAT AAAACGCGTG CGGAAGTGAA ATTTGAAGGC 480 
GACACATTAG TAAATCGTAT CGAACTGAAA GGTCGTGACT TCAAAGAAGA CGGCAACATT 540 
TTAGGCCATA AACTGGAATA TAACTTTAAT TCTCATAACG TGTATATTAC GGCCGATAAA 600 
CAGAAGAATG GTATCAAGGC AAATTTCAAA ATTCGCCATA ACGTGGAGGA CGGCAGCGTT 660 
CAATTAGCGG ATCATTATCA ACAAAACACG CCGATTGGTG ATGGGCCTGT ACTGTTACCT 720 
CGCAACCACT ACCTGAGCAC CCAATCTGCC CTGAGCAAAG ATCCGAAAGA AAAACGCGAT 780 
CACATGGTTC TGTTAGAATT CGTGACCGCT GCAGGCATTA CGCACGGAAT GGACGAACGC 840 
TACAAGGCCC ACATCGTGAT GGTGGACGCC TACAAGCCGA CGAAGTAA 888 
+36 sfGFP SpyTag
ATGGGCAGCA GCCATCATCA TCATCATCAC AGCAGCGGCC TGGTGCCGCG CGGCAGCCAT 60 
ATGGCTAGCA TGACTGGTGG ACAGCAAATG GGTCGCGGAT CCGAATTCGA GCTCCGTCGA 120 
CAAATGGGTG GCGCTAGCAA AGGTGAACGT CTGTTTCGTG GTAAAGTACC GATCTTAGTG 180 
GAATTAAAGG GCGACGTGAA CGGTCATAAA TTTAGCGTGC GCGGCAAAGG CAAAGGTGAC 240 
GCTACCCGTG GTAAATTGAC CCTGAAGTTT ATTTGCACAA CAGGCAAATT ACCCGTTCCG 300 
TGGCCCACCT TAGTGACCAC CCTGACCTAT GGCGTTCAGT GCTTCAGTCG TTACCCTAAA 360 
CATATGAAAC GTCACGATTT TTTCAAATCA GCCATGCCTA AAGGATATGT TCAAGAGCGT 420 
ACAATCAGCT TCAAGAAGGA TGGCAAATAT AAAACGCGTG CGGAAGTGAA ATTTGAAGGC 480 
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CGCACATTAG TAAATCGTAT CAAACTGAAA GGTCGTGACT TCAAAGAAAA AGGCAACATT 540 
TTAGGCCATA AACTGCGTTA TAACTTTAAT TCTCATAAGG TGTATATTAC GGCCGATAAA 600 
CGCAAGAATG GTATCAAGGC AAAATTCAAA ATTCGCCATA ACGTGAAAGA CGGCAGCGTT 660 
CAATTAGCGG ATCATTATCA ACAAAACACG CCGATTGGTC GCGGGCCTGT ACTGTTACCT 720 
CGCAACCACT ACCTGAGCAC CCGTTCTAAA CTGAGCAAAG ATCCGAAAGA AAAACGCGAT 780 
CACATGGTTC TGTTAGAATT CGTGACCGCT GCAGGCATTA AGCACGGACG CGACGAACGC 840 
TACAAGGCCC ACATCGTGAT GGTGGACGCC TACAAGCCGA CGAAGTAA 888 
 
Amino Acid Sequences 
-30 sfGFP SpyTag: 
 
MGSSHHHHHH SSGLVPRGSH MASMTGGQQM GRGSEFELRR QMGGASKGEE LFDGVVPILV 60 
ELDGDVNGHE FSVRGEGEGD ATEGELTLKF ICTTGELPVP WPTLVTTLTY GVQCFSDYPD 120 
HMDQHDFFKS AMPEGYVQER TISFKDDGTY KTRAEVKFEG DTLVNRIELK GIDFKEDGNI 180 
LGHKLEYNFN SHDVYITADK QENGIKAEFE IRHNVEDGSV QLADHYQQNT PIGDGPVLLP 240 
DDHYLSTESA LSKDPNEDRD HMVLLEFVTA AGIDHGMDEL YKAHIVMVDA YKPTK 295 
 
0 sfGFP SpyTag: 
 
MGSSHHHHHH SSGLVPRGSH MASMTGGQQM GRGSEFELRR QMGGASKGER LFTGVVPILV 60 
ELDGDVNGHK FSVRGEGEGD ATNGKLTLKF ICTTGKLPVP WPTLVTTLTY GVQCFSRYPD 120 
HMKQHDFFKS AMPEGYVQER TISFKDDGTY KTRAEVKFEG DTLVNRIELK GRDFKEDGNI 180 
LGHKLEYNFN SHNVYITADK QKNGIKANFK IRHNVEDGSV QLADHYQQNT PIGDGPVLLP 240 
RNHYLSTQSA LSKDPKEKRD HMVLLEFVTA AGITHGMDER YKAHIVMVDA YKPTK 295 
+36 sfGFP SpyTag: 
 
MGSSHHHHHH SSGLVPRGSH MASMTGGQQM GRGSEFELRR QMGGASKGER LFRGKVPILV 60 
ELKGDVNGHK FSVRGKGKGD ATRGKLTLKF ICTTGKLPVP WPTLVTTLTY GVQCFSRYPK 120 
HMKRHDFFKS AMPKGYVQER TISFKKDGKY KTRAEVKFEG RTLVNRIKLK GRDFKEKGNI 180 
LGHKLRYNFN SHKVYITADK RKNGIKAKFK IRHNVKDGSV QLADHYQQNT PIGRGPVLLP 240 
RNHYLSTRSK LSKDPKEKRD HMVLLEFVTA AGIKHGRDER YKAHIVMVDA YKPTK 295 
(**Amino acid mutated to stop codon highlighted in red – to remove SpyTag) 
(**Amino acid mutated to amber stop codon for unnatural amino acid incorporation highlighted in blue) 
 
Ultramers to clone SnoopTag at the N-terminus of sfGFP-SpyTag pET-28a(+) 













SnoopTag +36 sfGFP SpyTag DNA Sequence 
ATGGGCAGCA GCCATCATCA TCATCATCAC AGCAGCGGCC TGGTGCCGCG CGGCAGCCAT 60 
ATGGCTAGCA TGACTGGTGG ACAGCAAATG GGTCGCGGAT CCGAATTCGA GCTCCGTCGA 120 
CAAATGGGAA AACTGGGCGA TATTGAATTT ATTAAAGTGA ACAAAGGTAG TGGTGAAAGT 180 
GGTATGGGTG GCGCTAGCAA AGGTGAACGT CTGTTTCGTG GTAAAGTACC GATCTTAGTG 240 
GAATTAAAGG GCGACGTGAA CGGTCATAAA TTTAGCGTGC GCGGCAAAGG CAAAGGTGAC 300 
GCTACCCGTG GTAAATTGAC CCTGAAGTTT ATTTGCACAA CAGGCAAATT ACCCGTTCCG 360 
TGGCCCACCT TAGTGACCAC CCTGACCTAT GGCGTTCAGT GCTTCAGTCG TTACCCTAAA 420 
CATATGAAAC GTCACGATTT TTTCAAATCA GCCATGCCTA AAGGATATGT TCAAGAGCGT 480 
ACAATCAGCT TCAAGAAGGA TGGCAAATAT AAAACGCGTG CGGAAGTGAA ATTTGAAGGC 540 
CGCACATTAG TAAATCGTAT CAAACTGAAA GGTCGTGACT TCAAAGAAAA AGGCAACATT 600 
TTAGGCCATA AACTGCGTTA TAACTTTAAT TCTCATAAGG TGTATATTAC GGCCGATAAA 660 
CGCAAGAATG GTATCAAGGC AAAATTCAAA ATTCGCCATA ACGTGAAAGA CGGCAGCGTT 720 
CAATTAGCGG ATCATTATCA ACAAAACACG CCGATTGGTC GCGGGCCTGT ACTGTTACCT 780 
CGCAACCACT ACCTGAGCAC CCGTTCTAAA CTGAGCAAAG ATCCGAAAGA AAAACGCGAT 840 
CACATGGTTC TGTTAGAATT CGTGACCGCT GCAGGCATTA AGCACGGACG CGACGAACGC 900 
TACAAGGCCC ACATCGTGAT GGTGGACGCC TACAAGCCGA CGAAGTAA 948 
SnoopTag +36 sfGFP SpyTag Protein Sequence (SnoopTag / sfGFP / SpyTag) 
MGSSHHHHHH SSGLVPRGSH MASMTGGQQM GRGSEFELRR QMGKLGDIEF IKVNKGSGES 60 
GMGGASKGER LFRGKVPILV ELKGDVNGHK FSVRGKGKGD ATRGKLTLKF ICTTGKLPVP 120 
WPTLVTTLTY GVQCFSRYPK HMKRHDFFKS AMPKGYVQER TISFKKDGKY KTRAEVKFEG 180 
RTLVNRIKLK GRDFKEKGNI LGHKLRYNFN SHKVYITADK RKNGIKAKFK IRHNVKDGSV 240 
QLADHYQQNT PIGRGPVLLP RNHYLSTRSK LSKDPKEKRD HMVLLEFVTA AGIKHGRDER 300 
YKAHIVMVDA YKPTK 315




Primers to Clone SnoopCatcher at C-terminus of HK2 pET-28a(+) at Hind III 
FWD: GGACAGTGATGACGAATGAAGCCGCTGCGTGGTGC 
REV: GTGCGGCCGCAAGCTTCATTTCGGCGGTATCGGTTCATTGGTGATATAATGT 
Primers to remove stop codon between HK2 and SnoopCatcher 
FWD: CCGCATCCGTGAGGCTGGACAGTCATCACGAATGAAGCCGCTGCGTGGTG 
REV: CACCACGCAGCGGCTTCATTCGTGATGACTGTCCAGCCTCACGGATGCGG 
HK2-pET28a(+) SnoopCatcher DNA sequence 
atgggcagca gccatcatca tcatcatcac agcagcggcc tggttccgcg tggtagtgac 60 
caagtgcaga aggttgacca gtatctctac cacatgcgcc tctctgatga gaccctcttg 120 
gagatctcta agcggttccg caaggagatg gagaaagggc ttggagccac cactcaccct 180 
actgcagcag tgaagatgct gcccaccttt gtgaggtcca ctccagatgg gacagaacac 240 
ggagagttcc tggctctgga tcttggaggg accaacttcc gtgtgctttg ggtgaaagta 300 
acggacaatg ggctccagaa ggtggagatg gagaatcaga tctatgccat ccctgaggac 360 
atcatgcgag gcagtggcac ccagctgttt gaccacattg ccgaatgcct ggctaacttc 420 
atggataagc tacaaatcaa agacaagaag ctcccactgg gttttacctt ctcgttcccc 480 
tgccaccaga ctaaactaga cgagagtttc ctggtctcat ggaccaaggg attcaagtcc 540 
agtggagtgg aaggcagaga cgttgtggct ctgatccgga aggccatcca gaggagaggg 600 
gactttgata tcgacattgt ggctgtggtg aatgacacag ttgggaccat gatgacctgt 660 
ggttatgatg accacaactg tgagattggt ctcattgtgg gcacgggcag caacgcctgc 720 
tacatggaag agatgcgcca catcgacatg gtggaaggcg atgaggggcg gatgtgtatc 780 
aatatggagt ggggggcctt cggggacgat ggctcgctca acgacattcg cactgagttt 840 
gaccaggaga ttgacatggg ctcactgaac ccgggaaagc aactgtttga gaagatgatc 900 
agtgggatgt acatggggga gctggtgagg cttatcctgg tgaagatggc caaggaggag 960 
ctgctctttg gggggaagct cagcccagag cttctcaaca ccggtcgctt tgagaccaaa 1020 
gacatctcag acattgaagg ggagaaggat ggcatccgga aggcccgtga ggtcctgatg 1080 
cggttgggcc tggacccgac tcaggaggac tgcgtggcca ctcaccggat ctgccagatc 1140 
gtgtccacac gctccgccag cctgtgcgca gccaccctgg ccgccgtgct gcagcgcatc 1200 
aaggagaaca aaggcgagga gcggctgcgc tctactattg gggtcgacgg ttccgtctac 1260 
aagaaacacc cccattttgc caagcgtcta cataagaccg tgcggcggct ggtgcccggc 1320 
tgcgatgtcc gcttcctccg ctccgaggat ggcagtggca aaggtgcagc catggtgaca 1380 
gcagtggctt accggctggc cgatcaacac cgtgcccgcc agaagacatt agagcatctg 1440 
cagctgagcc atgaccagct gctggaggtc aagaggagga tgaaggtaga aatggagcga 1500 
ggtctgagca aggagactca tgccagtgcc cccgtcaaga tgctgcccac ctacgtgtgt 1560 
gctaccccgg acggcacaga gaaaggggac ttcttggcct tggaccttgg aggaacaaat 1620 
ttccgggtcc tgctggtccg tgttcggaat gggaagtggg gtggagtgga gatgcacaac 1680 
aagatctacg ccatcccgca ggaggtcatg cacggcaccg gggacgagct ctttgaccac 1740 
attgtccagt gcatcgcgga cttcctcgag tacatgggca tgaagggcgt gtccctgcct 1800 
ctgggtttta ccttctcctt cccctgccag cagaacagcc tggacgagag catcctcctc 1860 
aagtggacaa aaggcttcaa ggcatctggc tgcgagggcg aggacgtggt gaccctgctg 1920 
aaggaagcga tccaccggcg agaggagttt gacctggatg tggttgctgt ggtgaacgac 1980 
acagtcggaa ctatgatgac ctgtggcttt gaagaccctc actgtgaagt tggcctcatt 2040 
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gttggcacgg gcagcaatgc ctgctacatg gaggagatgc gcaacgtgga actggtggaa 2100 
ggagaagagg ggcggatgtg tgtgaacatg gaatgggggg ccttcgggga caatggatgc 2160 
ctagatgact tccgcacaga atttgatgtg gctgtggatg agctttcact caaccccggc 2220 
aagcagaggt tcgagaaaat gatcagtgga atgtacctgg gtgagattgt ccgtaacatt 2280 
ctcatcgatt tcaccaagcg tggactactc ttccgaggcc gcatctcaga gcggctcaag 2340 
acaaggggca tctttgaaac caagttcttg tctcagattg agagtgactg cctggccctg 2400 
ctgcaagtcc gagccatcct gcaacactta gggcttgaga gcacctgtga cgacagcatc 2460 
attgttaagg aggtgtgcac tgtggtggcc cggcgggcag cccagctctg tggcgcaggc 2520 
atggccgctg tggtggacag gatacgagaa aaccgtgggc tggacgctct caaagtgaca 2580 
gtgggtgtgg atgggaccct ctacaagcta catcctcact ttgccaaagt catgcatgag 2640 
acagtgaagg acctggctcc gaaatgtgat gtgtctttcc tgcagtcaga ggatggcagc 2700 
gggaaggggg cggcgctcat cactgctgtg gcctgccgca tccgtgaggc tggacagtca 2760 
tcacgaatga agccgctgcg tggtgccgtg tttagcctgc agaaacagca tcccgactat 2820 
cccgatatct atggcgcgat tgatcagaat gggacctatc aaaatgtgcg taccggcgaa 2880 
gatggtaaac tgacctttaa gaatctgagc gatggcaaat atcgcctgtt tgaaaatagc 2940 
gaacccgctg gctataaacc ggtgcagaat aagccgattg tggcgtttca gattgtgaat 3000 
ggcgaagtgc gtgatgtgac cagcattgtg ccgcaggata ttccggctac atatgaattt 3060 
accaacggta aacattatat caccaatgaa ccgataccgc cgaaa 3105 
HK2-pET28a(+) SnoopCatcher Protein Sequence (SnoopCatcher highlighted in red) 
MGSSHHHHHH SSGLVPRGSD QVQKVDQYLY HMRLSDETLL EISKRFRKEM EKGLGATTHP 60 
TAAVKMLPTF VRSTPDGTEH GEFLALDLGG TNFRVLWVKV TDNGLQKVEM ENQIYAIPED 120 
IMRGSGTQLF DHIAECLANF MDKLQIKDKK LPLGFTFSFP CHQTKLDESF LVSWTKGFKS 180 
SGVEGRDVVA LIRKAIQRRG DFDIDIVAVV NDTVGTMMTC GYDDHNCEIG LIVGTGSNAC 240 
YMEEMRHIDM VEGDEGRMCI NMEWGAFGDD GSLNDIRTEF DQEIDMGSLN PGKQLFEKMI 300 
SGMYMGELVR LILVKMAKEE LLFGGKLSPE LLNTGRFETK DISDIEGEKD GIRKAREVLM 360 
RLGLDPTQED CVATHRICQI VSTRSASLCA ATLAAVLQRI KENKGEERLR STIGVDGSVY 420 
KKHPHFAKRL HKTVRRLVPG CDVRFLRSED GSGKGAAMVT AVAYRLADQH RARQKTLEHL 480 
QLSHDQLLEV KRRMKVEMER GLSKETHASA PVKMLPTYVC ATPDGTEKGD FLALDLGGTN 540 
FRVLLVRVRN GKWGGVEMHN KIYAIPQEVM HGTGDELFDH IVQCIADFLE YMGMKGVSLP 600 
LGFTFSFPCQ QNSLDESILL KWTKGFKASG CEGEDVVTLL KEAIHRREEF DLDVVAVVND 660 
TVGTMMTCGF EDPHCEVGLI VGTGSNACYM EEMRNVELVE GEEGRMCVNM EWGAFGDNGC 720 
LDDFRTEFDV AVDELSLNPG KQRFEKMISG MYLGEIVRNI LIDFTKRGLL FRGRISERLK 780 
TRGIFETKFL SQIESDCLAL LQVRAILQHL GLESTCDDSI IVKEVCTVVA RRAAQLCGAG 840 
MAAVVDRIRE NRGLDALKVT VGVDGTLYKL HPHFAKVMHE TVKDLAPKCD VSFLQSEDGS 900 
GKGAALITAV ACRIREAGQS SRMKPLRGAV FSLQKQHPDY PDIYGAIDQN GTYQNVRTGE 960 
DGKLTFKNLS DGKYRLFENS EPAGYKPVQN KPIVAFQIVN GEVRDVTSIV PQDIPATYEF 1020 
TNGKHYITNE PIPPK 1035 
** Amino acid mutated to amber stop codon to test unnatural amino acid incorporation 
highlighted in blue. Stop codon for HK2 D19TAG gene in pET-28a(+) would be where the 




Figure 6.8 SDS-PAGE of SpyCatcher G6PD nickel column purification.  A band at around 75 




Figure 6.9 SDS-PAGE of sfGFP after normalizing at 485 nm.  Lane 1: molecular weight marker, 
lane 2: -30 sfGFP, lane 3: 0 sfGFP, and lane 4: +36 sfGFP. A band at approximately 33 kDa is 
observed, consistent with the theoretical molecular masses.  
 
 
Figure 6.10 SDS-PAGE of SnoopTag sfGFP SpyTag purification on nickel column.  Protein 
ladder followed by elution with varying immidizole concentrations. SnoopTag sfGFP SpyTag 
runs at approximately 36 kDa, consistent with its theoretical molecular weight. 
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Figure 6.11 SDS-PAGE of HK2 and HK2 D19TAG.  Protein runs at approximately 100 kDa, 
consistent with its theoretical molecular weight (band followed by molecular weight marker). 
Figure 6.12 SDS-PAGE of HK2 SnoopCatcher.  Lane 1: molecular weight marker, lane 2-8: 
HK2 SnoopCatcher with varying immidizole concentrations. Protein runs at approximately 115 


























In this thesis work, we extensively engineered thermostable alcohol dehydrogenase D, 
AdhD, from deep thermal sea vent archaea Pyrococcus furiosus. AdhD, our model enzyme, was 
used to develop engineering approaches to control activity and selectivity of enzymes for multi-
step catalysis (chapters 2-6). AdhD was chosen as it is well studied in our lab, is monomeric, 
thermostable, and easy to engineer, all of which makes it a potentially relevant industrial catalyst. 
Through our various engineering approaches, we have developed an engineering toolbox that can 
be used to control activity and selectivity of enzymes to enable the development of biomimetic 
cascades. This should increase the throughput of multi-step systems and prevent the need for 
multiple recovery steps. Additionally, it should allow for effective substrate channeling to prevent 
loss of intermediates and increase catalysis. 
Using point mutations or insertions in substrate loop B (chapter 2) and domain insertion in 
substrate loop A (chapter 3) of AdhD, we have controlled cofactor specificity. The difference lies 
in the external control of this selectivity provided by introducing an intrinsically disordered protein 
(chapter 3). To expand the substrate selectivity of AdhD, we broadened its functionality through 
site-specific unnatural amino acid incorporation. This allowed for the development of hybrids with 
an organic catalyst (TEMPO) to enable selective alcohol oxidation and to impart enzymatic 
selectivity onto organic catalysts both in solution and in hydrogels (chapter 4). Approaches that 
retain the structure of AdhD but increase catalysis through microenvironment engineering was also 
studied through fusions with sfGFP (chapter 5). The end goal was to combine the various 
approaches and tools developed through our work with AdhD and use what we learned to engineer 
substrate channeling in a three-enzyme system (chapter 6). 
In chapter 2, we proved that a single mutation or insertion in substrate loop B of AdhD can 
control cofactor selectivity. Single point amino acid mutations or insertions on the back side of the 
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cofactor binding pocket resulted in a change in cofactor selectivity. This approach emphasizes that 
changes in substrate loops can affect cofactor selectivity and that substrate and cofactor selectivity 
are not exclusive. The reversal or broadening of cofactor selectivity affected the transition binding 
energies suggesting that point mutations can affect the stability of the ternary 
enzyme/cofactor/substrate complex. This approach should be modular, and a similar effect should 
be seen in other members of the aldo-keto (AKR) superfamily as they contain similar substrate 
loops. Therefore, potential future work can include testing the affect of these mutations in other 
aldo-keto reductases such as human aldose reductase, which has been engineered in the Banta Lab. 
In chapter 3, additional work was done with AdhD to control cofactor selectivity, but 
changes were made in substrate loop A. A repeat-in-toxin domain from Bordetella pertussis, which 
is intrinsically disordered in the absence of calcium and folds into the β-roll secondary structure in 
the presence of calcium, was inserted into AdhD in a process called domain insertion. Both parts 
retained their function, namely the folding of the RTX domain was calcium-dependent while 
AdhD retained its activity with alcohols. The chimeric protein, β-AdhD, was reminiscent of a 
dimmer where, as calcium is titrated into the system, the cofactor selectivity switches from NAD+ 
to NADP+. This approach can be used to impart dynamic regulation of cofactor specificity to 
develop novel biocatalysts and biopathways for both in vivo and in vitro systems. This type of real-
time external control can be used to develop multi-step cascades. 
Future work involving β-AdhD includes inserting different enzymes after β-AdhD in a 
multi-step cascade. If enzymes with different cofactor selectivity (NADH versus NADPH) are 
utilized, the direction of the pathway can be controlled externally depending on the absence or 
presence of calcium. In the absence of calcium, β-AdhD utilizes NAD+ and converts it to NADH 
whereas in the presence of calcium, NADP+ is converted to NAPDH. Depending on the cofactor 
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preference of the proceeding enzymes, one route in the cascade will proceed while the other will 
not. These types of  approaches are modular as AdhD is a member of the AKR superfamily which 
shares many characteristics including varying substrate loops, which was the insertion site used 
here.  
In chapter 4, site-specific unnatural amino acid incorporation was used to introduce a new 
functional group into AdhD and expand its capabilities. A biological catalyst, AdhD, was modified 
with an azide-containing unnatural amino acid. This was clicked with an organic catalyst, TEMPO, 
containing an alkyne group. The result was an AdhD-TEMPO bio-organo hybrid. The 
development of various hybrids between TEMPO and different AdhD mutants with different sites 
containing the unnatural amino acid served multiple functions. As AdhD oxidizes secondary 
alcohols with medium carbon chain lengths and TEMPO oxidizes primary alcohols of any chain 
length, a hybrid of these two catalysts should be able to selectivity oxidize alcohols. Furthermore, 
since AdhD is cofactor dependent and since TEMPO must be regenerated, the reaction that 
proceeds can be externally controlled. In two of the hybrids (M1 AdhD/TEMPO and Y205 
AdhD/TEMPO) selective oxidation of alcohols should result, with Y205 imparting steric 
hindrance as it is buried in the cofactor binding pocket. The third hybrid (Y64 AdhD/TEMPO) 
resulted in enzymatic selectivity being transferred to an organic catalyst. Future work that has 
already been started includes expanding the use of these hybrids by inserting them into hydrogels. 
This will allow for selective alcohol oxidation as well as hydrogel formation.  
Furthermore, site-specific incorporation into AdhD containing substrate loops from 
another AKR member, human aldose reductase (hAR) has been completed. This chimeric protein 
has previously been shown to impart hAR cofactor and substrate selectivity onto AdhD. 
Developing a hybrid of this chimera with TEMPO will serve the purposes previously mentioned, 
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but this time with a different cofactor and substrate than those preferred by AdhD. This work can 
be expanded through residue-specific incorporation of unnatural amino acids onto AdhD to 
increase the number of TEMPO molecules attached to AdhD. The number of TEMPO molecules 
and its positions may affect activity in unanticipated ways. 
In chapter 5, AdhD structure was retained while increasing its catalytic efficiency through 
microenvironment engineering. We developed a three-domain protein system consisting of AdhD, 
SpyTag/SpyCatcher, and supercharged superfolder GFP (sfGFP). It was determined that there is a 
complex interplay between salt, pH, and protein charge. Although the various effects and 
interactions are not completely understood, we have shown that using charged sfGFP can increase 
the catalytic efficiency of AdhD. It seems that negative sfGFP increases the apparent local ionic 
strength which accelerates rates in a certain pH range. Additionally, although salt and pH affected 
the kinetic parameters of AdhD-sfGFP fusions, the overall catalytic efficiency was a function of 
protein charge. This work can be expanded with other supercharged proteins to determine if this 
trend is consistent and if other changes, such as changes in local pH, play a role in catalysis. 
In chapter 6, sfGFP was used to engineer substrate channeling between hexokinase II 
(HK2) and glucose-6-phosphate-dehydrogenase (G6PD). The previous tools and approaches that 
were studied with AdhD in chapters 2-5 were used to engineer substrate channeling in a three-
enzyme system: HK2, G6PD, and sfGFP. HK2 converts D-glucose and ATP to D-glucose-6-
phosphate and ADP. G6PD converts glucose-6-phosphate and NADP+, in the presence of 
magnesium chloride, to 6-phospho-D-gluconate and NADPH. The intermediate, glucose-6-
phosphate is negatively charged allowing for electrostatic guidance along a positively charged 
patch (such as +36 sfGFP). Channeling should decrease diffusion of the intermediate into the bulk 
thereby increasing the efficiency of the cascades. Preliminary work has shown the ability to 
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develop the cascades through orthogonal tagged systems. Additionally, the ability of having HK2 
and G6PD work in tandem has been successful. Future work includes testing the difference in 
kinetics between HK2 and G6PD complexes with various supercharged sfGFP including -30, 0, 
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